<SEC-DOCUMENT>0001012477-23-000012.txt : 20230504
<SEC-HEADER>0001012477-23-000012.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504161458
ACCESSION NUMBER:		0001012477-23-000012
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVADEL PHARMACEUTICALS PLC
		CENTRAL INDEX KEY:			0001012477
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37977
		FILM NUMBER:		23888911

	BUSINESS ADDRESS:	
		STREET 1:		BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
		STREET 2:		BALLYCOOLIN
		CITY:			DUBLIN
		STATE:			L2
		ZIP:			15
		BUSINESS PHONE:		636-449-1830

	MAIL ADDRESS:	
		STREET 1:		16640 CHESTERFIELD GROVE ROAD
		STREET 2:		SUITE 200
		CITY:			CHESTERFIELD
		STATE:			MO
		ZIP:			63005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLAMEL TECHNOLOGIES SA
		DATE OF NAME CHANGE:	19960422
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>avdl-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:ff4affb4-5e35-499d-a060-a6a189fb41ed,g:0e980074-2bb1-4083-b23a-3722f5917d03,d:250897ddd94942958d86fa6dfe7818ac--><html xmlns:srt="http://fasb.org/srt/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:avdl="http://www.avadel.com/20230331" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>avdl-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV8zLTEtMS0xLTc5ODY5_90af719d-7c95-4eca-b688-069e93658986">0001012477</ix:nonNumeric><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV80LTEtMS0xLTc5ODY5_a61b71ba-2a70-4e0b-b476-1a0ef28af65e">12/31</ix:nonNumeric><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV81LTEtMS0xLTc5ODY5_6cd10ac9-8b96-400b-97ec-070aaec30ae6">2023</ix:nonNumeric><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV82LTEtMS0xLTc5ODY5_9c83fea0-77d0-443a-997d-9937a212c94f">Q1</ix:nonNumeric><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV83LTEtMS0xLTc5ODY5_4e0b60bb-f620-4e39-9b41-655ba02b3324">false</ix:nonNumeric><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:NoTradingSymbolFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV84LTEtMS0xLTc5ODY5_2e2eb1fb-154e-4247-9dd2-dc9497e9af32">&#9746;</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="avdl-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNMS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04f6a9d16de04b789dc6900996a220d4_I20230502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7323a019b2284fc9b9e443691e400926_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89062f4901fb4064b1b764e65dc9de58_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec6d203b20e439bb7974159ee3ab285_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdf3bdc941f34464a7bf9fa40be806db_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903766d6ab144cbabad37ccee612e697_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia55c8b3b05ca4e97a8b5e8eb0f54ab51_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6233a25a0f6643039089e9b1c97130c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2baa5a80eec849b5a0f4486fe12793a0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c24b9e23aa046298a51a9d754352ec0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a7ff8ffbee244ca80509872316b062e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e92efbb4524c27a795aa3163971409_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cffb9bdee21463cb69a3591e5b768cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie36421a8d31c40bf86ddc323c5462b99_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b7320cd55fe4ab18058db41d1e57eda_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78f1152e9a48466b8a215efaaae5e183_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27631202d5c046d8aaf1d23d3fbe0814_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b3ed1730d5b44a7bf45fddfd3a024e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66549b0c08954370865a41008c6d2694_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b9e677c14d452196aa5ad64d25e194_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc61d0dbbd146d5a43f9b069e875f34_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98483cdf58e04129a5ec6313f54c3cdc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e77b5caf7c40d2bbeb45dfdb667b30_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a509c386f934036a0284ec3e87da794_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i840bad64c34a40a3ad9185867cb3360a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0ad5233c5c44233ba54f59fd93af68c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53004be10dab4639ba1fae12c5448ea0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id929b7b0a00141a7808a5632cbfd6d5e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8b9adec52d54e12a5433ac63da3e86b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23425f025c4444db993802f31591093_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23c52e144f274ff58d06a0258a38c8ec_D20230501-20230501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5fa690543384264a81ade629ded5283_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i458c9dc9da4541feb9ebbfe26480f40d_D20230501-20230501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e5c2953230a4966ba6f9cfa4b87083d_D20230329-20230329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd1c37ae66634e459ee51595272f19f9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9937162cb764e1e9c3a6cde0e7174e9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3eb511cdd4014d98821a17670a113607_D20230404-20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-04</xbrli:startDate><xbrli:endDate>2023-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife27a702c1604bfaab93fe6b27c28f80_I20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26f74d8cc0d245b9946db9086ec31c5f_I20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fdfb2995db447c186216c675ed244de_I20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8c8d5df3b6943cbb2ac5bbcccf925a6_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9961149acfda4623881e412da9b843c4_D20230331-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-31</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaa294d327ad4af790c20a25c207e257_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62caf1e030104340aab6ddd08244c618_D20200205-20200205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:A2020ShelfRegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-05</xbrli:startDate><xbrli:endDate>2020-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf7fc9b9d98940b28248abcf3e548647_I20200214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:A2020ShelfRegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04744cf318cb4dcaa7cd020e5cec855f_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:A2022ShelfRegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e0581315acc4d4d86c90d917988c952_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:AtTheMarketOfferingProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i319121ad18c140788a5641e1758ab387_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie620788155bb4059a6e43c59c3299fdf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2657941fbea4497186c9ab34cdb5e0d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7643c428b463493c881600eddf2ee8f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if50b3d2f207a4e44a847e37ad9bb46e1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19812fad0ea54d67b5f37e1104be5f74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b9a4e9f1f88462cab7139b14d632c0a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1a64b1bae7e4770bf4e011bfe5a528d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6e58f2a47674b17839bf947e34800b8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8995e89e6594401fb4c210df4fd2a8de_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83723dc6749c4f99a73b5cf748193371_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21753e8a8465424f9ed070cf17ff922a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64906691143a44d69f831d716ff11840_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied3528fbe48041a2a95e43b3cafa950d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic89b1f1ffe254a5fb320780bad1a88fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3e3492dee14060b385540d4e0d7c18_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id408a9d6c330487193d4d6ecb5fd3650_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id57ed34c966748e1b0953df5e00479df_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b6a8070618442e9e19c0442c464ee3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc7030dee104960a48e1ef403016742_I20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id58b0ae1b79f447e8ae6e65bded423ca_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf529448191847138180cb35876adf3b_I20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c67c57f5e464d2eb219e11bb8fa61ac_I20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe2ecd298ed14718958abd43e1bed64f_I20230201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic84949ac67fc4d3487c6ff9086f64946_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb2258e7de744756bfdc93eb9badd9e4_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">avdl:ThirdPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if20286047c044da782884c54495ecb0e_D20220405-20220405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-05</xbrli:startDate><xbrli:endDate>2022-04-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1082dbc3efe8463fa3c8d5d339c6f683_D20180216-20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-16</xbrli:startDate><xbrli:endDate>2018-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i4bff811514e04cf0a407a2178a42e153_I20180216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-02-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>avdl:day</xbrli:measure></xbrli:unit><xbrli:context id="i2c693d85f33f4ea6b145f6db4f849879_I20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6165ba48ac2542de9fc80cf68aaf7a7c_D20230404-20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-04</xbrli:startDate><xbrli:endDate>2023-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e1dda052ae749c4b067a6c95a6a1377_D20230404-20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-04</xbrli:startDate><xbrli:endDate>2023-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3721e3e0c345868370c7da3c4161dc_I20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-04</xbrli:startDate><xbrli:endDate>2023-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5886c0d106614c858fffef30aab67fd4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f2e203d2b94d95b66e864ec15b4449_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfab2c03c2f64e0390fe6350accb23da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib999fc432bf54ee889b0167c94099114_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74c73f0392b24707bcf0aa081fb42453_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41dce19a3844455fae5e06d004fb2dae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfed34d223564ae39def036cff17412b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie970e5169b154723b235fcca299a98c3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3b73e469fad46e381038498c748c0c5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb3550bc32e4b638a3f1849f6d8fac3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884a39afb0a843b09e81a9e1e807a434_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4600b4ecedc44e2181775b186fbc6c78_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib86ab8d9c4634403b053a99efce9ad0f_D20180201-20180228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:FSCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieee9f18c297a4b43b9cc2748153d6ed6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:CerecorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd63efb1c00f48f3823eae02ac5437c1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4b8d582396945bdab449e41a5853249_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38b943b369fe40318b5dc1a1abcb5786_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide7281a9b4cc4e4a95874ed482a2c8f6_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if79cc4b4f8a24f1db47139a8b309feab_D20230403-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-03</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i472c73ab7bb046679dab57540005d848_D20230329-20230403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012477</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-29</xbrli:startDate><xbrli:endDate>2023-04-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i250897ddd94942958d86fa6dfe7818ac_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjU3_b1af9a85-c68a-4d2c-8759-e36c3d3a7159">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYz_7ed4748d-f878-441c-9000-16088f990ce3">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended: <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yMzM_e3ed94b0-56de-4405-bbed-b08b22364a92">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY4_46d4adf5-2c26-4f99-8a70-fd86965c3bab">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.690%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commission File Number</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6ODBiZDZhMTE5OTQ0NDA3MDk2NzJkYmM4MTVjZjUzNjYvdGFibGVyYW5nZTo4MGJkNmExMTk5NDQ0MDcwOTY3MmRiYzgxNWNmNTM2Nl8wLTAtMS0xLTg1NzA0L3RleHRyZWdpb246YjUxNmI4Mzc5ZTIwNGE5NzhlODJmOWI4ZTQ1ZWZhODhfMjc0ODc3OTA2OTU0Ng_f813c9fd-1048-4cf2-8118-deea62590bc6">001-37977</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY0_b8fd1b4a-7969-4469-b14a-c1f95e8e9e93">AVADEL PHARMACEUTICALS PLC</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NDFlMTAxMzMxZmQ4NGI4ZjlmMDhkNmQ2MzM3MGYyOWQvdGFibGVyYW5nZTo0MWUxMDEzMzFmZDg0YjhmOWYwOGQ2ZDYzMzcwZjI5ZF8wLTAtMS0xLTc5ODY5_f5bdb44f-cdf8-457e-842a-c4b5eeda70a2">Ireland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NDFlMTAxMzMxZmQ4NGI4ZjlmMDhkNmQ2MzM3MGYyOWQvdGFibGVyYW5nZTo0MWUxMDEzMzFmZDg0YjhmOWYwOGQ2ZDYzMzcwZjI5ZF8wLTItMS0xLTc5ODY5_e7c43bed-9513-4898-b3f8-4abe5e293cc1">98-1341933</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjU5_a7c22711-ddad-48cd-bbff-33652d1feb76">10 Earlsfort Terrace</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY5_ce9bc2af-c00c-49c2-b722-6c3db576e6fa">Dublin 2</ix:nonNumeric> <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYw_dc91da06-8e72-42f3-a174-ba58d09d6542">D02 T380</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYx_139376e9-b185-42d2-8258-9e58b470336e">Ireland</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Office and Zip Code)</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+<ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYy_5107cc9f-6caf-455b-9adc-cdb349703ff7">353</ix:nonNumeric>-<ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY1_41d64aad-8ba0-4182-a375-84403fb04dd5">1</ix:nonNumeric>-<ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjcw_f79a3a35-49fd-4350-a916-3c87a6feb022">901-5201</ix:nonNumeric> </span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8xLTAtMS0xLTc5ODY5_d0a5493c-5baa-4fd0-956d-28f7fb3e6104">American Depositary Shares*</ix:nonNumeric>&#160;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8xLTEtMS0xLTc5ODY5_6482e52e-4216-48d3-98fd-354f472a72c1">AVDL</ix:nonNumeric>&#160;</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8xLTItMS0xLTc5ODY5_beedc726-8f2d-44fa-8fdc-2122919c3dda">The Nasdaq Global Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8yLTAtMS0xLTc5ODY5_52d68036-2d77-408b-9a87-bc30aca61328">Ordinary Shares, nominal value $0.01 per share**</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:2pt;margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*American Depositary Shares may be evidenced by American Depositary Receipts. Each American Depositary Share represents one (1) Ordinary Share.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Not for trading, but only in connection with the listing of American Depositary Shares on The Nasdaq Global Market.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjU4_85728188-c3b1-46d2-ad24-c785683d01b3">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;<ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY2_a9a1db23-2c03-4649-b86d-0193c689c67a">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.019%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#168;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer  </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NTYwOGE4NmQxZDlhNDFjYTkyNjhlYTM0YTc1Y2I4MTYvdGFibGVyYW5nZTo1NjA4YTg2ZDFkOWE0MWNhOTI2OGVhMzRhNzVjYjgxNl8xLTAtMS0xLTg1NDc2_712813ae-24a4-4927-a51e-e22ac2c39039">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NTYwOGE4NmQxZDlhNDFjYTkyNjhlYTM0YTc1Y2I4MTYvdGFibGVyYW5nZTo1NjA4YTg2ZDFkOWE0MWNhOTI2OGVhMzRhNzVjYjgxNl8xLTMtMS0xLTc5ODY5_e8fd4176-3c5e-424e-b28e-6adae96effbb">&#254;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NTYwOGE4NmQxZDlhNDFjYTkyNjhlYTM0YTc1Y2I4MTYvdGFibGVyYW5nZTo1NjA4YTg2ZDFkOWE0MWNhOTI2OGVhMzRhNzVjYjgxNl8yLTMtMS0xLTc5ODY5_ece86009-d031-4785-9158-5ad17872aead">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjcx_0af8efb5-8593-4e65-bfc4-98360225be56">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#254;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t May&#160;2, 2023, <ix:nonFraction unitRef="shares" contextRef="i04f6a9d16de04b789dc6900996a220d4_I20230502" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8zODQ4MjkwNjk5OTU3_6c7925c7-fff7-4e55-8c94-c41e793d7c68">76,768,391</ix:nonFraction> ord</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inary shares, nominal value $0.01 each, of the Company were outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.782%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page #</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_10">Cautionary Note Regarding Forward Looking Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_10">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_13">PART I - FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_16">Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_16">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_85">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_85">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_106">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_106">29</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_109">Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_109">30</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_112">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_115">Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_115">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_118">Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_118">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_121">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_121">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_124">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_124">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_127">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_127">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_130">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_130">31</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_133">Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i250897ddd94942958d86fa6dfe7818ac_133">32</a></span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">NOTE REGARDING TRADEMARKS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own various trademark registrations and applications, and unregistered trademarks, including AVADEL</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LUMRYZ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, MICROPUMP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, LIQUITIME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and MEDUSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All other trade names, trademarks and service marks of other companies appearing in this Quarterly Report are the property of their respective holders. Solely for convenience, the trademarks and trade names in this Quarterly Report may be referred to without the &#174; and &#8482; symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or display other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may use our website, LinkedIn or our Twitter account (@AvadelPharma) to distribute material information. Our financial and other material information is routinely posted to and accessible on the Investors section of our website, available at www.avadel.com. Investors are encouraged to review the Investors section of our website because we may post material information on that site that is not otherwise disseminated by us. Information that is contained in and can be accessed through our website, our LinkedIn posts or our Twitter posts are not incorporated into, and does not form a part of, this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 2 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Disclosure Regarding Forward-Looking Statements</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section&#160;21E of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;). Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but are not always, made through the use of words or phrases such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; and similar expressions, or the negative of these terms, or similar expressions. Accordingly, these statements involve estimates, assumptions, risks and uncertainties which could cause actual results to differ materially from those expressed in them. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements that are based on our management&#8217;s belief and assumptions and on information currently available to our management. These statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The ability of LUMRYZ to be successfully commercialized and gain market acceptance;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our ability to successfully launch and commercialize LUMRYZ (sodium oxybate) in the United States (&#8220;U.S.&#8221;) for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Our plans with respect to our commercial infrastructure and marketing, market access and commercial activities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to maintain and receive additional regulatory approvals for LUMRYZ in any other jurisdictions outside the U.S., and any related restrictions, limitations, and/or warnings in the label of LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the rate and degree of market acceptance for LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to enter into strategic partnerships for the commercialization, manufacturing and distribution of LUMRYZ in the U.S.;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our reliance on a single lead product, LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dependence on a limited number of suppliers for the manufacturing of LUMRYZ and certain raw materials used in LUMRYZ and any failure of such suppliers to deliver sufficient quantities of these raw materials, which could have a material adverse effect on our business, including commercialization of LUMRYZ in the U.S.;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to finance our operations on acceptable terms, either through the raising of capital, the incurrence of convertible or other indebtedness, issuance of equity, royalty-based financings, or through strategic financing or commercialization partnerships;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the pricing and reimbursement of, and the extent to which patient assistance programs are utilized for, LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations about the potential market size and market participation for LUMRYZ;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding litigation related to LUMRYZ; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the timing and results of our cost structure optimization efforts, including the estimated charges and costs expected to be incurred and projected cost savings in connection with such cost structure optimization efforts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding our cash runway lasting through the anticipated commercial launch of LUMRYZ in the U.S.;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to continue to service our Exchangeable Senior Notes due April 2027 (the &#8220;April 2027 Notes&#8221;) and our Exchangeable Senior Notes due October 2023 (the &#8220;October 2023 Notes&#8221;, together with the April 2027 Notes, the &#8220;Notes&#8221;), including making the ongoing interest payments on the Notes, settling exchanges of the Notes in cash or completing any required repurchases of the Notes;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impacts of COVID-19, inflation and rising interest rates on our business and future operating results;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to hire and retain key members of our leadership team and other personnel; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition existing today or that may arise in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are neither promises nor guarantees of future performance due to a variety of risks and uncertainties and other factors more fully discussed in the &#8220;Risk Factors&#8221; section in Part I, Item 1A of the Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 29, 2023 and the risk factors and cautionary statements described in our subsequent filings with the SEC. Given these uncertainties, readers should not place undue reliance on our forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to revise any forward-looking statements to reflect events or developments occurring after the date of this Quarterly Report, even if new information becomes available in the future.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 3 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION&#160;</span></div><div id="i250897ddd94942958d86fa6dfe7818ac_16"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. &#160;&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS&#160;</span></div><div id="i250897ddd94942958d86fa6dfe7818ac_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNi02LTEtMS03OTg2OQ_1451160e-e492-49d4-95ef-1e22d09469f1">3,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNi04LTEtMS03OTg2OQ_046c73a9-fa93-411c-88f8-deeac93951b3">6,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNy02LTEtMS03OTg2OQ_22135089-ff43-4ab3-bbde-18748b0f4c8b">24,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNy04LTEtMS03OTg2OQ_e9999be5-3e46-4209-9632-4e3c1f197619">21,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfOS02LTEtMS03OTg2OQ_ee779532-8dee-4295-9b29-504a289db5f8">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfOS04LTEtMS03OTg2OQ_2b944bb4-2614-48fe-9851-c4edc2823377">28,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTAtNi0xLTEtNzk4Njk_33b55b9a-a4b4-415f-8aec-c89b8f506e13">28,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTAtOC0xLTEtNzk4Njk_5c3055f6-669c-4d14-8e09-46e3d9a2eeaf">28,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTEtNi0xLTEtNzk4Njk_6b05aa1f-4824-4ca3-aad4-4e12145addef">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTEtOC0xLTEtNzk4Njk_fa2df3b2-9c07-4330-acfe-21f8f35c70f8">104</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTItNi0xLTEtNzk4Njk_969014ed-ac21-47b4-983b-73beeae9664f">3,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTItOC0xLTEtNzk4Njk_adf0dddf-b213-4376-b987-83843b0fad9f">2,017</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTQtNi0xLTEtNzk4Njk_c77f90e4-b729-4a52-bfa6-ee4427506621">31,364</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTQtOC0xLTEtNzk4Njk_94c2a972-573c-41f0-9f67-38979658347f">30,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTUtNi0xLTEtNzk4Njk_cc99fe6a-cc69-4d7d-a5c6-3e084075f58f">580</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTUtOC0xLTEtNzk4Njk_5beb4ba3-b07f-4c38-8681-1941fd4140f5">4,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTYtNi0xLTEtNzk4Njk_d6e105b4-d946-49ae-845b-e27c8f8c41d0">30,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTYtOC0xLTEtNzk4Njk_f0f748ea-6536-4f65-9474-e830789594f7">26,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTgtNi0xLTEtNzk4Njk_372781b3-3140-429d-8e60-4b20bec36c37">0.48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTgtOC0xLTEtNzk4Njk_ae96e544-b46f-4c50-ab23-5a9b5fa3d386">0.45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTktNi0xLTEtNzk4Njk_b3357ae1-6540-4f22-bde7-833b059e5c4a">0.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTktOC0xLTEtNzk4Njk_67e9f468-1ba3-4231-901e-049eea53edc3">0.45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjEtNi0xLTEtNzk4Njk_bdcb4196-88fc-4e75-a712-5c9990c50032">63,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjEtOC0xLTEtNzk4Njk_7aee6cc7-252f-404e-82f7-e0902bd40642">58,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding - diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjItNi0xLTEtNzk4Njk_a0b54c10-0035-4c71-bb56-525d1f037547">63,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjItOC0xLTEtNzk4Njk_3c26e5f7-0fcb-4241-9e99-b318f6942d23">58,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 4 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.952%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfMy02LTEtMS03OTg2OQ_d6e105b4-d946-49ae-845b-e27c8f8c41d0">30,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfMy04LTEtMS03OTg2OQ_f0f748ea-6536-4f65-9474-e830789594f7">26,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNS02LTEtMS03OTg2OQ_bed7007a-f966-4cc0-808e-028d691a38ef">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNS04LTEtMS03OTg2OQ_24c9bffa-3f06-40a2-aa26-e461a96b99ea">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss), net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmY5NzhjNTM2MGVkYTRlZDk4NDQ0ZGNhYTUyNmRmOGI3Xzcz_fed9c667-3f02-4402-886f-0af874491a7f">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmY5NzhjNTM2MGVkYTRlZDk4NDQ0ZGNhYTUyNmRmOGI3Xzgw_9841e0ea-dd43-4132-90ef-b2ee3e08231c">330</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi02LTEtMS03OTg2OQ_d73d788c-afb6-4682-bc09-0302567b55c8">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi04LTEtMS03OTg2OQ_d240de32-4928-4983-a828-942ec2d6f153">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNy02LTEtMS03OTg2OQ_461c0947-af95-4d4f-a7ed-dd8d06cddc3f">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNy04LTEtMS03OTg2OQ_9373e779-120f-4054-9b51-aeccca0b14bf">1,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfOC02LTEtMS03OTg2OQ_7efd1fe0-00fa-4909-b019-9ca01caa76ae">30,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfOC04LTEtMS03OTg2OQ_be546daf-0893-41ca-8d7a-1eb80768b93e">27,526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 5 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:63.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNC0yLTEtMS03OTg2OQ_7f8f8625-de1c-40cb-97ef-ac34926e8ca9">83,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNC00LTEtMS03OTg2OQ_90d30df4-47f0-4f9d-81b5-86a86a117471">73,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNS0yLTEtMS03OTg2OQ_89c77ef6-0d21-41f5-b167-df05d1dd264a">17,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNS00LTEtMS03OTg2OQ_e101235d-bfbf-4690-ab8f-f919e6ac4a9b">22,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOC0yLTEtMS03OTg2OQ_5c416e62-58e7-4600-a345-2a4183aae382">2,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOC00LTEtMS03OTg2OQ_6b3179c7-36ac-4b17-9ba2-d7fd966177cd">2,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOS0yLTEtMS03OTg2OQ_0f4e4c01-614f-47e9-a4c7-d1d10a904ff4">6,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOS00LTEtMS03OTg2OQ_a5578c6e-2778-4f54-9ad4-a1993c1118d5">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTAtMi0xLTEtNzk4Njk_f397f4b6-cd8f-4107-af51-58fadbfc32a6">109,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTAtNC0xLTEtNzk4Njk_ae5ebddf-3ed6-4a3d-b23d-fe0b1828b516">100,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTEtMi0xLTEtNzk4Njk_27d15cb5-fa62-4e1d-87ef-c0889fa7aee6">782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTEtNC0xLTEtNzk4Njk_f7b34e0d-3b46-4e25-b6a5-684d4609421e">839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTItMi0xLTEtNzk4Njk_7b112689-6ec0-4774-9644-2ecbb12c52f2">1,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTItNC0xLTEtNzk4Njk_76f76cc8-eee9-4bc6-8bde-feef9e5e9893">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTMtMi0xLTEtNzk4Njk_37a49a98-f1e3-43b9-b70e-108cf2de0c87">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTMtNC0xLTEtNzk4Njk_5e888be8-f630-4cda-ad09-5fb0642b4579">16,836</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTUtMi0xLTEtNzk4Njk_cd6c6234-d366-45b0-a9cc-95ad452c392c">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTUtNC0xLTEtNzk4Njk_781a0ab9-b119-4cbf-bda6-18e53bcfb5b8">1,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTYtMi0xLTEtNzk4Njk_fd0aa0f9-646e-42b2-9c16-c57f14c9fdf5">10,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTYtNC0xLTEtNzk4Njk_f6ab6d23-4fe5-49b4-8967-4abc12977658">11,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTctMi0xLTEtNzk4Njk_eaa053fe-c25d-480c-a0a7-eff80caa9340">140,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTctNC0xLTEtNzk4Njk_7d88a140-e42e-4d21-b8f0-62c2caccaaee">132,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS&#8217; (DEFICIT) EQUITY </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjEtMi0xLTEtNzk4Njk_243acd71-f220-421d-9eb5-c1f8bf109d7a">20,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjEtNC0xLTEtNzk4Njk_dc9e7fe5-56a2-4188-8a41-b7a01e47150f">37,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjItMi0xLTEtNzk4Njk_0b555068-613c-4fe6-b173-d06f09ea1e41">871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjItNC0xLTEtNzk4Njk_32da00c9-f5b3-4765-a861-c2de23b07469">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjMtMi0xLTEtNzk4Njk_d03f2379-27ca-42b0-994d-af6db14f8714">10,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjMtNC0xLTEtNzk4Njk_5d350c2c-c1e0-40b8-882e-c71cc2dbc4fd">7,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjQtMi0xLTEtNzk4Njk_9ec3117c-0d34-4dd8-b47c-9fb3acb1abf7">7,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjQtNC0xLTEtNzk4Njk_72b19c09-2928-4ff2-946e-87a41c0910e2">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds received in advance of Series B Preferred Shares issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:ProceedsReceivedInAdvanceOfShareIssuanceCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtMi0xLTEtODgwNDk_56c3caad-fbfd-4012-9652-e3922acae7cb">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:ProceedsReceivedInAdvanceOfShareIssuanceCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtNC0xLTEtODgwNDk_6c0ff198-61a5-4165-90f5-904a868114a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtMi0xLTEtNzk4Njk_f5efc04e-70c2-4199-bbdf-ee720807c927">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtNC0xLTEtNzk4Njk_af4bb454-8833-402d-bb9e-ce7fcf85a83d">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjctMi0xLTEtNzk4Njk_52de76e2-8d92-465d-ac43-64493b722b62">79,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjctNC0xLTEtNzk4Njk_a88c3d38-a4eb-4645-ba6d-632aa37c7007">55,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjgtMi0xLTEtNzk4Njk_08264db7-2a46-4308-aa21-0708a6f25fd3">93,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjgtNC0xLTEtNzk4Njk_66f1a45a-becc-4746-8744-44aa3bfc3d8c">91,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzAtMi0xLTEtNzk4Njk_5ce2692f-7a5a-45f6-ab1a-2a6c1d265736">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzAtNC0xLTEtNzk4Njk_72e4d703-e5c0-4fed-9ac5-0da03a7983d0">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzEtMi0xLTEtNzk4Njk_89806222-874e-4478-b8b1-a5d218ea0dd7">5,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzEtNC0xLTEtNzk4Njk_3ac7b645-5530-416b-9b85-e3960a387415">5,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzItMi0xLTEtNzk4Njk_6a919ab9-bc55-4ec2-aa3a-18e94c0778c8">178,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzItNC0xLTEtNzk4Njk_84529a00-9498-4611-8feb-5fa43dbd1df7">153,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; (deficit) equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18zOQ_7120fc8b-4829-40c9-9100-75699b61b15f"><ix:nonFraction unitRef="usdPerShare" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="2" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18zOQ_be46c5f3-455b-4923-abde-b73cca241b4d">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM181Mw_71d940f6-302f-4ceb-b7e1-f32502c78810"><ix:nonFraction unitRef="shares" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM181Mw_98629c53-0dd8-4f53-b2a7-2123c6f584ad">50,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM183NQ_43cff656-70c0-49e4-8b18-f2ce212641b4"><ix:nonFraction unitRef="shares" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM183NQ_9807aa7b-e037-4b87-bf6a-ab42a43759d7">488</ix:nonFraction></ix:nonFraction> issued and outstanding at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18xMTE_4a1db895-256f-427f-8d0a-530fde0e0832"><ix:nonFraction unitRef="shares" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18xMTE_8a3ade48-acf3-414e-bf50-e70f1bd24e29">488</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMi0xLTEtNzk4Njk_f933e961-ecbf-475e-b567-9a12fb2edc6a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtNC0xLTEtNzk4Njk_390f62cf-962f-47c6-b212-0d9b0132fab4">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary shares, nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8zOA_6a10b503-42fb-4439-b972-9e4dde0f2483"><ix:nonFraction unitRef="usdPerShare" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8zOA_a90a67cf-62fd-4c51-ad28-03ca9e88579c">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF81Mg_48daf4c1-7cb4-4f1a-b775-9bc269bdf5b6"><ix:nonFraction unitRef="shares" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF81Mg_b2434a9f-dce0-4df2-adc3-8ef728759d5f">500,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF83NA_5f305913-f326-470b-9c30-9a9e4a9be51e"><ix:nonFraction unitRef="shares" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF83NA_8a715d15-7356-485c-b7fd-32d560055b7f">64,478</ix:nonFraction></ix:nonFraction> issued and outstanding at March&#160;31, 2023 and <ix:nonFraction unitRef="shares" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8xMTA_14cff396-08f4-43e2-8d57-c208956f7208"><ix:nonFraction unitRef="shares" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8xMTA_d59a30fe-827b-4a4e-9e3e-2fa89b1edfb6">62,878</ix:nonFraction></ix:nonFraction> issued and outstanding at December&#160;31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMi0xLTEtNzk4Njk_2cc26d7b-b635-4f7f-ae58-f4bdaf536c09">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtNC0xLTEtNzk4Njk_5d82c8c8-7d40-4037-aae4-18dfc893b54f">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzctMi0xLTEtNzk4Njk_884dc3c6-650e-4daf-8101-f72bc3cac3e0">603,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzctNC0xLTEtNzk4Njk_66158ccd-f075-4e98-a733-f0b8fc4b485e">589,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzgtMi0xLTEtNzk4Njk_2f631486-84f9-4aeb-b16a-629e9879cf97">616,004</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzgtNC0xLTEtNzk4Njk_c042bdd4-863b-49e4-8323-2111ae6dd3eb">585,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzktMi0xLTEtNzk4Njk_4de91cbc-887d-4015-9150-dd896d8adf16">26,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzktNC0xLTEtNzk4Njk_5dcedeae-bd18-4258-b9aa-2834e96f2716">26,341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; (deficit) equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDAtMi0xLTEtNzk4Njk_ce70bda4-387f-47ba-9bd1-bc27f9f6df7b">38,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDAtNC0xLTEtNzk4Njk_c04cc523-4e0f-4c66-8290-5e3298f64e38">21,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; (deficit) equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDEtMi0xLTEtNzk4Njk_ef46ed05-1067-4bc5-88b6-538c1bbfb8e1">140,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDEtNC0xLTEtNzk4Njk_40a22205-145d-48e3-9dd3-89f1296e4e87">132,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 6 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March&#160;31, 2023 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;(deficit) equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaec6d203b20e439bb7974159ee3ab285_I20221231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0yLTEtMS03OTg2OQ_a1103371-290b-486c-ba94-3119ea69830b">62,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec6d203b20e439bb7974159ee3ab285_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi00LTEtMS03OTg2OQ_97b6d093-219b-4a66-8514-3e997a01ef4d">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdf3bdc941f34464a7bf9fa40be806db_I20221231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi02LTEtMS03OTg2OQ_022dd6d9-8d73-4225-b48c-8277ea1d0624">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf3bdc941f34464a7bf9fa40be806db_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi04LTEtMS03OTg2OQ_31766244-c054-4b0b-b6b2-c8eb665689ed">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903766d6ab144cbabad37ccee612e697_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xMC0xLTEtNzk4Njk_83c2cf34-0560-4ba4-afd4-650e301b5c73">589,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia55c8b3b05ca4e97a8b5e8eb0f54ab51_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xMi0xLTEtNzk4Njk_0c4ba4ed-05d9-4201-af3d-4cb71bbc8406">585,220</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6233a25a0f6643039089e9b1c97130c3_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xNC0xLTEtNzk4Njk_2863e9f2-ee63-4722-90d6-df5c1b12c106">26,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xNi0xLTEtNzk4Njk_f68dbe96-d5fb-486b-ab35-f18a4e4bb96b">21,145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2baa5a80eec849b5a0f4486fe12793a0_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMy0xMi0xLTEtNzk4Njk_d0069496-cff0-4dff-ae0f-43909b88cd8c">30,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMy0xNi0xLTEtNzk4Njk_732d9dbc-b1a5-4f59-abfe-dad8a777b97a">30,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c24b9e23aa046298a51a9d754352ec0_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNC0xNC0xLTEtNzk4Njk_46d55516-035e-4073-bd11-a7784550076a">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNC0xNi0xLTEtNzk4Njk_b4fbd47f-e282-4f4c-85b4-709a1a449e24">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under at-the-market offering program, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS0yLTEtMS04ODA1NQ_8170f2bf-b714-46c3-a837-33a5d73f695c">1,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS00LTEtMS04ODA1NQ_4faff733-64e8-4431-b424-c58dca785992">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS0xMC0xLTEtODgwNTU_66ab6c45-b7d0-4032-90df-5d102d47cbe6">11,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS0xNi0xLTEtODgwNTU_f5446329-7067-4bba-9e91-29349989eeb2">11,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0xMC0xLTEtODgwNTk_e8be07ff-536f-491c-ac7b-7b3ed03e7fd2">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0xNi0xLTEtODgwNTk_caf6eb94-ef3e-456f-b163-56b163f20ed7">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0yLTEtMS03OTg2OQ_77bab506-6429-416f-be78-80df198c3e27">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0xNi0xLTEtNzk4Njk_edffa176-f94b-4a71-97b0-ff28cdbba555">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNy0yLTEtMS03OTg2OQ_8e4e6d00-50e8-4f2e-bede-221e4eec3c02">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNy0xMC0xLTEtNzk4Njk_5e80dadb-869e-4929-ad22-56fd9b1daf43">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNy0xNi0xLTEtNzk4Njk_ff5a9dbc-7445-4f55-a9f6-89e82ebea9ac">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOC0xMC0xLTEtNzk4Njk_5600c497-9092-403c-aea6-b438f9ee2b82">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOC0xNi0xLTEtNzk4Njk_6a376af4-bfc9-4728-b33a-e1c4d6091ea4">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, March 31, 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a7ff8ffbee244ca80509872316b062e_I20230331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0yLTEtMS03OTg2OQ_314e6792-5fc2-40a3-9a88-de28304a5111">64,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a7ff8ffbee244ca80509872316b062e_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS00LTEtMS03OTg2OQ_c5559bb8-285d-4c01-960d-57aaf54ba280">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i63e92efbb4524c27a795aa3163971409_I20230331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS02LTEtMS03OTg2OQ_8c13d933-8b33-4978-bb2c-2231eac9fef9">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e92efbb4524c27a795aa3163971409_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS04LTEtMS03OTg2OQ_d6deaf0a-896c-4054-9062-ab30fe9ca81d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cffb9bdee21463cb69a3591e5b768cf_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xMC0xLTEtNzk4Njk_63a22b26-5f91-4482-8ceb-f1d6e605cda6">603,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie36421a8d31c40bf86ddc323c5462b99_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xMi0xLTEtNzk4Njk_5a403277-313c-4c52-9bb4-bfe375fefe76">616,004</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b7320cd55fe4ab18058db41d1e57eda_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xNC0xLTEtNzk4Njk_65f25e2b-5255-4e16-a7ac-4eb891d85909">26,026</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xNi0xLTEtNzk4Njk_8f324cd1-4869-4b7c-9ef3-c93b7124db40">38,166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 7 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March&#160;31, 2022 </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.327%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ordinary shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preferred shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>shareholders&#8217; </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(deficit) equity </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, December 31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i78f1152e9a48466b8a215efaaae5e183_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0yLTEtMS03OTg2OQ_16bd7eda-23d1-4889-9f6a-28ffe9e8ee8f">58,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78f1152e9a48466b8a215efaaae5e183_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi00LTEtMS03OTg2OQ_e2040619-8c23-44e0-b4d7-31b094e41dee">586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27631202d5c046d8aaf1d23d3fbe0814_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi02LTEtMS03OTg2OQ_199b3297-bd30-481a-b793-cf6244474c3e">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27631202d5c046d8aaf1d23d3fbe0814_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi04LTEtMS03OTg2OQ_ccf87c0e-bd61-40dd-9c77-638304af4b48">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b3ed1730d5b44a7bf45fddfd3a024e3_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xMC0xLTEtNzk4Njk_f9cc8679-24b1-46ac-ab15-994c4d946307">549,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66549b0c08954370865a41008c6d2694_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xMi0xLTEtNzk4Njk_7a24db0a-5e28-4830-964a-03a7bd643806">447,756</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b9e677c14d452196aa5ad64d25e194_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xNC0xLTEtNzk4Njk_ba75cb70-8902-46af-88b9-aa074712b74a">23,940</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc61d0dbbd146d5a43f9b069e875f34_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xNi0xLTEtNzk4Njk_82049507-4c2f-4a12-93dc-427622c2f965">78,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98483cdf58e04129a5ec6313f54c3cdc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNC0xMi0xLTEtNzk4Njk_9f97cff4-a54c-4305-9e98-5741f7705955">26,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNC0xNi0xLTEtNzk4Njk_3104f7d2-6c02-4af4-b926-0ecf13e8a965">26,424</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i18e77b5caf7c40d2bbeb45dfdb667b30_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNS0xNC0xLTEtNzk4Njk_3ae34c77-869e-4ffa-bb74-25cdec67ac01">1,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNS0xNi0xLTEtNzk4Njk_7629cd32-a9fb-4df0-a3ea-f6a9a0749e59">1,102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi0yLTEtMS03OTg2OQ_804dff06-1db4-43a5-b1e6-88151337e513">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi00LTEtMS04ODA1Mw_82382f3e-dc23-4d04-bbd8-8cb22ba2e454">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi0xMC0xLTEtNzk4Njk_28825ea6-6038-41c5-b81b-cf1ae9df94ca">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi0xNi0xLTEtNzk4Njk_b716b7a0-577a-4d19-853d-58744cd831cf">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vesting of restricted shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy0yLTEtMS03OTg2OQ_aeca7abc-27fa-4058-9f40-d38cf6b935c6">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy00LTEtMS03OTg2OQ_0ba165a3-c978-4ac9-b27f-c2c3e054b2bd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy0xMC0xLTEtNzk4Njk_432e2594-289a-40ca-b950-f61ec1c55b67">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueOther" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy0xNi0xLTEtNzk4Njk_036524a8-b460-4693-a3f6-da3bb5ae37f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee share purchase plan share issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOC0yLTEtMS03OTg2OQ_49d08e86-1e96-44aa-811f-1a35f5d5dc91">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOC0xMC0xLTEtNzk4Njk_7309ae2d-70f5-464d-833a-97c10528f9e7">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOC0xNi0xLTEtNzk4Njk_933f4c4c-8a66-4d40-8f15-1b6cefeabbcd">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOS0xMC0xLTEtNzk4Njk_620ea592-52d3-4065-bbcb-0f59646de456">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOS0xNi0xLTEtNzk4Njk_03a4f0f6-79f4-49c0-a550-ececc2d0a545">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance, March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i840bad64c34a40a3ad9185867cb3360a_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMi0xLTEtNzk4Njk_8229d450-05f4-46fe-b25e-e9303d63df60">59,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840bad64c34a40a3ad9185867cb3360a_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtNC0xLTEtNzk4Njk_b55a2e2a-e321-4d6b-8b6a-3ec2042b6145">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0ad5233c5c44233ba54f59fd93af68c_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtNi0xLTEtNzk4Njk_323b2460-1d46-4a6b-a332-44c7a993edf2">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0ad5233c5c44233ba54f59fd93af68c_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtOC0xLTEtNzk4Njk_1f96bfc7-a851-468b-b673-fb587dfccf63">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53004be10dab4639ba1fae12c5448ea0_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTAtMS0xLTc5ODY5_2a2310fa-bd27-43c3-a7fc-c042fc0f2098">553,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id929b7b0a00141a7808a5632cbfd6d5e_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTItMS0xLTc5ODY5_7e8d5b34-a1f0-47e4-9270-4b3bc3f713c8">474,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8b9adec52d54e12a5433ac63da3e86b_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTQtMS0xLTc5ODY5_0b6f372f-31d0-4cf3-8f26-32b3299459bf">25,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23425f025c4444db993802f31591093_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTYtMS0xLTc5ODY5_7966dd8d-3eee-4a6b-8c6a-525247785bb1">55,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 8 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:68.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.564%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNC0yLTEtMS03OTg2OQ_d6e105b4-d946-49ae-845b-e27c8f8c41d0">30,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNC00LTEtMS03OTg2OQ_f0f748ea-6536-4f65-9474-e830789594f7">26,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNi0yLTEtMS03OTg2OQ_d8dd9f4d-42ed-4ae3-9240-ced23d65e6ff">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNi00LTEtMS03OTg2OQ_1bcfb2b4-40f5-4a20-973d-3ae7e430abd0">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discount and debt issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNy0yLTEtMS03OTg2OQ_20e0962c-f78f-4a12-969c-47439c29fb3a">1,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNy00LTEtMS03OTg2OQ_e479e800-2f70-4684-9593-7bad4e0605ef">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in deferred taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOC0yLTEtMS03OTg2OQ_9e5b0cda-d941-45fd-a286-e8177f5646b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOC00LTEtMS03OTg2OQ_fadfb71b-bcb4-45ec-b7d1-4a97a4db021a">4,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOS0yLTEtMS03OTg2OQ_c4ea6b93-edde-425d-ab5e-40a1435774ad">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOS00LTEtMS03OTg2OQ_c0345b30-cbe2-4ce8-8234-825f4a3df6a6">2,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTEtMi0xLTEtNzk4Njk_3e968185-1c4b-48cc-b28b-04fe583a880c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTEtNC0xLTEtNzk4Njk_f5eb0b8f-2618-4c74-a24e-167cd7943063">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net changes in assets and liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTUtMi0xLTEtNzk4Njk_18678758-4942-4f1e-b18f-b9b1390ab841">4,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTUtNC0xLTEtNzk4Njk_5db75a6f-363a-480f-9650-426bfc995506">2,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development tax credit receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTYtMi0xLTEtNzk4Njk_ac6ffad8-aa91-4bd8-9d77-54b5bb9ce46a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTYtNC0xLTEtNzk4Njk_55465fb5-d8a4-4a3c-b07c-034596a52b40">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable &amp; other current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTctMi0xLTEtNzk4Njk_317cd402-282d-4899-ac0e-f3571a83e247">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTctNC0xLTEtNzk4Njk_f063951a-e8bd-4f18-bc90-6461ddf8c806">5,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTgtMi0xLTEtNzk4Njk_c5be649f-7c5d-4107-b77e-b5478bb9764c">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTgtNC0xLTEtNzk4Njk_88746c40-2c7c-4474-a4d4-82d6e0d5815f">2,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTktMi0xLTEtNzk4Njk_38bfe2e7-1539-4ec1-b827-f74a384529bf">116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTktNC0xLTEtNzk4Njk_1da2d7dd-996e-42ad-b5c4-32bbb579ef6f">1,667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjAtMi0xLTEtNzk4Njk_a8432874-46b2-4959-bc04-81ca0f5c5420">30,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjAtNC0xLTEtNzk4Njk_c9a82fc9-711f-4f0d-8feb-b21df26a6cce">34,045</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjUtMi0xLTEtNzk4Njk_7c2b02d6-a232-4ddf-b349-cceda55ab3d5">15,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjUtNC0xLTEtNzk4Njk_acb2a9f9-1a84-40ef-a7e2-0d44aa173d27">44,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjYtMi0xLTEtNzk4Njk_e62e7ab5-cb7e-4c37-af87-03e574fa0552">10,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjYtNC0xLTEtNzk4Njk_360c99a3-d8f2-42e4-9e82-5def2d4ced27">2,090</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjctMi0xLTEtNzk4Njk_d6427206-a597-4e7b-b4a9-b22626219bc0">5,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjctNC0xLTEtNzk4Njk_7a58e2ec-4de1-4201-afd4-145f1f14e60b">42,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds received in advance of Series B Preferred Shares Issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="avdl:ProceedsReceivedInAdvanceOfShareIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjktMi0xLTEtODg4NDY_b308e1ec-69db-418b-85a7-6d8bcc0549f6">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="avdl:ProceedsReceivedInAdvanceOfShareIssuance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjktNC0xLTEtODkxNTk_cda81e07-d99d-4307-8029-2bf7031387a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for February 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtMi0xLTEtODgwNjc_d369528d-9031-4ecf-a93d-c42d6d5f2916">17,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtNC0xLTEtODgwNjc_f4712513-8e11-445b-a508-301cdee300f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of shares off the at-the-market offering program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtMi0xLTEtODgwNjc_7a862e1e-b05b-4fe2-bf60-69599c3e68f5">11,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtNC0xLTEtODgwNjc_d8fb9a70-b52c-4845-a33f-9b6bab301f80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from stock option exercises and employee share purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtMi0xLTEtNzk4Njk_818a517e-2ab6-4f3a-8636-636e1995285e">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtNC0xLTEtNzk4Njk_caf0bf49-0083-44d1-b6b4-1963e74b2d1c">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtMi0xLTEtNzk4Njk_c19e1a4d-59aa-400f-b4a1-8f2679d164ab">34,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtNC0xLTEtNzk4Njk_1fb21fe5-e168-4050-ac07-a2679fe63ee2">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of foreign currency exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzMtMi0xLTEtNzk4Njk_f89c77dd-93a7-4fca-9b1c-6f38c612cb3e">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzMtNC0xLTEtNzk4Njk_827d2c97-6b80-47f9-b97d-7aa3a03b2073">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzUtMi0xLTEtNzk4Njk_6d6425c1-94a5-4394-9a00-a93f08a174c7">9,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzUtNC0xLTEtNzk4Njk_a1fac248-67d4-4195-b6c0-9ebfa13cf75f">10,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzYtMi0xLTEtNzk4Njk_367a095e-1b29-4a82-8852-242580e45f40">73,981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc61d0dbbd146d5a43f9b069e875f34_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzYtNC0xLTEtNzk4Njk_e3220e2a-30a6-4104-a6a7-53099e71d94a">50,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzctMi0xLTEtNzk4Njk_c1765b30-069e-4f9f-bb99-a871a8c3a40d">83,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia23425f025c4444db993802f31591093_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzctNC0xLTEtNzk4Njk_e1476903-6b77-47d6-9cab-18c7e309c401">60,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDAtMi0xLTEtNzk4Njk_c037f2a9-d29f-474c-828f-b4d5fc538661">3,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDAtNC0xLTEtNzk4Njk_e11a9421-037b-4248-9b82-90f5e108a0ae">5,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income taxes paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDEtMi0xLTEtNzk4Njk_0da4a98b-abc6-475f-bebe-f5bebbacd7e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDEtNC0xLTEtNzk4Njk_4a8f282d-48a7-4e24-a351-8bb12a37b14e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 9 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVADEL PHARMACEUTICALS PLC</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)&#160;</span></div><div id="i250897ddd94942958d86fa6dfe7818ac_37"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzA2Ng_b08c0e8f-30ea-4589-be2a-eab70ec0ecf1" continuedAt="ie0e48a435e8b4f56a1dc7da091537bd3" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie0e48a435e8b4f56a1dc7da091537bd3" continuedAt="i2f2d020c57784543bc6d87beff03236a"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="avdl:NatureOfBusinessPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzA3NA_53e7e9ff-3424-459e-8dd4-4be073e1cd58" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company.  The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product, LUMRYZ, formally known as FT218, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. On May 1, 2023, LUMRYZ was approved by the U.S. Food and Drug Administration (&#8220;FDA&#8221;). In approving LUMRYZ, the FDA approved a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) for LUMRYZ to help ensure that the benefits of the drug in the treatment of cataplexy and EDS in narcolepsy outweigh the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion of the drug. Under this REMS, healthcare providers must be specially certified, pharmacies, practitioners, or health care settings that dispense the drug must be specially certified and the drug must be dispensed to patients with documentation of safe use conditions. The FDA also granted Orphan Drug Exclusivity (&#8220;ODE&#8221;) to LUMRYZ for a period of <ix:nonNumeric contextRef="i23c52e144f274ff58d06a0258a38c8ec_D20230501-20230501" name="avdl:OrphanDrugExclusivityTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDc0MDExOQ_5dcdf192-9efd-489c-bdf1-fc32434c3d3a">seven years</ix:nonNumeric> until May 1, 2030.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of LUMRYZ, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any other commercialized products in its portfolio.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="avdl:LiquidityAndGoingConcernPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyMTg3Ng_daaba7d3-f794-4325-8102-e6190936f9f0" escape="true"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#8217; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODM5NDE2_7f8f8625-de1c-40cb-97ef-ac34926e8ca9">83,391</ix:nonFraction> of cash and cash equivalents and $<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODM5NDIw_89c77ef6-0d21-41f5-b167-df05d1dd264a">17,532</ix:nonFraction> of marketable securities available for use to fund its operations, debt service and capital requirements. The Company&#8217;s ability to generate revenue is expected to start following the commercial launch of LUMRYZ in the U.S., which is dependent, in part, on the Company&#8217;s ability to successfully complete its commercialization efforts and on market acceptance of LUMRYZ in the U.S. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023, the Company and Avadel CNS Pharmaceuticals, LLC, an indirect wholly-owned subsidiary of the Company (&#8220;Avadel CNS&#8221;) entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $<ix:nonFraction unitRef="usd" contextRef="if5fa690543384264a81ade629ded5283_D20230329-20230329" decimals="-3" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODQxMTQ5_8f637e33-87e1-4bbc-8f96-c8795fe1d21a">75,000</ix:nonFraction> of royalty financing in two tranches. The first tranche of $<ix:nonFraction unitRef="usd" contextRef="i458c9dc9da4541feb9ebbfe26480f40d_D20230501-20230501" decimals="-3" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyNTg5MQ_5d30e8e1-04f6-4943-a25d-0a893b49f5f4">30,000</ix:nonFraction> is available subject to the Company&#8217;s first shipment of LUMRYZ. The second tranche is available to use, at the Company&#8217;s election, upon achieving quarterly net revenue of $<ix:nonFraction unitRef="usd" contextRef="i4e5c2953230a4966ba6f9cfa4b87083d_D20230329-20230329" decimals="-3" name="avdl:RoyaltyFinancingQuarterlyNetRevenueTarget" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMjc0ODc3OTExMjMwNw_db87f8db-234a-469f-98b2-1faf658ab97b">25,000</ix:nonFraction>. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company had outstanding $<ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NTM0_1f64595f-5eaa-4fca-970a-4d7ebe795b3d">117,375</ix:nonFraction>&#160;aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="ie9937162cb764e1e9c3a6cde0e7174e9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NTQw_24e2e4a6-86e0-42d9-886f-927acd9c4fcd">4.50</ix:nonFraction>% exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;). Over the course of April 3 and April 4, 2023, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), completed an exchange of $<ix:nonFraction unitRef="usd" contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjUw_f6cefa4e-234a-450c-a593-dd1f992ba21c">96,188</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its $<ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjU2_1f64595f-5eaa-4fca-970a-4d7ebe795b3d">117,375</ix:nonFraction> October 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ife27a702c1604bfaab93fe6b27c28f80_I20230404" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyNTkwMw_2ae4d092-919a-4815-8312-3d010f2f8c04">106,268</ix:nonFraction> of a new series <ix:nonFraction unitRef="number" contextRef="i26f74d8cc0d245b9946db9086ec31c5f_I20230404" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjYy_20976b5a-dd84-4862-bf18-f7043aac6b75">6.0</ix:nonFraction>% exchangeable notes due April 2027 (the &#8220;April 2027 Notes&#8221;) (the &#8220;2023 Exchange Transaction&#8221;). The remaining $<ix:nonFraction unitRef="usd" contextRef="i8fdfb2995db447c186216c675ed244de_I20230404" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjY4_0831a0a0-a5ff-478a-90f2-c25b7ee7d77b">21,187</ix:nonFraction> aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2023, the Company completed the sale of ordinary shares, nominal value $<ix:nonFraction unitRef="usdPerShare" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTAyOQ_f1f70493-97f6-44f8-a58b-150fc24ceb6f">0.01</ix:nonFraction> per share (&#8220;Ordinary Shares&#8221;) in the form of American Depositary Shares (&#8220;ADSs&#8221;) and Series B Non-Voting Convertible Preferred Shares (&#8220;Series B Preferred Shares&#8221;) in an underwritten public offering. The Company received net proceeds from the equity financing of $<ix:nonFraction unitRef="usd" contextRef="if8c8d5df3b6943cbb2ac5bbcccf925a6_D20230403-20230403" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyNTkxNg_9275e637-000d-4fd9-bfff-9740f7415c1b">135,125</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i9961149acfda4623881e412da9b843c4_D20230331-20230331" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyMjg2OA_14b3696a-d02f-4a05-abe9-b40cd8a92949">40,000</ix:nonFraction> was received on March 31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="iaaa294d327ad4af790c20a25c207e257_D20230403-20230403" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyMjg3Nw_c787afb6-4b58-46b7-b70b-b204831a02e5">95,125</ix:nonFraction> was received on April 3, 2023. The $<ix:nonFraction unitRef="usd" contextRef="i9961149acfda4623881e412da9b843c4_D20230331-20230331" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzI5ODUzNDkxMTgyNw_14b3696a-d02f-4a05-abe9-b40cd8a92949">40,000</ix:nonFraction> of net proceeds received prior to the completed public offering was included in the unaudited condensed consolidated balance sheet as proceeds received in advance of Series B Preferred Shares issuance at March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the 2023 Exchange Transaction and the public offering, the Company has concluded that cash on hand provides sufficient capital to meet the Company&#8217;s operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Repor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 10 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2f2d020c57784543bc6d87beff03236a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-the-Market Offering Program</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2020, the Company entered into an Open Market Sale Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program (&#8220;ATM Program&#8221;) under which the Company may offer and sell its ADSs (such ADSs sold under the ATM Program, &#8220;ATM ADSs&#8221;) through Jefferies as its sales agent. The Company agreed to pay Jefferies a commission up to <ix:nonFraction unitRef="number" contextRef="i62caf1e030104340aab6ddd08244c618_D20200205-20200205" decimals="3" name="avdl:SaleOfStockSalesAgentCommissionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTAzNg_65257939-ceb0-48c5-a393-9e5ac2843e58">3.0</ix:nonFraction>% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $<ix:nonFraction unitRef="usd" contextRef="idf7fc9b9d98940b28248abcf3e548647_I20200214" decimals="-3" name="avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTA0Mg_8340abd5-0780-423e-8b21-83b414ecbba9">50,000</ix:nonFraction> of ADSs pursuant to its prospectus, dated February 14, 2020, included with the Company&#8217;s Registration Statement on Form S-3 (File No. 333-236258) (the &#8220;2020 Prospectus&#8221;). In August 2022, the Company filed an additional prospectus, dated September 12, 2022, included with the Company&#8217;s new Registration Statement on Form S-3 (File No. 333-267198) (the &#8220;2022 Prospectus&#8221;), in order to allocate up to $<ix:nonFraction unitRef="usd" contextRef="i04744cf318cb4dcaa7cd020e5cec855f_I20220831" decimals="-3" name="avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTA1NA_cf234040-fa3c-4d12-8780-2e6eeaba3250">100,000</ix:nonFraction> in additional ADSs to the ATM Program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Shelf Registration expired on February 14, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Sales Agreement, the Company had issued and sold <ix:nonFraction unitRef="shares" contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMjc0ODc3OTEwNjY4Nw_8170f2bf-b714-46c3-a837-33a5d73f695c">1,564</ix:nonFraction> ADSs during the quarter ended March 31, 2023, resulting in net proceeds to the Company of approximately $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMjc0ODc3OTEwNjc5Ng_f5446329-7067-4bba-9e91-29349989eeb2">11,913</ix:nonFraction>. The Company may offer and sell up to an additional $<ix:nonFraction unitRef="usd" contextRef="i3e0581315acc4d4d86c90d917988c952_I20230331" decimals="-3" name="avdl:SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTA2Nw_184556d9-5db3-4080-b393-06969fc3a5aa">96,064</ix:nonFraction> of ADSs under the ATM Program that remain available for sale pursuant to the 2022 Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzA2MQ_4be324f7-0072-46c4-a9da-0819fb6a1b22" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of March&#160;31, 2023, which is derived from the prior year 2022 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2022 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 29, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2: <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfMzU4OQ_3619040c-934e-4983-aa5f-0c7b58244d4a" continuedAt="ife2e80b3433049ac9cd3811eb87b2697" escape="true">Fair Value Measurement</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ife2e80b3433049ac9cd3811eb87b2697" continuedAt="ifccbc2dd9fd1478fbc6506dd742a76e3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 11 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifccbc2dd9fd1478fbc6506dd742a76e3"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfMzU4Mw_e3f6de8e-20c6-46d5-9aca-ec34d11d72df" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i319121ad18c140788a5641e1758ab387_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC0yLTEtMS03OTg2OQ_9d926306-ffe9-4891-a967-262499b35806">17,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie620788155bb4059a6e43c59c3299fdf_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC00LTEtMS03OTg2OQ_7849a5f8-aca1-4446-8ae7-b2192c930db0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2657941fbea4497186c9ab34cdb5e0d2_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC02LTEtMS03OTg2OQ_d437f518-2a7e-4957-81a7-8f39ae3a5694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7643c428b463493c881600eddf2ee8f4_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC04LTEtMS03OTg2OQ_b9d682f7-41a2-4f0d-acc0-5528cd671a88">22,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if50b3d2f207a4e44a847e37ad9bb46e1_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC0xMC0xLTEtNzk4Njk_33ef1cb3-8c6c-45b9-845a-a925ab55ff5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19812fad0ea54d67b5f37e1104be5f74_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC0xMi0xLTEtNzk4Njk_816b0730-e4ca-42ea-a554-a108328cdeab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9a4e9f1f88462cab7139b14d632c0a_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC0yLTEtMS03OTg2OQ_adf5ab62-652a-4acc-8edd-1bdba952af99">17,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a64b1bae7e4770bf4e011bfe5a528d_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC00LTEtMS03OTg2OQ_d0373610-5bda-4796-aaf6-ff238e8f0f2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e58f2a47674b17839bf947e34800b8_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC02LTEtMS03OTg2OQ_a68b512f-11a0-4fbe-9af7-59b5bcebb0df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8995e89e6594401fb4c210df4fd2a8de_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC04LTEtMS03OTg2OQ_e6b94472-cbd1-4242-8824-10e1126008cb">22,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83723dc6749c4f99a73b5cf748193371_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC0xMC0xLTEtNzk4Njk_f09af004-d5db-42bd-a97b-884aa4716d9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21753e8a8465424f9ed070cf17ff922a_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC0xMi0xLTEtNzk4Njk_eb5e5895-412e-4353-a6a5-36ba5418dce1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160;Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended March&#160;31, 2023 and December&#160;31, 2022, respectively, there were no transfers in and out of&#160;Level&#160;1, 2, or 3. During the three months ended March&#160;31, 2023 and 2022, respectively, the Company did not recognize any allowances for credit losses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its $<ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfNTQ5NzU1ODE4MjQ1_ebface8a-ad7e-4ac1-b70a-31881cc5e5fd">117,375</ix:nonFraction> aggregate principal amount of&#160;its October 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair value of the October 2023 Notes at March&#160;31, 2023 is $<ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfMzQ5Mg_bf4f99c1-e3cf-494b-bf9a-c197d28a1350">124,418</ix:nonFraction>. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the Company&#8217;s debt obligations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMjIwOQ_cea88265-acd3-44bf-ae63-d8915874849e" continuedAt="if9a3efe502424b358b0f4b40c884d199" escape="true">Marketable Securities&#160;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if9a3efe502424b358b0f4b40c884d199" continuedAt="i6901eec9553348158a311bfedc6fd6b8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in available-for-sale debt securities which are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#8217; (deficit) equity, net of income tax effects. As of March&#160;31, 2023, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.  </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMjIwMQ_af0d468a-1af8-431f-a7c9-581bad354177" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64906691143a44d69f831d716ff11840_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy0yLTEtMS03OTg2OQ_d92a929b-d9cf-4e0a-88f3-ec8ca2511291">19,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64906691143a44d69f831d716ff11840_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy00LTEtMS03OTg2OQ_5b52ce33-1440-4b6f-bb48-d928745a6337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64906691143a44d69f831d716ff11840_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy02LTEtMS03OTg2OQ_834badef-5138-4fea-a04f-f427fe32ba29">1,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64906691143a44d69f831d716ff11840_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy04LTEtMS03OTg2OQ_ec38b6d4-1934-4f93-ab4f-8a3fcb22921f">17,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy0yLTEtMS03OTg2OQ_e085653b-be01-4da0-9e9c-4824eca2af9e">19,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy00LTEtMS03OTg2OQ_bc3f0398-52f2-4eea-a468-4dcfa3303bae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy02LTEtMS03OTg2OQ_3ddc394d-b10b-42f7-b17a-ad95f9694281">1,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy04LTEtMS03OTg2OQ_a2692fef-c23e-4f46-bdd8-fb867740e305">17,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.623%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy0yLTEtMS03OTg2OQ_17c754bc-924d-4e20-9b99-500f27fccee3">24,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy00LTEtMS03OTg2OQ_f737f7ae-1b70-4ffe-9316-41059b1d83a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy02LTEtMS03OTg2OQ_24448f89-a9dd-481c-8e84-519351e5baeb">1,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy04LTEtMS03OTg2OQ_b4301285-be43-479f-ad2e-4d9418ea4622">22,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy0yLTEtMS03OTg2OQ_6cd09364-ad9d-41f1-a477-f8333b522f8d">24,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy00LTEtMS03OTg2OQ_840ce862-0e23-4636-bbdb-4b1f2f84f839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy02LTEtMS03OTg2OQ_234ece6d-e2c3-495d-b784-8cd6b93fd280">1,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy04LTEtMS03OTg2OQ_509f4262-1312-4a1d-9afc-959de5ab5035">22,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income (expense), net in the accompanying unaudited condensed consolidated statements of loss.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 12 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i6901eec9553348158a311bfedc6fd6b8" continuedAt="i33730eed91024c29920b4fc407ec9af9"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized gross realized gains of $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTA1MA_7e053a18-9dfa-4d7a-8c73-6299be53b803">1</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGain" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTA1Nw_e6694cdb-ee60-44fa-8bec-94ca88cdefa1">304</ix:nonFraction> for the three months ended March&#160;31, 2023 and 2022, respectively. These realized gains were offset by realized losses of $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTE2NA_acf47241-4bd5-42d2-8875-001d1e9dd8ba">61</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTE3MQ_54ff50b8-2f01-4169-8a37-0f94e34689f3">790</ix:nonFraction> for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its investment in available-for-sale marketable securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#8217;s investment portfolio.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i33730eed91024c29920b4fc407ec9af9">Total gross unrealized losses and fair value of the Company&#8217;s marketable securities at March&#160;31, 2023 are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.</ix:continuation>  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4: <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTA4MzA_bd012106-2179-4902-b8ca-aa6f08602368" continuedAt="i9c544b5a047a48b0b80a22243529a3dd" escape="true">Long-Term Debt</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9c544b5a047a48b0b80a22243529a3dd" continuedAt="i72c2897f23524004ac790f75ba7be62c"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTA4NDA_6d6e4901-7aa5-44de-8fb9-3e632b8dab81" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of <ix:nonFraction unitRef="number" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMS0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmFjMGZjMjFlMTdjODQzNGY5MmJmYzcyYWMzZGExNTkwXzI3NDg3NzkwNjk1MjQ_98e2269a-3cbd-492c-b37a-7b9f43dd2406">4.50</ix:nonFraction>% exchangeable senior notes due October 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMS0yLTEtMS03OTg2OQ_ebface8a-ad7e-4ac1-b70a-31881cc5e5fd">117,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89b1f1ffe254a5fb320780bad1a88fc_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMS00LTEtMS03OTg2OQ_d7441ce6-9dbe-48bc-9934-aad0bcb414d9">117,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of <ix:nonFraction unitRef="number" contextRef="i7e3e3492dee14060b385540d4e0d7c18_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi0wLTEtMS04NDM5My90ZXh0cmVnaW9uOjYzNGE1ZDdiMTNkNTRjOTc4ZmZhZWRkYzlhZDVjYzQ5XzI0_039d430e-89ac-4088-af79-02ca4cf73f82">4.50</ix:nonFraction>% exchangeable senior notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e3e3492dee14060b385540d4e0d7c18_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi0yLTEtMS04NDM4Mg_c2a86ba2-c0d8-4354-8534-63ac1f8c4e03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id408a9d6c330487193d4d6ecb5fd3650_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi00LTEtMS04NDM4Mg_6d5f0aba-9904-4a1e-86c4-09eb29a8f69b">17,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id57ed34c966748e1b0953df5e00479df_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi0yLTEtMS03OTg2OQ_28a6320c-6a5e-4633-a7f8-4da5b11e6304">3,721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23b6a8070618442e9e19c0442c464ee3_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi00LTEtMS03OTg2OQ_a5a002f0-20f9-42e3-9ccb-a2f3120bb68a">5,593</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id57ed34c966748e1b0953df5e00479df_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMy0yLTEtMS03OTg2OQ_ee6aaddd-cc7c-4b5f-b9ef-1070b7c6accc">113,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23b6a8070618442e9e19c0442c464ee3_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMy00LTEtMS03OTg2OQ_98db23e6-f1f1-4333-9f91-36b58fe9c787">129,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities, net of $<ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmM3OTg0YzU1YThlNjRkZGY4M2FlYjI4OTM0YmIyZDJjXzM3_d28884ac-9e74-479c-8e6b-3c1058d4380a">672</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmM3OTg0YzU1YThlNjRkZGY4M2FlYjI4OTM0YmIyZDJjXzIxOTkwMjMyNTU2NDA_eb44aa00-420a-48b7-a24b-37a4cd4e158e">1,019</ix:nonFraction> unamortized debt discount and issuance costs, respectively </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi0yLTEtMS03OTg2OQ_bbb19a86-cf24-485f-870d-aa3f0aefe036">20,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi00LTEtMS03OTg2OQ_d9377317-4d42-4728-95fc-a013cb2c6e9f">37,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNy0yLTEtMS03OTg2OQ_6e23d8fa-e499-4680-b757-41abb0a56b51">93,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNy00LTEtMS03OTg2OQ_2e26d69c-2370-438f-ac55-2befe757e6e3">91,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ended March&#160;31, 2023 and 2022, the total interest expense was $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTQz_902818f2-a640-4637-9e3f-2f749f4fe0ba">3,259</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTUw_72a99ccc-45f2-4c6e-b809-e5e6fef1f8dd">2,017</ix:nonFraction>, respectively, with coupon interest expense of $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjAw_01d75995-f317-474c-9280-807918458c7a">1,386</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="avdl:CouponInterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjE5OTAyMzI5MTEwMQ_6819738e-0cf8-4f2b-9408-5c2eb9940469">1,617</ix:nonFraction> for each period, respectively, and the amortization of debt issuance costs and debt discount of $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjg0_6f50d4ba-60c2-43f5-9a0b-6b7071b9c4e4">1,873</ix:nonFraction> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjE5OTAyMzI5MTIwOQ_e8a7aeee-0b29-4591-91bb-278d3997d4fe">312</ix:nonFraction> for each period, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">February 2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, the Issuer issued $<ix:nonFraction unitRef="usd" contextRef="i6cc7030dee104960a48e1ef403016742_I20180216" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNjcz_80e9f2df-519c-4967-9d31-40dbbd71809f">125,000</ix:nonFraction> aggregate principal amount of its February 2023 Notes in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the February 2023 Notes a <ix:nonNumeric contextRef="id58b0ae1b79f447e8ae6e65bded423ca_D20180216-20180216" name="avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTA4Mzc_ea774c4b-9cc1-4d09-aa6b-143012f8779d">30-day</ix:nonNumeric> option to purchase up to an additional $<ix:nonFraction unitRef="usd" contextRef="i6cc7030dee104960a48e1ef403016742_I20180216" decimals="-3" name="avdl:DebtInstrumentOptiontoIncreaseFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTAwMg_9b0dbecb-43e5-49ad-a38b-9ba6d18e793f">18,750</ix:nonFraction> aggregate principal amount of the February 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $<ix:nonFraction unitRef="usd" contextRef="id58b0ae1b79f447e8ae6e65bded423ca_D20180216-20180216" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTIwMQ_25c346b4-d85a-4b73-9603-4892f20ab956">137,560</ix:nonFraction>. The February 2023 Notes were the Company&#8217;s senior unsecured obligations and ranked equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">October 2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2022, the Issuer completed the exchange of $<ix:nonFraction unitRef="usd" contextRef="iaf529448191847138180cb35876adf3b_I20220405" decimals="-3" name="avdl:DebtInstrumentExchangeAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI3Njg2_417ced84-48b9-4727-8360-31d852d3d62c">117,375</ix:nonFraction> of its February 2023 Notes for a new series of its October 2023 Notes (the &#8220;2022 Exchange Transaction&#8221;). The remaining $<ix:nonFraction unitRef="usd" contextRef="iaf529448191847138180cb35876adf3b_I20220405" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI3ODA0_25b06552-5b8f-44a5-bef5-01b2e3c232fe">26,375</ix:nonFraction> aggregate principal amount of the February 2023 Notes were not exchanged and maintained a maturity date of February 1, 2023. On November 4, 2022, the Company repurchased $<ix:nonFraction unitRef="usd" contextRef="i4c67c57f5e464d2eb219e11bb8fa61ac_I20221104" decimals="-3" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI3OTc4_6484ccb0-0fd3-4d02-8249-273f7e93f13c">8,875</ix:nonFraction> of its February 2023 Notes and on the maturity date of February 1, 2023, the Company repaid, with cash on hand, the remaining $<ix:nonFraction unitRef="usd" contextRef="ibe2ecd298ed14718958abd43e1bed64f_I20230201" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4MTA4_9a3f7211-6a8a-40bb-915a-7e69645fb579">17,500</ix:nonFraction> aggregate principal amount of its February 2023 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the October 2023 Notes as a modification to the February 2023 Notes. The Company paid $<ix:nonFraction unitRef="usd" contextRef="ic84949ac67fc4d3487c6ff9086f64946_D20220405-20220405" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4Mjgw_f3f1a4e5-35a8-482c-949c-2f86dd895df7">4,804</ix:nonFraction> in fees to note holders of the October 2023 Notes that are amortized over the remaining term of the October 2023 Notes. The Company paid approximately $<ix:nonFraction unitRef="usd" contextRef="icb2258e7de744756bfdc93eb9badd9e4_D20220405-20220405" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4NDM1_fd64944c-ceda-4366-9d40-aff9fe9f4976">5,450</ix:nonFraction> in fees to third parties that were expensed as part of the completed 2022 Exchange Transaction. Additionally, the fair value of the unseparated, embedded conversion feature increased by $<ix:nonFraction unitRef="usd" contextRef="if20286047c044da782884c54495ecb0e_D20220405-20220405" decimals="-3" name="avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4NjIw_2c44690e-8161-4156-93b1-2ca44d8e7e18"><ix:nonFraction unitRef="usd" contextRef="if20286047c044da782884c54495ecb0e_D20220405-20220405" decimals="-3" name="avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4NjIw_a4222b0e-4217-43e8-b591-4934e0dd8ae4">5,508</ix:nonFraction></ix:nonFraction>, which reduced the carrying amount of the convertible debt instrument as an unamortized debt discount, with a corresponding increase in additional paid-in capital. The $<ix:nonFraction unitRef="usd" contextRef="if20286047c044da782884c54495ecb0e_D20220405-20220405" decimals="-3" name="avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4Nzky_1c10421d-2004-49d1-b5c6-12bb90bf4625">5,508</ix:nonFraction> is amortized over the remaining term of the October 2023 Notes as a component of interest expense. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 13 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i72c2897f23524004ac790f75ba7be62c" continuedAt="i90f1c23a17f64344b6a4615b60105df4"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The October 2023 Notes are exchangeable at the option of the holders at an initial exchange rate of <ix:nonFraction unitRef="rate" contextRef="i1082dbc3efe8463fa3c8d5d339c6f683_D20180216-20180216" decimals="INF" name="avdl:AmericanDepositorySharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5MjA1_f38386a0-196f-4731-88bc-eeedeb64b604">92.6956</ix:nonFraction> ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i4bff811514e04cf0a407a2178a42e153_I20180216" decimals="2" name="avdl:AmericanDepositarySharesOptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5MzE5_ecfbc6aa-cb0d-4538-a20e-6e1d414127e9">10.79</ix:nonFraction> per ADS. Such initial exchange price represents a premium of approximately <ix:nonFraction unitRef="number" contextRef="i4bff811514e04cf0a407a2178a42e153_I20180216" decimals="4" name="avdl:AmericanDepositarySharesPremiumPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5Mzk4_ae2534ac-653b-4ea9-9743-b0adba5cf77c">20</ix:nonFraction>% to the $<ix:nonFraction unitRef="usdPerShare" contextRef="i4bff811514e04cf0a407a2178a42e153_I20180216" decimals="2" name="avdl:AmericanDepositarySharesPurchasedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5NDA5_5804a0bf-dcbf-4ebf-a540-dd4015fb892a">8.99</ix:nonFraction> per ADS closing price on The Nasdaq Global Market on February 13, 2018. Upon the exchange of any October 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, at its option, may redeem for cash all of the October 2023 Notes if the last reported sale price (as defined by the indenture) of the ADSs has been at least <ix:nonFraction unitRef="number" contextRef="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMDA_9ac564b0-0b00-43e5-8b47-60a62784cb63">130</ix:nonFraction>% of the Exchange Price then in effect for at least <ix:nonFraction unitRef="day" contextRef="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMDQ_e3741eaa-448d-447d-bcf6-12dde8c38704">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMDg_2287c91e-31ba-492d-ab34-651a7cde45c9">30</ix:nonFraction> consecutive trading-day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice to redeem the October 2023 Notes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">April 2027 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Over the course of April 3 and April 4, 2023, the Issuer completed an exchange of $<ix:nonFraction unitRef="usd" contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NDUx_f6cefa4e-234a-450c-a593-dd1f992ba21c">96,188</ix:nonFraction> of its $<ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NDU3_1f64595f-5eaa-4fca-970a-4d7ebe795b3d">117,375</ix:nonFraction> October 2023 Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for $<ix:nonFraction unitRef="usd" contextRef="i2c693d85f33f4ea6b145f6db4f849879_I20230403" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMTI_6b91f266-d201-4de8-bf5b-b68ebf5cda9e">106,268</ix:nonFraction> of new</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> April 2027 Notes. The remaining $<ix:nonFraction unitRef="usd" contextRef="i8fdfb2995db447c186216c675ed244de_I20230404" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NTI3_0831a0a0-a5ff-478a-90f2-c25b7ee7d77b">21,187</ix:nonFraction> aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023. Due to the 2023 Exchange Transaction, the $<ix:nonFraction unitRef="usd" contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NTc2_f6cefa4e-234a-450c-a593-dd1f992ba21c">96,188</ix:nonFraction> principal amount of the October 2023 Notes is classified as long-term debt, net of unamortized debt discount and issuance costs, as of March&#160;31, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the April 2027 Notes may convert their April 2027 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding January 15, 2027, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after January 15, 2027 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding January 15, 2027, a holder of the April 2027 Notes may surrender all or any portion of its April 2027 Notes at an initial exchange rate (the &#8220;Exchange Rate&#8221;) of <ix:nonFraction unitRef="rate" contextRef="i6165ba48ac2542de9fc80cf68aaf7a7c_D20230404-20230404" decimals="INF" name="avdl:AmericanDepositorySharesConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODMzMQ_04371ce2-d046-4321-b7e0-2182b33b5d54">102.3018</ix:nonFraction> ADSs of the Company (each of which represents as of the date hereof one ordinary share of the Company, nominal value $<ix:nonFraction unitRef="usdPerShare" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM2Mg_0a72a7cc-7140-4acb-bd3d-6000f17e9ad0">0.01</ix:nonFraction> per share (the &#8220;Ordinary Shares&#8221;)) per $1,000 principal amount of the April 2027 Notes (so long as the principal amount of such holder&#8217;s April 2027 Notes not exchanged is at least $<ix:nonFraction unitRef="usd" contextRef="i4e1dda052ae749c4b067a6c95a6a1377_D20230404-20230404" decimals="-3" name="avdl:DebtConversionPrincipalAmountNotExchanged" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM2OQ_f5b4f6ca-314b-4aa6-8519-581609db6f17">200,000</ix:nonFraction>), which is equal to an initial exchange price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ibb3721e3e0c345868370c7da3c4161dc_I20230404" decimals="2" name="avdl:AmericanDepositarySharesOptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM1NQ_80bf604a-47a1-4e60-9260-2666024df718">9.78</ix:nonFraction> per ADS. Upon exchange, the April 2027 Notes may be settled in cash, ADSs, or a combination of cash and ADSs, at the Issuer&#8217;s election. The Exchange Rate is subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. Following a &#8220;Make-Whole Fundamental Change&#8221; (as defined in the Indenture) or upon the Issuer&#8217;s issuance of a notice of redemption, the Issuer will increase the Exchange Rate for a holder who elects to exchange its April 2027 Notes in connection with such &#8220;make-whole fundamental change&#8221; or during the related redemption period in certain circumstances. In addition, the Issuer will increase the Exchange Rate for a holder who elects to exchange its April 2027 Notes prior to January 15, 2027 or whose April 2027 Notes are subject to a Mandatory Exchange (as defined below) in certain circumstances.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The Issuer may cause the then outstanding principal amount of the April 2027 Notes to be exchanged, in whole but not in part, at its option (the &#8220;Mandatory Exchange&#8221;), prior to the close of business on January 15, 2027, if the last reported sale price of the ADSs has been at least <ix:nonFraction unitRef="number" contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM0MQ_39e52caa-2292-4139-b360-8295cec2e1cb">130</ix:nonFraction>% of the exchange price then in effect on (x) each of at least <ix:nonFraction unitRef="day" contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM0Nw_edc35104-68fa-4b19-8e76-dccede0fac67">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="day" contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM1MQ_614be247-78ac-4258-973e-c4747ef67c00">30</ix:nonFraction> consecutive trading days ending on, and including, the trading day immediately before the date that the Issuer provides notice of the Mandatory Exchange in accordance with the Indenture (the &#8220;Mandatory Exchange Notice Date&#8221;); and (y) the trading day immediately before such Mandatory Exchange Notice Date, at the then prevailing Exchange Rate, subject to adjustment described above. The Issuer may settle Mandatory Exchanges in cash, ADSs, or a combination of cash and ADSs, at the Issuer&#8217;s election. Accrued and unpaid interest, if any, on April 2027 Notes subject to Mandatory Exchange to, but excluding, the exchange date in respect of the Mandatory Exchange shall be paid by the Issuer to holders of the April 2027 Notes in cash concurrently with the delivery of the other exchange consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Issuer may redeem for cash all of the April 2027 Notes in connection with certain tax-related events at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODQwNQ_b3c7a8bf-0ce4-432d-b975-7d4a048ad2cd">100</ix:nonFraction>% of the principal amount of the April 2027 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date, but may not otherwise redeem the April 2027 Notes. No sinking fund is provided for the April 2027 Notes, which means that the Company is not required to redeem or retire the April 2027 Notes periodically.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the guidance in ASC 815-15, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to the Company&#8217;s ability to settle the October 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#8217;s option. The Company has therefore applied the guidance provided by ASC 470-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as amended by ASU 2020-06. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 14 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i90f1c23a17f64344b6a4615b60105df4"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Financing Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 29, 2023, the Company and Avadel CNS entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $<ix:nonFraction unitRef="usd" contextRef="if5fa690543384264a81ade629ded5283_D20230329-20230329" decimals="-3" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjc0ODc3OTEwODUwNg_8f637e33-87e1-4bbc-8f96-c8795fe1d21a">75,000</ix:nonFraction> of royalty financing in two tranches. The first tranche of $<ix:nonFraction unitRef="usd" contextRef="i458c9dc9da4541feb9ebbfe26480f40d_D20230501-20230501" decimals="-3" name="us-gaap:ProceedsFromRoyaltiesReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjc0ODc3OTEwODUxMg_5d30e8e1-04f6-4943-a25d-0a893b49f5f4">30,000</ix:nonFraction> is available subject to the Company&#8217;s first shipment of LUMRYZ. The second tranche is available to use, at the Company&#8217;s election, upon achieving quarterly net revenue of $<ix:nonFraction unitRef="usd" contextRef="i4e5c2953230a4966ba6f9cfa4b87083d_D20230329-20230329" decimals="-3" name="avdl:RoyaltyFinancingQuarterlyNetRevenueTarget" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjc0ODc3OTExMDg1Ng_db87f8db-234a-469f-98b2-1faf658ab97b">25,000</ix:nonFraction>. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNDQw_b4fc1315-dcf0-4357-a347-784d7324f08a" continuedAt="i1b3f4f8107d14d5396cbfcc2f075c647" escape="true">Income Taxes </ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b3f4f8107d14d5396cbfcc2f075c647" continuedAt="i6c87ee4404724a12af76531a6f8425a1">The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNTY_cc99fe6a-cc69-4d7d-a5c6-3e084075f58f">580</ix:nonFraction> for the three months ended March&#160;31, 2023 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNTQ5NzU1ODE2OTE2_140e1bee-043b-4e4f-bf3f-a2612da636da">1.8</ix:nonFraction>%.  The income tax benefit was $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfMTU5_5beb4ba3-b07f-4c38-8681-1941fd4140f5">4,323</ix:nonFraction> for the three months ended March&#160;31, 2022 resulting in an effective tax rate of <ix:nonFraction unitRef="number" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNTQ5NzU1ODE2OTIw_c5f6d561-f0a0-4983-a965-1b01746f48be">14.1</ix:nonFraction>%.  The change in the effective tax rate for the three months ended March&#160;31, 2023, when compared to the same period in 2022, is primarily driven by the valuation allowances recorded against net deferred tax assets established in the second quarter of 2022. </ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i6c87ee4404724a12af76531a6f8425a1">The Company's cumulative loss position was significant negative evidence in assessing the need for a valuation allowance on its deferred tax assets. Given the weight of objectively verifiable historical losses from operations, the Company recorded a full valuation allowance on its deferred tax assets. The Company will be able to reverse the valuation allowance when it has shown its ability to generate taxable income on a consistent basis in future periods. The valuation allowance does not have an impact on the Company's ability to utilize any net operating losses or other tax attributes to offset cash taxes payable as these items are still eligible to be used.</ix:continuation> </span></div><div><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTIz_67ccc553-29bd-415f-ba71-a97a6a4d0ecd" continuedAt="if5e7c80fc9f942e18cee7b7c86c7aa00" escape="true">Other Assets and Liabilities&#160;</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="if5e7c80fc9f942e18cee7b7c86c7aa00" continuedAt="i92db9735a24f479fbcccd1b37211b8b6"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTQx_8c8f600f-225f-48da-8afb-c9b377c09603" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMi0yLTEtMS03OTg2OQ_b3ab0bb2-03af-4650-a7f3-609a58ebf7f1">5,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMi00LTEtMS03OTg2OQ_15d5c608-f1e1-4a82-825b-a123dd685333">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMy0yLTEtMS03OTg2OQ_90f1bccc-2fa5-4e6f-ba11-7d3e55ee2af7">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMy00LTEtMS03OTg2OQ_cecd918a-feb9-4dc5-a0d9-f7dd281da90e">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNC0yLTEtMS03OTg2OQ_afc36e85-aa26-47d7-a60d-a124408aadcd">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:GuaranteeCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNC00LTEtMS03OTg2OQ_d00c10d9-93a3-4cab-a955-56ddb1fd7e9b">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNS0yLTEtMS03OTg2OQ_db9cc86b-ca61-429c-8b8a-bdd0f86872b4">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNS00LTEtMS03OTg2OQ_57b3f6ec-8115-4067-a843-98d4f2dba1e0">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNi0yLTEtMS03OTg2OQ_424b3287-27e6-484a-8fb4-34a9d2445235">6,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNi00LTEtMS03OTg2OQ_ae73b9a7-9b75-4918-8d14-7b6d4b5025ea">2,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:4pt"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTI2_6ebe3f89-a021-4326-8e22-83d9acf5b51e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMi0yLTEtMS03OTg2OQ_e8cba4bd-6b9c-471e-9ebc-08a117f2b840">10,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMi00LTEtMS03OTg2OQ_3e03877e-fbb3-4653-b0cb-d0679c4b67f1">10,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMy0yLTEtMS03OTg2OQ_acdad8bc-9cfc-479f-ba41-776ba3d8c1d1">433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:GuaranteeNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMy00LTEtMS03OTg2OQ_1cb0664f-fd41-4079-9b75-345170262239">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNC0yLTEtMS03OTg2OQ_2d453d56-65d4-4396-98fd-c784b08ff1a5">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:OtherNoncurrentReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNC00LTEtMS03OTg2OQ_395c6811-75d1-4927-901b-5cdee9cf5cd7">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNi0yLTEtMS03OTg2OQ_15cdb4e9-2ba9-4267-ac02-ee02de99d23c">10,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNi00LTEtMS03OTg2OQ_0afd185f-58b9-410b-9186-fc171733fe2a">11,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:4pt"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTM3_8aae1feb-162f-4c9b-bf9e-a0bc10209599" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMi0yLTEtMS03OTg2OQ_0e9026a5-454b-435e-8318-64230142a76f">5,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMi00LTEtMS03OTg2OQ_45263a2e-a992-4f32-83ab-79bd51394a26">4,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMy0yLTEtMS03OTg2OQ_73f83752-426c-4712-a540-821a17648120">1,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMy00LTEtMS03OTg2OQ_12f92049-4307-429d-8726-c27575165383">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNC0yLTEtMS03OTg2OQ_5001358a-09c0-40df-9c4d-141a931f8fcc">246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:RestructuringReserveCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNC00LTEtMS03OTg2OQ_961dd8e0-6294-4c03-8a8b-a5d72a74d648">473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsourced contract manufacturing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:AccruedOutsourceContractCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNS0yLTEtMS03OTg2OQ_c4b9a77a-8157-4c4a-b01d-43cd9122815e">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:AccruedOutsourceContractCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNS00LTEtMS03OTg2OQ_bab7fb9d-08dd-40c3-a8fb-742e4cb851f6">1,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNy0yLTEtMS03OTg2OQ_5c3499d8-2048-4a58-91a9-1a7959312bbf">7,683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNy00LTEtMS03OTg2OQ_9ccdb057-ca5d-4d68-a09c-c2346db9d011">7,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:1pt"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTIx_36fc0a41-4551-4ff9-be37-c714c396cc4b" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMi0yLTEtMS03OTg2OQ_86f37ec5-8545-45c1-bcfb-9d22a92657e2">269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:OtherGuarantorObligationsCurrentCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMi00LTEtMS03OTg2OQ_69c9dc3b-9811-4058-8c3e-77d857ef6bbe">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMy0yLTEtMS03OTg2OQ_71ecfd89-2e28-474c-9863-1f20e74ea918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:OtherLiabilitiesMiscellaneousCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMy00LTEtMS03OTg2OQ_47dd10e1-d949-4f37-9555-843257fa7bf1">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:AccruedInterestCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNC0yLTEtMS03OTg2OQ_84ed7265-65fc-4eff-acc2-f6487179410d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:AccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNC00LTEtMS03OTg2OQ_ca0735ae-1315-423b-8a62-5a2f96046dbb">1,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNS0yLTEtMS03OTg2OQ_454ff65e-31ee-4165-93b3-d94c8ea2c869">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNS00LTEtMS03OTg2OQ_5b4350b4-4ba2-4379-a499-3e31a3ac549d">1,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="margin-bottom:1pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 15 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><ix:continuation id="i92db9735a24f479fbcccd1b37211b8b6"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTMw_89b785a2-6286-4058-bdce-2ae8fcd3ffdf" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:61.418%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.908%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMi0yLTEtMS03OTg2OQ_3432535c-b872-4408-9c68-555cae9c7539">5,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMi00LTEtMS03OTg2OQ_925e9e7f-b74c-4f5f-a314-840e86f881cc">5,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMy0yLTEtMS03OTg2OQ_3b153dbf-a2ae-4ae2-be61-8733fe18a6ff">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMy00LTEtMS03OTg2OQ_b348ea9a-fff8-441f-a581-1d2325be44fe">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfNC0yLTEtMS03OTg2OQ_dcd2d4d2-71d5-4142-9ba5-1041bee7100c">5,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfNC00LTEtMS03OTg2OQ_2f41d644-a8ee-44df-ba59-0f647b483134">5,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMjE1Mw_a5708041-bc9e-4b6c-b219-27d2761da04e" continuedAt="i37613cccee1d47e98759c0f715fbcabc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i37613cccee1d47e98759c0f715fbcabc" continuedAt="if8cba8edca074f13901f104549dbc0bd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net loss per share is calculated by dividing net loss - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#8217;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#8217;s Employee Share Purchase Plan (&#8220;ESPP&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#8217;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#8217;s ESPP has been calculated using the treasury stock method. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMjE0Nw_7f57db81-6a22-4ee7-ba51-6970e6819bc0" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.768%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Loss Per Share:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMy02LTEtMS03OTg2OQ_d6e105b4-d946-49ae-845b-e27c8f8c41d0">30,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMy04LTEtMS03OTg2OQ_f0f748ea-6536-4f65-9474-e830789594f7">26,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOC02LTEtMS03OTg2OQ_190242a7-d6d3-45cc-a9ab-c478eff1fbca">63,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOC04LTEtMS03OTg2OQ_5b8f1823-a919-4983-9165-8b6934fe0512">58,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOS02LTEtMS03OTg2OQ_994fa049-f4f5-4812-999a-e5deebf8a197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOS04LTEtMS03OTg2OQ_c989492b-39e7-4505-a013-51c65fe8bb34">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTEtNi0xLTEtNzk4Njk_ad0fba21-9693-4dc2-9cec-de1c23f702d2">63,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTEtOC0xLTEtNzk4Njk_16ecc962-acad-42e0-9d31-e59ba50dfe1d">58,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTMtNi0xLTEtNzk4Njk_5c86b28a-74a8-4338-8b47-6774b36dc064">0.48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTMtOC0xLTEtNzk4Njk_9e56b18f-7a76-42dd-801b-00df02322536">0.45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTQtNi0xLTEtNzk4Njk_d5884f18-f526-4487-8f8a-55e7fc068ef3">0.48</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTQtOC0xLTEtNzk4Njk_f7bf368f-c8d0-490d-9913-f7624351a86a">0.45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if8cba8edca074f13901f104549dbc0bd">Potential ordinary shares of&#160;<ix:nonFraction unitRef="shares" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMTY2OA_6478e21d-7730-44c0-b506-d1555a329e7d">12,463</ix:nonFraction>&#160;and&#160;<ix:nonFraction unitRef="shares" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMTY3NQ_1c584787-00de-4dfe-a995-71143a92803d">17,696</ix:nonFraction>&#160;were excluded from the calculation of weighted average shares for the three months ended March&#160;31, 2023 and 2022, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from performance share unit awards (&#8220;PSUs&#8221;) for which the contingent vesting condition had not been achieved. For the three months ended March&#160;31, 2023 and 2022, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.</ix:continuation>&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 16 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RleHRyZWdpb246ZWFhNDU1ODRiNjk5NDZjZDlkMDI2ZmNmZjcxNjAyYmFfMzg2_338f37f0-fabb-4af8-8611-8bf2d69d8c55" continuedAt="i35cfb6ab448c433591733adff7bd6f6b" escape="true">Comprehensive Loss&#160;</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i35cfb6ab448c433591733adff7bd6f6b"><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RleHRyZWdpb246ZWFhNDU1ODRiNjk5NDZjZDlkMDI2ZmNmZjcxNjAyYmFfMzgz_976ec1be-f9a2-4583-b743-2c93140d3116" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three months ended March&#160;31, 2023 and 2022, respectively, net of tax effects:&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:73.055%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.381%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5886c0d106614c858fffef30aab67fd4_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNC02LTEtMS03OTg2OQ_ac10313b-84a4-4c68-94ab-e054ef8c5917">24,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f2e203d2b94d95b66e864ec15b4449_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNC04LTEtMS03OTg2OQ_5556d9a1-4a6c-4e7d-89d2-2c0870e0bc43">23,855</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfab2c03c2f64e0390fe6350accb23da_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNS02LTEtMS03OTg2OQ_45d6937c-a960-431a-804c-a2d07dd8fbb2">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib999fc432bf54ee889b0167c94099114_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNS04LTEtMS03OTg2OQ_458b1db4-bd04-4327-922f-e9e01399ec86">185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74c73f0392b24707bcf0aa081fb42453_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNi02LTEtMS03OTg2OQ_43291122-b02c-42a4-993f-c5c19e0306fe">24,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41dce19a3844455fae5e06d004fb2dae_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNi04LTEtMS03OTg2OQ_e19cf1f8-240d-4659-a3db-3b2fe35452a0">24,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfed34d223564ae39def036cff17412b_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfOS02LTEtMS03OTg2OQ_bbcc6853-ca1d-432e-b830-41a644c40e1f">1,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie970e5169b154723b235fcca299a98c3_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfOS04LTEtMS03OTg2OQ_fe45dd76-1922-4dec-a4d7-22410fac932f">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss), net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo5MmFjZDk1NTI3NzU0MjExOTNmZmU0M2M4ZjJhMGYxN183NA_fed9c667-3f02-4402-886f-0af874491a7f">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo5MmFjZDk1NTI3NzU0MjExOTNmZmU0M2M4ZjJhMGYxN184MQ_9841e0ea-dd43-4132-90ef-b2ee3e08231c">330</ix:nonFraction>, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b73e469fad46e381038498c748c0c5_D20230101-20230331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtNi0xLTEtNzk4Njk_efbf4487-a1b6-4a10-886a-dc77f7a3305f">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb3550bc32e4b638a3f1849f6d8fac3_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtOC0xLTEtNzk4Njk_a77a8683-383f-4e15-afe3-fbfbd26b6011">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i884a39afb0a843b09e81a9e1e807a434_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTEtNi0xLTEtNzk4Njk_8a7c72fa-002b-46fe-87b0-62f0efc4d05d">1,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4600b4ecedc44e2181775b186fbc6c78_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTEtOC0xLTEtNzk4Njk_ada07f06-7e8a-4c9d-bfc8-f0200a7c8ac4">1,002</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b7320cd55fe4ab18058db41d1e57eda_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTItNi0xLTEtNzk4Njk_2e3c2d62-fdfb-4ef1-9d5e-ba78b9a7e0ec">26,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8b9adec52d54e12a5433ac63da3e86b_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTItOC0xLTEtNzk4Njk_35f8315b-c2eb-410e-b369-7f1405dac65c">25,042</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on the Company&#8217;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfODcwMw_09abbab1-53ef-48c5-9b99-4bf5ee51cc2d" continuedAt="i6d3658bbd3fe4b06a503e745f63de86a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></ix:nonNumeric></div><div><span><br/></span></div><ix:continuation id="i6d3658bbd3fe4b06a503e745f63de86a" continuedAt="i80140fd77e984c4683844672d7fa29d8"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At March 31, 2023 and December 31, 2022, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations, cash flows or liquidity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Jazz Complaint</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;First Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the First Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC (&#8220;Avadel CNS&#8221;) will infringe at least one claim of U.S. Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 17 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i80140fd77e984c4683844672d7fa29d8" continuedAt="i062e5e0c7d574db9b52c4ee2a4ee6703"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#8217;s action on Avadel CNS&#8217;s NDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation. A corresponding order was entered in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, Jazz filed an amended Answer to the Avadel Parties&#8217; Counterclaims (&#8220;the Jazz First Amended Answer&#8221;). The Jazz First Amended Answer is substantially similar to the Jazz Answer except insofar as it adds an affirmative defense for judicial estoppel and unclean hands. Corresponding amended answers were filed in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2022, Avadel CNS filed a Renewed Motion for Judgment on the Pleadings, with respect to its counterclaim against Jazz seeking to have U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;) delisted from the Orange Book and seeking to have the motion resolved concurrent with the parties&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing on August 31, 2022. On July 7, 2022, Jazz filed a response it styled as Objections to Avadel CNS&#8217; Motion for Judgment on the Pleadings. On July 14, 2022, Avadel CNS replied to Jazz&#8217;s response, and on July 21, 2022, Avadel CNS requested oral argument on its delisting motion simultaneous with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing. On August 24, 2022, the Court ordered Jazz to respond substantively to Avadel CNS&#8217; motion, which Jazz did on August 26, 2022. Avadel CNS filed its reply on August 28, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2022, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was postponed. On September 7, 2022, the case was reassigned to a new judge, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was held on October 25, 2022. At the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing, Avadel CNS reiterated its request for an expedited hearing on the Renewed Motion for Judgment on the Pleadings for the delisting of the REMS Patent. On October 28, 2022, the Court granted Avadel CNS&#8217; request and scheduled the hearing for November 15, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Court held the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing on November 15, 2022 and issued a claim construction ruling on November 18, 2022.  Also on November 18, 2022 the Court granted Avadel&#8217;s Renewed Motion for Judgment on the Pleadings and ordered Jazz to request delisting of the REMS Patent from the Orange Book. On November 22, 2022, Jazz appealed that decision and on December 14, 2022, the Federal Circuit issued a stay of the delisting order until further notice. Oral argument was held February 14, 2023. On February 24, 2023, the United States Court of Appeals for the Federal Court affirmed the previous ruling from the Court, ordering the delisting of the REMS Patent from the Orange Book, which has since occurred. On March 7, 2023, in response to a joint stipulation filed by the parties, the Court issued an order dismissing Jazz&#8217;s infringement claims against the Avadel Parties relating to the REMS Patent as well as Avadel Parties&#8217; noninfringement and invalidity counterclaims relating to the REMS Patent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, the parties submitted a Stipulation and Proposed Order Modifying the Case Schedule to accommodate additional claim construction proceedings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">That stipulation remains pending before the Court. On April 26, 2023 the parties filed their Supplemental Joint Claim Construction Brief.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Second Jazz Complaint </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Second Avadel Answer&#8221;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 18 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i062e5e0c7d574db9b52c4ee2a4ee6703" continuedAt="i3b0f1ee721e044588a5db71c4e80be03"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, Jazz filed another formal complaint (the &#8220;Third Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Third Avadel Answer&#8221;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fourth Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2022, Jazz filed another formal complaint (the &#8220;Fourth Complaint&#8221;) initiating a lawsuit in the Court against Avadel CNS. In the Fourth Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of the REMS Patent, which was asserted in the First Complaint. The FDA required Avadel CNS to file a Paragraph IV certification against the REMS Patent, which Avadel CNS did under protest, consistent with its Renewed Motion for Judgment on the Pleadings for the delisting of the REMS Patent from the Orange Book, which was later ordered to be delisted in the above First Jazz Complaint action. Avadel CNS provided the required notice of its Paragraph IV certification to Jazz, and Jazz reasserted the REMS Patent in a separate action following receipt of that notice. The Fourth Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 21, 2022, Jazz served the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 21, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Fourth Avadel Answer&#8221;) with the Court in response to the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Fourth Avadel Answer generally denies the allegations set forth in the Fourth Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims for i) a declaratory judgment of non-infringement of the patent-in-suit,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit, iii) delisting of the patent-in-suit from the Orange Book; iv) monopolization under the Sherman Antitrust Act of 1890 (the &#8220;Sherman Act&#8221;); and v) attempted monopolization under the Sherman Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 9, 2022, Jazz filed a Motion to Dismiss Avadel&#8217;s Antitrust Counterclaims.  Avadel filed its opposition brief on December 27, 2022, and Jazz filed its reply brief on January 6, 2022.  On January 11, 2023, Avadel filed a request for oral argument on the motion, which is still pending.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 6, 2023, the parties filed a stipulation of dismissal, dismissing Jazz&#8217;s claims with respect to the REMS Patent and Avadel&#8217;s related non-infringement and invalidity counterclaims.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court entered that stipulation on March 7, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avadel Complaint</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2022, Avadel CNS and Avadel Pharmaceuticals plc (collectively the &#8220;Avadel Plaintiffs&#8221;) filed a formal complaint (the &#8220;Avadel Complaint&#8221;) initiating a lawsuit in the Court against Jazz and Jazz Pharmaceuticals Ireland Ltd. (collectively, the &#8220;Jazz Parties&#8221;). In the Avadel Complaint, the Avadel Plaintiffs allege that the Jazz Parties breached certain confidential disclosure agreements and misappropriated certain of the Avadel Plaintiffs&#8217; trade secrets. The Avadel Complaint further </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 19 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i3b0f1ee721e044588a5db71c4e80be03" continuedAt="idbf8f9bf5e5a46739f0ad8fa76cdbe9e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes typical relief requests such as injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses, as well as seeking correction of inventorship of certain Jazz patents, for which the Jazz Parties claim ownership, to include former Avadel Plaintiffs&#8217; scientists.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2022, Jazz answered the Avadel Complaint. The Answer generally denies the allegations set forth in the Avadel Complaint and includes various affirmative defenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 8, 2022, Jazz filed a Motion for Judgment on the Pleadings seeking to have all Counts dismissed for failure to state a claim upon which relief can be granted. The Avadel Plaintiffs&#8217; response to that Motion was filed with the Court on July 29, 2022. Jazz&#8217;s reply was filed with the Court on August 5, 2022. On February 2, 2023, the Court held a hearing on Jazz&#8217;s Motion for Judgment on the Pleadings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 2, 2023, the Court held a hearing on Jazz&#8217;s Motion for Judgment on the Pleadings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administrative Procedure Act</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2022, Avadel CNS filed an Administrative Procedure Act suit against the FDA, the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs (the &#8220;Federal Defendants&#8221;) in the United States District Court for the District of Columbia (the &#8220;DC Court&#8221;) related to the NDA for LUMRYZ (sodium oxybate). This suit alleges that the FDA&#8217;s decision requiring Avadel CNS to file a patent certification concerning the REMS Patent was arbitrary, capricious and contrary to law and asks the DC Court to vacate the FDA&#8217;s decision and order the FDA to take final action on the LUMRYZ NDA. On July 28, 2022, the DC Court granted Jazz&#8217;s unopposed motion to intervene in the case to defend the FDA&#8217;s decision. The DC Court also entered an expedited briefing schedule governing Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and the Federal Defendant&#8217;s and Jazz&#8217;s oppositions to that motion and anticipated cross-motions for summary judgment. On August 19, 2022, the Federal Defendants and Jazz filed their combined oppositions to Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and cross-motions for summary judgment. On September 2, 2022, Avadel CNS filed its combined reply in support of its motion for preliminary injunction or, in the alternative, summary judgment, and opposition to the cross-motions for summary judgment. On September 14, 2022, the Federal Defendants and Jazz filed their replies in support of their cross-motions for summary judgment. On October 7, 2022, the DC Court heard oral arguments of Avadel CNS&#8217;s motion and the Federal Defendants and Jazz&#8217;s cross-motions. On November 3, 2022, the DC Court issued its opinion determining that Avadel CNS is not entitled to seek relief under the APA because of the availability of adequate alternative relief in the Court, specifically, in the form of its counterclaim to have the REMS Patent delisted from the FDA&#8217;s Orange Book described above in the section regarding the First Jazz Complaint.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than commitments disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 11: Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's consolidated financial statements included in the 2022 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s guarantee to Deerfield Capital L.P. (&#8220;Deerfield&#8221;) and the guarantee received by the Company from Armistice Capital Master Fund, Ltd. largely offset and when combined are not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of its pediatric assets, including four pediatric commercial stage assets &#8211; Karbinal&#8482; ER, Cefaclor, Flexichamber&#8482; and AcipHex&#174; Sprinkle&#8482; (&#8220;FSC products&#8221;), to Cerecor, Inc. (&#8220;Cerecor&#8221;), the Company guaranteed to Deerfield a quarterly royalty payment of <ix:nonFraction unitRef="number" contextRef="ib86ab8d9c4634403b053a99efce9ad0f_D20180201-20180228" decimals="2" name="avdl:PercentageOfRoyaltyPayableOnNetSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfNTQ5NzU1ODQ5MjI2_f7cc511e-92a6-4722-8248-ecfbe5333360">15</ix:nonFraction>% on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately $<ix:nonFraction unitRef="usd" contextRef="ib86ab8d9c4634403b053a99efce9ad0f_D20180201-20180228" decimals="-3" name="avdl:RoyaltyPayableonNetSalesMaximum" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfNTQ5NzU1ODQ5MzYx_a3ae7d1d-003f-4df5-8b3b-a47462085c28">10,300</ix:nonFraction>. Given the Company&#8217;s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $<ix:nonFraction unitRef="usd" contextRef="ieee9f18c297a4b43b9cc2748153d6ed6_I20230331" decimals="-3" name="us-gaap:GuarantyAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfMjE5OTAyMzI5NTA2Ng_94f545e2-8e98-4e43-bd80-97c04338e0a4">703</ix:nonFraction> at March&#160;31, 2023.  This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 20 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idbf8f9bf5e5a46739f0ad8fa76cdbe9e">In connection with the Company&#8217;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $<ix:nonFraction unitRef="usd" contextRef="ifd63efb1c00f48f3823eae02ac5437c1_I20230331" decimals="-3" name="us-gaap:GuarantyLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfMjE5OTAyMzI5NTA2Mg_c3a7c5de-d58f-4b89-8cc2-7b293cd6c59a">702</ix:nonFraction> at March&#160;31, 2023. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield noted above.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_1122"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10: <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV80Mzk4MDQ2NTEyMTY5_ea418790-2ad6-4bac-a467-5892c5bd4e85" continuedAt="i9ad5763099af49878f3ea243cb61d261" escape="true">Restructuring Costs</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i9ad5763099af49878f3ea243cb61d261"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Corporate Restructuring Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company announced a plan to optimize its cost structure to reduce total quarterly cash operating expenses, excluding inventory purchases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost structure optimization efforts included a nearly <ix:nonFraction unitRef="number" contextRef="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331" decimals="2" name="avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV81NDk3NTU4MTQyMzM_e0907bf9-c1f2-497b-bd1f-1646ba8a414b">50</ix:nonFraction>% reduction in its workforce that was completed at the end of August 2022 (the &#8220;2022 Corporate Restructuring Plan&#8221;).  </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV80Mzk4MDQ2NTEyMTcw_785237b8-3423-45f1-845d-b75f7dadf5b7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s 2022 Corporate Restructuring Plan obligations as of March 31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.913%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Corporate Restructuring Plan Obligation:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b8d582396945bdab449e41a5853249_I20221231" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl8yLTItMS0xLTgzNTM0_bc2a7693-9e92-4ca8-a1e9-30b6e1614fe2">435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331" decimals="-3" name="avdl:RestructuringChargesBeforeGainLossDuetoCurtailment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl8zLTItMS0xLTgzNTM0_2646bd3d-e697-4af3-947e-e3ab9e6b51c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRestructuring" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl80LTItMS0xLTgzNTM0_fba9906e-ccc9-42ba-965f-c664ba00141a">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331" decimals="-3" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl81LTItMS0xLTgzNTM0_7c3725c3-b962-4133-8207-361d197a41dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl82LTItMS0xLTg0MDI0_29a80633-9385-4331-aea7-e1641010d02f">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 Corporate Restructuring Plan liabilities of $<ix:nonFraction unitRef="usd" contextRef="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331" decimals="-3" name="us-gaap:RestructuringReserve" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV8zODQ4MjkwNjk4NzI2_031b0827-5c09-4379-905d-89eb908f942c">207</ix:nonFraction> are included in the unaudited condensed consolidated balance sheet in accrued expenses at March 31, 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11: <ix:nonNumeric contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMTM1Mw_c87070b2-6689-4a3e-b4fc-cdf5fb2c63d0" continuedAt="ib3de2d9cafd44e8aaa6dd451fa1b7c8c" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib3de2d9cafd44e8aaa6dd451fa1b7c8c"><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Over the course of April 3 and April 4, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Issuer completed an exchange of $<ix:nonFraction unitRef="usd" contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfNTQ5NzU1ODE2NTU1_f6cefa4e-234a-450c-a593-dd1f992ba21c">96,188</ix:nonFraction> of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">its $<ix:nonFraction unitRef="usd" contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfNTQ5NzU1ODE2NTYx_1f64595f-5eaa-4fca-970a-4d7ebe795b3d">117,375</ix:nonFraction> October 2023 Notes. The $<ix:nonFraction unitRef="usd" contextRef="i38b943b369fe40318b5dc1a1abcb5786_D20230403-20230403" decimals="-3" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzY4Mw_35b23e9f-3256-40f2-a7ef-c5bb05ee598c">96,188</ix:nonFraction> of notes were exchanged for $<ix:nonFraction unitRef="usd" contextRef="ife27a702c1604bfaab93fe6b27c28f80_I20230404" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzY5Mg_bbb8aacd-7965-4995-9663-298e97c35ede">106,268</ix:nonFraction> of a new series of <ix:nonFraction unitRef="number" contextRef="i26f74d8cc0d245b9946db9086ec31c5f_I20230404" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcwMg_9f9b4492-b9aa-4426-b459-dad911a238e8">6.0</ix:nonFraction>% exchangeable notes due April 2027 (the &#8220;April 2027 Notes&#8221;). The remaining $<ix:nonFraction unitRef="usd" contextRef="i8fdfb2995db447c186216c675ed244de_I20230404" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcwOA_46cc133a-7027-43b7-86b4-bcfa65a90651">21,187</ix:nonFraction> aggregate principal amount of the October 2023 Notes will mature October 2, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 3 2023, the Company completed the sale of ordinary shares, nominal value $<ix:nonFraction unitRef="usdPerShare" contextRef="i7323a019b2284fc9b9e443691e400926_I20230331" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwNDM1MA_f643b972-760e-4858-b053-36b5e2007b25">0.01</ix:nonFraction> per share (&#8220;Ordinary Shares&#8221;) in the form of ADSs and Series B Preferred Shares in an underwritten public offering. The Company issued <ix:nonFraction unitRef="shares" contextRef="ide7281a9b4cc4e4a95874ed482a2c8f6_D20230403-20230403" decimals="-3" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcxNw_e8b3518f-22f3-435c-815f-d2be418720c4">4,706</ix:nonFraction> Series B Preferred Shares and <ix:nonFraction unitRef="shares" contextRef="if79cc4b4f8a24f1db47139a8b309feab_D20230403-20230403" decimals="-3" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzczNw_001b56a6-460a-41da-9212-1c92ad3c3508">12,205</ix:nonFraction> of its ADSs and received net proceeds from the equity financing of $<ix:nonFraction unitRef="usd" contextRef="i472c73ab7bb046679dab57540005d848_D20230329-20230403" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcyNA_2a137925-6580-48f7-be7f-6358402afc7e">135,125</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i9961149acfda4623881e412da9b843c4_D20230331-20230331" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzI5ODUzNDg4OTcxMA_14b3696a-d02f-4a05-abe9-b40cd8a92949">40,000</ix:nonFraction> was received on March 31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="iaaa294d327ad4af790c20a25c207e257_D20230403-20230403" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzI5ODUzNDg4OTc0OQ_c787afb6-4b58-46b7-b70b-b204831a02e5">95,125</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> was received on April 3, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 1, 2023, LUMRYZ was approved by the FDA. At that time, the FDA granted Orphan Drug Exclusivity (&#8220;ODE&#8221;) to LUMRYZ for a period of <ix:nonNumeric contextRef="i23c52e144f274ff58d06a0258a38c8ec_D20230501-20230501" name="avdl:OrphanDrugExclusivityTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwNDM3Nw_0187ecc3-7e32-471b-8a2b-bfe9ea267780">seven years</ix:nonNumeric> until May 1, 2030.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 21 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND&#160;RESULTS OF OPERATIONS&#160;</span></div><div id="i250897ddd94942958d86fa6dfe7818ac_88"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You should read the discussion and analysis of our financial condition and results of operations set forth in this Item 2 together with our unaudited condensed consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this Quarterly Report on Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties, and reference is made to the &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; set forth immediately following the Table of Contents of this Quarterly Report on Form 10-Q for further information on the forward looking statements herein. In addition, you should read the &#8220;Risk Factors&#8221; section in Part I, Item 1A of our Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> March 29, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> and Part II, Item 1A in this Quarterly Report on Form 10-Q for a discussion of additional important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis and elsewhere in this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company. Our lead product, LUMRYZ, formerly known as FT218, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of our lead product, we continue to evaluate opportunities to expand our product portfolio. As of the date of this Quarterly Report, LUMRYZ is the only commercialized product in our portfolio.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LUMRYZ</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lead product LUMRYZ was approved by the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;) in May 2023 for the treatment of cataplexy or EDS in adults with narcolepsy. In approving LUMRYZ, the FDA approved a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) for LUMRYZ to help ensure that the benefits of the drug in the treatment of cataplexy and EDS in narcolepsy outweigh the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion of the drug. Under this REMS, healthcare providers must be specially certified, pharmacies, practitioners, or health care settings that dispense the drug must be specially certified and the drug must be dispensed to patients with documentation of safe use conditions. Additionally, with its approval, the FDA also granted seven years of orphan drug exclusivity to LUMRYZ for the treatment of cataplexy or EDS in adults with narcolepsy due to a finding of clinical superiority of LUMRYZ relative to currently marketed oxybate treatments. In particular, FDA found that LUMRYZ makes a major contribution to patient care over currently marketed, twice-nightly oxybate treatments by providing a once-nightly dosing regimen that avoids nocturnal arousal to take a second dose. We are advancing our preparations for the commercial launch of LUMRYZ. For example, on March 15, 2023, we were notified by the FDA that we are permitted to conduct certain pre-launch activities including the importation of foreign manufactured product under the Pre-launch Activities Importation Request (&#8220;PLAIR&#8221;) Program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to clinical data generated for LUMRYZ, we conducted a Phase 3 clinical trial of LUMRYZ (the &#8220;REST-ON trial&#8221;), which was a randomized, double-blind, placebo-controlled study that enrolled 212 patients who received at least one dose of LUMRYZ or placebo, and was conducted in clinical sites in the U.S., Canada, Western Europe and Australia. The last patient&#8217;s last visit was completed at the end of the first quarter of 2020, and positive top line data from the REST-ON trial was announced on April 27, 2020. Patients who received 9 g of once-at-bedtime LUMRYZ, the highest dose administered in the trial, demonstrated statistically significant and clinically meaningful improvement compared to placebo across the three co-primary endpoints of the trial: maintenance of wakefulness test (&#8220;MWT&#8221;), clinical global impression-improvement (&#8220;CGI-I&#8221;), and mean weekly cataplexy attacks. The lower doses assessed, 6 g and 7.5 g, also demonstrated statistically significant and clinically meaningful improvement on all three co-primary endpoints compared to placebo. We observed the 9 g dose of once-at-bedtime LUMRYZ to be generally well-tolerated. Adverse reactions commonly associated with sodium oxybate were observed in a small number of patients (nausea 1.3%, vomiting 5.2%, decreased appetite 2.6%, dizziness 5.2%, somnolence </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 22 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9%, tremor 1.3% and enuresis 9%), and 3.9% of the patients who received 9 g of LUMRYZ discontinued the trial due to adverse reactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, the FDA granted LUMRYZ orphan drug designation for the treatment of narcolepsy, which made LUMRYZ eligible for certain development and commercial incentives, including potential U.S. market exclusivity for up to seven years. With the approval of LUMRYZ on May 1, 2023, the FDA also granted seven years of orphan drug exclusivity to LUMRYZ for the treatment of cataplexy or EDS in adults with narcolepsy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">That orphan exclusivity will continue until May 1, 2030.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, thirteen LUMRYZ-related U.S. patents have been issued having expiration dates spanning from mid-2037 to early-2042, and there are additional patent applications currently in development and/or pending at the U.S. Patent and Trademark Office (&#8220;USPTO&#8221;), as well as foreign patent offices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, we announced that the first patient was dosed in our open-label extension (&#8220;OLE&#8221;)/switch study of LUMRYZ as a potential treatment for cataplexy or EDS in patients with narcolepsy (&#8220;RESTORE&#8221;). The RESTORE study is examining the long-term safety and maintenance of efficacy of LUMRYZ in patients with narcolepsy who participated in the REST-ON study, as well as dosing and preference data for patients switching from twice-nightly sodium oxybate to once-at-bedtime LUMRYZ, regardless of whether they participated in REST-ON. In May 2021, inclusion criteria were expanded to allow for oxybate na&#239;ve patients to enter the study. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New secondary endpoints from the REST-ON trial were presented at the American Academy of Neurology, beginning April 17, 2021. The first poster described LUMRYZ improvements in disturbed nocturnal sleep (&#8220;DNS&#8221;), defined in REST-ON as the number of shifts from stages N1, N2, N3, and rapid eye movement (&#8220;REM&#8221;) sleep to wake and from stages N2, N3, and REM sleep to stage N1. LUMRYZ also decreased the number of nocturnal arousals as measured on polysomnography. Improvements in DNS were further supported by post-hoc analyses demonstrating increased time in deep sleep (N3, also known as slow wave sleep), and less time in N1. A second poster described the statistically significant improvements in the Epworth Sleepiness Scale (&#8220;ESS&#8221;), both the quality of sleep and the refreshing nature of sleep, and a decrease in sleep paralysis. These clinically relevant improvements were observed for all doses, beginning at week 3, for the lowest 6 g dose, compared to placebo. LUMRYZ did not demonstrate significant improvement for hypnagogic hallucinations compared to placebo. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data supportive of the efficacy findings in REST-ON were presented at the 35th Annual Meeting of the Associated Professional Sleep Societies, a joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society, also known as SLEEP 2021, beginning June 10, 2021. New data included post-hoc analyses demonstrating endpoints improvements, regardless of concomitant stimulant use, in both narcolepsy Type 1 (&#8220;NT1&#8221;) or Type 2 (&#8220;NT2&#8221;). Additionally, a post-hoc analysis showed that LUMRYZ was associated with decreased body mass index compared to placebo, which may be relevant as people with narcolepsy often have co-morbid obesity. In August 2021, the primary results from the REST-ON trial were published by Kushida et al. in the journal SLEEP. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New data was presented at the American College of Chest Physicians annual meeting (&#8220;CHEST&#8221;), beginning October 17, 2021, including additional post-hoc analyses from the REST-ON trial, demonstrating a greater proportion of patients receiving LUMRYZ experienced reductions in weekly cataplexy attacks and improvement in mean sleep latency compared to placebo, as well as the results of a discrete choice experiment, indicating that the overall driver of patient preference between sodium oxybate treatments is a once-at-bedtime, versus twice-nightly, formulation.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New data was presented at World Sleep 2022 Congress in March 2022, in Rome, Italy. A total of eight posters were presented, including five new post-hoc analyses from the REST-ON trial. Most notably, the post-hoc analyses showed that LUMRYZ demonstrated improvement in subjective measures of daytime sleepiness, sleep quality and refreshing nature of sleep as early as week 1 with the 4.5 g starting dose, with even greater improvement at week 2 soon after starting the 6 g dose compared to placebo. Additional post-hoc analyses, stratified by narcolepsy type, as well as concomitant stimulant use, or without stimulants, demonstrated positive results that are generally consistent with previously reported positive endpoints from REST-ON and add to the existing body of evidence for LUMRYZ.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the results of a discrete choice experiment (&#8220;DCE&#8221;) were presented, which showed that once-at-bedtime dosing, when compared to twice-nightly dosing, was the most important attribute driving both patient and clinician preference for overall oxybate product choice, as well as patient quality of life and reduction of patient anxiety/stress; dosing frequency (twice-nightly versus once-at-bedtime) was also viewed as a more important attribute as compared to other attributes assessed, including sodium content. Accompanying the DCE was a background survey for both patients and clinicians, which showed that dosing frequency was noted as a significant stressor by both patients and clinicians. The World Sleep 2022 presentations also included the first presentation of an interim safety analysis from the ongoing RESTORE study, which showed that LUMRYZ has generally been well-tolerated, with some patients receiving therapy for more than 18 months. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 23 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional peer-reviewed publications have included data on improvement on DNS, the first DCE and a Plain Language Summary reviewing sodium oxybate and cardiovascular health, which did not identify a signal of cardiovascular disease in the twenty years that sodium oxybate has been available. At the annual SLEEP Congress in June 2022, nine posters were presented, including five post-hoc analyses from REST-ON which support the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A low number-needed-to-treat to achieve effectiveness across all three evaluated doses, as well as effect sizes, showing a moderate-to-high effect for improving MWT, ESS, and number of cataplexy attacks; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation via various statistical methods to handle missing data that LUMRYZ improved cataplexy and EDS symptoms versus placebo; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation of benefit for NT1 and NT2 for DNS and ESS; </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confirmation of benefit for subgroups taking stimulants and those without stimulants for DNS and ESS; and </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Early efficacy (Week 1 and Week 2) for ESS, refreshing nature of sleep and quality of sleep. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, interim data from RESTORE were presented demonstrating that a high proportion of patients switching from twice-nightly sodium oxybate formulations had difficulty in taking the second dose, with a high proportion (92.5%) stating a preference for the once-at-bedtime dosing regimen and that most participants (62%) switching from twice-nightly sodium oxybate formulations had a stable dose equal to their starting dose; participants not currently taking sodium oxybate formulations or oxybate naive reached a stable dose with 2&#8211;4 dose titrations within four weeks. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional peer-review publications have included a relative bioavailability pharmacokinetics (&#8220;PK&#8221;) study and a Plain Language Summary of the primary REST-ON trial results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe LUMRYZ has the potential to demonstrate improved dosing compliance, safety and patient satisfaction over the current standards of care for cataplexy or EDS in patients with narcolepsy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Business Trends and Highlights</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In operating our business and monitoring our performance, we consider a number of performance measures, as well as trends affecting our industry as a whole, which include the following:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Healthcare and Regulatory Reform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Various health care reform laws in the U.S. may impact our ability to successfully commercialize our products and technologies. The success of our commercialization efforts may depend on the extent to which the government health administration authorities, the health insurance funds in the E.U. Member States, private health insurers and other third-party payers in the U.S. will reimburse consumers for the cost of healthcare products and services.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competition and Technological Change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition in the pharmaceutical and biotechnology industry continues to be intense and is expected to increase. We compete with academic laboratories, research institutions, universities, joint ventures, and other pharmaceutical and biotechnology companies, including other companies developing niche branded or generic specialty pharmaceutical products or drug delivery platforms. Furthermore, major technological changes can happen quickly in the pharmaceutical and biotechnology industries. Such rapid technological change, or the development by our competitors of technologically improved or differentiated products, could render our products, product candidates, or drug delivery platforms obsolete or noncompetitive.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Pricing Environment for Pharmaceuticals</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The pricing environment continues to be in the political spotlight in the U.S. As a result, the need to obtain and maintain appropriate pricing for pharmaceutical products may become more challenging due to, among other things, the attention being paid to healthcare cost containment and other austerity measures in the U.S. and worldwide.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Generics Playing a Larger Role in Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Generic pharmaceutical products will continue to play a large role in the U.S. healthcare system. As such, we expect to see generic competition for our products in the future.</span></div><div style="padding-left:33.75pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 24 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Access to and Cost of Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We have a recent history of generating losses from operations and expect to continue generating losses until we are able to commercially launch LUMRYZ, and generate revenues sufficient to generate positive cash flow from operations. Similar to other businesses in our industry and at our stage of development, we will continue to rely on external sources of capital to fund our business. The process of raising capital and associated cost of such capital for a company of our financial profile can be difficult and potentially expensive. If the need were to arise to raise additional capital, access to that capital may be difficult, expensive and/or dilutive and, as a result, could create liquidity challenges for us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%;padding-left:14.5pt">Continuing Net Loss from Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">LUMRYZ is the only commercialized product in our portfolio. We will incur substantial expenses to continue our preparations for commercial launch of LUMRYZ. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of COVID-19 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to actively monitor the COVID-19 pandemic, as well as new variants of the virus and recent increases in case numbers, and have taken measures to mitigate the potential impacts to our employees and business, such as continuing to offer a work from home policy. An extended period of global supply chain and economic disruption could materially affect our business, results of operations, access to sources of liquidity and financial condition. Despite vaccination efforts, future developments and impact on our operations remain uncertain and cannot be predicted with confidence, including the duration of the COVID-19 pandemic, new variants of the virus, new information which may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or we, may direct, which may result in extending continued business disruptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Corporate Restructuring Plan</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2022, we announced a plan to optimize our cost structure to reduce total quarterly cash operating expenses to between $12,000 and $14,000, excluding inventory purchases, by the quarter ended December 31, 2022. The targeted reduction in cash operating expenses, together with cash, cash equivalents and marketable securities currently on hand, was implemented to extend our cash runway to the middle of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost structure optimization efforts included a nearly 50% reduction in our workforce (the &#8220;2022 Corporate Restructuring Plan&#8221;). See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 10: Restructuring Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q for more information. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offering Program</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, we entered into an Open Market Sale Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program (&#8220;ATM Program&#8221;) under which we may offer and sell our ADSs (and such ADSs sold under the ATM Program, &#8220;ATM ADSs&#8221;) through Jefferies as our sales agent. We agreed to pay Jefferies a commission up to 3.0% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $50,000 of ADSs pursuant to its prospectus, dated February 14, 2020, included with our Registration Statement on Form S-3 (File No. 333-236258) (the &#8220;2020 Shelf Registration&#8221;). In August 2022, we filed an additional prospectus, dated September 12, 2022, included with our new Registration Statement on Form S-3 (File No. 333-267198) (the &#8220;2022 Shelf Registration&#8221;), in order to allocate up to $100,000 in additional ADSs to the ATM Program. The 2020 Shelf Registration expired on February 14, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Sales Agreement, we issued and sold </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,564 AD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ss during the quarter ended March 31, 2023, resulting in net proceeds to us of approximate</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ly $11,913.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Highlights</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Highlights of our consolidated results for the three months ended March&#160;31, 2023 are as follows:&#160;</span></div><div><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.53pt">Operating loss was $28,298 for the three months ended March&#160;31, 2023, compared to operating loss of $28,626 for the three months ended March 31, 2022. Selling, general and administrative expenses increased in the current period by $2,833, driven by higher legal costs of approximately $2,000, costs related to financing activities of approximately $1,300 and higher consulting fees of approximately $800, offset by lower compensation costs of $1,000. Research and development expenses decreased in the current period by&#160;$3,161,&#160;driven by lower active pharmaceutical ingredients (&#8220;API&#8221;) purchases during the current period of approximately $2,600.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 25 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net loss was $30,784 for the three months ended March&#160;31, 2023, compared to net loss of $26,424 in the same period last year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted net loss per share was $0.48 for the three months ended March&#160;31, 2023, compared to diluted net loss per share of $0.45 in the same period last year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:33.75pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cash and marketable securities increased $4,424 to $100,923 at March&#160;31, 2023, from $96,499 at December&#160;31, 2022. The increase in cash during the three months ended March 31, 2023 was driven primarily by net cash provided by financing activities of $34,442, which included approximately $40,000 of proceeds received in advance of Series B Preferred Shares issuance for the public offering and $11,913 of net proceeds from the sale of ADSs through the ATM Program, offset by $17,500 of payments for the February 2023 Notes, and net cash provided by investing activities of $5,066 due to net proceeds received from the excess of sales over purchases of marketable securities. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Critical Accounting Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. To prepare these financial statements, management makes estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, as well as the disclosures of contingent assets and liabilities. Actual results could be significantly different from these estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting policies are described in Note 1 of the audited consolidated financial statements included in our Annual Report Form 10-K for the year ended December 31, 2022 (the &#8220;2022 Form 10-K&#8221;). The SEC suggests companies provide additional disclosure on those accounting policies considered most critical. The SEC considers an accounting policy to be critical if it is important to our financial condition and results of operations and requires significant judgments and estimates on the part of management in its application. Our estimates are often based on complex judgments, probabilities and assumptions that management believes to be reasonable, but that are inherently uncertain and unpredictable. It is also possible that other professionals, applying reasonable judgment to the same facts and circumstances, could develop and support a range of alternative estimated amounts. For a complete discussion of our critical accounting policies, see the &#8220;Critical Accounting Policies&#8221; section of the Management&#8217;s Discussion &amp; Analysis in our 2022 Form 10-K. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_97"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Results of Operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial results (in thousands, except per share amounts) for the&#160;three&#160;months ended&#160;March&#160;31, 2023&#160;and&#160;2022, respectively:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comparative Statements of Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,991&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expense </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,298)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28,626)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment and other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(285.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,017)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31,364)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,747)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(617)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,424)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,360)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 26 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Research and Development Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,161)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased&#160;$3,161&#160;or&#160;45.2%&#160;during the&#160;three&#160;months ended&#160;March&#160;31, 2023&#160;as compared to the same period in the prior year. This decrease was driven by lower active pharmaceutical ingredients (&#8220;API&#8221;) purchases during the current period of approximately $2,600. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Selling, General and Administrative Expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased&#160;$2,833&#160;or&#160;13.1%&#160;during the&#160;three&#160;months ended&#160;March&#160;31, 2023&#160;as compared to the same period in the prior year, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">driven by higher legal costs of approximately $2,000, costs related to financing activities of approximately $1,300 and higher cons</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ulting fees of approximately $800. The increase in selling, general and administrative expense was offset by lower compensation costs of approximately $1,000.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,259)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,017)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,242)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $1,242 or 61.6% during the three months ended March&#160;31, 2023 as compared to the same period in the prior year. Interest expense increased by approximately $900 due to amortization of the $5,500 of debt discount related to the change in the fair value of the conversion feature of the October 2023 Notes. In addition, interest expense increased by $600 due to amortization of the $4,800 of debt issuance fees paid to note holders that participated in the Exchange Transaction in April 2022. These fees are amortized over the life of the October 2023 Notes. See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our unaudited condensed consolidated financial statements included in Part 1, Item 1 of this Quarterly Report on Form 10-Q for further details for further details. </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:46.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.274%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Tax Benefit:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(580)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Percentage of loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax benefit was $580 for the three months ended March&#160;31, 2023 resulting in an effective tax rate of 1.8%. The income tax benefit was $4,323 for the three months ended March 31, 2022 resulting in an effective tax rate of 14.1%. The change in the effective tax rate for the three months ended March&#160;31, 2023, when compared to the same period in 2022, is primarily driven by the valuation allowances recorded against net deferred tax assets established in the second quarter of 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 27 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash flows from operating, investing and financing activities, as reflected in the unaudited condensed consolidated statements of cash flows, are summarized in the following table:&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:41.252%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.580%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023 vs. 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash (used in) provided by:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,045)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,066&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(88.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,009&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,614.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $30,233 and $34,045 for the three months ended March&#160;31, 2023 and 2022. Net cash used in operating activities for the three months ended March&#160;31, 2023 was driven by net loss of $30,784 and unfavorable changes in working capital of $3,431, offset by favorable non-cash adjustments of $3,982. For the three months ended March 31, 2022, net cash used in operating activities was driven by net loss of $26,424 and a $7,043 unfavorable change in working capital. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $5,066 and $42,251 for the three months ended March&#160;31, 2023 and 2022, respectively. Net cash provided by investing activities for the three months ended March&#160;31, 2023 was due to net proceeds received from the excess of sales over purchases of marketable securities of $5,066. Net cash provided by investing activities for the three months ended March&#160;31, 2022 was du</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e to net proceeds received from the excess of sales over purchases of marketable securities of $42,251.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the three months ended March&#160;31, 2023 of $34,442 related to proceeds received in advance of Series B Preferred Shares issuance for the public offering of $40,000 and net proceeds from the sale of ADSs through the ATM Program of $11,913, offset by payments for the February 2023 Notes of $17,500. Net cash provided by financing activities for the three months ended March&#160;31, 2022 of $2,009 related to proceeds from stock option exercises and ESPP issuances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adequacy of our cash resources depends on the outcome of certain business conditions including the cost of our LUMRYZ commercial launch plans, our cost structure, and other factors set forth in &#8220;Risk Factors&#8221; within Part I, Item 1A of our Annual Report on Form 10-K filed with the SEC on March 29, 2023. To complete the LUMRYZ commercial launch plans we will need to commit substantial resources, which could result in future losses or otherwise limit our opportunities or affect our ability to operate our business. Our assumptions concerning the outcome of certain business conditions may prove to be wrong or other factors may adversely affect our business, and as a result we could exhaust or significantly decrease our available cash and marketable securities balances which could, among other things, force us to raise additional funds and/or force us to reduce our expenses, either of which could have a material adverse effect on our business. Additionally, we are unable to estimate the near or long term impacts of COVID-19 and inflation, which may have a material adverse impact on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#8217; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $83,391 of cash and cash equivalents and $17,532 of marketable securities available for use to fund its operations, debt service and capital requirements. Our ability to generate revenue is expected to start following the commercial launch of LUMRYZ in the U.S., which is dependent, in part, on our ability to successfully complete our commercialization efforts and on market acceptance of LUMRYZ in the U.S. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 29, 2023, we entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $75,000 of royalty financing in two tranches. The first tranche of $30,000 is available subject to the Company&#8217;s </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 28 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">first shipment of LUMRYZ. The second tranche is available to use, at the our election, upon achieving quarterly net revenue of $25,000. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">March&#160;31, 2023</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we had outstanding $117,375&#160;aggregate principal amount of its 4.50% exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;). Over the course of April 3 and April 4, 2023, we completed an exchange of $96,188 of our $117,375 October 2023 Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for $106,268 of a new series</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> 6.0% exchangeable notes due April 2027 (the &#8220;April 2027 Notes&#8221;) (the &#8220;2023 Exchange Transaction&#8221;). The remaining $21,187 aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 3, 2023, we completed the sale of ordinary shares, nominal value $0.01 per share (&#8220;Ordinary Shares&#8221;) in the form of ADSs and Series B Non-Voting Convertible Preferred Shares (&#8220;Series B Preferred Shares&#8221;) in an underwritten public offering. We received net proceeds from the equity financing of $135,125, of which $40,000 was received on March 31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$95,125</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> was received on April 3, 2023. The $40,000 of net proceeds received prior to the completed public offering was included in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">unaudited condensed consolidated balance sheet as p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">roceeds received in advance of Series B Preferred Shares issuance at March 31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As a result of the 2023 Exchange Transaction and public offering, we have concluded that cash on hand provides sufficient capital to meet our operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Report.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Other Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to potential liabilities generally incidental to our business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. We accrue for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At March 31, 2023 and December 31, 2022, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on our consolidated finan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cial position, results of operations, cash flows or liquidity. For information regarding legal proceedings we are involved in, see </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9: Commitments and Contingencies - Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_106"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Interest Rate Risk</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to interest rate risk as a result of our portfolio of marketable securities. The primary objectives of our investment policy are as follows: safety and preservation of principal and diversification of risk; liquidity of investments sufficient to meet cash flow requirements; and competitive yield. Although our investments are subject to market risk, our investment policy specifies credit quality standards for our investments and limits the amount of credit exposure from any single issue, issuer or certain types of investment. Our investment policy allows us to maintain a portfolio of cash equivalents and marketable securities in a variety of instruments, including U.S. federal government and federal agency securities, European Government bonds, corporate bonds or commercial paper issued by U.S. or European corporations, money market instruments, certain qualifying money market mutual funds, certain repurchase agreements, tax-exempt obligations of states, agencies, and municipalities in the U.S. and Europe, and equities.&#160;A hypothetical 50 basis point change in interest rates would not result in a material decrease or increase in the fair value of our securities due to the general short-term nature of our investment portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 29 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Foreign Exchange Risk</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to foreign currency exchange risk as the functional currency financial statements of a non-U.S. subsidiary is translated to U.S. dollars. The assets and liabilities of this non-U.S. subsidiary having a functional currency other than the U.S. dollar is translated into U.S. dollars at the exchange rate prevailing at the balance sheet date, and at the average exchange rate for the reporting period for revenue and expense accounts. The cumulative foreign currency translation adjustment is recorded as a component of accumulated other comprehensive loss in shareholders&#8217; (deficit) equity. The reported results of this non-U.S. subsidiary will be influenced by their translation into U.S. dollars by currency movements against the U.S. dollar. Our primary currency translation exposure is related to one subsidiary that has functional currencies denominated in euro. A 10% strengthening/weakening in the rates used to translate the results of our non-U.S. subsidiaries that have functional currencies denominated in euro as of March&#160;31, 2023 would have had an immaterial impact on net loss for the three months ended March&#160;31, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transactional exposure arises where transactions occur in currencies other than the functional currency. Transactions in foreign currencies are recorded at the exchange rate prevailing at the date of the transaction. The resulting monetary assets and liabilities are translated into the appropriate functional currency at exchange rates prevailing at the balance sheet date and the resulting gains and losses are reported in investment and other (expense)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income, net in the consolidated statements of loss.&#160; As of March&#160;31, 2023, our primary exposure is to transaction risk related to euro net monetary assets and liabilities held by subsidiaries with a U.S. dollar functional currency. Realized and unrealized foreign exchange gains and losses resulting from transactional exposure were immaterial for the three months ended March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Inflation Risk</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inflation generally affects us by increasing our costs of labor and supplies and the costs of our third parties we rely on for the development, manufacture and supply of our product candidates. We do not believe that inflation had a material effect on our business, financial condition or results of operations during the three months ended March&#160;31, 2023. Although we do not believe that inflation has had a material impact on our financial position or results of operations to date, we may experience some effect in the near future (especially if inflation rates continue to rise) due to an impact on the costs to conduct clinical trials, the costs to prepare for the commercialization of LUMRYZ, labor costs we incur to attract and retain qualified personnel, and other operational costs. Inflationary costs could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_109"></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of the Company, with the participation of its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of March&#160;31, 2023, the end of the period covered by this Quarterly Report on Form 10-Q.&#160; The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), means controls and other procedures of a company that are designed to provide reasonable assurance that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to provide reasonable assurance that such information is accumulated and communicated to the Company&#8217;s management, including its Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.&#160; Based on their evaluation, as of the end of the period covered by this Quarterly Report on Form 10-Q, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) were effective as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Changes in Internal Controls</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rule 13a-15 or 15d-15 that occurred during the three months ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_112"></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 30 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9: Commitments and Contingencies - Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Company&#8217;s unaudited condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.&#160;&#160;&#160;&#160;RISK FACTORS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our risk factors from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the SEC</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on March 29, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_124"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. &#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES.&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_127"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i250897ddd94942958d86fa6dfe7818ac_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5.&#160;&#160;&#160;&#160;OTHER INFORMATION.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 31 -</span></div></div></div><div id="i250897ddd94942958d86fa6dfe7818ac_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6.&#160;&#160;&#160;&#160;EXHIBITS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923039263/tm2310752d3_ex3-1.htm">Certificate of Designation of Series B Non-Voting Convertible Preferred Shares of Avadel Pharmaceuticals plc, dated March 29, 2023. (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-37977) filed with the SEC on March 30, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923041879/tm2311825d1_ex4-1.htm">Indenture, dated as of April 3, 2023, by and between Avadel Finance Cayman Limited, the Company and The Bank of New York Mellon, as Trustee (incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-37977) filed with the SEC on April 5, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923041879/tm2311825d1_ex4-1.htm">Form of 6.00% Exchangeable Senior Note due 2027 (included in Exhibit 4.1, which is incorporated by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-37977) filed with the SEC on April 5, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923038304/tm2310752d1_ex10-1.htm">Form of Exchange Agreement by and between Avadel Finance Cayman Limited, the Company and certain holders of the </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923038304/tm2310752d1_ex10-1.htm">2023 </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923038304/tm2310752d1_ex10-1.htm">Notes (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K (File No. 001-37977) filed with the SEC on March 29, 2023)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1012477/000110465923038584/tm2310752d2_ex10-2.htm">Purchase and Sale Agreement, dated March 29, 2023, between Avadel CNS Pharmaceuticals, LLC, the Company, Flamel Ireland Ltd., and RTW Royalty II DAC (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K (File No. 001-37977) filed with the SEC on March 30, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q12023.htm">Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q12023.htm">Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) promulgated under the Exchange Act</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q12023.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322q12023.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*) </span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.&#160;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Furnished herewith.&#160;</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 32 -</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:14pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:40.873%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AVADEL PHARMACEUTICALS PLC</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 4, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Duly Authorized Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer)</span></div></td></tr></table></div><div style="margin-bottom:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:40.920%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 4, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Thomas S. McHugh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Duly Authorized Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- 33 -</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311q12023.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i600fef5ec21b49a8a2deb2ab67a790ad_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gregory J. Divis, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 4, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312q12023.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i49133f7e08bf4293a5629b075788de1d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Thomas S. McHugh, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;4, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321q12023.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibd9f4da9829a4058bdad3394b0f597a8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;), the undersigned hereby certifies in his capacity as Chief Executive Officer of the Company pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)), as amended&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May&#160;4, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory J. Divis</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit322q12023.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1d4262b0790040f09b65783f1bfb245c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report on Form 10-Q of Avadel Pharmaceuticals plc (the &#8220;Company&#8221;) for the period ended March&#160;31, 2023 (the &#8220;Report&#8221;), the undersigned hereby certifies in his capacity as Chief Financial Officer of the Company pursuant to 18&#160;U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">o</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)), as amended&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; May 4, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas S. McHugh</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>avdl-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ff4affb4-5e35-499d-a060-a6a189fb41ed,g:0e980074-2bb1-4083-b23a-3722f5917d03-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:avdl="http://www.avadel.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.avadel.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avdl-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Coverpage" roleURI="http://www.avadel.com/role/Coverpage">
        <link:definition>0000001 - Document - Cover page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>0000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical">
        <link:definition>0000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurement" roleURI="http://www.avadel.com/role/FairValueMeasurement">
        <link:definition>0000010 - Disclosure - Fair Value Measurement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecurities" roleURI="http://www.avadel.com/role/MarketableSecurities">
        <link:definition>0000011 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.avadel.com/role/LongTermDebt">
        <link:definition>0000012 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.avadel.com/role/IncomeTaxes">
        <link:definition>0000013 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilities" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities">
        <link:definition>0000014 - Disclosure - Other Assets and Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.avadel.com/role/NetLossPerShare">
        <link:definition>0000015 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLoss" roleURI="http://www.avadel.com/role/ComprehensiveLoss">
        <link:definition>0000016 - Disclosure - Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.avadel.com/role/CommitmentsandContingencies">
        <link:definition>0000017 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCosts" roleURI="http://www.avadel.com/role/RestructuringCosts">
        <link:definition>0000018 - Disclosure - Restructuring Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.avadel.com/role/SubsequentEvents">
        <link:definition>0000019 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000020 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementTables" roleURI="http://www.avadel.com/role/FairValueMeasurementTables">
        <link:definition>0000021 - Disclosure - Fair Value Measurement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesTables" roleURI="http://www.avadel.com/role/MarketableSecuritiesTables">
        <link:definition>0000022 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://www.avadel.com/role/LongTermDebtTables">
        <link:definition>0000023 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesTables" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables">
        <link:definition>0000024 - Disclosure - Other Assets and Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.avadel.com/role/NetLossPerShareTables">
        <link:definition>0000025 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLossTables" roleURI="http://www.avadel.com/role/ComprehensiveLossTables">
        <link:definition>0000026 - Disclosure - Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsTables" roleURI="http://www.avadel.com/role/RestructuringCostsTables">
        <link:definition>0000027 - Disclosure - Restructuring Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000028 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementMeasuredonRecurringBasisDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails">
        <link:definition>0000029 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementNarrativeDetails" roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails">
        <link:definition>0000030 - Disclosure - Fair Value Measurement - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails">
        <link:definition>0000031 - Disclosure - Marketable Securities - Summary of Available-for-sale and Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MarketableSecuritiesNarrativeDetails" roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails">
        <link:definition>0000032 - Disclosure - Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofDebtDetails" roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails">
        <link:definition>0000033 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails">
        <link:definition>0000034 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.avadel.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000035 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>0000036 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails">
        <link:definition>0000037 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesAccruedExpensesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails">
        <link:definition>0000038 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails">
        <link:definition>0000039 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails">
        <link:definition>0000040 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>0000041 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareNarrativeDetails" roleURI="http://www.avadel.com/role/NetLossPerShareNarrativeDetails">
        <link:definition>0000042 - Disclosure - Net Loss Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLossComponentsDetails" roleURI="http://www.avadel.com/role/ComprehensiveLossComponentsDetails">
        <link:definition>0000043 - Disclosure - Comprehensive Loss - Components (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ComprehensiveLossNarrativeDetails" roleURI="http://www.avadel.com/role/ComprehensiveLossNarrativeDetails">
        <link:definition>0000044 - Disclosure - Comprehensive Loss - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.avadel.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000045 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsNarrativeDetails" roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails">
        <link:definition>0000046 - Disclosure - Restructuring Costs - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCostsSeveranceObligationDetails" roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails">
        <link:definition>0000047 - Disclosure - Restructuring Costs - Severance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.avadel.com/role/SubsequentEventsDetails">
        <link:definition>0000048 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentOptiontoIncreaseFaceAmount" abstract="false" name="DebtInstrumentOptiontoIncreaseFaceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" abstract="false" name="MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OtherNoncurrentReceivables" abstract="false" name="OtherNoncurrentReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" abstract="false" name="RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_SaleOfStockSalesAgentCommissionPercent" abstract="false" name="SaleOfStockSalesAgentCommissionPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_PublicStockOfferingMember" abstract="true" name="PublicStockOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_A2022CorporateRestructuringPlanMember" abstract="true" name="A2022CorporateRestructuringPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OrphanDrugExclusivityTerm" abstract="false" name="OrphanDrugExclusivityTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_RoyaltyPayableonNetSalesMaximum" abstract="false" name="RoyaltyPayableonNetSalesMaximum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A2022ShelfRegistrationStatementMember" abstract="true" name="A2022ShelfRegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_FSCMember" abstract="true" name="FSCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_GuaranteeNoncurrent" abstract="false" name="GuaranteeNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" abstract="false" name="DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" abstract="false" name="IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositorySharesConversionRatio" abstract="false" name="AmericanDepositorySharesConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="avdl_NatureOfBusinessPolicyPolicyTextBlock" abstract="false" name="NatureOfBusinessPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_OtherGuarantorObligationsCurrentCarryingValue" abstract="false" name="OtherGuarantorObligationsCurrentCarryingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_MutualAndMoneyMarketFundsMember" abstract="true" name="MutualAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AccruedInterestCurrent" abstract="false" name="AccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesOptionPricePerShare" abstract="false" name="AmericanDepositarySharesOptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_ProceedsReceivedInAdvanceOfShareIssuance" abstract="false" name="ProceedsReceivedInAdvanceOfShareIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesPurchasedPricePerShare" abstract="false" name="AmericanDepositarySharesPurchasedPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="avdl_DebtInstrumentExchangeAmount" abstract="false" name="DebtInstrumentExchangeAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" abstract="false" name="SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_CouponInterestExpense" abstract="false" name="CouponInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" abstract="false" name="OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AccruedOutsourceContractCosts" abstract="false" name="AccruedOutsourceContractCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" abstract="false" name="DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_April2027NotesMember" abstract="true" name="April2027NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_OtherLiabilitiesMiscellaneousCurrent" abstract="false" name="OtherLiabilitiesMiscellaneousCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_PublicStockOfferingTrancheTwoMember" abstract="true" name="PublicStockOfferingTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_ThirdPartyMember" abstract="true" name="ThirdPartyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" abstract="false" name="RoyaltyFinancingQuarterlyNetRevenueTarget" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" abstract="false" name="ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" abstract="false" name="RestructuringChargesBeforeGainLossDuetoCurtailment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesMember" abstract="true" name="AmericanDepositarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AmericanDepositarySharesPremiumPercentage" abstract="false" name="AmericanDepositarySharesPremiumPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_CerecorMember" abstract="true" name="CerecorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_PercentageOfRoyaltyPayableOnNetSales" abstract="false" name="PercentageOfRoyaltyPayableOnNetSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="avdl_LiquidityAndGoingConcernPolicyTextBlock" abstract="false" name="LiquidityAndGoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDueOctober22023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_A2016MIPAMember" abstract="true" name="A2016MIPAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" abstract="false" name="TaxLiabilitiesAndOtherNoncurrentLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_DebtConversionPrincipalAmountNotExchanged" abstract="false" name="DebtConversionPrincipalAmountNotExchanged" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" abstract="false" name="ProceedsReceivedInAdvanceOfShareIssuanceCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_A2020ShelfRegistrationStatementMember" abstract="true" name="A2020ShelfRegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_GuaranteeCurrent" abstract="false" name="GuaranteeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="avdl_PublicStockOfferingTrancheOneMember" abstract="true" name="PublicStockOfferingTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_AtTheMarketOfferingProgramMember" abstract="true" name="AtTheMarketOfferingProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" abstract="true" name="A450PercentExchangeableSeniorNotesDueFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" abstract="false" name="ResearchAndDevelopmentTaxCreditReceivableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>avdl-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ff4affb4-5e35-499d-a060-a6a189fb41ed,g:0e980074-2bb1-4083-b23a-3722f5917d03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e3403988-6914-40d0-a799-167f061de9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_dba63c5c-6c65-4c0c-92ea-aed4bb551ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e3403988-6914-40d0-a799-167f061de9eb" xlink:to="loc_us-gaap_OperatingIncomeLoss_dba63c5c-6c65-4c0c-92ea-aed4bb551ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ec324942-f331-4a14-81e4-d98a6525a5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e3403988-6914-40d0-a799-167f061de9eb" xlink:to="loc_us-gaap_InterestExpenseDebt_ec324942-f331-4a14-81e4-d98a6525a5a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_c79aaf87-68d0-423a-a7bb-ca94cd131aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e3403988-6914-40d0-a799-167f061de9eb" xlink:to="loc_us-gaap_InvestmentIncomeNet_c79aaf87-68d0-423a-a7bb-ca94cd131aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6a6e33b0-7d51-4b18-bccf-ad8cc27c0a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae825df-9504-480d-bce8-4ce3086e6e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6a6e33b0-7d51-4b18-bccf-ad8cc27c0a87" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae825df-9504-480d-bce8-4ce3086e6e91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_01d2e185-c0b6-44a8-b5d5-3f1c99172db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6a6e33b0-7d51-4b18-bccf-ad8cc27c0a87" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_01d2e185-c0b6-44a8-b5d5-3f1c99172db3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6df50a7c-5b7e-4f52-96c3-ac25233dc609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3668bebe-67e6-4261-81b2-69ffc9be9eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6df50a7c-5b7e-4f52-96c3-ac25233dc609" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3668bebe-67e6-4261-81b2-69ffc9be9eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3b0c0dc7-879d-40b6-92de-7106c527df6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_6df50a7c-5b7e-4f52-96c3-ac25233dc609" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3b0c0dc7-879d-40b6-92de-7106c527df6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c294968b-862f-4b95-a5ab-d5a33ef0ce5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f145b044-544f-4917-84ce-8b23d0c662b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c294968b-862f-4b95-a5ab-d5a33ef0ce5d" xlink:to="loc_us-gaap_CostsAndExpenses_f145b044-544f-4917-84ce-8b23d0c662b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="avdl-20230331.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e937542-f584-43ed-aeef-b71473a66920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e0365bd2-53ba-4f3d-a29f-ac907f67f3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e937542-f584-43ed-aeef-b71473a66920" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e0365bd2-53ba-4f3d-a29f-ac907f67f3b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_232152a9-4d1d-41da-a3a3-6340b19f6049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e937542-f584-43ed-aeef-b71473a66920" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_232152a9-4d1d-41da-a3a3-6340b19f6049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_db9fd8a8-4184-46aa-bbba-90dae7227cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_27ac722b-9030-4700-a9e8-fef4481f5300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_db9fd8a8-4184-46aa-bbba-90dae7227cc2" xlink:to="loc_us-gaap_NetIncomeLoss_27ac722b-9030-4700-a9e8-fef4481f5300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_68a9041d-4c24-4023-bffc-02c26162e12d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_db9fd8a8-4184-46aa-bbba-90dae7227cc2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_68a9041d-4c24-4023-bffc-02c26162e12d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c2a901c4-825d-4120-9a1b-d662d1e28660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3389c549-4464-4350-8023-23c03b5f11ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2a901c4-825d-4120-9a1b-d662d1e28660" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3389c549-4464-4350-8023-23c03b5f11ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_fdb991c6-81df-4d20-b780-7ed955470248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2a901c4-825d-4120-9a1b-d662d1e28660" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_fdb991c6-81df-4d20-b780-7ed955470248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_29c46a0b-bf67-4f22-a526-b2990a3c3a03" xlink:href="avdl-20230331.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2a901c4-825d-4120-9a1b-d662d1e28660" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_29c46a0b-bf67-4f22-a526-b2990a3c3a03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_253c6392-e5e3-4118-8602-bfc90b45847a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c2a901c4-825d-4120-9a1b-d662d1e28660" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_253c6392-e5e3-4118-8602-bfc90b45847a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_94ff0477-1df5-4a47-8429-69490eead469" xlink:href="avdl-20230331.xsd#avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:to="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_94ff0477-1df5-4a47-8429-69490eead469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2ca5c5b8-4961-482b-a0bc-98b8e9817266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2ca5c5b8-4961-482b-a0bc-98b8e9817266" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a7409252-8680-47d2-bbc7-eb83ecad02fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a7409252-8680-47d2-bbc7-eb83ecad02fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e65594a8-6414-4871-961a-65153d10edcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e65594a8-6414-4871-961a-65153d10edcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_419f4718-6670-498e-ab7b-3dc512b2f358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:to="loc_us-gaap_LongTermDebtCurrent_419f4718-6670-498e-ab7b-3dc512b2f358" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_5d342113-cebc-425c-a65f-cdca4dc65028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cd8a363c-be70-41f3-9dc1-6b4e988fae04" xlink:to="loc_us-gaap_AccountsPayableCurrent_5d342113-cebc-425c-a65f-cdca4dc65028" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7f184477-e76f-48bc-b9d5-c21ffca71f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:to="loc_us-gaap_AssetsCurrent_7f184477-e76f-48bc-b9d5-c21ffca71f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9d3e99a1-27bd-4360-bc0f-b24936274310" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9d3e99a1-27bd-4360-bc0f-b24936274310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e001835f-4ccd-47c8-bb61-f129f726f635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e001835f-4ccd-47c8-bb61-f129f726f635" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9752a5c-8938-42b4-8916-867a75bcd029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:to="loc_us-gaap_Goodwill_c9752a5c-8938-42b4-8916-867a75bcd029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_3ac939a9-46dd-4b3e-9a74-1f81f4c7a617" xlink:href="avdl-20230331.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_3ac939a9-46dd-4b3e-9a74-1f81f4c7a617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8724fc1a-7c88-4f98-95e7-633e5a6b12f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b8f1ce21-a5f5-4732-9b4b-00595e605aa2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8724fc1a-7c88-4f98-95e7-633e5a6b12f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_69218d93-24d9-4356-bdbd-516f5f8d9bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f2e30c65-4f27-440e-9d44-7b70d65010cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_69218d93-24d9-4356-bdbd-516f5f8d9bb0" xlink:to="loc_us-gaap_Liabilities_f2e30c65-4f27-440e-9d44-7b70d65010cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b1b4fca-aafc-45b3-af60-7a113b2b2073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_69218d93-24d9-4356-bdbd-516f5f8d9bb0" xlink:to="loc_us-gaap_StockholdersEquity_3b1b4fca-aafc-45b3-af60-7a113b2b2073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bd2a8d44-7b8f-40c1-ba03-010e7a0be28e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fbf3f15f-9376-4e1b-8d43-c91cc23663a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd2a8d44-7b8f-40c1-ba03-010e7a0be28e" xlink:to="loc_us-gaap_LiabilitiesCurrent_fbf3f15f-9376-4e1b-8d43-c91cc23663a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_00f077ae-6551-4c95-8ba9-a0dea8d6c2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd2a8d44-7b8f-40c1-ba03-010e7a0be28e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_00f077ae-6551-4c95-8ba9-a0dea8d6c2b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fb3dc8c8-3e56-4865-bda2-db50871a64e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd2a8d44-7b8f-40c1-ba03-010e7a0be28e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fb3dc8c8-3e56-4865-bda2-db50871a64e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_bc1ddb39-e5a8-4d31-a94f-4d1b78266591" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_bd2a8d44-7b8f-40c1-ba03-010e7a0be28e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_bc1ddb39-e5a8-4d31-a94f-4d1b78266591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_185db7e6-e911-4f39-8c07-8c07ba1f10ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_20c22901-725e-4bfc-bbd1-750f5a169044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_185db7e6-e911-4f39-8c07-8c07ba1f10ce" xlink:to="loc_us-gaap_PreferredStockValue_20c22901-725e-4bfc-bbd1-750f5a169044" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3fe27e47-c040-4c9d-9e23-6ae90cdc4186" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_185db7e6-e911-4f39-8c07-8c07ba1f10ce" xlink:to="loc_us-gaap_CommonStockValue_3fe27e47-c040-4c9d-9e23-6ae90cdc4186" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d893a9f1-fca9-4b74-af51-40b6886a355d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_185db7e6-e911-4f39-8c07-8c07ba1f10ce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d893a9f1-fca9-4b74-af51-40b6886a355d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f9c5db56-8662-4d5e-954b-c0024defac0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_185db7e6-e911-4f39-8c07-8c07ba1f10ce" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f9c5db56-8662-4d5e-954b-c0024defac0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5d0b946f-d554-46e7-91e9-84c1e7f9b6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_185db7e6-e911-4f39-8c07-8c07ba1f10ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5d0b946f-d554-46e7-91e9-84c1e7f9b6a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_583931cd-2cfe-4bee-8c3d-bb84fa2a77c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_583931cd-2cfe-4bee-8c3d-bb84fa2a77c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d68ab9fd-1dd0-4cfb-944f-ea038cc59fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_ShareBasedCompensation_d68ab9fd-1dd0-4cfb-944f-ea038cc59fe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_0d051b07-f463-49b6-b801-41d3d8a0dd11" xlink:href="avdl-20230331.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_0d051b07-f463-49b6-b801-41d3d8a0dd11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dc09c95c-ef9f-4912-8428-7927a67835ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_NetIncomeLoss_dc09c95c-ef9f-4912-8428-7927a67835ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f0ffe105-0df5-4ec8-972a-d3724c683607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_f0ffe105-0df5-4ec8-972a-d3724c683607" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9e3aa95b-b10b-45f4-8b51-988884464cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9e3aa95b-b10b-45f4-8b51-988884464cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_08d1603b-b43c-4201-9934-667416d3bcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_08d1603b-b43c-4201-9934-667416d3bcc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a0537ede-4a19-48e2-a159-f66fa558f257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a0537ede-4a19-48e2-a159-f66fa558f257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_ee311340-4213-4975-954b-1c63be86196b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_ee311340-4213-4975-954b-1c63be86196b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_1bdbccd5-82ad-417e-892a-02e4776224e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_1bdbccd5-82ad-417e-892a-02e4776224e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_b67617b8-f89d-40f5-98a5-e5eafed0eaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0ae140af-41b3-47f8-857e-50f0999476a9" xlink:to="loc_us-gaap_DepreciationAndAmortization_b67617b8-f89d-40f5-98a5-e5eafed0eaf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9845d7f5-8fdd-45f9-b4f1-adc49ccf5f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b478ffa5-c5cb-4c71-b106-7f201c8ff3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9845d7f5-8fdd-45f9-b4f1-adc49ccf5f3d" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_b478ffa5-c5cb-4c71-b106-7f201c8ff3c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1965ad8f-4b14-4a1f-a095-dd5345785655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9845d7f5-8fdd-45f9-b4f1-adc49ccf5f3d" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1965ad8f-4b14-4a1f-a095-dd5345785655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b357e5b9-85b1-4fef-b71b-f26a0b85492f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a282a1c-1d1c-4f3a-b36a-3fa7bdc4457e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b357e5b9-85b1-4fef-b71b-f26a0b85492f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8a282a1c-1d1c-4f3a-b36a-3fa7bdc4457e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81b1e895-f7c9-4c00-bf80-21f9bf773c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b357e5b9-85b1-4fef-b71b-f26a0b85492f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_81b1e895-f7c9-4c00-bf80-21f9bf773c0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f888b66-b4c2-433e-98ec-6cd227928b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b357e5b9-85b1-4fef-b71b-f26a0b85492f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_7f888b66-b4c2-433e-98ec-6cd227928b95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d0d0a64-395a-449c-ad26-ea7baed8fbba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b357e5b9-85b1-4fef-b71b-f26a0b85492f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d0d0a64-395a-449c-ad26-ea7baed8fbba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc4c4de3-db5e-445d-9692-092318fe7456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_5a6e5d04-5726-4f43-8d08-eda40582caca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc4c4de3-db5e-445d-9692-092318fe7456" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_5a6e5d04-5726-4f43-8d08-eda40582caca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuance_ad6827b0-f683-4184-84f0-9b83048b262d" xlink:href="avdl-20230331.xsd#avdl_ProceedsReceivedInAdvanceOfShareIssuance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc4c4de3-db5e-445d-9692-092318fe7456" xlink:to="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuance_ad6827b0-f683-4184-84f0-9b83048b262d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50f2a9c1-1a29-4f44-807d-001768c5c6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc4c4de3-db5e-445d-9692-092318fe7456" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_50f2a9c1-1a29-4f44-807d-001768c5c6ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_03ac9ab0-3eb9-4672-87f6-077b5b63de89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc4c4de3-db5e-445d-9692-092318fe7456" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_03ac9ab0-3eb9-4672-87f6-077b5b63de89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_562542db-5796-44fb-915c-b9b6de556c27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ff5c0555-d56c-425c-ae0d-b0b3c20ebc77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_562542db-5796-44fb-915c-b9b6de556c27" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ff5c0555-d56c-425c-ae0d-b0b3c20ebc77" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_693fe0b5-98bb-4784-9180-e5f127684c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e9f3c4d9-d5dd-475f-90c7-e208bbe0565c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_693fe0b5-98bb-4784-9180-e5f127684c3d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e9f3c4d9-d5dd-475f-90c7-e208bbe0565c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f8377209-3a8b-43d4-b74a-86c13aa7f659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_693fe0b5-98bb-4784-9180-e5f127684c3d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f8377209-3a8b-43d4-b74a-86c13aa7f659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a75f5c3a-65cd-4b5b-b658-6e0551ad5e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_693fe0b5-98bb-4784-9180-e5f127684c3d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a75f5c3a-65cd-4b5b-b658-6e0551ad5e05" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f91b8301-0b67-4904-9736-5034d373f183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6af7a55f-ffc5-475f-8e86-5301009c44c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f91b8301-0b67-4904-9736-5034d373f183" xlink:to="loc_us-gaap_LongTermDebtCurrent_6af7a55f-ffc5-475f-8e86-5301009c44c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_89de20fa-cebb-4614-853c-3674ee7b0679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f91b8301-0b67-4904-9736-5034d373f183" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_89de20fa-cebb-4614-853c-3674ee7b0679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_770d00c5-e0ea-4245-af49-3383c7316ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f91b8301-0b67-4904-9736-5034d373f183" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_770d00c5-e0ea-4245-af49-3383c7316ef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_3d68130a-0bca-468a-9c43-56651ac85f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f91b8301-0b67-4904-9736-5034d373f183" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_3d68130a-0bca-468a-9c43-56651ac85f71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9433817c-a0be-46e6-96d5-6d5b3a8e27f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_558a39d1-c377-498e-873d-7df0f621a187" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9433817c-a0be-46e6-96d5-6d5b3a8e27f0" xlink:to="loc_us-gaap_IncomeTaxesReceivable_558a39d1-c377-498e-873d-7df0f621a187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_d13572a9-0f62-4305-a0ae-0ad1002b9112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9433817c-a0be-46e6-96d5-6d5b3a8e27f0" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_d13572a9-0f62-4305-a0ae-0ad1002b9112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_53d948c6-cd91-4c71-a65d-79691852c52f" xlink:href="avdl-20230331.xsd#avdl_GuaranteeCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9433817c-a0be-46e6-96d5-6d5b3a8e27f0" xlink:to="loc_avdl_GuaranteeCurrent_53d948c6-cd91-4c71-a65d-79691852c52f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cd2948e3-9756-44b6-9262-c7c5f58450bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9433817c-a0be-46e6-96d5-6d5b3a8e27f0" xlink:to="loc_us-gaap_OtherAssetsCurrent_cd2948e3-9756-44b6-9262-c7c5f58450bf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8db1b32f-fc2b-4590-8dc9-18461c07881f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_6aa74a79-ee2a-4690-9979-2bfda8368b00" xlink:href="avdl-20230331.xsd#avdl_GuaranteeNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_8db1b32f-fc2b-4590-8dc9-18461c07881f" xlink:to="loc_avdl_GuaranteeNoncurrent_6aa74a79-ee2a-4690-9979-2bfda8368b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_292f54ff-1ec4-4323-b3c7-f8343133504c" xlink:href="avdl-20230331.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_8db1b32f-fc2b-4590-8dc9-18461c07881f" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_292f54ff-1ec4-4323-b3c7-f8343133504c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_10f2222b-92a1-4d7b-9daf-1495a8d73233" xlink:href="avdl-20230331.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_8db1b32f-fc2b-4590-8dc9-18461c07881f" xlink:to="loc_avdl_OtherNoncurrentReceivables_10f2222b-92a1-4d7b-9daf-1495a8d73233" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f3f374f8-461d-4040-afd1-6e38f1ddc7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_67176c12-7628-4b73-bda5-3f2b76c44fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f3f374f8-461d-4040-afd1-6e38f1ddc7a6" xlink:to="loc_us-gaap_RestructuringReserveCurrent_67176c12-7628-4b73-bda5-3f2b76c44fda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_83ec5048-8b18-4aa6-bf87-aebcd4edddc5" xlink:href="avdl-20230331.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f3f374f8-461d-4040-afd1-6e38f1ddc7a6" xlink:to="loc_avdl_AccruedOutsourceContractCosts_83ec5048-8b18-4aa6-bf87-aebcd4edddc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_4084b71e-0921-404d-a167-4ffe448ab3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f3f374f8-461d-4040-afd1-6e38f1ddc7a6" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_4084b71e-0921-404d-a167-4ffe448ab3a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_05054f59-17f6-4d01-9390-1d9463cb2006" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_f3f374f8-461d-4040-afd1-6e38f1ddc7a6" xlink:to="loc_us-gaap_AccruedSalariesCurrent_05054f59-17f6-4d01-9390-1d9463cb2006" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_3480a533-dbdc-4a6c-bfa5-aac2659e5f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_ac786dfd-8922-4653-818d-b00a856ed53d" xlink:href="avdl-20230331.xsd#avdl_AccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_3480a533-dbdc-4a6c-bfa5-aac2659e5f11" xlink:to="loc_avdl_AccruedInterestCurrent_ac786dfd-8922-4653-818d-b00a856ed53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_1e0567f9-0e72-4453-93c9-02a4833b8aee" xlink:href="avdl-20230331.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_3480a533-dbdc-4a6c-bfa5-aac2659e5f11" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_1e0567f9-0e72-4453-93c9-02a4833b8aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_cb855d02-94f8-42a1-8479-fa2d9cb1f5ed" xlink:href="avdl-20230331.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_3480a533-dbdc-4a6c-bfa5-aac2659e5f11" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_cb855d02-94f8-42a1-8479-fa2d9cb1f5ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2feb68d2-da38-4c53-bbbb-b4d0e6f5d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_6552ac05-4d93-4154-bbfc-a9e1f607ae52" xlink:href="avdl-20230331.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_2feb68d2-da38-4c53-bbbb-b4d0e6f5d4a7" xlink:to="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_6552ac05-4d93-4154-bbfc-a9e1f607ae52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_7408fda5-8fd8-4f78-b600-631a9fd749a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_2feb68d2-da38-4c53-bbbb-b4d0e6f5d4a7" xlink:to="loc_us-gaap_GuarantyLiabilities_7408fda5-8fd8-4f78-b600-631a9fd749a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89c5138f-c514-493a-a969-829bfdf8d80f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a03cf1d9-bae4-4aaa-a1ae-5d5d4bd3854d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89c5138f-c514-493a-a969-829bfdf8d80f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a03cf1d9-bae4-4aaa-a1ae-5d5d4bd3854d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0270ff8-cb45-469f-817f-d1af0c5b7ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_89c5138f-c514-493a-a969-829bfdf8d80f" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_d0270ff8-cb45-469f-817f-d1af0c5b7ffc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>avdl-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ff4affb4-5e35-499d-a060-a6a189fb41ed,g:0e980074-2bb1-4083-b23a-3722f5917d03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.avadel.com/role/Coverpage" xlink:type="simple" xlink:href="avdl-20230331.xsd#Coverpage"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/Coverpage" xlink:type="extended" id="i43565cf90d214ea587fa841d6535e627_Coverpage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a99e9d5f-d062-4277-bb27-ba29315e7601" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentType_a99e9d5f-d062-4277-bb27-ba29315e7601" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4b3c0557-146a-41ee-a48f-dd4d437b3ce3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentQuarterlyReport_4b3c0557-146a-41ee-a48f-dd4d437b3ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fcaedfb0-f24a-45ef-b6cb-a8db6bd30548" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentPeriodEndDate_fcaedfb0-f24a-45ef-b6cb-a8db6bd30548" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_49cb5e1c-4b73-4642-a1b8-1a4c555151cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentTransitionReport_49cb5e1c-4b73-4642-a1b8-1a4c555151cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_88a2a7b9-1ddc-4fae-ab73-a6d929c3c96f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityFileNumber_88a2a7b9-1ddc-4fae-ab73-a6d929c3c96f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a48c1351-3768-414b-9be7-1de60feaaa9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityRegistrantName_a48c1351-3768-414b-9be7-1de60feaaa9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7d47c3d9-d09a-421e-b5ac-6162645879b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7d47c3d9-d09a-421e-b5ac-6162645879b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_75ba57f5-c3fb-4399-860b-4644c76c9f76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityTaxIdentificationNumber_75ba57f5-c3fb-4399-860b-4644c76c9f76" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_13424cfa-8410-4bce-a12a-a7820533e6e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressAddressLine1_13424cfa-8410-4bce-a12a-a7820533e6e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2d470f2c-d795-4f60-acd1-785728e651fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressCityOrTown_2d470f2c-d795-4f60-acd1-785728e651fa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_25598874-6d4a-49ee-b480-d70712634620" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressPostalZipCode_25598874-6d4a-49ee-b480-d70712634620" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_4d41c972-f6ea-4440-9143-b9870a395abc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressCountry_4d41c972-f6ea-4440-9143-b9870a395abc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_650ce23a-2c7f-4f4e-a651-37191856a782" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_CountryRegion_650ce23a-2c7f-4f4e-a651-37191856a782" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_11b57fc2-2f7e-4238-8ea8-5abfea33c396" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_CityAreaCode_11b57fc2-2f7e-4238-8ea8-5abfea33c396" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_33243aef-9985-4c4a-a089-9ea4ca759f30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_LocalPhoneNumber_33243aef-9985-4c4a-a089-9ea4ca759f30" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_45337e54-2ce4-493f-8abb-622fca65f68d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_Security12bTitle_45337e54-2ce4-493f-8abb-622fca65f68d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_84d40194-bedf-4615-89c0-a3708d2cf2dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_TradingSymbol_84d40194-bedf-4615-89c0-a3708d2cf2dd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8ee8ed51-4ab8-4bd7-83fe-b508eba4ea07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_SecurityExchangeName_8ee8ed51-4ab8-4bd7-83fe-b508eba4ea07" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_75491c64-9685-4159-9323-0422e3129ef4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_NoTradingSymbolFlag_75491c64-9685-4159-9323-0422e3129ef4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_65b3cafd-ed60-4eb1-892b-9643a803f1aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityCurrentReportingStatus_65b3cafd-ed60-4eb1-892b-9643a803f1aa" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f372407c-6c3d-4412-bf3f-cd031277251b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityInteractiveDataCurrent_f372407c-6c3d-4412-bf3f-cd031277251b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_529eb17e-fa53-4855-9f2d-a7401b06cfdc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityFilerCategory_529eb17e-fa53-4855-9f2d-a7401b06cfdc" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8c706bbf-0d30-4168-b215-fe0876d5386e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntitySmallBusiness_8c706bbf-0d30-4168-b215-fe0876d5386e" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_609f8e27-58fa-4c69-b686-791812c69cfc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityEmergingGrowthCompany_609f8e27-58fa-4c69-b686-791812c69cfc" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_be7de687-d144-46da-920e-688e860e623a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityShellCompany_be7de687-d144-46da-920e-688e860e623a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_630eb880-2b6b-4739-bc40-0d6fbf1f9031" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_630eb880-2b6b-4739-bc40-0d6fbf1f9031" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b3b0dd7-4d29-44d3-81f4-a051a57792f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityCentralIndexKey_7b3b0dd7-4d29-44d3-81f4-a051a57792f0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2a136619-ba58-4b21-a47b-87ee4c899eeb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_CurrentFiscalYearEndDate_2a136619-ba58-4b21-a47b-87ee4c899eeb" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a3903759-11d4-46ad-9a6e-714bd436303a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentFiscalYearFocus_a3903759-11d4-46ad-9a6e-714bd436303a" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_940d82fd-7948-41d6-8b01-24adbc2d350a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_940d82fd-7948-41d6-8b01-24adbc2d350a" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c8cad5d0-20de-4626-9a93-03d98a69eb8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_AmendmentFlag_c8cad5d0-20de-4626-9a93-03d98a69eb8d" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:to="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_daddbc51-e7c4-49db-9b53-0dac795a95cd_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:to="loc_dei_ExchangeDomain_daddbc51-e7c4-49db-9b53-0dac795a95cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_bf0c4d9f-a0bd-47e6-a969-0d59f758e5f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:to="loc_dei_ExchangeDomain_bf0c4d9f-a0bd-47e6-a969-0d59f758e5f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS_da82c445-6acd-4877-8fcf-5ea26bf33bd1" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNMS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_bf0c4d9f-a0bd-47e6-a969-0d59f758e5f0" xlink:to="loc_exch_XNMS_da82c445-6acd-4877-8fcf-5ea26bf33bd1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="extended" id="i2c361ef875714d1fb59a0c551c79e2ac_CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cc735525-9157-406a-9908-12f2ff5ed83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_cc735525-9157-406a-9908-12f2ff5ed83f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_26b3073d-9783-487e-9d5d-f2aad5a73e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_SharesOutstanding_26b3073d-9783-487e-9d5d-f2aad5a73e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29dba0ff-bde8-4c93-9f37-17a7b5965d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockholdersEquity_29dba0ff-bde8-4c93-9f37-17a7b5965d9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fdc65c02-74ef-49b5-9304-3cf361aaeb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_NetIncomeLoss_fdc65c02-74ef-49b5-9304-3cf361aaeb32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b667764e-ba9e-448d-bd3d-17201f0bbdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b667764e-ba9e-448d-bd3d-17201f0bbdf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb2164e9-052b-4e93-8db0-2ab29659ccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb2164e9-052b-4e93-8db0-2ab29659ccf1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_faa10a16-f68c-4474-90ba-bc56acd3803f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_faa10a16-f68c-4474-90ba-bc56acd3803f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d8459e20-1cdc-4f22-95db-d571873875ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d8459e20-1cdc-4f22-95db-d571873875ee" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea5ce33b-7ae6-4c00-889b-408dffb923fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea5ce33b-7ae6-4c00-889b-408dffb923fd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3ba6aa8e-f0f1-48ca-ad17-572f92701dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3ba6aa8e-f0f1-48ca-ad17-572f92701dc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_266074d1-faa3-4b15-9097-b9b6b331a021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_266074d1-faa3-4b15-9097-b9b6b331a021" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_bb104d3e-4c5e-48db-bc99-c3bbd3c35b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_bb104d3e-4c5e-48db-bc99-c3bbd3c35b7a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_ae8fa77b-992b-45ce-8b2e-8909ac902167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_ae8fa77b-992b-45ce-8b2e-8909ac902167" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_70f7033d-f13d-47bd-a449-62df292f8ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_70f7033d-f13d-47bd-a449-62df292f8ba8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fefbe2ea-a37f-42eb-a1a5-a3dbc2b4638c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fefbe2ea-a37f-42eb-a1a5-a3dbc2b4638c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_574c6bbb-cac4-4e3f-9f48-07640e90505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5ef222c4-9bba-4e28-808a-35da8f9693a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_cc735525-9157-406a-9908-12f2ff5ed83f" xlink:to="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_db275f43-cf73-4fd9-9b5e-d4b618c39558_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:to="loc_us-gaap_EquityComponentDomain_db275f43-cf73-4fd9-9b5e-d4b618c39558_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:to="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c45aeae0-ba5e-4674-80db-6f5ddf67c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_CommonStockMember_c45aeae0-ba5e-4674-80db-6f5ddf67c3a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_4ec44374-8c9e-40d1-8224-6d335919ef05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_PreferredStockMember_4ec44374-8c9e-40d1-8224-6d335919ef05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_92b2ee25-a949-43e1-8f4b-f1082ea440c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_92b2ee25-a949-43e1-8f4b-f1082ea440c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c58d93e9-3188-41f3-abe2-a856678f7114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_RetainedEarningsMember_c58d93e9-3188-41f3-abe2-a856678f7114" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c7fc7d3f-f176-4b94-bc47-bd3c33a951b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c7fc7d3f-f176-4b94-bc47-bd3c33a951b7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i05299811bd704c93a7a6878165bc48a3_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrphanDrugExclusivityTerm_bebfbd1e-3599-401b-82c9-91a45ee0b5f0" xlink:href="avdl-20230331.xsd#avdl_OrphanDrugExclusivityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_OrphanDrugExclusivityTerm_bebfbd1e-3599-401b-82c9-91a45ee0b5f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e67a8ac5-a198-4746-802e-218ab168291c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e67a8ac5-a198-4746-802e-218ab168291c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c6d02868-4465-47e2-aaba-c5824459f954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c6d02868-4465-47e2-aaba-c5824459f954" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_34aada79-459f-4343-930d-73d4ce76f2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_34aada79-459f-4343-930d-73d4ce76f2ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_48497391-650f-407b-a57b-5b74befd8b61" xlink:href="avdl-20230331.xsd#avdl_RoyaltyFinancingQuarterlyNetRevenueTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_48497391-650f-407b-a57b-5b74befd8b61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6dfd1f8e-4311-4e17-bc4e-57aaa6eac688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6dfd1f8e-4311-4e17-bc4e-57aaa6eac688" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93b9036f-b6e0-4b6c-8e6f-0f02aee3973d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93b9036f-b6e0-4b6c-8e6f-0f02aee3973d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_f6fc04f4-d87f-4e94-b2d1-efbb004e18b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_f6fc04f4-d87f-4e94-b2d1-efbb004e18b9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ba7d43bb-7c61-45cd-a0aa-cbdbfcb8d1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ba7d43bb-7c61-45cd-a0aa-cbdbfcb8d1d7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_aaf56d7c-8ff7-4805-9fc3-c59bc717b155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_aaf56d7c-8ff7-4805-9fc3-c59bc717b155" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7267404d-808e-42c0-86bc-d9ec597aa657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7267404d-808e-42c0-86bc-d9ec597aa657" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockSalesAgentCommissionPercent_dd67d1c8-c937-4e11-ae84-aa43463d322a" xlink:href="avdl-20230331.xsd#avdl_SaleOfStockSalesAgentCommissionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_SaleOfStockSalesAgentCommissionPercent_dd67d1c8-c937-4e11-ae84-aa43463d322a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_49fcbae0-eb0a-4280-8c79-8ed8f62c6f12" xlink:href="avdl-20230331.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_49fcbae0-eb0a-4280-8c79-8ed8f62c6f12" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_51664add-f1f3-4a09-8423-d49a26ed8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_51664add-f1f3-4a09-8423-d49a26ed8e32" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ade5575d-912c-40a7-9216-b564c3a95dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ade5575d-912c-40a7-9216-b564c3a95dd1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_c976a011-74df-412d-8ac0-263958c2b56e" xlink:href="avdl-20230331.xsd#avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_c976a011-74df-412d-8ac0-263958c2b56e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c8b0cc9b-a625-49ad-bbee-868c4f316be1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c8b0cc9b-a625-49ad-bbee-868c4f316be1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_e9f3928b-a72e-4d6c-abcd-407e6d753586" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_e9f3928b-a72e-4d6c-abcd-407e6d753586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember_f39e59bc-496b-4c95-aebf-5e96dc3e8a31" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:to="loc_avdl_April2027NotesMember_f39e59bc-496b-4c95-aebf-5e96dc3e8a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bc31b2b5-f31f-41aa-864a-ec35fefd919b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bc31b2b5-f31f-41aa-864a-ec35fefd919b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4f17425f-e422-4557-9a55-f012db16c567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4f17425f-e422-4557-9a55-f012db16c567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_80695238-3538-4534-84f1-adad10221cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f17425f-e422-4557-9a55-f012db16c567" xlink:to="loc_us-gaap_SeniorNotesMember_80695238-3538-4534-84f1-adad10221cb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0205984-fe2a-4026-a785-51e05eb691a9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:to="loc_srt_RangeMember_e0205984-fe2a-4026-a785-51e05eb691a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aaa1b53f-f150-4a9e-9abb-3921eece014e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:to="loc_srt_RangeMember_aaa1b53f-f150-4a9e-9abb-3921eece014e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30d7432b-9851-4bc7-86fb-946ecc6a2b7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_aaa1b53f-f150-4a9e-9abb-3921eece014e" xlink:to="loc_srt_MaximumMember_30d7432b-9851-4bc7-86fb-946ecc6a2b7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2a133094-b28f-4877-ada6-ed0aa8d8ae48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2a133094-b28f-4877-ada6-ed0aa8d8ae48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheOneMember_261feda5-001b-495b-a96d-d07104ec49ce" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:to="loc_avdl_PublicStockOfferingTrancheOneMember_261feda5-001b-495b-a96d-d07104ec49ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheTwoMember_633c6e0f-956b-4943-b5a9-e3bcae5cd14e" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:to="loc_avdl_PublicStockOfferingTrancheTwoMember_633c6e0f-956b-4943-b5a9-e3bcae5cd14e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2020ShelfRegistrationStatementMember_a88cfa02-fb75-4003-8432-e989d64efa1b" xlink:href="avdl-20230331.xsd#avdl_A2020ShelfRegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_A2020ShelfRegistrationStatementMember_a88cfa02-fb75-4003-8432-e989d64efa1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022ShelfRegistrationStatementMember_48eae247-67fd-4138-80a2-3869aacb56bd" xlink:href="avdl-20230331.xsd#avdl_A2022ShelfRegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_A2022ShelfRegistrationStatementMember_48eae247-67fd-4138-80a2-3869aacb56bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AtTheMarketOfferingProgramMember_685e5538-4429-48cb-92a2-60c2b2240ca2" xlink:href="avdl-20230331.xsd#avdl_AtTheMarketOfferingProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_AtTheMarketOfferingProgramMember_685e5538-4429-48cb-92a2-60c2b2240ca2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_da9ba44b-eed3-4276-b1ad-b64ece3fa111_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_da9ba44b-eed3-4276-b1ad-b64ece3fa111_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6846ce8b-9670-418c-a8b6-b59a90e4e092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6846ce8b-9670-418c-a8b6-b59a90e4e092" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_572487ea-224a-42c7-a125-82fbdb1fe8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6846ce8b-9670-418c-a8b6-b59a90e4e092" xlink:to="loc_us-gaap_SubsequentEventMember_572487ea-224a-42c7-a125-82fbdb1fe8a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b5950c75-0f54-4dbe-9928-dbbe96e1f53f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b5950c75-0f54-4dbe-9928-dbbe96e1f53f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f937cc2f-119d-459b-9def-d068a38f89e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f937cc2f-119d-459b-9def-d068a38f89e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_5064818e-cfa4-4994-b540-8b0fe516ccda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f937cc2f-119d-459b-9def-d068a38f89e4" xlink:to="loc_srt_ScenarioForecastMember_5064818e-cfa4-4994-b540-8b0fe516ccda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_779e7957-78a0-4f1c-9be6-ad89fc8beea5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:to="loc_us-gaap_EquityComponentDomain_779e7957-78a0-4f1c-9be6-ad89fc8beea5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee841b49-dbac-4458-b365-68ed1bc0fbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:to="loc_us-gaap_EquityComponentDomain_ee841b49-dbac-4458-b365-68ed1bc0fbad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df10d398-6958-4fc7-87da-7b57f638fbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_ee841b49-dbac-4458-b365-68ed1bc0fbad" xlink:to="loc_us-gaap_CommonStockMember_df10d398-6958-4fc7-87da-7b57f638fbf6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended" id="i21e24dbef3fe48f59c79c8565d283a6f_FairValueMeasurementMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8e904462-6b49-4aee-a9d8-b8edc27bb953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8e904462-6b49-4aee-a9d8-b8edc27bb953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6562a448-d8b1-4620-a001-f0f31dc59cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6562a448-d8b1-4620-a001-f0f31dc59cdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_03d1cb42-cd9b-4f17-a647-18049e80fbf9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_03d1cb42-cd9b-4f17-a647-18049e80fbf9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea15715b-422a-4571-b8fc-722aea123b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea15715b-422a-4571-b8fc-722aea123b16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d9a90f7f-a835-496b-9df8-3e2d866e9acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea15715b-422a-4571-b8fc-722aea123b16" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d9a90f7f-a835-496b-9df8-3e2d866e9acc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0904cc59-7eff-4ff9-9411-fbb6927109d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0904cc59-7eff-4ff9-9411-fbb6927109d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e9ab4d0e-97dc-4179-8070-fdac2e834f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e9ab4d0e-97dc-4179-8070-fdac2e834f71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b87a4137-89f7-4cbc-b4f3-5e8d3de9044e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b87a4137-89f7-4cbc-b4f3-5e8d3de9044e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_aac1fac7-5a01-4ac0-8680-64d0079c39b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_aac1fac7-5a01-4ac0-8680-64d0079c39b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_225b6966-0971-4acf-898f-719dbf6a2487_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_225b6966-0971-4acf-898f-719dbf6a2487_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_36c681ab-bba9-4b3c-a581-3d22b9b4d7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_36c681ab-bba9-4b3c-a581-3d22b9b4d7ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_0607b562-cf7d-478f-a634-59c0dea743b1" xlink:href="avdl-20230331.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_36c681ab-bba9-4b3c-a581-3d22b9b4d7ab" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_0607b562-cf7d-478f-a634-59c0dea743b1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended" id="ie6965fdb88ee4355a4500db1cd8f8c4b_FairValueMeasurementNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e78002ee-beff-4b65-a8e0-3809afb6cb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e78002ee-beff-4b65-a8e0-3809afb6cb66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_20854693-907e-48d8-b4a4-ca8c586ee343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:to="loc_us-gaap_LongTermDebtFairValue_20854693-907e-48d8-b4a4-ca8c586ee343" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c8e02ee2-f8cb-4b7f-8aa3-948337c261e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c8e02ee2-f8cb-4b7f-8aa3-948337c261e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_53b4c1b5-13a8-439d-893f-c307debf36e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c8e02ee2-f8cb-4b7f-8aa3-948337c261e5" xlink:to="loc_us-gaap_SeniorNotesMember_53b4c1b5-13a8-439d-893f-c307debf36e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1d81f002-43c3-4811-8b6f-decd9ff96bab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1d81f002-43c3-4811-8b6f-decd9ff96bab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b742289-2dfd-4b70-98a6-34edaa9d1a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b742289-2dfd-4b70-98a6-34edaa9d1a84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_9e6ddfa3-eb11-494f-a276-5f19646bb775" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b742289-2dfd-4b70-98a6-34edaa9d1a84" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_9e6ddfa3-eb11-494f-a276-5f19646bb775" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" xlink:type="extended" id="ie234297af3eb4c8f84422fe8faec44a0_MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4131cce-8bb5-4038-8b9c-9d8bb94459db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4131cce-8bb5-4038-8b9c-9d8bb94459db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e3511124-62a2-4413-b035-03f6ee32b762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e3511124-62a2-4413-b035-03f6ee32b762" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6ecf69ba-309c-4e7b-965a-3c2f0327315b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6ecf69ba-309c-4e7b-965a-3c2f0327315b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c7856603-bf49-452b-bcf1-66946ff00b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c7856603-bf49-452b-bcf1-66946ff00b85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6f4f8cb5-877f-480c-ab3e-a41b260f6bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6f4f8cb5-877f-480c-ab3e-a41b260f6bae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4131cce-8bb5-4038-8b9c-9d8bb94459db" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_421f39bc-7447-48f1-af74-a608eef3b86a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_421f39bc-7447-48f1-af74-a608eef3b86a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d0b0065-5fcd-42ba-9ddf-c4de1fa646be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d0b0065-5fcd-42ba-9ddf-c4de1fa646be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_d5fcc920-c7cd-4ba5-8481-e0f68ccca497" xlink:href="avdl-20230331.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d0b0065-5fcd-42ba-9ddf-c4de1fa646be" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_d5fcc920-c7cd-4ba5-8481-e0f68ccca497" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended" id="ibe3430f20fca47ada2820cad34bc4d83_LongTermDebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_805e8238-30df-45b4-9bd2-5b3c27040d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_805e8238-30df-45b4-9bd2-5b3c27040d80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_956d7164-a026-44e4-8a60-ddbb109ce199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_805e8238-30df-45b4-9bd2-5b3c27040d80" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_956d7164-a026-44e4-8a60-ddbb109ce199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_32002a72-68c4-4476-b2e1-ae0fc066c016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_32002a72-68c4-4476-b2e1-ae0fc066c016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0c1ccfe3-2637-4997-82ac-fe72d9ecbc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_LongTermDebt_0c1ccfe3-2637-4997-82ac-fe72d9ecbc22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ff1ab60a-7a61-42ee-9176-43d6ffa04e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_LongTermDebtCurrent_ff1ab60a-7a61-42ee-9176-43d6ffa04e5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a43cceb3-8929-45ee-80ca-0dd79dde90f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a43cceb3-8929-45ee-80ca-0dd79dde90f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5c217301-7cc3-4426-ab4f-09f9f5692a09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5c217301-7cc3-4426-ab4f-09f9f5692a09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5100fcda-7806-4575-80b0-0278ca00c8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5100fcda-7806-4575-80b0-0278ca00c8b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ed64f35a-6165-4587-9693-0dcb585185fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5100fcda-7806-4575-80b0-0278ca00c8b9" xlink:to="loc_us-gaap_SeniorNotesMember_ed64f35a-6165-4587-9693-0dcb585185fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:to="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2d267dc-64bd-4651-b71d-ea104c1e4153_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2d267dc-64bd-4651-b71d-ea104c1e4153_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_4f9eb526-0856-4b80-93bf-23d5afb9ad0e" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_4f9eb526-0856-4b80-93bf-23d5afb9ad0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_7def6cd7-ea6f-4356-9cae-b41996618bff" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_7def6cd7-ea6f-4356-9cae-b41996618bff" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i735e2fddddd34b5988bc5338af27e9e7_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9b4aa991-a961-4a35-9152-10f4f94bb33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_InterestExpenseDebt_9b4aa991-a961-4a35-9152-10f4f94bb33d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_725624b3-3377-43de-aa28-e772c375a7e2" xlink:href="avdl-20230331.xsd#avdl_CouponInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_CouponInterestExpense_725624b3-3377-43de-aa28-e772c375a7e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_dcbddbb5-a1af-4a27-bec3-10279ce0fe60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_dcbddbb5-a1af-4a27-bec3-10279ce0fe60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cb373603-21e9-4475-8fda-77fa97de45ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cb373603-21e9-4475-8fda-77fa97de45ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_cf13b280-c2c9-44e7-bbda-87c02bac7599" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_cf13b280-c2c9-44e7-bbda-87c02bac7599" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_f7aae577-f8af-4c5e-9613-36db7531b7da" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_f7aae577-f8af-4c5e-9613-36db7531b7da" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e318c837-0ced-4cc6-80f1-92b69d929f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e318c837-0ced-4cc6-80f1-92b69d929f64" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentExchangeAmount_882a671f-be68-4b8d-b9df-86f6f5b57370" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentExchangeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentExchangeAmount_882a671f-be68-4b8d-b9df-86f6f5b57370" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_852229a4-dacf-4021-975e-8c64b798ccce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_852229a4-dacf-4021-975e-8c64b798ccce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_df651566-153f-4540-87f4-7b4dd3b1c712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_df651566-153f-4540-87f4-7b4dd3b1c712" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f238c8c8-c074-4293-ae16-c47361188f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f238c8c8-c074-4293-ae16-c47361188f31" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_e23a548d-44c3-476b-9a57-5899e9a00937" xlink:href="avdl-20230331.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_e23a548d-44c3-476b-9a57-5899e9a00937" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_8378e127-03a3-4f6a-ada8-c50839e7cbce" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_8378e127-03a3-4f6a-ada8-c50839e7cbce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_ff79bb57-f3b1-465d-9c55-08250f1005f8" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_ff79bb57-f3b1-465d-9c55-08250f1005f8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_5ba2be93-8707-4d91-b972-ea2e35a7916e" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_5ba2be93-8707-4d91-b972-ea2e35a7916e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage_77013fb1-7bb6-49a2-a020-aa08d12dc7fe" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositarySharesPremiumPercentage_77013fb1-7bb6-49a2-a020-aa08d12dc7fe" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_9542f0d9-eef6-4bb3-b809-59444af13eab" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_9542f0d9-eef6-4bb3-b809-59444af13eab" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b825ce29-ad4c-4120-b4f5-60432bebf26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b825ce29-ad4c-4120-b4f5-60432bebf26d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_e828197d-eb14-4ca2-8ba0-863823eca346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_e828197d-eb14-4ca2-8ba0-863823eca346" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c17f4d47-530b-47df-828c-2d0e39261249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c17f4d47-530b-47df-828c-2d0e39261249" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_f9c62936-0bc6-4590-88b5-809c6c13d0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_f9c62936-0bc6-4590-88b5-809c6c13d0d8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ddb2a317-c98a-4182-b4ea-7b314a724af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ddb2a317-c98a-4182-b4ea-7b314a724af6" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtConversionPrincipalAmountNotExchanged_5eff6dbb-c2d4-4825-afd5-bea4bdf69519" xlink:href="avdl-20230331.xsd#avdl_DebtConversionPrincipalAmountNotExchanged"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtConversionPrincipalAmountNotExchanged_5eff6dbb-c2d4-4825-afd5-bea4bdf69519" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_be0f8b61-fceb-43d5-9246-6bce0d05004e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_be0f8b61-fceb-43d5-9246-6bce0d05004e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_50e7c8b4-d4ca-4b40-8bf9-f20f5716fe78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_50e7c8b4-d4ca-4b40-8bf9-f20f5716fe78" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_b1f1db9f-1858-4dd0-ac3b-3ba341a821df" xlink:href="avdl-20230331.xsd#avdl_RoyaltyFinancingQuarterlyNetRevenueTarget"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_b1f1db9f-1858-4dd0-ac3b-3ba341a821df" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7f430ab3-f75d-44ec-b03c-887e14e6d18c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7f430ab3-f75d-44ec-b03c-887e14e6d18c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_01b66bef-2b3f-45b0-b090-158b2fc25f98" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_01b66bef-2b3f-45b0-b090-158b2fc25f98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_fe4fd6e6-159c-41fb-a3a9-e539d03880d3" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_fe4fd6e6-159c-41fb-a3a9-e539d03880d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember_cb21b495-9e13-486a-9913-3a1c88b79376" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:to="loc_avdl_April2027NotesMember_cb21b495-9e13-486a-9913-3a1c88b79376" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_833c8b7b-d02d-4596-ad6b-2acb45303b6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_833c8b7b-d02d-4596-ad6b-2acb45303b6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a5d84a09-63a3-4449-b564-dc61cd9c7ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:to="loc_us-gaap_ConvertibleDebtMember_a5d84a09-63a3-4449-b564-dc61cd9c7ced" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7c40cc1b-e01c-46d1-8061-76ff258c25a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:to="loc_us-gaap_SeniorNotesMember_7c40cc1b-e01c-46d1-8061-76ff258c25a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5920a70-3c18-40c2-ba23-379d4cdc569d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a5920a70-3c18-40c2-ba23-379d4cdc569d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3867499-b183-4c1d-94ff-a6550da2e23e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3867499-b183-4c1d-94ff-a6550da2e23e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ThirdPartyMember_95f0395f-b171-42e0-9efc-6ceb3ff290cc" xlink:href="avdl-20230331.xsd#avdl_ThirdPartyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3867499-b183-4c1d-94ff-a6550da2e23e" xlink:to="loc_avdl_ThirdPartyMember_95f0395f-b171-42e0-9efc-6ceb3ff290cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1677e141-5e12-402b-a124-31851b3230c8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1677e141-5e12-402b-a124-31851b3230c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_54cd6f6b-8a6d-43de-b3c1-4596f8b95153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_54cd6f6b-8a6d-43de-b3c1-4596f8b95153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e287eb1c-c424-4c44-abe6-8865501a3c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_54cd6f6b-8a6d-43de-b3c1-4596f8b95153" xlink:to="loc_us-gaap_SubsequentEventMember_e287eb1c-c424-4c44-abe6-8865501a3c04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b7008f83-5619-4844-ae29-1300077eeb66_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:to="loc_srt_RangeMember_b7008f83-5619-4844-ae29-1300077eeb66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:to="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e95ea623-0f6d-4882-99f6-2ad306604018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:to="loc_srt_MinimumMember_e95ea623-0f6d-4882-99f6-2ad306604018" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_67d45002-5bb8-47fe-b4b5-d9977dcb0cfe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:to="loc_srt_MaximumMember_67d45002-5bb8-47fe-b4b5-d9977dcb0cfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_824e39ba-0f4b-4b72-86f2-9a6e925b7e89_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:to="loc_srt_ScenarioUnspecifiedDomain_824e39ba-0f4b-4b72-86f2-9a6e925b7e89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_49146e3d-aa10-4c38-aa1d-d0cd1f2f2b50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:to="loc_srt_ScenarioUnspecifiedDomain_49146e3d-aa10-4c38-aa1d-d0cd1f2f2b50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a7dfaaab-25dd-437a-8dba-ca523713e4d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_49146e3d-aa10-4c38-aa1d-d0cd1f2f2b50" xlink:to="loc_srt_ScenarioForecastMember_a7dfaaab-25dd-437a-8dba-ca523713e4d8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossComponentsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#ComprehensiveLossComponentsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/ComprehensiveLossComponentsDetails" xlink:type="extended" id="i549b4a8de5f44e3cb7598315a7a9df64_ComprehensiveLossComponentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bbd8acb9-9601-4099-a527-f91ba8ffaab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bbd8acb9-9601-4099-a527-f91ba8ffaab3" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6bf07394-4f3c-41c9-b6fc-1007231f0cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:to="loc_us-gaap_StockholdersEquity_6bf07394-4f3c-41c9-b6fc-1007231f0cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b726f041-a0e9-4448-9db0-60419fb197e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b726f041-a0e9-4448-9db0-60419fb197e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2370777f-78e6-45c5-affa-884fd145c220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bbd8acb9-9601-4099-a527-f91ba8ffaab3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_efdf69b3-042f-4c4f-aebe-1d60e45440c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:to="loc_us-gaap_EquityComponentDomain_efdf69b3-042f-4c4f-aebe-1d60e45440c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_834c868a-71c6-4e62-ab39-bc62a5b6a509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:to="loc_us-gaap_EquityComponentDomain_834c868a-71c6-4e62-ab39-bc62a5b6a509" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_834c868a-71c6-4e62-ab39-bc62a5b6a509" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3d35c3cc-c85e-4337-b33d-22e9029cb6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3d35c3cc-c85e-4337-b33d-22e9029cb6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_bfa251fa-6445-4741-a38a-f9f036f57237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_bfa251fa-6445-4741-a38a-f9f036f57237" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ia2674d376abb46898786e91f9e37b3f8_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_2b52ddbc-ec95-4291-8cb3-df4318f3369d" xlink:href="avdl-20230331.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_2b52ddbc-ec95-4291-8cb3-df4318f3369d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyPayableonNetSalesMaximum_b01d9f1f-1a3a-4494-a112-4c9e31593896" xlink:href="avdl-20230331.xsd#avdl_RoyaltyPayableonNetSalesMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_avdl_RoyaltyPayableonNetSalesMaximum_b01d9f1f-1a3a-4494-a112-4c9e31593896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_72d79a6c-0f24-4b65-b77c-5029366ad208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_us-gaap_GuarantyLiabilities_72d79a6c-0f24-4b65-b77c-5029366ad208" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyAssets_408a08aa-30a1-442d-bc89-a0acaa897338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_us-gaap_GuarantyAssets_408a08aa-30a1-442d-bc89-a0acaa897338" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_285c29db-6946-4d3a-bd07-037bb5714025_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:to="loc_srt_ProductsAndServicesDomain_285c29db-6946-4d3a-bd07-037bb5714025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92bcde4b-ba61-48ea-aa6f-dce814ae8b61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:to="loc_srt_ProductsAndServicesDomain_92bcde4b-ba61-48ea-aa6f-dce814ae8b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FSCMember_f1267e16-b85d-429d-aad8-32229be571b4" xlink:href="avdl-20230331.xsd#avdl_FSCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_92bcde4b-ba61-48ea-aa6f-dce814ae8b61" xlink:to="loc_avdl_FSCMember_f1267e16-b85d-429d-aad8-32229be571b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_3815f6de-06e7-46e6-bb2b-736af5e70d82_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_3815f6de-06e7-46e6-bb2b-736af5e70d82_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bcffc188-fae7-4eb1-af32-918821daa3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bcffc188-fae7-4eb1-af32-918821daa3ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_dafe8b38-302d-4fff-9453-13b9b096001b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bcffc188-fae7-4eb1-af32-918821daa3ad" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_dafe8b38-302d-4fff-9453-13b9b096001b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2016MIPAMember_779ce556-1936-4f05-84bf-15f9534a1ee6" xlink:href="avdl-20230331.xsd#avdl_A2016MIPAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:to="loc_avdl_A2016MIPAMember_779ce556-1936-4f05-84bf-15f9534a1ee6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CerecorMember_8a14d72f-3c6b-4c92-a8a6-cc7da698019a" xlink:href="avdl-20230331.xsd#avdl_CerecorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:to="loc_avdl_CerecorMember_8a14d72f-3c6b-4c92-a8a6-cc7da698019a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#RestructuringCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended" id="i33ef0f7050344ba6994a5ee2a1481efc_RestructuringCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_c1f8a4a3-0eb6-469f-989c-9a928e7b3900" xlink:href="avdl-20230331.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:to="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_c1f8a4a3-0eb6-469f-989c-9a928e7b3900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4be8bbdc-616b-4212-86c8-29366437d17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:to="loc_us-gaap_RestructuringReserve_4be8bbdc-616b-4212-86c8-29366437d17f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:to="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_73f5929c-b5e8-457d-a947-33f4bb4c8725_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:to="loc_us-gaap_RestructuringPlanDomain_73f5929c-b5e8-457d-a947-33f4bb4c8725_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0c1545ed-260b-49b4-bb13-32f03f4916b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:to="loc_us-gaap_RestructuringPlanDomain_0c1545ed-260b-49b4-bb13-32f03f4916b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember_c0792eb5-7c09-4faa-a10a-d876a5b92036" xlink:href="avdl-20230331.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c1545ed-260b-49b4-bb13-32f03f4916b4" xlink:to="loc_avdl_A2022CorporateRestructuringPlanMember_c0792eb5-7c09-4faa-a10a-d876a5b92036" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended" id="ie8ca604f6c2a47fc97ab059e31713fb5_RestructuringCostsSeveranceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4b930789-5fef-4f7a-89d7-fc9c9fe1b183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4b930789-5fef-4f7a-89d7-fc9c9fe1b183" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_92e30ed7-22f7-4da3-9718-9b8da849e36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_RestructuringReserve_92e30ed7-22f7-4da3-9718-9b8da849e36e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_56bfe585-98db-4fd7-92d9-784b98fb78b8" xlink:href="avdl-20230331.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_56bfe585-98db-4fd7-92d9-784b98fb78b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_3b8f33c6-69aa-4e75-ad6a-37a8360ba487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_PaymentsForRestructuring_3b8f33c6-69aa-4e75-ad6a-37a8360ba487" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_dc83aa1d-9585-49a0-9732-843c7c331572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_dc83aa1d-9585-49a0-9732-843c7c331572" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_cca669e3-b9e6-4850-ad52-f9b269e13416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4b930789-5fef-4f7a-89d7-fc9c9fe1b183" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:to="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0dd6437c-ad3b-45f4-8b05-ca00a13602e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:to="loc_us-gaap_RestructuringPlanDomain_0dd6437c-ad3b-45f4-8b05-ca00a13602e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_369c6ece-341b-47f0-86db-be9d02f2c656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:to="loc_us-gaap_RestructuringPlanDomain_369c6ece-341b-47f0-86db-be9d02f2c656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember_1c4c6060-685d-4ea1-ac3a-5112388f4277" xlink:href="avdl-20230331.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_369c6ece-341b-47f0-86db-be9d02f2c656" xlink:to="loc_avdl_A2022CorporateRestructuringPlanMember_1c4c6060-685d-4ea1-ac3a-5112388f4277" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="extended" id="iac3218e86aad460a859c52b2355a9012_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_5d447aa2-8b6d-45a5-be71-4da6e410c64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_5d447aa2-8b6d-45a5-be71-4da6e410c64c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8b97492b-9e30-40eb-bcc5-3b145df45c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8b97492b-9e30-40eb-bcc5-3b145df45c26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_79e9d836-c578-4da3-9e6f-5f626326b589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_79e9d836-c578-4da3-9e6f-5f626326b589" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_45635cb6-bb6c-4101-b92b-47c948b985bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_45635cb6-bb6c-4101-b92b-47c948b985bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_03146da0-12e2-419f-8268-e3dc8d930951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_03146da0-12e2-419f-8268-e3dc8d930951" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_865dd36a-0543-4a22-a355-57c53bb7bbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_865dd36a-0543-4a22-a355-57c53bb7bbae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ae67b7e8-b921-450b-a995-d309b1950118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ae67b7e8-b921-450b-a995-d309b1950118" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrphanDrugExclusivityTerm_eda6fe55-ba99-4861-886b-119ec28edda5" xlink:href="avdl-20230331.xsd#avdl_OrphanDrugExclusivityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_avdl_OrphanDrugExclusivityTerm_eda6fe55-ba99-4861-886b-119ec28edda5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ce124abc-6925-4cf3-969a-48389a507d5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ce124abc-6925-4cf3-969a-48389a507d5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_c760712e-ded8-4e13-8a39-529e1a49ab95" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_c760712e-ded8-4e13-8a39-529e1a49ab95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember_4e993afc-408a-4ce6-a037-f05a677a5e31" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:to="loc_avdl_April2027NotesMember_4e993afc-408a-4ce6-a037-f05a677a5e31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bd48d87a-d5f7-4bef-9690-34111e6fcdce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bd48d87a-d5f7-4bef-9690-34111e6fcdce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c1183ba5-d8fb-4a21-8b53-1bb631953a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c1183ba5-d8fb-4a21-8b53-1bb631953a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d75c3fad-5385-4420-a71f-732f28c776e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1183ba5-d8fb-4a21-8b53-1bb631953a70" xlink:to="loc_us-gaap_SeniorNotesMember_d75c3fad-5385-4420-a71f-732f28c776e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b92dca66-d780-48be-8fc2-5a7d15aefaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b92dca66-d780-48be-8fc2-5a7d15aefaaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_05a88285-5361-4b23-b2e4-946a519762c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b92dca66-d780-48be-8fc2-5a7d15aefaaf" xlink:to="loc_us-gaap_SubsequentEventMember_05a88285-5361-4b23-b2e4-946a519762c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_17226893-5715-41ea-9468-e86ffe863fe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_17226893-5715-41ea-9468-e86ffe863fe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3a5cfe27-4caf-47c5-86ab-ed6364ee95ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3a5cfe27-4caf-47c5-86ab-ed6364ee95ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3a5cfe27-4caf-47c5-86ab-ed6364ee95ff" xlink:to="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheOneMember_a140d976-93d2-4352-9a05-2ddec69e1349" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:to="loc_avdl_PublicStockOfferingTrancheOneMember_a140d976-93d2-4352-9a05-2ddec69e1349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheTwoMember_64ebfc57-2e34-4fee-8988-3f71d73c547d" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:to="loc_avdl_PublicStockOfferingTrancheTwoMember_64ebfc57-2e34-4fee-8988-3f71d73c547d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_31191f19-d660-4b49-89ee-0c1c652562f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:to="loc_us-gaap_ClassOfStockDomain_31191f19-d660-4b49-89ee-0c1c652562f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:to="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_49f723d4-809c-46d1-aeb2-156be98edf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_49f723d4-809c-46d1-aeb2-156be98edf2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember_4362a44f-a50d-4356-8adc-96197932ff72" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:to="loc_avdl_AmericanDepositarySharesMember_4362a44f-a50d-4356-8adc-96197932ff72" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>avdl-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ff4affb4-5e35-499d-a060-a6a189fb41ed,g:0e980074-2bb1-4083-b23a-3722f5917d03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eb69b441-b78b-4c1f-abef-4e415e6bcc0e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3432d4ef-3ea2-4c74-be41-c5a0c12ed967_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_e7914700-ae17-435b-9013-e74e173716ac_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due October 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due October 2 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_250c47f3-4254-431f-b8a9-da45a1c45184_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_257dd4b9-77b5-4fd6-a4d2-0291c33ae738_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c47b0403-2f3e-4a51-91fd-bf5e731ef7cf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4018ff04-da32-4ccd-af0c-94a090979016_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of 4.50% exchangeable senior notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_6fb28d57-a349-4ee8-a97d-6d50c3c5eed1_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_2cb451e8-3097-40b6-81b1-3baeb51b2d9d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_08c1a192-e9db-4dc4-b5cb-e046790dee80_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_0fa6a527-353a-4c4b-b88f-875ef8dc09aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_6c418dc3-deac-4383-83e3-ad649b03f048_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_1166cd33-aabd-49dd-b8c8-ba9c0e1b142b_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADSs, conversion ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_label_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:label id="lab_avdl_AmericanDepositorySharesConversionRatio_documentation_en-US" xlink:label="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depository Shares, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositorySharesConversionRatio" xlink:to="lab_avdl_AmericanDepositorySharesConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_a5cb98c4-c713-47e9-b367-97439e6966cb_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase aggregate principal amount, term</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:to="lab_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_2c4be070-84ca-4d7f-a022-a18b7347c396_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_0ecdb8ef-cccc-4375-b25f-efa7b67763d9_verboseLabel_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax liabilities</link:label>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liabilities And Other Noncurrent Liabilities</link:label>
    <link:label id="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_documentation_en-US" xlink:label="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liabilities And Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:href="avdl-20230331.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:to="lab_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_85e688e2-c618-45c2-8dfa-aad05ffcfd35_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7d30d02c-b9f2-436f-8268-7b254c4a8eca_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_720a0740-f8b0-44c3-833b-3da9e1d277d1_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_d26d46d9-07ce-4131-88d3-01b7fbed07ce_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_e2f53d0e-a6a7-42e1-a010-d7b33a8f27d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_2c249800-13b1-4cf5-9d01-0fb6ce6cf68c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_3306246e-452d-4809-b4f8-5be0ff4e3be0_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS premium percentage</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Premium Percentage</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPremiumPercentage_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Premium Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesPremiumPercentage" xlink:to="lab_avdl_AmericanDepositarySharesPremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_8dc8129e-70d7-413c-b677-7544f1b27b61_verboseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Tax Credit Receivable Non Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The non current portion of tax credit receivable on research and development as on the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:href="avdl-20230331.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_7570367c-838b-4d16-b79a-c865ae428dc3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5557a470-1021-4c00-964c-f44606af7c02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_b349ab03-ae52-4910-8dce-bb76ca78841d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring reserve</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_71281393-cce2-4f77-9efa-c2f9eb019410_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_37485d6f-33ec-4ac9-a828-5cde3726729f_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of 2022 Corporate Restructuring Plan accrual at March 31,</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_8dfdc23d-6d8d-47db-aa09-83a76e5e0b19_terseLabel_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_label_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:label id="lab_avdl_OtherLiabilitiesMiscellaneousCurrent_documentation_en-US" xlink:label="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Miscellaneous, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:href="avdl-20230331.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:to="lab_avdl_OtherLiabilitiesMiscellaneousCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_877c1087-0aa6-454a-a0a0-9c284227bae5_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets:</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_bcba49fb-f708-4418-a47b-028280437e75_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Ownership Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_08cb0c05-d506-4955-bfb2-8ca2b0965d63_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 64,478 issued and outstanding at March&#160;31, 2023 and 62,878 issued and outstanding at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_1cb864f8-c37a-48a0-967f-b967334d4943_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt exchanged</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a1354eb5-e35d-453d-8f02-02d3f7b9c739_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockMember_7aa98159-a1b7-4a85-af84-1182f992b68d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares</link:label>
    <link:label id="lab_us-gaap_PreferredStockMember_label_en-US" xlink:label="lab_us-gaap_PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockMember" xlink:to="lab_us-gaap_PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_31ab13b9-31da-448e-83c8-69247ae73708_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PublicStockOfferingMember_4a5615a5-bf72-4821-b311-995e95f2a5cd_terseLabel_en-US" xlink:label="lab_avdl_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering</link:label>
    <link:label id="lab_avdl_PublicStockOfferingMember_label_en-US" xlink:label="lab_avdl_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering [Member]</link:label>
    <link:label id="lab_avdl_PublicStockOfferingMember_documentation_en-US" xlink:label="lab_avdl_PublicStockOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingMember" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PublicStockOfferingMember" xlink:to="lab_avdl_PublicStockOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_5674ad6d-1ac5-4d71-823b-c19c6004373d_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d703435d-ed33-4bd4-bd22-4a66d4136428_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2022CorporateRestructuringPlanMember_606bb7f6-8f03-4152-84b8-db199391fb3b_terseLabel_en-US" xlink:label="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Corporate Restructuring Plan</link:label>
    <link:label id="lab_avdl_A2022CorporateRestructuringPlanMember_label_en-US" xlink:label="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Corporate Restructuring Plan [Member]</link:label>
    <link:label id="lab_avdl_A2022CorporateRestructuringPlanMember_documentation_en-US" xlink:label="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Corporate Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember" xlink:href="avdl-20230331.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2022CorporateRestructuringPlanMember" xlink:to="lab_avdl_A2022CorporateRestructuringPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5ed262e6-42be-47ea-ae2f-960db15a5a7f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_6a1a7d60-3dd4-454e-9454-98b655a98ed0_terseLabel_en-US" xlink:label="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received in advance of Series B Preferred Shares issuance</link:label>
    <link:label id="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_label_en-US" xlink:label="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received In Advance Of Share Issuance, Current</link:label>
    <link:label id="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_documentation_en-US" xlink:label="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received In Advance Of Share Issuance, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" xlink:href="avdl-20230331.xsd#avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" xlink:to="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_46896891-4e97-4ab2-9928-9322142ef8a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Instruments Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_4caf31fb-8562-4cbd-ac13-6213bf3f2356_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9823279e-04d8-4bf1-9ca0-08c167c1c67a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_7298eab0-b341-4210-b68d-eee60b7928af_terseLabel_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Exchangeable Senior Notes Due February 2023</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_label_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Exchangeable Senior Notes Due February 2023 [Member]</link:label>
    <link:label id="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_documentation_en-US" xlink:label="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" xlink:to="lab_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_df878bfb-b141-4e61-9a75-c22a038580cf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_07607f57-ae81-4eb2-8bc2-a5f84491f1a7_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_93707268-32ae-4db1-8830-247704bfb792_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at January 1,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_978cda34-c5aa-41b4-8320-871dc2061cd9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at March 31,</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyAssets_250f4c63-a661-42c9-a55d-8022104c13b6_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty assets</link:label>
    <link:label id="lab_us-gaap_GuarantyAssets_label_en-US" xlink:label="lab_us-gaap_GuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyAssets" xlink:to="lab_us-gaap_GuarantyAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_98eea80d-dd06-4cca-a95a-cae6b99b7206_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_c9809471-1048-4675-a547-e51efef2ae52_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_1bddf34a-a3e6-49a5-ba06-66e584371fea_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from loans or conditional grants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_b62ced61-482c-491f-8b30-4315ed6e483c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty financing</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRoyaltiesReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Royalties Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRoyaltiesReceived" xlink:to="lab_us-gaap_ProceedsFromRoyaltiesReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_074da3b9-f0af-4b7a-b96f-1d7fcca472f2_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2bd235d8-90e3-40b3-b8bd-2e188f9623cd_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_9a2abe00-3ce7-48bf-ae82-cbc47cf93ee7_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4a74d668-7656-4494-a5e2-c5c51ff22c8d_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_8fb1a5c1-5967-40de-878b-403f2e1a3baf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CouponInterestExpense_3579bbd2-af6d-44c7-a77b-22d7e467f4cb_terseLabel_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon interest expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_label_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:label id="lab_avdl_CouponInterestExpense_documentation_en-US" xlink:label="lab_avdl_CouponInterestExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coupon Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense" xlink:href="avdl-20230331.xsd#avdl_CouponInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CouponInterestExpense" xlink:to="lab_avdl_CouponInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_b5d8f700-603c-4121-89a7-5ae87e606643_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_fb0dda38-04df-4818-9e77-129381fd9a79_verboseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale and Equity Securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0849351b-d088-40a9-a6a4-02b7ea26e691_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c6521271-f3ac-4a50-ad00-90e04af380d8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_79664479-06a8-4865-af7f-827d418c464f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a1bdb9a0-5e6a-4ecc-8740-bf6881d306cb_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_b2dbf8c8-5688-49a0-b2a0-972712590d81_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance_1204c2bf-a0bc-4033-9d5b-3e1696d28019_terseLabel_en-US" xlink:label="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received in advance of Series B Preferred Shares Issuance</link:label>
    <link:label id="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance_label_en-US" xlink:label="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received In Advance Of Share Issuance</link:label>
    <link:label id="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance_documentation_en-US" xlink:label="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received In Advance Of Share Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuance" xlink:href="avdl-20230331.xsd#avdl_ProceedsReceivedInAdvanceOfShareIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuance" xlink:to="lab_avdl_ProceedsReceivedInAdvanceOfShareIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_6c990b5c-cde9-4bc9-b23e-35f33c0bf325_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_0d4f4120-0816-4087-acad-e94c6106f3a2_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_fc64764c-888c-46ab-bf52-6a803390f122_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_0741fd7e-e5a8-491e-b2f3-64e31553e17a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1b97c145-5ce8-4360-8b73-cefeba28c9bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_31973ff9-ac0e-4655-9a80-658a3cdbc300_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_817a676a-d36d-42e6-8a10-050ee351490b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee share purchase plan share issuance</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_67ac8b86-1f7d-413b-b34b-1724ed6636d9_terseLabel_en-US" xlink:label="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of notes conversion feature</link:label>
    <link:label id="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_label_en-US" xlink:label="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</link:label>
    <link:label id="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_documentation_en-US" xlink:label="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:href="avdl-20230331.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:to="lab_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_ca7e2ad3-6888-4bb9-88b3-1a1c76de98d8_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2269da8e-ac0b-4577-b584-645c0b7454f3_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_342ca069-1a5a-41d5-b663-80d4e878b8f5_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock option exercises and employee share purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_b809f66b-21b8-4d0f-8d84-44a0598f7f5f_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS purchased, price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares Purchased, Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares Purchased, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesPurchasedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_661156e8-bcdf-417f-850c-c7fd80517a8c_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveCurrent_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveCurrent" xlink:to="lab_us-gaap_RestructuringReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_164687d3-2c54-453d-8be9-6f0b813633e5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_861e61f5-00c5-44d4-9ceb-718483081e5c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_616a5661-2893-42e5-b427-bda5475a85f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_1b285fa8-fc6e-4917-81dd-c3d5168adedd_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_fe88af46-f7d1-4de0-8143-ebd1bd5352c5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_769dcc54-c3cf-4019-8b1f-44c838607910_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_85bc16ab-a161-4f3d-84d0-6d354e8cf815_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5e25832c-5835-4829-bcde-f19f237cdef3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_60daf63d-3a80-4c2d-a48c-b6da8c2bac20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_510dd1b9-85c3-4fbe-9c03-a533e0330c49_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_dab4861d-ed1c-450a-a739-c72d578cf9bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for February 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_bd08ea8a-40ef-487f-9b79-9005c1d8e95c_terseLabel_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of royalty payable on net sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_label_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Royalty Payable On Net Sales</link:label>
    <link:label id="lab_avdl_PercentageOfRoyaltyPayableOnNetSales_documentation_en-US" xlink:label="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of royalty that has to be paid by the company as per the royalty agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:href="avdl-20230331.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:to="lab_avdl_PercentageOfRoyaltyPayableOnNetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8aee7486-8bf1-4d16-9b74-7111822a2201_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_1b3dde4a-cda1-40db-8a8a-4092e861526e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_7d5d8dbc-aa3a-422d-8d12-f8479ed88e63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_987055d6-4cb8-4a7b-bfc3-0b89dd567dcf_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_47c37e6d-3562-4ef8-bf5b-35551f7bd0d3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_6d69c129-16e4-44d3-b243-127841025e31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt discount and issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_ffd0c784-67f1-4b51-bf79-60592a67c49d_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADS, option price per share (in dollars per share)</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesOptionPricePerShare_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares, Option Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:to="lab_avdl_AmericanDepositarySharesOptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AtTheMarketOfferingProgramMember_cdfb4d67-c5a2-4f35-8b9f-8bf439745d25_terseLabel_en-US" xlink:label="lab_avdl_AtTheMarketOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Program</link:label>
    <link:label id="lab_avdl_AtTheMarketOfferingProgramMember_label_en-US" xlink:label="lab_avdl_AtTheMarketOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Program [Member]</link:label>
    <link:label id="lab_avdl_AtTheMarketOfferingProgramMember_documentation_en-US" xlink:label="lab_avdl_AtTheMarketOfferingProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AtTheMarketOfferingProgramMember" xlink:href="avdl-20230331.xsd#avdl_AtTheMarketOfferingProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AtTheMarketOfferingProgramMember" xlink:to="lab_avdl_AtTheMarketOfferingProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_93878af7-06d7-4f83-8403-275b9ade43bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8619ce1f-9a38-4427-add4-b409672ccc31_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_38c470a9-f43f-4465-ac1f-934614d74fea_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ddab87c7-fbf6-4cac-9070-35a1438a5b27_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5d655295-9034-4fe5-a687-56690afdd5bd_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ed7359b-82a0-4cce-8e05-6df63470c931_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b08a35e5-c6c5-4078-ba55-858613a37b82_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_f9623788-c052-4439-aa64-cdae06885d93_terseLabel_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual and money market funds</link:label>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual And Money Market Funds [Member]</link:label>
    <link:label id="lab_avdl_MutualAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual And Money Market Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember" xlink:href="avdl-20230331.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MutualAndMoneyMarketFundsMember" xlink:to="lab_avdl_MutualAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2022ShelfRegistrationStatementMember_96435bfb-61ac-474d-b62a-b5343f6fdc54_terseLabel_en-US" xlink:label="lab_avdl_A2022ShelfRegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Shelf Registration Statement</link:label>
    <link:label id="lab_avdl_A2022ShelfRegistrationStatementMember_label_en-US" xlink:label="lab_avdl_A2022ShelfRegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Shelf Registration Statement [Member]</link:label>
    <link:label id="lab_avdl_A2022ShelfRegistrationStatementMember_documentation_en-US" xlink:label="lab_avdl_A2022ShelfRegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Shelf Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022ShelfRegistrationStatementMember" xlink:href="avdl-20230331.xsd#avdl_A2022ShelfRegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2022ShelfRegistrationStatementMember" xlink:to="lab_avdl_A2022ShelfRegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_84040031-0e75-424d-a5db-134e4364f2aa_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_5e001cfd-13a6-4fec-b605-dcb8c1f4a2d3_verboseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SaleOfStockSalesAgentCommissionPercent_83e66feb-9996-4463-ba50-94c5921ff7e3_terseLabel_en-US" xlink:label="lab_avdl_SaleOfStockSalesAgentCommissionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales agent commission, as a percent of aggregate gross sales proceeds</link:label>
    <link:label id="lab_avdl_SaleOfStockSalesAgentCommissionPercent_label_en-US" xlink:label="lab_avdl_SaleOfStockSalesAgentCommissionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Sales Agent Commission, Percent</link:label>
    <link:label id="lab_avdl_SaleOfStockSalesAgentCommissionPercent_documentation_en-US" xlink:label="lab_avdl_SaleOfStockSalesAgentCommissionPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Sales Agent Commission, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockSalesAgentCommissionPercent" xlink:href="avdl-20230331.xsd#avdl_SaleOfStockSalesAgentCommissionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SaleOfStockSalesAgentCommissionPercent" xlink:to="lab_avdl_SaleOfStockSalesAgentCommissionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_58b888fe-329b-4a80-863d-596971d74b04_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7d100a62-473c-4230-9383-fb8cc08d018f_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_d8ad6d5e-57e8-4828-b2e3-eea013911226_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_9ffbe47c-4394-452c-99b8-c7fcfb293c3f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_169522b8-fd19-4c63-87bf-26ce4404e1ab_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c306e574-9786-4083-b297-ea809c119c25_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_3c64836a-d7cf-403c-8b69-06d07c765392_terseLabel_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:href="avdl-20230331.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_1b777355-8950-41d1-8beb-bbdb3e4d51d3_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_cdaf389f-5865-4847-90b8-b9a6aa24e92d_terseLabel_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued outsourced contract manufacturing costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_label_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:label id="lab_avdl_AccruedOutsourceContractCosts_documentation_en-US" xlink:label="lab_avdl_AccruedOutsourceContractCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Outsource Contract Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts" xlink:href="avdl-20230331.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedOutsourceContractCosts" xlink:to="lab_avdl_AccruedOutsourceContractCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_1a47a09b-5976-4b6c-8022-886e27fc7ed3_terseLabel_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_label_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:label id="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_documentation_en-US" xlink:label="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Tax Credit Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:href="avdl-20230331.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:to="lab_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_542dab17-b9d1-4b76-b88a-59e9b8c06df2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f6585a48-b729-4ff5-8e5d-3924a32df3fc_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_80de3576-8f94-42b3-9d4f-b3980bf3edb1_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_30a1942f-0469-431a-83ff-924a6734dfb8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_d3214c59-11fc-4abb-a2e3-83f56b868317_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under at-the-market offering program, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_2a15531c-3ad7-44f6-b65f-073b608448d5_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4c6c2f14-e865-4104-b205-88c941ea91ab_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d3662920-a5cd-4326-a92d-e543ad8e82ec_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_964e5264-2c95-4f21-ad1f-bb36391744c7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_d82bbafb-ffd3-4c01-9781-c497176311cd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on marketable debt securities, net</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_104141a1-450d-4d38-a62b-76a29a9a0b2e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_7e42ccf7-4dbc-4c73-8fe6-e56744290f49_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ea7260da-1abd-4c5e-914c-18d7ae24e837_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1f077931-8829-48e3-a331-c8a8cceaf997_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Smaller Reporting Company</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_19c36a8f-76c9-4003-8e50-57abc8443d06_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_756cf8a1-f2a7-430a-a0db-0e24421c0091_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_efff4ac1-7f55-4727-a3ed-6ba349bf0b27_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_a44f591d-64ea-4d8e-98bd-32d4479ac6d9_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_2e912554-4234-4786-a459-c582a006005f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Capitalization, Long-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:to="lab_us-gaap_ScheduleOfCapitalizationLongtermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9890c4ad-bee4-43e8-a420-2205dccec1f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_9f9714b7-075f-4950-bc4c-59be8e755efe_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_00690c24-4ce2-4e77-8859-16136e8c8b05_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_0bdae90d-7583-432f-8ec7-238a3f2a10de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_e1e3acfe-4f4e-428f-85da-0b6c54036880_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f2a5e65b-cf00-4f77-9866-fa56bd0c9bf6_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_c0f96414-4fed-4661-b086-c474b249c958_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_bb16940c-c624-4268-ad2e-1d9e7efcab18_terseLabel_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:label id="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue_documentation_en-US" xlink:label="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:href="avdl-20230331.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:to="lab_avdl_OtherGuarantorObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PublicStockOfferingTrancheOneMember_313d0244-a6d3-454b-9d05-46400a379588_terseLabel_en-US" xlink:label="lab_avdl_PublicStockOfferingTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Tranche One</link:label>
    <link:label id="lab_avdl_PublicStockOfferingTrancheOneMember_label_en-US" xlink:label="lab_avdl_PublicStockOfferingTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Tranche One [Member]</link:label>
    <link:label id="lab_avdl_PublicStockOfferingTrancheOneMember_documentation_en-US" xlink:label="lab_avdl_PublicStockOfferingTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheOneMember" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PublicStockOfferingTrancheOneMember" xlink:to="lab_avdl_PublicStockOfferingTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_6334f1ab-6b76-4888-83c4-0c9e4090e507_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_230635cb-3e9d-4c76-8059-85936e937b90_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Non-Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_81c1681e-ef01-4144-88e1-1f1494df4d9f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9dca5bfa-2bdb-4bc9-8d71-13058abc87d8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_a590f6d6-edc7-45e3-b927-e07b425415fb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d4649d4c-cfe4-4ea7-9e1a-c70ff817e4ba_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_a11a66db-6a5c-4fb0-9be7-083ff170e684_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_8f0fc9ec-079b-43f3-9d27-ddff48b0f8b5_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expense</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_fb682795-a9e8-45f2-9dbe-a1e3594aac33_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_06ef7514-9bb3-4693-9dee-226e9beaae96_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b1bfd00d-b491-4327-8cb0-58185b2b435b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_ac23196c-9940-4744-8e4e-07176a194ff9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_f7467adb-52d4-4697-a21a-09d948b26abf_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_4a6e5e12-a735-45a8-bc2d-d08f73036be0_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ba15e767-e2a4-49f2-a71a-de3f1fcbb75b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_628fe177-2a39-4533-910a-593fb0a49db1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_b24b3652-c402-415b-8b7c-a23a41cdc8f1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_fa84c8fb-350f-45b3-aaa0-b8e934268755_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_059dc745-69bd-4d74-a891-abd67e525dec_negatedTerseLabel_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_label_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Research and Development Tax Credit Receivable</link:label>
    <link:label id="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_documentation_en-US" xlink:label="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in research and development tax credit receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:href="avdl-20230331.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:to="lab_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_67d32e8f-ba53-490e-b2a9-d7d467a08273_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_4057b706-990d-439e-bb7e-1e2849de569e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_3489c531-23a6-4d9c-bcc4-db3c0603c099_terseLabel_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_label_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Receivables</link:label>
    <link:label id="lab_avdl_OtherNoncurrentReceivables_documentation_en-US" xlink:label="lab_avdl_OtherNoncurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amount of other noncurrent receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables" xlink:href="avdl-20230331.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OtherNoncurrentReceivables" xlink:to="lab_avdl_OtherNoncurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_ThirdPartyMember_2fe390ed-ebaf-41a1-83c2-d97a2373911e_terseLabel_en-US" xlink:label="lab_avdl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:label id="lab_avdl_ThirdPartyMember_label_en-US" xlink:label="lab_avdl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party [Member]</link:label>
    <link:label id="lab_avdl_ThirdPartyMember_documentation_en-US" xlink:label="lab_avdl_ThirdPartyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ThirdPartyMember" xlink:href="avdl-20230331.xsd#avdl_ThirdPartyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_ThirdPartyMember" xlink:to="lab_avdl_ThirdPartyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0e2dfa4d-a8c7-4dc1-af6f-ffb86301fdcb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; (DEFICIT) EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_497ed75f-fa40-40c6-a5bd-b7bd2d19dfb0_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_de4c3436-cd74-425d-8911-3ea6f7844392_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_0b594472-18d7-4029-985c-491b158ac3af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_81157f35-6cdc-491c-8fdf-b31b2befd97c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fc37fa4d-996e-4ee8-ab57-7d456def600a_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_73f7e858-47eb-4726-a6ba-911c8a7854a1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_2c4f6e6e-d178-452e-9e7a-baac449d67e4_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_21111727-16f8-470f-916d-6c0e7a4f5886_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_b4ed0a36-7ee9-4de2-b791-2d9345bd61d4_verboseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_4602f80d-083d-4dc8-8ca0-869cb3779cfc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5c4e94c6-71bd-411d-8b74-f146b62e2c8f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_83ebf9a7-4c7e-4938-9d80-36b2f0e5f968_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_9816c710-c733-442a-86e4-7935806a8f5d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_c5addf18-f28d-4887-a629-d6f68c51509a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_34e01b86-7fd0-4c3e-98c8-571a8c8297fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_788db449-d8df-4668-bf81-da141b9a055d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_NoTradingSymbolFlag_5399d54e-51d5-4bbb-94e4-f05ea17568c1_terseLabel_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:label id="lab_dei_NoTradingSymbolFlag_label_en-US" xlink:label="lab_dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">No Trading Symbol Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_NoTradingSymbolFlag" xlink:to="lab_dei_NoTradingSymbolFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_06bd4793-37d1-4207-a2d0-1fe5e0f95531_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_143fd8e4-b97d-461b-a38b-95874731de05_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate net proceeds from stock offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_5335ca20-5cb3-4f1e-86e5-5d4e21aa6c0e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fa89d8ae-bc80-4c1c-9bac-e7f802d42642_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; (deficit) equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f0ee7d5e-dbb6-45e9-991e-b991a4dd214f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b85bfdfa-0c1a-40dd-9bd7-c286b4ae3bb5_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cfdcf402-d553-4115-979b-47a0473d31e6_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_022a1a5b-f32b-44c2-aa12-c4615cfb82d3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_5ceb649e-79f8-4568-a8eb-2e3192de8aa9_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d5172877-b183-4e23-9c6f-b27fff7fb11e_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_79e606ff-be7b-4856-a865-dccb9e76ef93_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_97d65e9b-970a-4fd8-9fd8-498d7cb3b7da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, benefit (tax)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_a3e9f024-2583-40c3-ac1b-4fe5e597bb82_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_b528e699-6143-474e-bc67-63c741711f0b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of shares off the at-the-market offering program</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_faf303ce-adff-4462-863f-6ff8cb97ce66_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_811957d0-da74-4194-bce5-1f15abfd0a75_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_5ebde6e7-0c37-4655-bd73-da1ab9c9dc10_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_e3ffda61-320e-400d-9503-6f42624a65f9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_73cdf905-706a-4f56-bddb-35a0c9688ec8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_6d90a582-2fb7-4a5d-b0bc-570c3375515b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Non-Current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_67b43e36-1e4b-4d8f-9ef3-9237a732ecab_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_dcba293e-20ae-4f90-a130-06ecffbd623f_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_58cad586-b6b3-4c69-bbe8-3fd225356f68_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under at-the-market offering program, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_56d3dbbb-27de-415d-b93d-8d1daceba968_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2020 private placement (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_c3fce76c-ab9b-4b36-89e8-bbca66f3d305_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount of debt repurchased</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_cf4f54c7-c226-41d8-8fc0-6ebb48ee925a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_ea9118ba-cf1c-4027-b817-5c2b7aebf7a7_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to increase aggregate principal amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_label_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Option to Increase Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:to="lab_avdl_DebtInstrumentOptiontoIncreaseFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_697340b4-2c56-46ed-b2ee-aae3fc3adc0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_1bc82cf9-3741-4245-be22-2d8152157d2f_terseLabel_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use assets at contract manufacturing organizations</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_label_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:label id="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_documentation_en-US" xlink:label="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:href="avdl-20230331.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:to="lab_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_c1cd108e-eff5-4564-87eb-de4970181081_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_09ce812a-d952-463b-bd3a-091ae1e78d0e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at March&#160;31, 2023 and 488 issued and outstanding at December&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_dfacb867-acb9-455e-9ebe-54b557d0dc12_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_685001e7-dc4d-4efe-8624-406c270737b7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_b9c9e290-690a-40d5-adf3-2e2150b6e458_terseLabel_en-US" xlink:label="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized aggregate offering price under shelf registration</link:label>
    <link:label id="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_label_en-US" xlink:label="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Remaining Authorized Aggregate Offering Price Under Shelf Registration</link:label>
    <link:label id="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_documentation_en-US" xlink:label="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Remaining Authorized Aggregate Offering Price Under Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" xlink:href="avdl-20230331.xsd#avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" xlink:to="lab_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_945a03b8-c5e6-4de5-b5c3-f96e6a880934_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_76721b78-56ab-4920-9109-cf8febbf110a_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in embedded conversion feature</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_label_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)</link:label>
    <link:label id="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:to="lab_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2c93624c-228a-4953-a1ac-782380d05141_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AmericanDepositarySharesMember_5b2364a2-1fd9-4f21-a38a-87d8402484dc_terseLabel_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesMember_label_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:label id="lab_avdl_AmericanDepositarySharesMember_documentation_en-US" xlink:label="lab_avdl_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AmericanDepositarySharesMember" xlink:to="lab_avdl_AmericanDepositarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2020ShelfRegistrationStatementMember_ebe24fd2-b79a-4951-b2a3-ca20c748d359_terseLabel_en-US" xlink:label="lab_avdl_A2020ShelfRegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Shelf Registration Statement</link:label>
    <link:label id="lab_avdl_A2020ShelfRegistrationStatementMember_label_en-US" xlink:label="lab_avdl_A2020ShelfRegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Shelf Registration Statement [Member]</link:label>
    <link:label id="lab_avdl_A2020ShelfRegistrationStatementMember_documentation_en-US" xlink:label="lab_avdl_A2020ShelfRegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Shelf Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2020ShelfRegistrationStatementMember" xlink:href="avdl-20230331.xsd#avdl_A2020ShelfRegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2020ShelfRegistrationStatementMember" xlink:to="lab_avdl_A2020ShelfRegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_ea65e6c1-84f5-42bc-b5ff-714098f4e84f_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f4ff2816-b657-4afb-bf6c-b42c085b4173_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a858d327-b584-430a-bca0-3f2203846e1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_c74ed55c-ea11-4f6d-a897-9bdd90103483_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_6330ad72-06a7-4dd6-bf89-5509b4c1b6df_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_67bb4228-6149-4984-ad78-5a770169b648_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_c8a9c00e-86bb-4904-9399-109ace8a55e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9d4bb1a0-ad00-4d4c-a416-e6eb26fcbc5a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2a49a1c5-769d-4cf5-abf6-827d4916cdf0_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, nominal value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_7e5fd87c-e231-4014-be30-285d4cc51656_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_26fcd2df-0699-4135-886d-a4de638c4650_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_FSCMember_7613dab9-5cbc-4b4e-b1e4-f7b084253611_terseLabel_en-US" xlink:label="lab_avdl_FSCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC</link:label>
    <link:label id="lab_avdl_FSCMember_label_en-US" xlink:label="lab_avdl_FSCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC [Member]</link:label>
    <link:label id="lab_avdl_FSCMember_documentation_en-US" xlink:label="lab_avdl_FSCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FSC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FSCMember" xlink:href="avdl-20230331.xsd#avdl_FSCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_FSCMember" xlink:to="lab_avdl_FSCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_5c65ac8a-6fe6-41d7-9a7e-cc968c26772e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_eb8c6f30-ed0d-4340-a41c-afc1cf9570b2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; (deficit) equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5422ab4f-9dfb-415a-b734-2af0e707788f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e852a949-a19e-4a59-9e1d-a9d442bac59f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1df5505c-b538-48a3-86bd-9eb7375d7160_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_f5fa50ff-b528-46b3-8dec-b2ce852443d7_terseLabel_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum aggregate offering price of ADSs under shelf registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_label_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</link:label>
    <link:label id="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_documentation_en-US" xlink:label="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:href="avdl-20230331.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:to="lab_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_cbecb7e1-4727-4b43-9b81-a6a6cda92490_terseLabel_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges for employee severance, benefits and other costs</link:label>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_label_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Before Gain (Loss) Due to Curtailment</link:label>
    <link:label id="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_documentation_en-US" xlink:label="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Before Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:href="avdl-20230331.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:to="lab_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_b86e52f6-2dfb-404c-a4d0-e56cca06e444_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8668d8c1-6768-43a8-9e47-d9199f3e2142_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5c8833ac-b82e-4802-bb73-895ae3d6c994_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_7a67c31b-596d-4099-aa36-1e5e55df54b8_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss:</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_d7d44d1d-5dab-4f03-9e3c-8ec380ad7f87_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c32735f4-b908-450d-a589-4f7d5a7f187f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_aa1757cf-4615-42ea-a6c2-84b9b06c5758_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9f9f9f40-6504-42d1-a6b3-48040eab3562_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_6dcd3ce2-0bf8-4fe8-ab2a-89bfb8539184_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_c973e65f-5a11-4aae-ae82-963f29ba133f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized gain</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_3b87d40f-a8c1-4f5f-acb1-348e762ca001_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_bb4b8200-c99d-4483-8db6-a542968a5cbb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_a764b3a9-0448-43a5-8a20-e14e81388a63_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_37beb69c-7914-4264-a202-0e93cee52be7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f9fd5f11-d807-44f0-bfbf-cf9435176a44_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable &amp; other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf809505-f4ac-4ba2-bcfd-a2a7fe6bb8db_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_6bb0c0b2-4331-4fcd-8162-d767e26ede00_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNMS_0985ed8c-d69a-49e6-8ad8-00a4fc609c20_terseLabel_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NASDAQ/NMS (GLOBAL MARKET)</link:label>
    <link:label id="lab_exch_XNMS_label_en-US" xlink:label="lab_exch_XNMS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NASDAQ/NMS (GLOBAL MARKET) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNMS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNMS" xlink:to="lab_exch_XNMS" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_9da8616c-a8c2-4f19-8bc2-4b52bab872b4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuarantyLiabilities_5e19b854-4b84-4328-b079-b11082753514_terseLabel_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee to Deerfield</link:label>
    <link:label id="lab_us-gaap_GuarantyLiabilities_label_en-US" xlink:label="lab_us-gaap_GuarantyLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guaranty Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuarantyLiabilities" xlink:to="lab_us-gaap_GuarantyLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a7d7a77d-e2ed-4a63-8f05-14363bc36e33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_3efa06d2-6246-4764-8a5c-c103418f6a8a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNet_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNet" xlink:to="lab_us-gaap_InvestmentIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_890ca629-ba77-46c2-b3c2-c634a4dc2967_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_April2027NotesMember_3192541e-288b-4f88-9e3d-15f0d337643f_terseLabel_en-US" xlink:label="lab_avdl_April2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2027 Notes</link:label>
    <link:label id="lab_avdl_April2027NotesMember_label_en-US" xlink:label="lab_avdl_April2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2027 Notes [Member]</link:label>
    <link:label id="lab_avdl_April2027NotesMember_documentation_en-US" xlink:label="lab_avdl_April2027NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">April 2027 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_April2027NotesMember" xlink:to="lab_avdl_April2027NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_6ba54904-bd63-452f-9f04-e54e6492306e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_PublicStockOfferingTrancheTwoMember_e3fa7002-e71c-417f-834b-9920d69556b6_terseLabel_en-US" xlink:label="lab_avdl_PublicStockOfferingTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Tranche Two</link:label>
    <link:label id="lab_avdl_PublicStockOfferingTrancheTwoMember_label_en-US" xlink:label="lab_avdl_PublicStockOfferingTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Tranche Two [Member]</link:label>
    <link:label id="lab_avdl_PublicStockOfferingTrancheTwoMember_documentation_en-US" xlink:label="lab_avdl_PublicStockOfferingTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Stock Offering, Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheTwoMember" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_PublicStockOfferingTrancheTwoMember" xlink:to="lab_avdl_PublicStockOfferingTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_OrphanDrugExclusivityTerm_fe26fdb4-0c8a-4d0b-a518-1ae67a73226e_terseLabel_en-US" xlink:label="lab_avdl_OrphanDrugExclusivityTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of orphan drug exclusivity</link:label>
    <link:label id="lab_avdl_OrphanDrugExclusivityTerm_label_en-US" xlink:label="lab_avdl_OrphanDrugExclusivityTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orphan Drug Exclusivity, Term</link:label>
    <link:label id="lab_avdl_OrphanDrugExclusivityTerm_documentation_en-US" xlink:label="lab_avdl_OrphanDrugExclusivityTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orphan Drug Exclusivity, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrphanDrugExclusivityTerm" xlink:href="avdl-20230331.xsd#avdl_OrphanDrugExclusivityTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_OrphanDrugExclusivityTerm" xlink:to="lab_avdl_OrphanDrugExclusivityTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c453893e-d09a-4f41-b665-fb62bff8507c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f9d0f7ab-4756-4dce-b568-000e4969a9d5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share - basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_61f5f8be-a704-4f87-80b3-a0bdf8753974_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_CerecorMember_1fbaa465-db1c-41de-91db-6c018dbdbd63_terseLabel_en-US" xlink:label="lab_avdl_CerecorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerecor</link:label>
    <link:label id="lab_avdl_CerecorMember_label_en-US" xlink:label="lab_avdl_CerecorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerecor [Member]</link:label>
    <link:label id="lab_avdl_CerecorMember_documentation_en-US" xlink:label="lab_avdl_CerecorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cerecor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CerecorMember" xlink:href="avdl-20230331.xsd#avdl_CerecorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_CerecorMember" xlink:to="lab_avdl_CerecorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_905199d7-d1cf-4ffe-bd8c-b32057c8fc07_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_AccruedInterestCurrent_0a6ca686-4890-4422-b7e8-ecfd4ad2b451_terseLabel_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_label_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:label id="lab_avdl_AccruedInterestCurrent_documentation_en-US" xlink:label="lab_avdl_AccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent" xlink:href="avdl-20230331.xsd#avdl_AccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_AccruedInterestCurrent" xlink:to="lab_avdl_AccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_2a8eb503-76a9-4514-bb77-170c047e224d_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_658a2144-0300-4b86-a1ef-4fc327aa3e4f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets:</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract" xlink:to="lab_us-gaap_OtherAssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_74f1be99-891a-4bb5-be44-755aaa042e72_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; (deficit) equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_fe97ba8f-5495-4e7f-b6f3-0b96ea17a83b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_bd251536-aa0a-48e7-83d9-d573f44b4a35_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_48ed7c6d-6637-4f12-a785-c54061b225c2_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_7176be7f-f4a2-43b6-9951-29636ee1c161_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_2e040909-e7e6-4b07-b212-a95ea374f581_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtConversionPrincipalAmountNotExchanged_b8d49789-8c85-4302-be38-0fc145451c06_terseLabel_en-US" xlink:label="lab_avdl_DebtConversionPrincipalAmountNotExchanged" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of debt not exchanged</link:label>
    <link:label id="lab_avdl_DebtConversionPrincipalAmountNotExchanged_label_en-US" xlink:label="lab_avdl_DebtConversionPrincipalAmountNotExchanged" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Principal Amount Not Exchanged</link:label>
    <link:label id="lab_avdl_DebtConversionPrincipalAmountNotExchanged_documentation_en-US" xlink:label="lab_avdl_DebtConversionPrincipalAmountNotExchanged" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Principal Amount Not Exchanged</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtConversionPrincipalAmountNotExchanged" xlink:href="avdl-20230331.xsd#avdl_DebtConversionPrincipalAmountNotExchanged"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtConversionPrincipalAmountNotExchanged" xlink:to="lab_avdl_DebtConversionPrincipalAmountNotExchanged" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_5c3a4409-1b20-48e7-ab74-4df7f2ae31de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_19dd8158-7019-4bc4-b2f8-524bee04aea0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_508d792e-58cb-4375-b29c-8638c1fe4680_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares sold in offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ExchangeDomain_401924df-9490-45cf-9cdd-8119d88ff773_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_6dce642f-450c-43f6-8251-ed4b1448afa4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_62d5152a-bf1e-4583-bfaf-b45ae533df04_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_45077f7f-084e-4d43-9d9d-f65aa5e23696_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9a6bd091-40bd-4823-a4a5-6d90843c4d0f_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_306ec81e-9190-4f9a-8059-74a0c3124fd1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RoyaltyPayableonNetSalesMaximum_65644f52-cd3d-4bc0-b234-854028d1363b_terseLabel_en-US" xlink:label="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty payable on net sales, maximum</link:label>
    <link:label id="lab_avdl_RoyaltyPayableonNetSalesMaximum_label_en-US" xlink:label="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Payable on Net Sales, Maximum</link:label>
    <link:label id="lab_avdl_RoyaltyPayableonNetSalesMaximum_documentation_en-US" xlink:label="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Payable on Net Sales, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyPayableonNetSalesMaximum" xlink:href="avdl-20230331.xsd#avdl_RoyaltyPayableonNetSalesMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RoyaltyPayableonNetSalesMaximum" xlink:to="lab_avdl_RoyaltyPayableonNetSalesMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_80c3f771-1204-4031-8871-1728b4a62756_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_905ecd76-9e73-4c23-b4d7-fbd8206458bb_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5e45de24-1b41-4b6f-a905-3b9e7da5da0b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_0a08fd61-c547-4916-9a4a-09fd2d81f4e5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_d8de4316-f5a3-406f-8d9a-a7187ed80154_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_9b18ab22-1cec-466b-a833-e0c257a5db83_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_d466bf5b-c78c-47d9-9647-c30431de4375_verboseLabel_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_label_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Business Policy [Policy Text Block]</link:label>
    <link:label id="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of accounting policy for nature of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:href="avdl-20230331.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:to="lab_avdl_NatureOfBusinessPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a0af4344-84ea-49ab-97e9-f465eaeb8de6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeCurrent_2e0aca23-cb6d-4b18-9ad5-7c15c9092023_terseLabel_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_label_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:label id="lab_avdl_GuaranteeCurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent" xlink:href="avdl-20230331.xsd#avdl_GuaranteeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeCurrent" xlink:to="lab_avdl_GuaranteeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_0e331308-ed17-4e0c-85fc-6f2a5bd54bd6_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_13c8badc-74c0-4860-bb2a-bbcbc2c1186a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_02867756-54ad-4fc6-956a-ffd94b1760c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_beaea67e-87cc-4720-99be-acb456a8eb79_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_GuaranteeNoncurrent_c69b1230-c15d-438a-93b6-3833a9d4a83f_verboseLabel_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee from Armistice</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_label_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:label id="lab_avdl_GuaranteeNoncurrent_documentation_en-US" xlink:label="lab_avdl_GuaranteeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantee, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent" xlink:href="avdl-20230331.xsd#avdl_GuaranteeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_GuaranteeNoncurrent" xlink:to="lab_avdl_GuaranteeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_3fb6847f-861c-445c-b880-ae9608cd5634_terseLabel_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected number of positions eliminated (as a percent)</link:label>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_label_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</link:label>
    <link:label id="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_documentation_en-US" xlink:label="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:href="avdl-20230331.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:to="lab_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c9ed4bc8-caf3-4a60-816a-03fdce3a2345_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ca286085-57f1-4dfc-87ee-6fff3a1169fe_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_10cc2c3b-1443-4223-a0e0-f162fbe66e29_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_36ac06e3-f1bb-4e53-b177-c8359d077ada_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_c8839eb2-18b7-47b5-9661-d6fbe2a29e1a_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e0548b07-269c-4658-802e-7b396b55624a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_24605b5b-423b-4a1c-9cc6-b000385a3bb4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_A2016MIPAMember_3a4f4b8c-c82d-4839-922b-72177df5dec3_terseLabel_en-US" xlink:label="lab_avdl_A2016MIPAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 MIPA</link:label>
    <link:label id="lab_avdl_A2016MIPAMember_label_en-US" xlink:label="lab_avdl_A2016MIPAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 MIPA [Member]</link:label>
    <link:label id="lab_avdl_A2016MIPAMember_documentation_en-US" xlink:label="lab_avdl_A2016MIPAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 MIPA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2016MIPAMember" xlink:href="avdl-20230331.xsd#avdl_A2016MIPAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_A2016MIPAMember" xlink:to="lab_avdl_A2016MIPAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_DebtInstrumentExchangeAmount_097a02da-0ebb-4bee-9cb9-63661e3e5f66_terseLabel_en-US" xlink:label="lab_avdl_DebtInstrumentExchangeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, exchange amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentExchangeAmount_label_en-US" xlink:label="lab_avdl_DebtInstrumentExchangeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Exchange Amount</link:label>
    <link:label id="lab_avdl_DebtInstrumentExchangeAmount_documentation_en-US" xlink:label="lab_avdl_DebtInstrumentExchangeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Exchange Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentExchangeAmount" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentExchangeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_DebtInstrumentExchangeAmount" xlink:to="lab_avdl_DebtInstrumentExchangeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_b0927017-291c-499f-a8e2-88504b3a2c59_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_efc252d2-af52-4ebd-bafb-bc6a030bc167_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4a596cf0-fb21-41e8-872e-b0a4156372a7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_eedd9e28-3666-476f-8d5c-1c7ed5b0c9b6_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_026a99ce-9190-4eda-96c2-e46852e7f0ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_8fb4eb59-a800-4a0c-b8e1-ba746f0e15ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_09948970-3454-457d-8cf2-7cf803fe15bd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbb106ad-de54-420a-886a-5ddcbbbcbfd9_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_528ebb36-77aa-4e6f-8bcc-8bc109258886_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_499b6541-263a-4018-96c5-1565f5a7010a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_5fa2d283-4a85-4414-baaf-511309815721_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1947e768-b020-42fd-ab24-6d92ceb1fa25_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_4c9c21a8-0850-4300-b477-d93d7ac61aca_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a2cc218d-7553-4437-9231-9050871bab2c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_2ec19c7d-b9dc-487d-beea-e16b1acc3bff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_bfeb6ab0-91af-40ad-8303-56040b48b17c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_da01dbbc-2b30-483b-94ea-011b7d416939_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a46562a3-e3d9-49f5-9225-06a144d6ad4d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock_02ae5578-d72d-4445-aaa1-292cc298fae5_terseLabel_en-US" xlink:label="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity and Going Concern</link:label>
    <link:label id="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock_label_en-US" xlink:label="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity and Going Concern [Policy Text Block]</link:label>
    <link:label id="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock_documentation_en-US" xlink:label="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidity and Going Concern</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:href="avdl-20230331.xsd#avdl_LiquidityAndGoingConcernPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:to="lab_avdl_LiquidityAndGoingConcernPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c1d5b7ed-dc3f-4b29-a71d-3b1d98545147_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3248b1e1-c5cf-47be-bff3-45032b50b931_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_cbf86fbc-0c41-45a2-bd91-eee489eb218a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eb2e7fe3-29f9-4801-a224-453cab7edffa_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_79efc272-b4de-4bb1-b757-897caa8a3a59_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0f98f7a7-f7f9-4fe1-b275-daeb4d6bfbde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_2bdcf235-aed7-444b-8dba-d2b16e97e187_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueOther_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_174a6003-92c7-406b-ac4e-867908db438f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d8c61780-e3da-46b7-bc68-d60a6407754d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total &#160;</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9fb7b29f-a347-456a-93b2-c01a4caab312_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_03182f0b-24fb-4ef1-8958-e25d4f997cea_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9a83433a-63ca-48d1-ba8f-7c3a194cd59e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2d393473-c476-4975-bc8c-e1e354b3d9cd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_a362c0a8-de15-4f2a-b823-92d6c7e6a267_terseLabel_en-US" xlink:label="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly net revenue target for royalty financing</link:label>
    <link:label id="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_label_en-US" xlink:label="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Financing, Quarterly Net Revenue Target</link:label>
    <link:label id="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_documentation_en-US" xlink:label="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Financing, Quarterly Net Revenue Target</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" xlink:href="avdl-20230331.xsd#avdl_RoyaltyFinancingQuarterlyNetRevenueTarget"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" xlink:to="lab_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_6f0a8e10-6dc3-4cce-a986-29be9cca2b14_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_30a99f3f-2904-4874-852e-97a9c437cbfe_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_fced72d5-7096-4b68-9974-54bb98b5b466_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_b1eaa97c-16ce-4cfb-86ae-c496a8c95d99_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, realized loss</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3e9107b1-4d66-4ca7-a622-86d9c38d8935_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6fdbb9cf-6257-4cad-9529-7eb695e2a7f3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0acefb95-4708-4990-9b2e-9533d78e7986_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>avdl-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:ff4affb4-5e35-499d-a060-a6a189fb41ed,g:0e980074-2bb1-4083-b23a-3722f5917d03-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avadel.com/role/Coverpage" xlink:type="simple" xlink:href="avdl-20230331.xsd#Coverpage"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/Coverpage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1e499e89-0a68-4201-b7d2-2f5761431bf1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1e499e89-0a68-4201-b7d2-2f5761431bf1" xlink:to="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:to="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_bf0c4d9f-a0bd-47e6-a969-0d59f758e5f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_daddbc51-e7c4-49db-9b53-0dac795a95cd" xlink:to="loc_dei_ExchangeDomain_bf0c4d9f-a0bd-47e6-a969-0d59f758e5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNMS_da82c445-6acd-4877-8fcf-5ea26bf33bd1" xlink:href="https://xbrl.sec.gov/exch/2022/exch-2022.xsd#exch_XNMS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_bf0c4d9f-a0bd-47e6-a969-0d59f758e5f0" xlink:to="loc_exch_XNMS_da82c445-6acd-4877-8fcf-5ea26bf33bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_f00faf0f-188b-49b2-9eb2-f78ded9cbe6a" xlink:to="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_a99e9d5f-d062-4277-bb27-ba29315e7601" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentType_a99e9d5f-d062-4277-bb27-ba29315e7601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_4b3c0557-146a-41ee-a48f-dd4d437b3ce3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentQuarterlyReport_4b3c0557-146a-41ee-a48f-dd4d437b3ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_fcaedfb0-f24a-45ef-b6cb-a8db6bd30548" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentPeriodEndDate_fcaedfb0-f24a-45ef-b6cb-a8db6bd30548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_49cb5e1c-4b73-4642-a1b8-1a4c555151cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentTransitionReport_49cb5e1c-4b73-4642-a1b8-1a4c555151cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_88a2a7b9-1ddc-4fae-ab73-a6d929c3c96f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityFileNumber_88a2a7b9-1ddc-4fae-ab73-a6d929c3c96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a48c1351-3768-414b-9be7-1de60feaaa9a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityRegistrantName_a48c1351-3768-414b-9be7-1de60feaaa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_7d47c3d9-d09a-421e-b5ac-6162645879b2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_7d47c3d9-d09a-421e-b5ac-6162645879b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_75ba57f5-c3fb-4399-860b-4644c76c9f76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityTaxIdentificationNumber_75ba57f5-c3fb-4399-860b-4644c76c9f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_13424cfa-8410-4bce-a12a-a7820533e6e9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressAddressLine1_13424cfa-8410-4bce-a12a-a7820533e6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2d470f2c-d795-4f60-acd1-785728e651fa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressCityOrTown_2d470f2c-d795-4f60-acd1-785728e651fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_25598874-6d4a-49ee-b480-d70712634620" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressPostalZipCode_25598874-6d4a-49ee-b480-d70712634620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_4d41c972-f6ea-4440-9143-b9870a395abc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityAddressCountry_4d41c972-f6ea-4440-9143-b9870a395abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_650ce23a-2c7f-4f4e-a651-37191856a782" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_CountryRegion_650ce23a-2c7f-4f4e-a651-37191856a782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_11b57fc2-2f7e-4238-8ea8-5abfea33c396" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_CityAreaCode_11b57fc2-2f7e-4238-8ea8-5abfea33c396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_33243aef-9985-4c4a-a089-9ea4ca759f30" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_LocalPhoneNumber_33243aef-9985-4c4a-a089-9ea4ca759f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_45337e54-2ce4-493f-8abb-622fca65f68d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_Security12bTitle_45337e54-2ce4-493f-8abb-622fca65f68d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_84d40194-bedf-4615-89c0-a3708d2cf2dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_TradingSymbol_84d40194-bedf-4615-89c0-a3708d2cf2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_8ee8ed51-4ab8-4bd7-83fe-b508eba4ea07" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_SecurityExchangeName_8ee8ed51-4ab8-4bd7-83fe-b508eba4ea07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_NoTradingSymbolFlag_75491c64-9685-4159-9323-0422e3129ef4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_NoTradingSymbolFlag_75491c64-9685-4159-9323-0422e3129ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_65b3cafd-ed60-4eb1-892b-9643a803f1aa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityCurrentReportingStatus_65b3cafd-ed60-4eb1-892b-9643a803f1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f372407c-6c3d-4412-bf3f-cd031277251b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityInteractiveDataCurrent_f372407c-6c3d-4412-bf3f-cd031277251b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_529eb17e-fa53-4855-9f2d-a7401b06cfdc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityFilerCategory_529eb17e-fa53-4855-9f2d-a7401b06cfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_8c706bbf-0d30-4168-b215-fe0876d5386e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntitySmallBusiness_8c706bbf-0d30-4168-b215-fe0876d5386e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_609f8e27-58fa-4c69-b686-791812c69cfc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityEmergingGrowthCompany_609f8e27-58fa-4c69-b686-791812c69cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_be7de687-d144-46da-920e-688e860e623a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityShellCompany_be7de687-d144-46da-920e-688e860e623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_630eb880-2b6b-4739-bc40-0d6fbf1f9031" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_630eb880-2b6b-4739-bc40-0d6fbf1f9031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_7b3b0dd7-4d29-44d3-81f4-a051a57792f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_EntityCentralIndexKey_7b3b0dd7-4d29-44d3-81f4-a051a57792f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2a136619-ba58-4b21-a47b-87ee4c899eeb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_CurrentFiscalYearEndDate_2a136619-ba58-4b21-a47b-87ee4c899eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a3903759-11d4-46ad-9a6e-714bd436303a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentFiscalYearFocus_a3903759-11d4-46ad-9a6e-714bd436303a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_940d82fd-7948-41d6-8b01-24adbc2d350a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_940d82fd-7948-41d6-8b01-24adbc2d350a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c8cad5d0-20de-4626-9a93-03d98a69eb8d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_528371a7-686b-4fdc-a41f-ac516053b4c7" xlink:to="loc_dei_AmendmentFlag_c8cad5d0-20de-4626-9a93-03d98a69eb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_773d7153-9727-4b66-817d-7bb127d72fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_773d7153-9727-4b66-817d-7bb127d72fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9c705054-5876-482d-9a03-ebc439694e93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_773d7153-9727-4b66-817d-7bb127d72fc9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9c705054-5876-482d-9a03-ebc439694e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_997ff231-da42-4ea6-801b-be8c4f390065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_773d7153-9727-4b66-817d-7bb127d72fc9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_997ff231-da42-4ea6-801b-be8c4f390065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d79b68f3-ca18-4b16-bbcf-29003aa15d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_773d7153-9727-4b66-817d-7bb127d72fc9" xlink:to="loc_us-gaap_CostsAndExpenses_d79b68f3-ca18-4b16-bbcf-29003aa15d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46febc89-79a1-4d51-b2aa-cba942a6fc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_OperatingIncomeLoss_46febc89-79a1-4d51-b2aa-cba942a6fc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_20845c51-2014-4360-8480-5d571c632797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_InvestmentIncomeNet_20845c51-2014-4360-8480-5d571c632797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_5f037a8f-8915-461f-a2b0-a7a6215af0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_InterestExpenseDebt_5f037a8f-8915-461f-a2b0-a7a6215af0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9fa608a3-62ec-4802-b6da-3cebb71d506e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9fa608a3-62ec-4802-b6da-3cebb71d506e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_138f7e59-fe4d-46de-a663-a5ba8479ffc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_138f7e59-fe4d-46de-a663-a5ba8479ffc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f98109ba-da15-4769-86aa-c6ac315222c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_NetIncomeLoss_f98109ba-da15-4769-86aa-c6ac315222c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7b794154-fe60-43bc-b948-c122bd8fbc21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_EarningsPerShareBasic_7b794154-fe60-43bc-b948-c122bd8fbc21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_e76e2e6e-6eb2-4af3-a715-026000937e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_e76e2e6e-6eb2-4af3-a715-026000937e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0fc78ec-49a6-4b8d-83a8-d5dac2f231fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0fc78ec-49a6-4b8d-83a8-d5dac2f231fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c54f928a-3187-4d6a-a297-06c20f5ba18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7c41fc09-b61c-481d-91e0-82ce5fcadbdc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c54f928a-3187-4d6a-a297-06c20f5ba18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="avdl-20230331.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4228a637-d840-4b93-b64d-a3990eabc286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9107d124-0237-440b-a850-46d587e99367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4228a637-d840-4b93-b64d-a3990eabc286" xlink:to="loc_us-gaap_NetIncomeLoss_9107d124-0237-440b-a850-46d587e99367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1f32dca6-5fd6-46a1-8c12-5bca79bfdc9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4228a637-d840-4b93-b64d-a3990eabc286" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1f32dca6-5fd6-46a1-8c12-5bca79bfdc9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f470902-ae26-4c79-8280-ba814a1fd637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1f32dca6-5fd6-46a1-8c12-5bca79bfdc9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7f470902-ae26-4c79-8280-ba814a1fd637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_81d6a9d9-414e-43d7-8b21-735a8514c7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1f32dca6-5fd6-46a1-8c12-5bca79bfdc9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_81d6a9d9-414e-43d7-8b21-735a8514c7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_86aa9bad-6658-4f6b-9b94-c140cbb253b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_1f32dca6-5fd6-46a1-8c12-5bca79bfdc9f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_86aa9bad-6658-4f6b-9b94-c140cbb253b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_558066de-e1b8-4b98-b6dd-44576f347ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4228a637-d840-4b93-b64d-a3990eabc286" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_558066de-e1b8-4b98-b6dd-44576f347ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="simple" xlink:href="avdl-20230331.xsd#UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_82ef39e4-4edc-4a8b-a25a-e8ce9318f6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_e4c8df0d-dca1-4939-9164-28ce97246091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_82ef39e4-4edc-4a8b-a25a-e8ce9318f6b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_e4c8df0d-dca1-4939-9164-28ce97246091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_153d944f-2425-4ec0-8db6-a025a1abd9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_153d944f-2425-4ec0-8db6-a025a1abd9f8" xlink:to="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_afd0b744-6cea-409b-be76-e3ee86ae75dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_afd0b744-6cea-409b-be76-e3ee86ae75dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_067029d4-dd3a-41dd-8c42-6598506e41b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_067029d4-dd3a-41dd-8c42-6598506e41b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_04990df8-1dbe-439b-b8d2-5efad67b19cc" xlink:href="avdl-20230331.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent_04990df8-1dbe-439b-b8d2-5efad67b19cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0f030d6e-f2ba-42da-8a83-583422edc3de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0f030d6e-f2ba-42da-8a83-583422edc3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d722ab42-2435-444a-89cc-95d357f8342a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_fc888e30-67b2-4afe-b64d-817f27ecc991" xlink:to="loc_us-gaap_AssetsCurrent_d722ab42-2435-444a-89cc-95d357f8342a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bfc924a8-38db-4815-816c-d97d1c8d099e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bfc924a8-38db-4815-816c-d97d1c8d099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0fcbaac8-0e10-4c93-8513-372a3c73dc93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0fcbaac8-0e10-4c93-8513-372a3c73dc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f31722ba-ef1e-411a-8bd3-45ce3a91fb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_us-gaap_Goodwill_f31722ba-ef1e-411a-8bd3-45ce3a91fb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_efe88a8e-a3d4-4ab9-8c52-83741567df8c" xlink:href="avdl-20230331.xsd#avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent_efe88a8e-a3d4-4ab9-8c52-83741567df8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cd7b3465-7778-4d61-a7ec-b3dbaedae4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_cd7b3465-7778-4d61-a7ec-b3dbaedae4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4186423c-9f97-412d-8d2e-3ca7dbbb66ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_05ab52f4-0310-4451-88db-3c4c96614984" xlink:to="loc_us-gaap_Assets_4186423c-9f97-412d-8d2e-3ca7dbbb66ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_153d944f-2425-4ec0-8db6-a025a1abd9f8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_c5fe4612-a786-4e8b-8779-866d714238e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_us-gaap_LongTermDebtCurrent_c5fe4612-a786-4e8b-8779-866d714238e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c2fd00b5-01ab-4264-a1bd-176434c34462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c2fd00b5-01ab-4264-a1bd-176434c34462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_28729316-73b1-42a9-8218-dbe41c488ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_us-gaap_AccountsPayableCurrent_28729316-73b1-42a9-8218-dbe41c488ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bc592a0f-e316-47f7-a9ab-d0763d334fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bc592a0f-e316-47f7-a9ab-d0763d334fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_ff022217-4455-4e7e-bf44-55dd50df4862" xlink:href="avdl-20230331.xsd#avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent_ff022217-4455-4e7e-bf44-55dd50df4862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_835dace5-17dd-4a8a-8123-5f60daa68445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_835dace5-17dd-4a8a-8123-5f60daa68445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8fad5353-7840-4863-a498-2eaa62c57d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_f62bdabf-8bf7-481e-b2f9-9738d854e072" xlink:to="loc_us-gaap_LiabilitiesCurrent_8fad5353-7840-4863-a498-2eaa62c57d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_005cb58a-eb88-4211-80fd-6051a97bd6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_005cb58a-eb88-4211-80fd-6051a97bd6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_400d56cd-43ea-42d5-8d89-0a0773adab7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_400d56cd-43ea-42d5-8d89-0a0773adab7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d47309f3-ee6f-48e9-9986-a8fcfae9dcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d47309f3-ee6f-48e9-9986-a8fcfae9dcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b7a1f065-d8d0-4c07-9b7c-99b45a495265" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_Liabilities_b7a1f065-d8d0-4c07-9b7c-99b45a495265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0ea133a1-cf69-4aea-ba71-ae4852870f99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:to="loc_us-gaap_PreferredStockValue_0ea133a1-cf69-4aea-ba71-ae4852870f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_171db488-99b2-4388-95e3-6b9a50449a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:to="loc_us-gaap_CommonStockValue_171db488-99b2-4388-95e3-6b9a50449a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4ff50234-696b-4e0c-95d5-84d3fd3047b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4ff50234-696b-4e0c-95d5-84d3fd3047b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c20e82c-2566-48af-8999-5064df3ce8e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2c20e82c-2566-48af-8999-5064df3ce8e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6c15e4b-f9a4-4480-855e-369619517307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b6c15e4b-f9a4-4480-855e-369619517307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e5f889f-d7b4-408d-bc96-99083bdaf015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6ab22c2e-da6e-4c29-a80b-f83cfee90155" xlink:to="loc_us-gaap_StockholdersEquity_5e5f889f-d7b4-408d-bc96-99083bdaf015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c373669b-35c0-47d8-8a54-d9a9ec2ce03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a7fd2bb1-6161-434e-b1e6-6a665983fbac" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_c373669b-35c0-47d8-8a54-d9a9ec2ce03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e822a390-8cec-4dcc-9908-3e8cfe7bd422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e822a390-8cec-4dcc-9908-3e8cfe7bd422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_21443d87-e349-43ae-8fa1-77a10b6b9203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_21443d87-e349-43ae-8fa1-77a10b6b9203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_59d33078-c28d-4411-ba62-cc0631b1da38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_PreferredStockSharesIssued_59d33078-c28d-4411-ba62-cc0631b1da38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_24be39a5-f83c-468d-84d7-affd637840c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_24be39a5-f83c-468d-84d7-affd637840c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ad3e4843-994f-4f85-b1dd-cd48a09a73bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ad3e4843-994f-4f85-b1dd-cd48a09a73bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7e1ebb86-63eb-4f24-b516-973fe99e62fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7e1ebb86-63eb-4f24-b516-973fe99e62fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_79e83e4a-94bc-4514-947c-f003dc912df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_CommonStockSharesIssued_79e83e4a-94bc-4514-947c-f003dc912df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_24d63cb7-2d83-48b4-b590-996a1c02c7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dd245e2b-3432-4970-878e-3f9a88b53185" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_24d63cb7-2d83-48b4-b590-996a1c02c7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a79f8d06-2133-4e7e-b636-4f910c091950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a79f8d06-2133-4e7e-b636-4f910c091950" xlink:to="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_db275f43-cf73-4fd9-9b5e-d4b618c39558" xlink:to="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c45aeae0-ba5e-4674-80db-6f5ddf67c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_CommonStockMember_c45aeae0-ba5e-4674-80db-6f5ddf67c3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_4ec44374-8c9e-40d1-8224-6d335919ef05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_PreferredStockMember_4ec44374-8c9e-40d1-8224-6d335919ef05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_92b2ee25-a949-43e1-8f4b-f1082ea440c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_92b2ee25-a949-43e1-8f4b-f1082ea440c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c58d93e9-3188-41f3-abe2-a856678f7114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_RetainedEarningsMember_c58d93e9-3188-41f3-abe2-a856678f7114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c7fc7d3f-f176-4b94-bc47-bd3c33a951b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_640ee3ad-2988-45d0-973b-d66bcd728a01" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c7fc7d3f-f176-4b94-bc47-bd3c33a951b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_cc735525-9157-406a-9908-12f2ff5ed83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1ff2d450-93ba-4626-acfd-c2cc9a2d8696" xlink:to="loc_us-gaap_StatementLineItems_cc735525-9157-406a-9908-12f2ff5ed83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_cc735525-9157-406a-9908-12f2ff5ed83f" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_26b3073d-9783-487e-9d5d-f2aad5a73e31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_SharesOutstanding_26b3073d-9783-487e-9d5d-f2aad5a73e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29dba0ff-bde8-4c93-9f37-17a7b5965d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockholdersEquity_29dba0ff-bde8-4c93-9f37-17a7b5965d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fdc65c02-74ef-49b5-9304-3cf361aaeb32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_NetIncomeLoss_fdc65c02-74ef-49b5-9304-3cf361aaeb32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b667764e-ba9e-448d-bd3d-17201f0bbdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b667764e-ba9e-448d-bd3d-17201f0bbdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb2164e9-052b-4e93-8db0-2ab29659ccf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_cb2164e9-052b-4e93-8db0-2ab29659ccf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_faa10a16-f68c-4474-90ba-bc56acd3803f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_faa10a16-f68c-4474-90ba-bc56acd3803f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d8459e20-1cdc-4f22-95db-d571873875ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_d8459e20-1cdc-4f22-95db-d571873875ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea5ce33b-7ae6-4c00-889b-408dffb923fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ea5ce33b-7ae6-4c00-889b-408dffb923fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3ba6aa8e-f0f1-48ca-ad17-572f92701dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3ba6aa8e-f0f1-48ca-ad17-572f92701dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesOther_266074d1-faa3-4b15-9097-b9b6b331a021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesOther_266074d1-faa3-4b15-9097-b9b6b331a021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueOther_bb104d3e-4c5e-48db-bc99-c3bbd3c35b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueOther_bb104d3e-4c5e-48db-bc99-c3bbd3c35b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_ae8fa77b-992b-45ce-8b2e-8909ac902167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan_ae8fa77b-992b-45ce-8b2e-8909ac902167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_70f7033d-f13d-47bd-a449-62df292f8ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_70f7033d-f13d-47bd-a449-62df292f8ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fefbe2ea-a37f-42eb-a1a5-a3dbc2b4638c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fefbe2ea-a37f-42eb-a1a5-a3dbc2b4638c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_574c6bbb-cac4-4e3f-9f48-07640e90505f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_SharesOutstanding_574c6bbb-cac4-4e3f-9f48-07640e90505f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5ef222c4-9bba-4e28-808a-35da8f9693a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ae16372f-3a20-4266-bddb-6db7375ae948" xlink:to="loc_us-gaap_StockholdersEquity_5ef222c4-9bba-4e28-808a-35da8f9693a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="avdl-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_411e90e0-9c62-4282-8428-30fb0bfe021a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_411e90e0-9c62-4282-8428-30fb0bfe021a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ba5dcaea-ebd5-4569-a58d-17c286b257fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_411e90e0-9c62-4282-8428-30fb0bfe021a" xlink:to="loc_us-gaap_NetIncomeLoss_ba5dcaea-ebd5-4569-a58d-17c286b257fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_411e90e0-9c62-4282-8428-30fb0bfe021a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_799e6556-baf0-4589-9115-3157ad61344d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:to="loc_us-gaap_DepreciationAndAmortization_799e6556-baf0-4589-9115-3157ad61344d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1dc7d181-5c5e-48ef-be5f-649c33c3bd49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_1dc7d181-5c5e-48ef-be5f-649c33c3bd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_00578f3e-cabb-4a29-a690-a6cc5545a488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_00578f3e-cabb-4a29-a690-a6cc5545a488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e150520d-8895-4db8-8801-c62157c6c139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:to="loc_us-gaap_ShareBasedCompensation_e150520d-8895-4db8-8801-c62157c6c139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_1b42c9ac-43fa-457d-8359-ac3e2cdfe65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_1b42c9ac-43fa-457d-8359-ac3e2cdfe65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02f4d80c-a020-4964-844b-47262628f53c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_88428768-382f-45f7-b240-ea1f39efebf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_88428768-382f-45f7-b240-ea1f39efebf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_3a9c0b03-d9b6-4212-9d77-2066d713db51" xlink:href="avdl-20230331.xsd#avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:to="loc_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable_3a9c0b03-d9b6-4212-9d77-2066d713db51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_358c8f95-0fd4-4524-89ba-c6d7e1145a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_358c8f95-0fd4-4524-89ba-c6d7e1145a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_bff5f277-cff2-4edf-a6da-504208742319" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_bff5f277-cff2-4edf-a6da-504208742319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_b82b841b-3424-46b0-b3ed-6deade1431a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_236f1b64-f829-4f7e-9c13-f776abb854cc" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_b82b841b-3424-46b0-b3ed-6deade1431a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e00b5960-81bf-42cf-90b0-8884007c6582" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_411e90e0-9c62-4282-8428-30fb0bfe021a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e00b5960-81bf-42cf-90b0-8884007c6582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f0ddd0c5-047b-4d6f-9d3f-8df2b817f052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f0ddd0c5-047b-4d6f-9d3f-8df2b817f052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fb488ecc-2b74-41ab-b7f7-7979f40e3c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f0ddd0c5-047b-4d6f-9d3f-8df2b817f052" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fb488ecc-2b74-41ab-b7f7-7979f40e3c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_31fe9631-04e9-4262-9869-b479d011c4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f0ddd0c5-047b-4d6f-9d3f-8df2b817f052" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_31fe9631-04e9-4262-9869-b479d011c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1c27fdfa-fc71-4ed0-9c9d-b5bb7bf3b8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f0ddd0c5-047b-4d6f-9d3f-8df2b817f052" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1c27fdfa-fc71-4ed0-9c9d-b5bb7bf3b8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuance_d508c345-6243-4bae-b801-087d6a1e07b6" xlink:href="avdl-20230331.xsd#avdl_ProceedsReceivedInAdvanceOfShareIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:to="loc_avdl_ProceedsReceivedInAdvanceOfShareIssuance_d508c345-6243-4bae-b801-087d6a1e07b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_557adf4c-23f7-4e5b-be38-850edb0ee538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_557adf4c-23f7-4e5b-be38-850edb0ee538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_19661308-bf8d-4de6-8793-ec0ff21e2dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_19661308-bf8d-4de6-8793-ec0ff21e2dd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4cda9827-a50b-4200-974d-6c3e4e966315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_4cda9827-a50b-4200-974d-6c3e4e966315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_492cb05e-e740-423c-9d46-29517df55556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad507102-1393-4749-8ad8-3ee437b9a746" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_492cb05e-e740-423c-9d46-29517df55556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_69fecd87-5a09-4b51-b050-c55b7f054bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_69fecd87-5a09-4b51-b050-c55b7f054bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fe659ff1-76d0-49a1-96a9-581aab517445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fe659ff1-76d0-49a1-96a9-581aab517445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f2e8c7c6-1cd0-4d68-bd38-3af0de334fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f2e8c7c6-1cd0-4d68-bd38-3af0de334fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a32bb9a-3f35-4bc9-915f-55c84c6a2699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5a32bb9a-3f35-4bc9-915f-55c84c6a2699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_da2591e7-533e-4935-9c86-68328168b249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d25d7d33-3076-4272-916e-9cc29b535c18" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_da2591e7-533e-4935-9c86-68328168b249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_ea47ff99-b07f-4aff-afa9-e968be2afc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_da2591e7-533e-4935-9c86-68328168b249" xlink:to="loc_us-gaap_InterestPaidNet_ea47ff99-b07f-4aff-afa9-e968be2afc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_af721e5b-72fc-497a-8c25-ce14214b811c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_da2591e7-533e-4935-9c86-68328168b249" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_af721e5b-72fc-497a-8c25-ce14214b811c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="avdl-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c0eeb942-a416-4f28-9abc-efa4a3e41f12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f7dd1b62-8220-4ac2-9215-09902c3e0e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c0eeb942-a416-4f28-9abc-efa4a3e41f12" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_f7dd1b62-8220-4ac2-9215-09902c3e0e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7faf84c9-05f4-49a8-9bee-ae6f5c15c715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7a9cbcad-4c90-4fa6-9e5c-5c104364bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7faf84c9-05f4-49a8-9bee-ae6f5c15c715" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7a9cbcad-4c90-4fa6-9e5c-5c104364bea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecurities" xlink:type="simple" xlink:href="avdl-20230331.xsd#MarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8a7aec1c-dacb-4bd5-84a6-5205463e1790" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_aa08ab12-a1a9-4661-a731-aa4bab8fd6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8a7aec1c-dacb-4bd5-84a6-5205463e1790" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_aa08ab12-a1a9-4661-a731-aa4bab8fd6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebt" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dd7d4466-dfa2-46b8-9874-fe483d666246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_2d8b2acd-8785-4800-a9a7-68341f244e60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dd7d4466-dfa2-46b8-9874-fe483d666246" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_2d8b2acd-8785-4800-a9a7-68341f244e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxes" xlink:type="simple" xlink:href="avdl-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ffec9242-8842-459f-afb3-736425c8ca97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_3377b4e6-4d54-429f-a167-dd767d560e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ffec9242-8842-459f-afb3-736425c8ca97" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_3377b4e6-4d54-429f-a167-dd767d560e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilities"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_503bc5e3-27f9-4f7f-98d2-3242181b23b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_660b484a-b2e8-4033-b392-4503ff3082bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_503bc5e3-27f9-4f7f-98d2-3242181b23b1" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_660b484a-b2e8-4033-b392-4503ff3082bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShare" xlink:type="simple" xlink:href="avdl-20230331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f745ecb0-39de-4288-bd7b-d67e2954235b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0e1fc5c1-118b-417e-af14-8a0adb66946d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f745ecb0-39de-4288-bd7b-d67e2954235b" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0e1fc5c1-118b-417e-af14-8a0adb66946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="simple" xlink:href="avdl-20230331.xsd#ComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_23c6e818-442c-4abe-a4d5-a16dbf9bd4c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_58c6daa4-3690-42d3-9da1-ffb923bd7189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_23c6e818-442c-4abe-a4d5-a16dbf9bd4c3" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_58c6daa4-3690-42d3-9da1-ffb923bd7189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="avdl-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25d16836-addb-48c8-9c60-cd36007d9ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eb9156da-1d58-42f7-96a4-95880edb566a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_25d16836-addb-48c8-9c60-cd36007d9ca0" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_eb9156da-1d58-42f7-96a4-95880edb566a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCosts" xlink:type="simple" xlink:href="avdl-20230331.xsd#RestructuringCosts"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f673c22f-2c5e-436a-9146-d4e3b4673da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_607f7b8b-0cd1-4c66-8dd7-f2d83cf64ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f673c22f-2c5e-436a-9146-d4e3b4673da2" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_607f7b8b-0cd1-4c66-8dd7-f2d83cf64ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEvents" xlink:type="simple" xlink:href="avdl-20230331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_1be14410-6e69-4e4a-88c8-232f1e677875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_f0a8eac0-08a3-4311-9456-9586abedc71f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_1be14410-6e69-4e4a-88c8-232f1e677875" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_f0a8eac0-08a3-4311-9456-9586abedc71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="avdl-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e0a801af-3343-413e-9ccf-e0b47ed5826b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_990cfd31-7dd4-4d07-8e05-7062b9b20531" xlink:href="avdl-20230331.xsd#avdl_NatureOfBusinessPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e0a801af-3343-413e-9ccf-e0b47ed5826b" xlink:to="loc_avdl_NatureOfBusinessPolicyPolicyTextBlock_990cfd31-7dd4-4d07-8e05-7062b9b20531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock_f1f260bf-4a0e-4d0f-b31c-8e63938f9d68" xlink:href="avdl-20230331.xsd#avdl_LiquidityAndGoingConcernPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e0a801af-3343-413e-9ccf-e0b47ed5826b" xlink:to="loc_avdl_LiquidityAndGoingConcernPolicyTextBlock_f1f260bf-4a0e-4d0f-b31c-8e63938f9d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_47232d6d-9224-4df6-a12a-657f20692842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e0a801af-3343-413e-9ccf-e0b47ed5826b" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_47232d6d-9224-4df6-a12a-657f20692842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8c9e9c85-7724-4fdd-b10d-2287168652ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1668169c-5dff-4043-b2fc-7d56c6d644f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8c9e9c85-7724-4fdd-b10d-2287168652ff" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_1668169c-5dff-4043-b2fc-7d56c6d644f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#MarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e388bed0-230a-4c79-a3b1-a08b05065f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_30a385e7-0a70-48ea-94d6-78e1d8cf8663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e388bed0-230a-4c79-a3b1-a08b05065f5f" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_30a385e7-0a70-48ea-94d6-78e1d8cf8663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_26988add-16a6-4010-87b0-627b03ba9238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3a479f8e-7c7b-475f-8b20-7e44874368ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_26988add-16a6-4010-87b0-627b03ba9238" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3a479f8e-7c7b-475f-8b20-7e44874368ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_911d60e7-2b8c-4ac4-9505-2bd422979f36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_6dab0e5a-9126-44b5-8062-07ea2e96d983" xlink:href="avdl-20230331.xsd#avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_911d60e7-2b8c-4ac4-9505-2bd422979f36" xlink:to="loc_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_6dab0e5a-9126-44b5-8062-07ea2e96d983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_53d45595-96fa-4e44-8a59-c7fc0e9fe758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_911d60e7-2b8c-4ac4-9505-2bd422979f36" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_53d45595-96fa-4e44-8a59-c7fc0e9fe758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6370b3bf-afdd-48d0-a826-fbb33c8f382e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_911d60e7-2b8c-4ac4-9505-2bd422979f36" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6370b3bf-afdd-48d0-a826-fbb33c8f382e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_da1770c5-2d71-4e21-90b0-6b959477746b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_911d60e7-2b8c-4ac4-9505-2bd422979f36" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_da1770c5-2d71-4e21-90b0-6b959477746b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_7f88579f-2708-4ad9-a272-2b9a41da413d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_911d60e7-2b8c-4ac4-9505-2bd422979f36" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_7f88579f-2708-4ad9-a272-2b9a41da413d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_acc56885-5357-4c8e-b04f-2fa462ed2acd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_455069ba-cfd6-4737-bfa8-a3fc16fe592e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_acc56885-5357-4c8e-b04f-2fa462ed2acd" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_455069ba-cfd6-4737-bfa8-a3fc16fe592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#ComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6d1b088b-203b-4226-a75c-779ff9f99b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b09e0b4a-6eee-4698-b982-99d9e9fb3d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6d1b088b-203b-4226-a75c-779ff9f99b52" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b09e0b4a-6eee-4698-b982-99d9e9fb3d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="simple" xlink:href="avdl-20230331.xsd#RestructuringCostsTables"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0663f515-1fb8-4d8b-bbf0-255a33791da4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ffb1a5c2-0f58-44a7-8f83-46c40424ee7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0663f515-1fb8-4d8b-bbf0-255a33791da4" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_ffb1a5c2-0f58-44a7-8f83-46c40424ee7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22f3e6ee-31f8-47a5-b25b-797f946ff318" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22f3e6ee-31f8-47a5-b25b-797f946ff318" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c8b0cc9b-a625-49ad-bbee-868c4f316be1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_e9f3928b-a72e-4d6c-abcd-407e6d753586" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_e9f3928b-a72e-4d6c-abcd-407e6d753586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember_f39e59bc-496b-4c95-aebf-5e96dc3e8a31" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_161746b5-3506-423b-a47e-20f7cb347734" xlink:to="loc_avdl_April2027NotesMember_f39e59bc-496b-4c95-aebf-5e96dc3e8a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4f17425f-e422-4557-9a55-f012db16c567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bc31b2b5-f31f-41aa-864a-ec35fefd919b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4f17425f-e422-4557-9a55-f012db16c567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_80695238-3538-4534-84f1-adad10221cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4f17425f-e422-4557-9a55-f012db16c567" xlink:to="loc_us-gaap_SeniorNotesMember_80695238-3538-4534-84f1-adad10221cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_aaa1b53f-f150-4a9e-9abb-3921eece014e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e0205984-fe2a-4026-a785-51e05eb691a9" xlink:to="loc_srt_RangeMember_aaa1b53f-f150-4a9e-9abb-3921eece014e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30d7432b-9851-4bc7-86fb-946ecc6a2b7b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_aaa1b53f-f150-4a9e-9abb-3921eece014e" xlink:to="loc_srt_MaximumMember_30d7432b-9851-4bc7-86fb-946ecc6a2b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2a133094-b28f-4877-ada6-ed0aa8d8ae48" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheOneMember_261feda5-001b-495b-a96d-d07104ec49ce" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:to="loc_avdl_PublicStockOfferingTrancheOneMember_261feda5-001b-495b-a96d-d07104ec49ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheTwoMember_633c6e0f-956b-4943-b5a9-e3bcae5cd14e" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_PublicStockOfferingMember_20f216e7-f385-45e7-be56-9be07ede9a22" xlink:to="loc_avdl_PublicStockOfferingTrancheTwoMember_633c6e0f-956b-4943-b5a9-e3bcae5cd14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2020ShelfRegistrationStatementMember_a88cfa02-fb75-4003-8432-e989d64efa1b" xlink:href="avdl-20230331.xsd#avdl_A2020ShelfRegistrationStatementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_A2020ShelfRegistrationStatementMember_a88cfa02-fb75-4003-8432-e989d64efa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022ShelfRegistrationStatementMember_48eae247-67fd-4138-80a2-3869aacb56bd" xlink:href="avdl-20230331.xsd#avdl_A2022ShelfRegistrationStatementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_A2022ShelfRegistrationStatementMember_48eae247-67fd-4138-80a2-3869aacb56bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AtTheMarketOfferingProgramMember_685e5538-4429-48cb-92a2-60c2b2240ca2" xlink:href="avdl-20230331.xsd#avdl_AtTheMarketOfferingProgramMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_8f2139b1-208b-40b6-9c69-8a71a783b1ea" xlink:to="loc_avdl_AtTheMarketOfferingProgramMember_685e5538-4429-48cb-92a2-60c2b2240ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6846ce8b-9670-418c-a8b6-b59a90e4e092" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_da9ba44b-eed3-4276-b1ad-b64ece3fa111" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6846ce8b-9670-418c-a8b6-b59a90e4e092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_572487ea-224a-42c7-a125-82fbdb1fe8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6846ce8b-9670-418c-a8b6-b59a90e4e092" xlink:to="loc_us-gaap_SubsequentEventMember_572487ea-224a-42c7-a125-82fbdb1fe8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f937cc2f-119d-459b-9def-d068a38f89e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_b5950c75-0f54-4dbe-9928-dbbe96e1f53f" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f937cc2f-119d-459b-9def-d068a38f89e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_5064818e-cfa4-4994-b540-8b0fe516ccda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f937cc2f-119d-459b-9def-d068a38f89e4" xlink:to="loc_srt_ScenarioForecastMember_5064818e-cfa4-4994-b540-8b0fe516ccda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee841b49-dbac-4458-b365-68ed1bc0fbad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_779e7957-78a0-4f1c-9be6-ad89fc8beea5" xlink:to="loc_us-gaap_EquityComponentDomain_ee841b49-dbac-4458-b365-68ed1bc0fbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_df10d398-6958-4fc7-87da-7b57f638fbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ee841b49-dbac-4458-b365-68ed1bc0fbad" xlink:to="loc_us-gaap_CommonStockMember_df10d398-6958-4fc7-87da-7b57f638fbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_dc8073b4-7ec6-48d2-93f6-7a73e63884bc" xlink:to="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrphanDrugExclusivityTerm_bebfbd1e-3599-401b-82c9-91a45ee0b5f0" xlink:href="avdl-20230331.xsd#avdl_OrphanDrugExclusivityTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_OrphanDrugExclusivityTerm_bebfbd1e-3599-401b-82c9-91a45ee0b5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e67a8ac5-a198-4746-802e-218ab168291c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e67a8ac5-a198-4746-802e-218ab168291c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c6d02868-4465-47e2-aaba-c5824459f954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c6d02868-4465-47e2-aaba-c5824459f954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_34aada79-459f-4343-930d-73d4ce76f2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_34aada79-459f-4343-930d-73d4ce76f2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_48497391-650f-407b-a57b-5b74befd8b61" xlink:href="avdl-20230331.xsd#avdl_RoyaltyFinancingQuarterlyNetRevenueTarget"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_48497391-650f-407b-a57b-5b74befd8b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_6dfd1f8e-4311-4e17-bc4e-57aaa6eac688" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_6dfd1f8e-4311-4e17-bc4e-57aaa6eac688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93b9036f-b6e0-4b6c-8e6f-0f02aee3973d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_93b9036f-b6e0-4b6c-8e6f-0f02aee3973d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_f6fc04f4-d87f-4e94-b2d1-efbb004e18b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_f6fc04f4-d87f-4e94-b2d1-efbb004e18b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ba7d43bb-7c61-45cd-a0aa-cbdbfcb8d1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ba7d43bb-7c61-45cd-a0aa-cbdbfcb8d1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_aaf56d7c-8ff7-4805-9fc3-c59bc717b155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_aaf56d7c-8ff7-4805-9fc3-c59bc717b155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7267404d-808e-42c0-86bc-d9ec597aa657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_7267404d-808e-42c0-86bc-d9ec597aa657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockSalesAgentCommissionPercent_dd67d1c8-c937-4e11-ae84-aa43463d322a" xlink:href="avdl-20230331.xsd#avdl_SaleOfStockSalesAgentCommissionPercent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_SaleOfStockSalesAgentCommissionPercent_dd67d1c8-c937-4e11-ae84-aa43463d322a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_49fcbae0-eb0a-4280-8c79-8ed8f62c6f12" xlink:href="avdl-20230331.xsd#avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration_49fcbae0-eb0a-4280-8c79-8ed8f62c6f12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_51664add-f1f3-4a09-8423-d49a26ed8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_51664add-f1f3-4a09-8423-d49a26ed8e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ade5575d-912c-40a7-9216-b564c3a95dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_ade5575d-912c-40a7-9216-b564c3a95dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_c976a011-74df-412d-8ac0-263958c2b56e" xlink:href="avdl-20230331.xsd#avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_be5c4014-72ec-41df-81f0-312e87d2685e" xlink:to="loc_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration_c976a011-74df-412d-8ac0-263958c2b56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurementMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dddf3206-4772-4544-8092-e1aabdc0a751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dddf3206-4772-4544-8092-e1aabdc0a751" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea15715b-422a-4571-b8fc-722aea123b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_03d1cb42-cd9b-4f17-a647-18049e80fbf9" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea15715b-422a-4571-b8fc-722aea123b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d9a90f7f-a835-496b-9df8-3e2d866e9acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ea15715b-422a-4571-b8fc-722aea123b16" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d9a90f7f-a835-496b-9df8-3e2d866e9acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0904cc59-7eff-4ff9-9411-fbb6927109d5" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e9ab4d0e-97dc-4179-8070-fdac2e834f71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e9ab4d0e-97dc-4179-8070-fdac2e834f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b87a4137-89f7-4cbc-b4f3-5e8d3de9044e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b87a4137-89f7-4cbc-b4f3-5e8d3de9044e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_aac1fac7-5a01-4ac0-8680-64d0079c39b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8fb5ca75-4c19-4c1f-99cb-c55908832faf" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_aac1fac7-5a01-4ac0-8680-64d0079c39b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_36c681ab-bba9-4b3c-a581-3d22b9b4d7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_225b6966-0971-4acf-898f-719dbf6a2487" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_36c681ab-bba9-4b3c-a581-3d22b9b4d7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_0607b562-cf7d-478f-a634-59c0dea743b1" xlink:href="avdl-20230331.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_36c681ab-bba9-4b3c-a581-3d22b9b4d7ab" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_0607b562-cf7d-478f-a634-59c0dea743b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_10731bbb-b0df-4a2c-9f67-7f18244ea35d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8e904462-6b49-4aee-a9d8-b8edc27bb953" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8e904462-6b49-4aee-a9d8-b8edc27bb953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_6562a448-d8b1-4620-a001-f0f31dc59cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e5a86731-548d-47de-9b95-35ed7043b781" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_6562a448-d8b1-4620-a001-f0f31dc59cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_72c2ceab-f326-4972-b728-b65fc323eb33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_72c2ceab-f326-4972-b728-b65fc323eb33" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c8e02ee2-f8cb-4b7f-8aa3-948337c261e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1dac9ce0-ffdb-404f-a5df-6d7e90641ad7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c8e02ee2-f8cb-4b7f-8aa3-948337c261e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_53b4c1b5-13a8-439d-893f-c307debf36e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c8e02ee2-f8cb-4b7f-8aa3-948337c261e5" xlink:to="loc_us-gaap_SeniorNotesMember_53b4c1b5-13a8-439d-893f-c307debf36e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:to="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5b742289-2dfd-4b70-98a6-34edaa9d1a84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1d81f002-43c3-4811-8b6f-decd9ff96bab" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5b742289-2dfd-4b70-98a6-34edaa9d1a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_9e6ddfa3-eb11-494f-a276-5f19646bb775" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5b742289-2dfd-4b70-98a6-34edaa9d1a84" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_9e6ddfa3-eb11-494f-a276-5f19646bb775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_13a0ff33-a50e-427f-bd4d-9dd94215967b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_e78002ee-beff-4b65-a8e0-3809afb6cb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_e78002ee-beff-4b65-a8e0-3809afb6cb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_20854693-907e-48d8-b4a4-ca8c586ee343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d8f1dc31-ca4f-4e8f-85b6-1fc5473f4407" xlink:to="loc_us-gaap_LongTermDebtFairValue_20854693-907e-48d8-b4a4-ca8c586ee343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1188de83-39bc-467a-a97e-02cb0f4763db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1188de83-39bc-467a-a97e-02cb0f4763db" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:to="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d0b0065-5fcd-42ba-9ddf-c4de1fa646be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_421f39bc-7447-48f1-af74-a608eef3b86a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d0b0065-5fcd-42ba-9ddf-c4de1fa646be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_MutualAndMoneyMarketFundsMember_d5fcc920-c7cd-4ba5-8481-e0f68ccca497" xlink:href="avdl-20230331.xsd#avdl_MutualAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d0b0065-5fcd-42ba-9ddf-c4de1fa646be" xlink:to="loc_avdl_MutualAndMoneyMarketFundsMember_d5fcc920-c7cd-4ba5-8481-e0f68ccca497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4131cce-8bb5-4038-8b9c-9d8bb94459db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_dfa3d445-9141-43ee-b815-e34372d0bfdc" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4131cce-8bb5-4038-8b9c-9d8bb94459db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_c4131cce-8bb5-4038-8b9c-9d8bb94459db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e3511124-62a2-4413-b035-03f6ee32b762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_e3511124-62a2-4413-b035-03f6ee32b762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6ecf69ba-309c-4e7b-965a-3c2f0327315b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6ecf69ba-309c-4e7b-965a-3c2f0327315b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c7856603-bf49-452b-bcf1-66946ff00b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c7856603-bf49-452b-bcf1-66946ff00b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6f4f8cb5-877f-480c-ab3e-a41b260f6bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_07e9d7f5-b410-4ded-8359-0daac94303ca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6f4f8cb5-877f-480c-ab3e-a41b260f6bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#MarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_039482c5-b217-4e51-bee6-c7b05e038a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_ff3ff300-c834-4adf-bbc6-67ccdbc39dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_039482c5-b217-4e51-bee6-c7b05e038a27" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain_ff3ff300-c834-4adf-bbc6-67ccdbc39dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_b6fba5f4-d3a4-4a0d-9b95-6ee73fcb7bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_039482c5-b217-4e51-bee6-c7b05e038a27" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss_b6fba5f4-d3a4-4a0d-9b95-6ee73fcb7bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ddd4c29b-bfe2-47b1-9c7f-ab0998dc9b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ddd4c29b-bfe2-47b1-9c7f-ab0998dc9b6a" xlink:to="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5100fcda-7806-4575-80b0-0278ca00c8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5c217301-7cc3-4426-ab4f-09f9f5692a09" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5100fcda-7806-4575-80b0-0278ca00c8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ed64f35a-6165-4587-9693-0dcb585185fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5100fcda-7806-4575-80b0-0278ca00c8b9" xlink:to="loc_us-gaap_SeniorNotesMember_ed64f35a-6165-4587-9693-0dcb585185fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:to="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2d267dc-64bd-4651-b71d-ea104c1e4153" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_4f9eb526-0856-4b80-93bf-23d5afb9ad0e" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_4f9eb526-0856-4b80-93bf-23d5afb9ad0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_7def6cd7-ea6f-4356-9cae-b41996618bff" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa7dfe77-4e1c-48c8-8f72-cd3e04c6ad41" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_7def6cd7-ea6f-4356-9cae-b41996618bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bf3c8520-d08a-4e68-bccd-4850e4ddaff8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_805e8238-30df-45b4-9bd2-5b3c27040d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_805e8238-30df-45b4-9bd2-5b3c27040d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_956d7164-a026-44e4-8a60-ddbb109ce199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_805e8238-30df-45b4-9bd2-5b3c27040d80" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_956d7164-a026-44e4-8a60-ddbb109ce199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_32002a72-68c4-4476-b2e1-ae0fc066c016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_32002a72-68c4-4476-b2e1-ae0fc066c016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0c1ccfe3-2637-4997-82ac-fe72d9ecbc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_LongTermDebt_0c1ccfe3-2637-4997-82ac-fe72d9ecbc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ff1ab60a-7a61-42ee-9176-43d6ffa04e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_LongTermDebtCurrent_ff1ab60a-7a61-42ee-9176-43d6ffa04e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a43cceb3-8929-45ee-80ca-0dd79dde90f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_30bed0dc-ac98-4046-a041-8275f08030eb" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a43cceb3-8929-45ee-80ca-0dd79dde90f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2a59419e-93bb-4f2f-a962-6ca2975f52a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2a59419e-93bb-4f2f-a962-6ca2975f52a3" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7f430ab3-f75d-44ec-b03c-887e14e6d18c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_01b66bef-2b3f-45b0-b090-158b2fc25f98" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member_01b66bef-2b3f-45b0-b090-158b2fc25f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_fe4fd6e6-159c-41fb-a3a9-e539d03880d3" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_fe4fd6e6-159c-41fb-a3a9-e539d03880d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember_cb21b495-9e13-486a-9913-3a1c88b79376" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_277661db-6077-44b0-a767-9efe141cee57" xlink:to="loc_avdl_April2027NotesMember_cb21b495-9e13-486a-9913-3a1c88b79376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_833c8b7b-d02d-4596-ad6b-2acb45303b6a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_a5d84a09-63a3-4449-b564-dc61cd9c7ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:to="loc_us-gaap_ConvertibleDebtMember_a5d84a09-63a3-4449-b564-dc61cd9c7ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7c40cc1b-e01c-46d1-8061-76ff258c25a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d05b4f81-067c-4d67-8362-f055355297e4" xlink:to="loc_us-gaap_SeniorNotesMember_7c40cc1b-e01c-46d1-8061-76ff258c25a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3867499-b183-4c1d-94ff-a6550da2e23e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a5920a70-3c18-40c2-ba23-379d4cdc569d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3867499-b183-4c1d-94ff-a6550da2e23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_ThirdPartyMember_95f0395f-b171-42e0-9efc-6ceb3ff290cc" xlink:href="avdl-20230331.xsd#avdl_ThirdPartyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b3867499-b183-4c1d-94ff-a6550da2e23e" xlink:to="loc_avdl_ThirdPartyMember_95f0395f-b171-42e0-9efc-6ceb3ff290cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_54cd6f6b-8a6d-43de-b3c1-4596f8b95153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1677e141-5e12-402b-a124-31851b3230c8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_54cd6f6b-8a6d-43de-b3c1-4596f8b95153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e287eb1c-c424-4c44-abe6-8865501a3c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_54cd6f6b-8a6d-43de-b3c1-4596f8b95153" xlink:to="loc_us-gaap_SubsequentEventMember_e287eb1c-c424-4c44-abe6-8865501a3c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b7008f83-5619-4844-ae29-1300077eeb66" xlink:to="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e95ea623-0f6d-4882-99f6-2ad306604018" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:to="loc_srt_MinimumMember_e95ea623-0f6d-4882-99f6-2ad306604018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_67d45002-5bb8-47fe-b4b5-d9977dcb0cfe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed22adee-db1c-4ec8-9eec-c41b94d69583" xlink:to="loc_srt_MaximumMember_67d45002-5bb8-47fe-b4b5-d9977dcb0cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_49146e3d-aa10-4c38-aa1d-d0cd1f2f2b50" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_824e39ba-0f4b-4b72-86f2-9a6e925b7e89" xlink:to="loc_srt_ScenarioUnspecifiedDomain_49146e3d-aa10-4c38-aa1d-d0cd1f2f2b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_a7dfaaab-25dd-437a-8dba-ca523713e4d8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_49146e3d-aa10-4c38-aa1d-d0cd1f2f2b50" xlink:to="loc_srt_ScenarioForecastMember_a7dfaaab-25dd-437a-8dba-ca523713e4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtTable_fcc18de9-37cf-4922-9add-8df6182e7005" xlink:to="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_9b4aa991-a961-4a35-9152-10f4f94bb33d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_InterestExpenseDebt_9b4aa991-a961-4a35-9152-10f4f94bb33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CouponInterestExpense_725624b3-3377-43de-aa28-e772c375a7e2" xlink:href="avdl-20230331.xsd#avdl_CouponInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_CouponInterestExpense_725624b3-3377-43de-aa28-e772c375a7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_dcbddbb5-a1af-4a27-bec3-10279ce0fe60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_dcbddbb5-a1af-4a27-bec3-10279ce0fe60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cb373603-21e9-4475-8fda-77fa97de45ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cb373603-21e9-4475-8fda-77fa97de45ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_cf13b280-c2c9-44e7-bbda-87c02bac7599" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm_cf13b280-c2c9-44e7-bbda-87c02bac7599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_f7aae577-f8af-4c5e-9613-36db7531b7da" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentOptiontoIncreaseFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentOptiontoIncreaseFaceAmount_f7aae577-f8af-4c5e-9613-36db7531b7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e318c837-0ced-4cc6-80f1-92b69d929f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e318c837-0ced-4cc6-80f1-92b69d929f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentExchangeAmount_882a671f-be68-4b8d-b9df-86f6f5b57370" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentExchangeAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentExchangeAmount_882a671f-be68-4b8d-b9df-86f6f5b57370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_852229a4-dacf-4021-975e-8c64b798ccce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_852229a4-dacf-4021-975e-8c64b798ccce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_df651566-153f-4540-87f4-7b4dd3b1c712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_df651566-153f-4540-87f4-7b4dd3b1c712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f238c8c8-c074-4293-ae16-c47361188f31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f238c8c8-c074-4293-ae16-c47361188f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_e23a548d-44c3-476b-9a57-5899e9a00937" xlink:href="avdl-20230331.xsd#avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature_e23a548d-44c3-476b-9a57-5899e9a00937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_8378e127-03a3-4f6a-ada8-c50839e7cbce" xlink:href="avdl-20230331.xsd#avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease_8378e127-03a3-4f6a-ada8-c50839e7cbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositorySharesConversionRatio_ff79bb57-f3b1-465d-9c55-08250f1005f8" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositorySharesConversionRatio"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositorySharesConversionRatio_ff79bb57-f3b1-465d-9c55-08250f1005f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesOptionPricePerShare_5ba2be93-8707-4d91-b972-ea2e35a7916e" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesOptionPricePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositarySharesOptionPricePerShare_5ba2be93-8707-4d91-b972-ea2e35a7916e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPremiumPercentage_77013fb1-7bb6-49a2-a020-aa08d12dc7fe" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesPremiumPercentage"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositarySharesPremiumPercentage_77013fb1-7bb6-49a2-a020-aa08d12dc7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_9542f0d9-eef6-4bb3-b809-59444af13eab" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesPurchasedPricePerShare"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_AmericanDepositarySharesPurchasedPricePerShare_9542f0d9-eef6-4bb3-b809-59444af13eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b825ce29-ad4c-4120-b4f5-60432bebf26d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b825ce29-ad4c-4120-b4f5-60432bebf26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_e828197d-eb14-4ca2-8ba0-863823eca346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_e828197d-eb14-4ca2-8ba0-863823eca346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c17f4d47-530b-47df-828c-2d0e39261249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_c17f4d47-530b-47df-828c-2d0e39261249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_f9c62936-0bc6-4590-88b5-809c6c13d0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_f9c62936-0bc6-4590-88b5-809c6c13d0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ddb2a317-c98a-4182-b4ea-7b314a724af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ddb2a317-c98a-4182-b4ea-7b314a724af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_DebtConversionPrincipalAmountNotExchanged_5eff6dbb-c2d4-4825-afd5-bea4bdf69519" xlink:href="avdl-20230331.xsd#avdl_DebtConversionPrincipalAmountNotExchanged"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_DebtConversionPrincipalAmountNotExchanged_5eff6dbb-c2d4-4825-afd5-bea4bdf69519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_be0f8b61-fceb-43d5-9246-6bce0d05004e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_be0f8b61-fceb-43d5-9246-6bce0d05004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRoyaltiesReceived_50e7c8b4-d4ca-4b40-8bf9-f20f5716fe78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRoyaltiesReceived"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_us-gaap_ProceedsFromRoyaltiesReceived_50e7c8b4-d4ca-4b40-8bf9-f20f5716fe78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_b1f1db9f-1858-4dd0-ac3b-3ba341a821df" xlink:href="avdl-20230331.xsd#avdl_RoyaltyFinancingQuarterlyNetRevenueTarget"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems_437587d3-9cce-46a9-9de1-6fd13bd5b440" xlink:to="loc_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget_b1f1db9f-1858-4dd0-ac3b-3ba341a821df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7c8a9c4a-3a24-46b2-9466-6b8c31de9fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b6f4f99a-51d0-457e-af02-adf433390c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c8a9c4a-3a24-46b2-9466-6b8c31de9fc2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b6f4f99a-51d0-457e-af02-adf433390c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f6eb7d3e-00c9-4ec6-8cde-ec7508987d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c8a9c4a-3a24-46b2-9466-6b8c31de9fc2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f6eb7d3e-00c9-4ec6-8cde-ec7508987d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_e637a642-9181-4762-8f19-7143b97222fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_e637a642-9181-4762-8f19-7143b97222fd" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_7043559f-27c8-40a0-99c0-de946c50cbc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_7043559f-27c8-40a0-99c0-de946c50cbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_66213e09-ff6c-471f-917d-f09a71dd9046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:to="loc_us-gaap_OtherAssetsCurrent_66213e09-ff6c-471f-917d-f09a71dd9046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeCurrent_ca7bafb6-6981-4201-813b-a7fef3e26ae2" xlink:href="avdl-20230331.xsd#avdl_GuaranteeCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:to="loc_avdl_GuaranteeCurrent_ca7bafb6-6981-4201-813b-a7fef3e26ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b503fe92-ad88-4883-85b9-4c5fc94debec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b503fe92-ad88-4883-85b9-4c5fc94debec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0aa5de79-d4a3-4828-b084-c1f011f21176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_d569add6-2cf3-4d01-9c37-e2e33ee6ea4d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0aa5de79-d4a3-4828-b084-c1f011f21176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c94e5b14-78d0-4d82-b742-f7f9ac4cb5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrentAbstract_d0146a1a-1989-42b8-8b33-c901d83826b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_c94e5b14-78d0-4d82-b742-f7f9ac4cb5b7" xlink:to="loc_us-gaap_OtherAssetsNoncurrentAbstract_d0146a1a-1989-42b8-8b33-c901d83826b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_a95d907c-6d3d-40b0-a9df-bb2c11d63d98" xlink:href="avdl-20230331.xsd#avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_d0146a1a-1989-42b8-8b33-c901d83826b4" xlink:to="loc_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent_a95d907c-6d3d-40b0-a9df-bb2c11d63d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_GuaranteeNoncurrent_4c14b23c-0b69-444d-9e61-f897b6a39a86" xlink:href="avdl-20230331.xsd#avdl_GuaranteeNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_d0146a1a-1989-42b8-8b33-c901d83826b4" xlink:to="loc_avdl_GuaranteeNoncurrent_4c14b23c-0b69-444d-9e61-f897b6a39a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherNoncurrentReceivables_cf1e993f-7cfa-41c1-9f2f-2fb4ea897545" xlink:href="avdl-20230331.xsd#avdl_OtherNoncurrentReceivables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_d0146a1a-1989-42b8-8b33-c901d83826b4" xlink:to="loc_avdl_OtherNoncurrentReceivables_cf1e993f-7cfa-41c1-9f2f-2fb4ea897545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_609f8a27-f509-429b-9d8a-dda0c4cce92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsNoncurrentAbstract_d0146a1a-1989-42b8-8b33-c901d83826b4" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_609f8a27-f509-429b-9d8a-dda0c4cce92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8ede50f8-823b-43e4-8b79-67ace5bea38a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8ede50f8-823b-43e4-8b79-67ace5bea38a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_f1b8541e-110f-49b9-9d57-9eb2131e9c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_f1b8541e-110f-49b9-9d57-9eb2131e9c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_de4ac6f6-b534-4ed2-ba5d-d2169328c3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:to="loc_us-gaap_AccruedSalariesCurrent_de4ac6f6-b534-4ed2-ba5d-d2169328c3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveCurrent_025a46d4-f2e6-40cb-bd69-c180a4081e45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:to="loc_us-gaap_RestructuringReserveCurrent_025a46d4-f2e6-40cb-bd69-c180a4081e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedOutsourceContractCosts_e73de9fb-2ae0-4ea9-b218-995220170d00" xlink:href="avdl-20230331.xsd#avdl_AccruedOutsourceContractCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:to="loc_avdl_AccruedOutsourceContractCosts_e73de9fb-2ae0-4ea9-b218-995220170d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_218b3e07-c4f6-4e4d-a435-3805c6cd36d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_47023947-8726-44db-aaec-05b1576e5882" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_218b3e07-c4f6-4e4d-a435-3805c6cd36d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8c649da7-9da5-4f79-a481-ce1e2602a689" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_25afa382-665e-4f11-8ee9-213d7be0e5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8c649da7-9da5-4f79-a481-ce1e2602a689" xlink:to="loc_us-gaap_OtherLiabilitiesCurrentAbstract_25afa382-665e-4f11-8ee9-213d7be0e5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_3fcfbde9-761c-46cd-b5ed-9f3b9de035bf" xlink:href="avdl-20230331.xsd#avdl_OtherGuarantorObligationsCurrentCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_25afa382-665e-4f11-8ee9-213d7be0e5a9" xlink:to="loc_avdl_OtherGuarantorObligationsCurrentCarryingValue_3fcfbde9-761c-46cd-b5ed-9f3b9de035bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_598fe738-b33f-4814-9f06-29c070914240" xlink:href="avdl-20230331.xsd#avdl_OtherLiabilitiesMiscellaneousCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_25afa382-665e-4f11-8ee9-213d7be0e5a9" xlink:to="loc_avdl_OtherLiabilitiesMiscellaneousCurrent_598fe738-b33f-4814-9f06-29c070914240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AccruedInterestCurrent_8d4bf0a6-939a-4c6f-adf5-eb799903641f" xlink:href="avdl-20230331.xsd#avdl_AccruedInterestCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_25afa382-665e-4f11-8ee9-213d7be0e5a9" xlink:to="loc_avdl_AccruedInterestCurrent_8d4bf0a6-939a-4c6f-adf5-eb799903641f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_5316d59b-aa2c-4ef5-8d1f-7fee5f7f058e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_25afa382-665e-4f11-8ee9-213d7be0e5a9" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_5316d59b-aa2c-4ef5-8d1f-7fee5f7f058e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_21df09c9-49cc-434a-9ea8-d1628dd92b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1b883e26-3217-40b1-90d4-7bc4320edb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_21df09c9-49cc-434a-9ea8-d1628dd92b58" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1b883e26-3217-40b1-90d4-7bc4320edb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_3cc4f3ad-96dd-4c6a-be1a-ac8de0e49f69" xlink:href="avdl-20230331.xsd#avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1b883e26-3217-40b1-90d4-7bc4320edb7f" xlink:to="loc_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities_3cc4f3ad-96dd-4c6a-be1a-ac8de0e49f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_04671bd0-a7f9-4bf7-bcd1-ce0e6cc38b76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1b883e26-3217-40b1-90d4-7bc4320edb7f" xlink:to="loc_us-gaap_GuarantyLiabilities_04671bd0-a7f9-4bf7-bcd1-ce0e6cc38b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ca49fead-adcd-4a2d-a0a4-b8f96b7015fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrentAbstract_1b883e26-3217-40b1-90d4-7bc4320edb7f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ca49fead-adcd-4a2d-a0a4-b8f96b7015fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b19185ab-eda5-4c80-a9a1-ea9b2ae16a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_828fec3f-1483-4045-94c4-2ae04b1885c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b19185ab-eda5-4c80-a9a1-ea9b2ae16a6c" xlink:to="loc_us-gaap_NetIncomeLoss_828fec3f-1483-4045-94c4-2ae04b1885c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b25cda48-014b-4538-be42-79e3166de6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b19185ab-eda5-4c80-a9a1-ea9b2ae16a6c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b25cda48-014b-4538-be42-79e3166de6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d2d44381-e262-484e-ac3e-577f4f2126de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b25cda48-014b-4538-be42-79e3166de6f3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d2d44381-e262-484e-ac3e-577f4f2126de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c926f1f5-d582-4168-a400-ce57fbe34108" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b25cda48-014b-4538-be42-79e3166de6f3" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_c926f1f5-d582-4168-a400-ce57fbe34108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31f8ad12-6dba-448a-b3cc-6bc72c365033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_b25cda48-014b-4538-be42-79e3166de6f3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31f8ad12-6dba-448a-b3cc-6bc72c365033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d7dbefc3-668e-472e-ac16-d45e938e9172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b19185ab-eda5-4c80-a9a1-ea9b2ae16a6c" xlink:to="loc_us-gaap_EarningsPerShareBasic_d7dbefc3-668e-472e-ac16-d45e938e9172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0671cf37-0ab8-4743-8fb3-c3cff9e3f6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b19185ab-eda5-4c80-a9a1-ea9b2ae16a6c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0671cf37-0ab8-4743-8fb3-c3cff9e3f6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/NetLossPerShareNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#NetLossPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/NetLossPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8014df73-95a4-4099-b28b-872c178a44a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0ed560dc-54fb-43be-b842-f22f00856c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8014df73-95a4-4099-b28b-872c178a44a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0ed560dc-54fb-43be-b842-f22f00856c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossComponentsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#ComprehensiveLossComponentsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLossComponentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_51b5766b-7668-4e92-bbe6-116b7875a9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_51b5766b-7668-4e92-bbe6-116b7875a9d1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_834c868a-71c6-4e62-ab39-bc62a5b6a509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_efdf69b3-042f-4c4f-aebe-1d60e45440c3" xlink:to="loc_us-gaap_EquityComponentDomain_834c868a-71c6-4e62-ab39-bc62a5b6a509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_834c868a-71c6-4e62-ab39-bc62a5b6a509" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3d35c3cc-c85e-4337-b33d-22e9029cb6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3d35c3cc-c85e-4337-b33d-22e9029cb6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_bfa251fa-6445-4741-a38a-f9f036f57237" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2fa4e274-aba8-4d08-8055-991afc488555" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_bfa251fa-6445-4741-a38a-f9f036f57237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bbd8acb9-9601-4099-a527-f91ba8ffaab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_8d17562e-cf9d-41ee-9d2f-e7c6173736cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bbd8acb9-9601-4099-a527-f91ba8ffaab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bbd8acb9-9601-4099-a527-f91ba8ffaab3" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6bf07394-4f3c-41c9-b6fc-1007231f0cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:to="loc_us-gaap_StockholdersEquity_6bf07394-4f3c-41c9-b6fc-1007231f0cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b726f041-a0e9-4448-9db0-60419fb197e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b726f041-a0e9-4448-9db0-60419fb197e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2370777f-78e6-45c5-affa-884fd145c220" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_b9ebb652-4719-4f2e-87af-2d01ca25ff4b" xlink:to="loc_us-gaap_StockholdersEquity_2370777f-78e6-45c5-affa-884fd145c220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/ComprehensiveLossNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#ComprehensiveLossNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/ComprehensiveLossNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_b2f1185f-aa00-4166-9ffb-d96634ce0939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1facd135-deb2-49d5-ab1a-138694f0ca32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_b2f1185f-aa00-4166-9ffb-d96634ce0939" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1facd135-deb2-49d5-ab1a-138694f0ca32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f19945e-9b89-462b-947c-069e3fd3e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7f19945e-9b89-462b-947c-069e3fd3e8d6" xlink:to="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_92bcde4b-ba61-48ea-aa6f-dce814ae8b61" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_285c29db-6946-4d3a-bd07-037bb5714025" xlink:to="loc_srt_ProductsAndServicesDomain_92bcde4b-ba61-48ea-aa6f-dce814ae8b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_FSCMember_f1267e16-b85d-429d-aad8-32229be571b4" xlink:href="avdl-20230331.xsd#avdl_FSCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_92bcde4b-ba61-48ea-aa6f-dce814ae8b61" xlink:to="loc_avdl_FSCMember_f1267e16-b85d-429d-aad8-32229be571b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_bcffc188-fae7-4eb1-af32-918821daa3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_3815f6de-06e7-46e6-bb2b-736af5e70d82" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_bcffc188-fae7-4eb1-af32-918821daa3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_dafe8b38-302d-4fff-9453-13b9b096001b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationsDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_bcffc188-fae7-4eb1-af32-918821daa3ad" xlink:to="loc_us-gaap_DiscontinuedOperationsDisposedOfBySaleMember_dafe8b38-302d-4fff-9453-13b9b096001b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c5d3a1e7-f7ee-41da-b9b5-7256258ec5c1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2016MIPAMember_779ce556-1936-4f05-84bf-15f9534a1ee6" xlink:href="avdl-20230331.xsd#avdl_A2016MIPAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:to="loc_avdl_A2016MIPAMember_779ce556-1936-4f05-84bf-15f9534a1ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_CerecorMember_8a14d72f-3c6b-4c92-a8a6-cc7da698019a" xlink:href="avdl-20230331.xsd#avdl_CerecorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5a51d76-c83d-45d2-abed-e221934851dd" xlink:to="loc_avdl_CerecorMember_8a14d72f-3c6b-4c92-a8a6-cc7da698019a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_0279037e-ee4e-4c9c-a719-9d925dd70523" xlink:to="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_2b52ddbc-ec95-4291-8cb3-df4318f3369d" xlink:href="avdl-20230331.xsd#avdl_PercentageOfRoyaltyPayableOnNetSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_avdl_PercentageOfRoyaltyPayableOnNetSales_2b52ddbc-ec95-4291-8cb3-df4318f3369d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RoyaltyPayableonNetSalesMaximum_b01d9f1f-1a3a-4494-a112-4c9e31593896" xlink:href="avdl-20230331.xsd#avdl_RoyaltyPayableonNetSalesMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_avdl_RoyaltyPayableonNetSalesMaximum_b01d9f1f-1a3a-4494-a112-4c9e31593896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyLiabilities_72d79a6c-0f24-4b65-b77c-5029366ad208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_us-gaap_GuarantyLiabilities_72d79a6c-0f24-4b65-b77c-5029366ad208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuarantyAssets_408a08aa-30a1-442d-bc89-a0acaa897338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuarantyAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ad212258-904c-47d5-9fe5-7ba0f93d6c4a" xlink:to="loc_us-gaap_GuarantyAssets_408a08aa-30a1-442d-bc89-a0acaa897338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#RestructuringCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_33313a6f-2380-4d2d-8a91-0b089809e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_33313a6f-2380-4d2d-8a91-0b089809e1de" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:to="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_0c1545ed-260b-49b4-bb13-32f03f4916b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_73f5929c-b5e8-457d-a947-33f4bb4c8725" xlink:to="loc_us-gaap_RestructuringPlanDomain_0c1545ed-260b-49b4-bb13-32f03f4916b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember_c0792eb5-7c09-4faa-a10a-d876a5b92036" xlink:href="avdl-20230331.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_0c1545ed-260b-49b4-bb13-32f03f4916b4" xlink:to="loc_avdl_A2022CorporateRestructuringPlanMember_c0792eb5-7c09-4faa-a10a-d876a5b92036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_d87b9014-1292-48ff-a75b-7b5d9ad1170b" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_c1f8a4a3-0eb6-469f-989c-9a928e7b3900" xlink:href="avdl-20230331.xsd#avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:to="loc_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent_c1f8a4a3-0eb6-469f-989c-9a928e7b3900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_4be8bbdc-616b-4212-86c8-29366437d17f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_9ef035c0-3349-4c33-89a2-77ce736e94d6" xlink:to="loc_us-gaap_RestructuringReserve_4be8bbdc-616b-4212-86c8-29366437d17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#RestructuringCostsSeveranceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_34cd7061-1e78-4c7c-833a-65708cd85440" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_34cd7061-1e78-4c7c-833a-65708cd85440" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:to="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_369c6ece-341b-47f0-86db-be9d02f2c656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_0dd6437c-ad3b-45f4-8b05-ca00a13602e2" xlink:to="loc_us-gaap_RestructuringPlanDomain_369c6ece-341b-47f0-86db-be9d02f2c656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A2022CorporateRestructuringPlanMember_1c4c6060-685d-4ea1-ac3a-5112388f4277" xlink:href="avdl-20230331.xsd#avdl_A2022CorporateRestructuringPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_369c6ece-341b-47f0-86db-be9d02f2c656" xlink:to="loc_avdl_A2022CorporateRestructuringPlanMember_1c4c6060-685d-4ea1-ac3a-5112388f4277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4b930789-5fef-4f7a-89d7-fc9c9fe1b183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7ef3281f-f12c-42ca-a7a7-2c5dbeb92986" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4b930789-5fef-4f7a-89d7-fc9c9fe1b183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4b930789-5fef-4f7a-89d7-fc9c9fe1b183" xlink:to="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_92e30ed7-22f7-4da3-9718-9b8da849e36e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_RestructuringReserve_92e30ed7-22f7-4da3-9718-9b8da849e36e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_56bfe585-98db-4fd7-92d9-784b98fb78b8" xlink:href="avdl-20230331.xsd#avdl_RestructuringChargesBeforeGainLossDuetoCurtailment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment_56bfe585-98db-4fd7-92d9-784b98fb78b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_3b8f33c6-69aa-4e75-ad6a-37a8360ba487" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_PaymentsForRestructuring_3b8f33c6-69aa-4e75-ad6a-37a8360ba487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_dc83aa1d-9585-49a0-9732-843c7c331572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_dc83aa1d-9585-49a0-9732-843c7c331572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_cca669e3-b9e6-4850-ad52-f9b269e13416" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_6927f53e-37ba-4d1a-a027-f5e74ca86a0a" xlink:to="loc_us-gaap_RestructuringReserve_cca669e3-b9e6-4850-ad52-f9b269e13416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="avdl-20230331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.avadel.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_a4db7800-1800-4dda-9d8b-cdd818b52663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_a4db7800-1800-4dda-9d8b-cdd818b52663" xlink:to="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ce124abc-6925-4cf3-969a-48389a507d5c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_c760712e-ded8-4e13-8a39-529e1a49ab95" xlink:href="avdl-20230331.xsd#avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:to="loc_avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member_c760712e-ded8-4e13-8a39-529e1a49ab95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_April2027NotesMember_4e993afc-408a-4ce6-a037-f05a677a5e31" xlink:href="avdl-20230331.xsd#avdl_April2027NotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_5bb6a895-d437-47c2-ad0a-6084061942ab" xlink:to="loc_avdl_April2027NotesMember_4e993afc-408a-4ce6-a037-f05a677a5e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c1183ba5-d8fb-4a21-8b53-1bb631953a70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bd48d87a-d5f7-4bef-9690-34111e6fcdce" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c1183ba5-d8fb-4a21-8b53-1bb631953a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d75c3fad-5385-4420-a71f-732f28c776e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c1183ba5-d8fb-4a21-8b53-1bb631953a70" xlink:to="loc_us-gaap_SeniorNotesMember_d75c3fad-5385-4420-a71f-732f28c776e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b92dca66-d780-48be-8fc2-5a7d15aefaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e9aee7ee-392d-4b2c-a335-6ae87cfb67f6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b92dca66-d780-48be-8fc2-5a7d15aefaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_05a88285-5361-4b23-b2e4-946a519762c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b92dca66-d780-48be-8fc2-5a7d15aefaaf" xlink:to="loc_us-gaap_SubsequentEventMember_05a88285-5361-4b23-b2e4-946a519762c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3a5cfe27-4caf-47c5-86ab-ed6364ee95ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17226893-5715-41ea-9468-e86ffe863fe6" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3a5cfe27-4caf-47c5-86ab-ed6364ee95ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3a5cfe27-4caf-47c5-86ab-ed6364ee95ff" xlink:to="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheOneMember_a140d976-93d2-4352-9a05-2ddec69e1349" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:to="loc_avdl_PublicStockOfferingTrancheOneMember_a140d976-93d2-4352-9a05-2ddec69e1349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_PublicStockOfferingTrancheTwoMember_64ebfc57-2e34-4fee-8988-3f71d73c547d" xlink:href="avdl-20230331.xsd#avdl_PublicStockOfferingTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_avdl_PublicStockOfferingMember_eb4a54d5-55b6-4f6b-8547-a8898bda02a8" xlink:to="loc_avdl_PublicStockOfferingTrancheTwoMember_64ebfc57-2e34-4fee-8988-3f71d73c547d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_31191f19-d660-4b49-89ee-0c1c652562f7" xlink:to="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_49f723d4-809c-46d1-aeb2-156be98edf2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_49f723d4-809c-46d1-aeb2-156be98edf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_AmericanDepositarySharesMember_4362a44f-a50d-4356-8adc-96197932ff72" xlink:href="avdl-20230331.xsd#avdl_AmericanDepositarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_13363479-5d0c-4975-8bb8-c1582ebd6613" xlink:to="loc_avdl_AmericanDepositarySharesMember_4362a44f-a50d-4356-8adc-96197932ff72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_5aa4f701-37f8-4587-8c32-7a165ccdb342" xlink:to="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_5d447aa2-8b6d-45a5-be71-4da6e410c64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_5d447aa2-8b6d-45a5-be71-4da6e410c64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8b97492b-9e30-40eb-bcc5-3b145df45c26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8b97492b-9e30-40eb-bcc5-3b145df45c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_79e9d836-c578-4da3-9e6f-5f626326b589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_79e9d836-c578-4da3-9e6f-5f626326b589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_45635cb6-bb6c-4101-b92b-47c948b985bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_45635cb6-bb6c-4101-b92b-47c948b985bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_03146da0-12e2-419f-8268-e3dc8d930951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_03146da0-12e2-419f-8268-e3dc8d930951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_865dd36a-0543-4a22-a355-57c53bb7bbae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_865dd36a-0543-4a22-a355-57c53bb7bbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ae67b7e8-b921-450b-a995-d309b1950118" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_ae67b7e8-b921-450b-a995-d309b1950118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_avdl_OrphanDrugExclusivityTerm_eda6fe55-ba99-4861-886b-119ec28edda5" xlink:href="avdl-20230331.xsd#avdl_OrphanDrugExclusivityTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_535f26cc-e8b5-47ed-9fc4-7f2508599c52" xlink:to="loc_avdl_OrphanDrugExclusivityTerm_eda6fe55-ba99-4861-886b-119ec28edda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313338923376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVADEL PHARMACEUTICALS PLC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1341933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10 Earlsfort Terrace<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">D02 T380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">901-5201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, nominal value $0.01 per share**<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoTradingSymbolFlag', window );">No Trading Symbol Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Smaller Reporting Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,768,391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001012477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNMS', window );">NASDAQ/NMS (GLOBAL MARKET)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares*<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVDL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoTradingSymbolFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a security having no trading symbol.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoTradingSymbolFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:trueItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNMS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNMS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340554256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="nump">$ 3,830<span></span>
</td>
<td class="nump">$ 6,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">24,468<span></span>
</td>
<td class="nump">21,635<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expense</a></td>
<td class="nump">28,298<span></span>
</td>
<td class="nump">28,626<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(28,298)<span></span>
</td>
<td class="num">(28,626)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment and other income (expense), net</a></td>
<td class="nump">193<span></span>
</td>
<td class="num">(104)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="num">(3,259)<span></span>
</td>
<td class="num">(2,017)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(31,364)<span></span>
</td>
<td class="num">(30,747)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(580)<span></span>
</td>
<td class="num">(4,323)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,784)<span></span>
</td>
<td class="num">$ (26,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of shares outstanding - basic (in shares)</a></td>
<td class="nump">63,886<span></span>
</td>
<td class="nump">58,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of shares outstanding - diluted (in shares)</a></td>
<td class="nump">63,886<span></span>
</td>
<td class="nump">58,824<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313344398800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,784)<span></span>
</td>
<td class="num">$ (26,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss, net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation income (loss)</a></td>
<td class="nump">175<span></span>
</td>
<td class="num">(185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively</a></td>
<td class="nump">140<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">315<span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (30,469)<span></span>
</td>
<td class="num">$ (27,526)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340503280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, benefit (tax)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339687280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 83,391<span></span>
</td>
<td class="nump">$ 73,981<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">22,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">2,283<span></span>
</td>
<td class="nump">2,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">6,264<span></span>
</td>
<td class="nump">2,096<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">109,470<span></span>
</td>
<td class="nump">100,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">782<span></span>
</td>
<td class="nump">839<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,475<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">16,836<span></span>
</td>
<td class="nump">16,836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent', window );">Research and development tax credit receivable</a></td>
<td class="nump">1,245<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">10,931<span></span>
</td>
<td class="nump">11,322<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">140,739<span></span>
</td>
<td class="nump">132,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">20,515<span></span>
</td>
<td class="nump">37,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">871<span></span>
</td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,023<span></span>
</td>
<td class="nump">7,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">7,683<span></span>
</td>
<td class="nump">7,334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent', window );">Proceeds received in advance of Series B Preferred Shares issuance</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">1,941<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">79,361<span></span>
</td>
<td class="nump">55,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">93,139<span></span>
</td>
<td class="nump">91,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">5,767<span></span>
</td>
<td class="nump">5,743<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">178,905<span></span>
</td>
<td class="nump">153,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; (deficit) equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at March&#160;31, 2023 and 488 issued and outstanding at December&#160;31, 2022</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 64,478 issued and outstanding at March&#160;31, 2023 and 62,878 issued and outstanding at December&#160;31, 2022</a></td>
<td class="nump">644<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">603,215<span></span>
</td>
<td class="nump">589,783<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(616,004)<span></span>
</td>
<td class="num">(585,220)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(26,026)<span></span>
</td>
<td class="num">(26,341)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; (deficit) equity</a></td>
<td class="num">(38,166)<span></span>
</td>
<td class="num">(21,145)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; (deficit) equity</a></td>
<td class="nump">$ 140,739<span></span>
</td>
<td class="nump">$ 132,785<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds Received In Advance Of Share Issuance, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Tax Credit Receivable, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non current portion of tax credit receivable on research and development as on the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313344382352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred shares, nominal value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred shares, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred shares, shares issued (in shares)</a></td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred shares, shares outstanding (in shares)</a></td>
<td class="nump">488,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued (in shares)</a></td>
<td class="nump">64,478,000<span></span>
</td>
<td class="nump">62,878,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding (in shares)</a></td>
<td class="nump">64,478,000<span></span>
</td>
<td class="nump">62,878,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339294352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; (DEFICIT) EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Ordinary shares</div></th>
<th class="th"><div>Preferred shares</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Accumulated deficit</div></th>
<th class="th"><div>Accumulated other comprehensive (loss) income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,620<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 78,244<span></span>
</td>
<td class="nump">$ 586<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 549,349<span></span>
</td>
<td class="num">$ (447,756)<span></span>
</td>
<td class="num">$ (23,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,424)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="num">(1,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,102)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,906<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,032<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">55,232<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">553,859<span></span>
</td>
<td class="num">(474,180)<span></span>
</td>
<td class="num">(25,042)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,878<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">(21,145)<span></span>
</td>
<td class="nump">$ 628<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">589,783<span></span>
</td>
<td class="num">(585,220)<span></span>
</td>
<td class="num">(26,341)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(30,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,784)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock under at-the-market offering program, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock under at-the-market offering program, net of issuance costs</a></td>
<td class="nump">11,913<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Amortization of deferred issuance costs</a></td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Vesting of restricted shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Vesting of restricted shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan', window );">Employee share purchase plan share issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee share purchase plan share issuance</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,478<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="num">$ (38,166)<span></span>
</td>
<td class="nump">$ 644<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 603,215<span></span>
</td>
<td class="num">$ (616,004)<span></span>
</td>
<td class="num">$ (26,026)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109244457&amp;loc=d3e16649-113920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340569744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,784)<span></span>
</td>
<td class="num">$ (26,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">588<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="nump">1,873<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Changes in deferred taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">1,522<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other adjustments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(4,131)<span></span>
</td>
<td class="num">(2,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable', window );">Research and development tax credit receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable &amp; other current liabilities</a></td>
<td class="nump">468<span></span>
</td>
<td class="num">(5,613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">2,314<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet', window );">Other assets and liabilities</a></td>
<td class="num">(116)<span></span>
</td>
<td class="num">(1,667)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(30,233)<span></span>
</td>
<td class="num">(34,045)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">15,295<span></span>
</td>
<td class="nump">44,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(10,229)<span></span>
</td>
<td class="num">(2,090)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">5,066<span></span>
</td>
<td class="nump">42,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ProceedsReceivedInAdvanceOfShareIssuance', window );">Proceeds received in advance of Series B Preferred Shares Issuance</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Payments for February 2023 Notes</a></td>
<td class="num">(17,500)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares off the at-the-market offering program</a></td>
<td class="nump">11,913<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from stock option exercises and employee share purchase plan</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">34,442<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">135<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="nump">9,410<span></span>
</td>
<td class="nump">10,165<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at January 1,</a></td>
<td class="nump">73,981<span></span>
</td>
<td class="nump">50,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at March 31,</a></td>
<td class="nump">83,391<span></span>
</td>
<td class="nump">60,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">3,050<span></span>
</td>
<td class="nump">5,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in research and development tax credit receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ProceedsReceivedInAdvanceOfShareIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds Received In Advance Of Share Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ProceedsReceivedInAdvanceOfShareIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342478592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company.  The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product, LUMRYZ, formally known as FT218, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. On May 1, 2023, LUMRYZ was approved by the U.S. Food and Drug Administration (&#8220;FDA&#8221;). In approving LUMRYZ, the FDA approved a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) for LUMRYZ to help ensure that the benefits of the drug in the treatment of cataplexy and EDS in narcolepsy outweigh the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion of the drug. Under this REMS, healthcare providers must be specially certified, pharmacies, practitioners, or health care settings that dispense the drug must be specially certified and the drug must be dispensed to patients with documentation of safe use conditions. The FDA also granted Orphan Drug Exclusivity (&#8220;ODE&#8221;) to LUMRYZ for a period of seven years until May 1, 2030.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of LUMRYZ, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any other commercialized products in its portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#8217; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $83,391 of cash and cash equivalents and $17,532 of marketable securities available for use to fund its operations, debt service and capital requirements. The Company&#8217;s ability to generate revenue is expected to start following the commercial launch of LUMRYZ in the U.S., which is dependent, in part, on the Company&#8217;s ability to successfully complete its commercialization efforts and on market acceptance of LUMRYZ in the U.S. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 29, 2023, the Company and Avadel CNS Pharmaceuticals, LLC, an indirect wholly-owned subsidiary of the Company (&#8220;Avadel CNS&#8221;) entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $75,000 of royalty financing in two tranches. The first tranche of $30,000 is available subject to the Company&#8217;s first shipment of LUMRYZ. The second tranche is available to use, at the Company&#8217;s election, upon achieving quarterly net revenue of $25,000. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the Company had outstanding $117,375&#160;aggregate principal amount of its 4.50% exchangeable senior notes due October 2023 (the &#8220;October 2023 Notes&#8221;). Over the course of April 3 and April 4, 2023, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#8220;Issuer&#8221;), completed an exchange of $96,188</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">its $117,375 October 2023 Notes for $106,268 of a new series 6.0% exchangeable notes due April 2027 (the &#8220;April 2027 Notes&#8221;) (the &#8220;2023 Exchange Transaction&#8221;). The remaining $21,187 aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 3, 2023, the Company completed the sale of ordinary shares, nominal value $0.01 per share (&#8220;Ordinary Shares&#8221;) in the form of American Depositary Shares (&#8220;ADSs&#8221;) and Series B Non-Voting Convertible Preferred Shares (&#8220;Series B Preferred Shares&#8221;) in an underwritten public offering. The Company received net proceeds from the equity financing of $135,125, of which $40,000 was received on March 31, 2023 and $95,125 was received on April 3, 2023. The $40,000 of net proceeds received prior to the completed public offering was included in the unaudited condensed consolidated balance sheet as proceeds received in advance of Series B Preferred Shares issuance at March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the 2023 Exchange Transaction and the public offering, the Company has concluded that cash on hand provides sufficient capital to meet the Company&#8217;s operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Repor</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">At-the-Market Offering Program</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 5, 2020, the Company entered into an Open Market Sale Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">SM</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the &#8220;Sales Agreement&#8221;) with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program (&#8220;ATM Program&#8221;) under which the Company may offer and sell its ADSs (such ADSs sold under the ATM Program, &#8220;ATM ADSs&#8221;) through Jefferies as its sales agent. The Company agreed to pay Jefferies a commission up to 3.0% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $50,000 of ADSs pursuant to its prospectus, dated February 14, 2020, included with the Company&#8217;s Registration Statement on Form S-3 (File No. 333-236258) (the &#8220;2020 Prospectus&#8221;). In August 2022, the Company filed an additional prospectus, dated September 12, 2022, included with the Company&#8217;s new Registration Statement on Form S-3 (File No. 333-267198) (the &#8220;2022 Prospectus&#8221;), in order to allocate up to $100,000 in additional ADSs to the ATM Program. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 Shelf Registration expired on February 14, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Sales Agreement, the Company had issued and sold 1,564 ADSs during the quarter ended March 31, 2023, resulting in net proceeds to the Company of approximately $11,913. The Company may offer and sell up to an additional $96,064 of ADSs under the ATM Program that remain available for sale pursuant to the 2022 Prospectus.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of March&#160;31, 2023, which is derived from the prior year 2022 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2022 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 29, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342272272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurement</a></td>
<td class="text">Fair Value Measurement<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Income approach, which is based on the present value of a future stream of net cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - Quoted prices for identical assets or liabilities in active markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - Unobservable inputs that reflect estimates and assumptions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160;Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended March&#160;31, 2023 and December&#160;31, 2022, respectively, there were no transfers in and out of&#160;Level&#160;1, 2, or 3. During the three months ended March&#160;31, 2023 and 2022, respectively, the Company did not recognize any allowances for credit losses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its $117,375 aggregate principal amount of&#160;its October 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair value of the October 2023 Notes at March&#160;31, 2023 is $124,418. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4: Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the Company&#8217;s debt obligations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342385152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text">Marketable Securities&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in available-for-sale debt securities which are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#8217; (deficit) equity, net of income tax effects. As of March&#160;31, 2023, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,749)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income (expense), net in the accompanying unaudited condensed consolidated statements of loss.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized gross realized gains of $1 and $304 for the three months ended March&#160;31, 2023 and 2022, respectively. These realized gains were offset by realized losses of $61 and $790 for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its investment in available-for-sale marketable securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#8217;s investment portfolio.</span></div>Total gross unrealized losses and fair value of the Company&#8217;s marketable securities at March&#160;31, 2023 are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342272272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due October 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,139&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,614&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ended March&#160;31, 2023 and 2022, the total interest expense was $3,259 and $2,017, respectively, with coupon interest expense of $1,386 and $1,617 for each period, respectively, and the amortization of debt issuance costs and debt discount of $1,873 and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $312 for each period, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">February 2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 16, 2018, the Issuer issued $125,000 aggregate principal amount of its February 2023 Notes in a private placement (the &#8220;Offering&#8221;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the February 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the February 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $137,560. The February 2023 Notes were the Company&#8217;s senior unsecured obligations and ranked equally in right of payment with all of the Company&#8217;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#8217;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">October 2023 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 5, 2022, the Issuer completed the exchange of $117,375 of its February 2023 Notes for a new series of its October 2023 Notes (the &#8220;2022 Exchange Transaction&#8221;). The remaining $26,375 aggregate principal amount of the February 2023 Notes were not exchanged and maintained a maturity date of February 1, 2023. On November 4, 2022, the Company repurchased $8,875 of its February 2023 Notes and on the maturity date of February 1, 2023, the Company repaid, with cash on hand, the remaining $17,500 aggregate principal amount of its February 2023 Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the October 2023 Notes as a modification to the February 2023 Notes. The Company paid $4,804 in fees to note holders of the October 2023 Notes that are amortized over the remaining term of the October 2023 Notes. The Company paid approximately $5,450 in fees to third parties that were expensed as part of the completed 2022 Exchange Transaction. Additionally, the fair value of the unseparated, embedded conversion feature increased by $5,508, which reduced the carrying amount of the convertible debt instrument as an unamortized debt discount, with a corresponding increase in additional paid-in capital. The $5,508 is amortized over the remaining term of the October 2023 Notes as a component of interest expense. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The October 2023 Notes are exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $10.79 per ADS. Such initial exchange price represents a premium of approximately 20% to the $8.99 per ADS closing price on The Nasdaq Global Market on February 13, 2018. Upon the exchange of any October 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#8217;s election. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, at its option, may redeem for cash all of the October 2023 Notes if the last reported sale price (as defined by the indenture) of the ADSs has been at least 130% of the Exchange Price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice to redeem the October 2023 Notes. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">April 2027 Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Over the course of April 3 and April 4, 2023, the Issuer completed an exchange of $96,188 of its $117,375 October 2023 Notes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for $106,268 of new</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> April 2027 Notes. The remaining $21,187 aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023. Due to the 2023 Exchange Transaction, the $96,188 principal amount of the October 2023 Notes is classified as long-term debt, net of unamortized debt discount and issuance costs, as of March&#160;31, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the April 2027 Notes may convert their April 2027 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding January 15, 2027, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after January 15, 2027 and prior to the close of business on the business day immediately preceding the maturity date:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Prior to the close of business on the business day immediately preceding January 15, 2027, a holder of the April 2027 Notes may surrender all or any portion of its April 2027 Notes at an initial exchange rate (the &#8220;Exchange Rate&#8221;) of 102.3018 ADSs of the Company (each of which represents as of the date hereof one ordinary share of the Company, nominal value $0.01 per share (the &#8220;Ordinary Shares&#8221;)) per $1,000 principal amount of the April 2027 Notes (so long as the principal amount of such holder&#8217;s April 2027 Notes not exchanged is at least $200,000), which is equal to an initial exchange price of approximately $9.78 per ADS. Upon exchange, the April 2027 Notes may be settled in cash, ADSs, or a combination of cash and ADSs, at the Issuer&#8217;s election. The Exchange Rate is subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. Following a &#8220;Make-Whole Fundamental Change&#8221; (as defined in the Indenture) or upon the Issuer&#8217;s issuance of a notice of redemption, the Issuer will increase the Exchange Rate for a holder who elects to exchange its April 2027 Notes in connection with such &#8220;make-whole fundamental change&#8221; or during the related redemption period in certain circumstances. In addition, the Issuer will increase the Exchange Rate for a holder who elects to exchange its April 2027 Notes prior to January 15, 2027 or whose April 2027 Notes are subject to a Mandatory Exchange (as defined below) in certain circumstances.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">The Issuer may cause the then outstanding principal amount of the April 2027 Notes to be exchanged, in whole but not in part, at its option (the &#8220;Mandatory Exchange&#8221;), prior to the close of business on January 15, 2027, if the last reported sale price of the ADSs has been at least 130% of the exchange price then in effect on (x) each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately before the date that the Issuer provides notice of the Mandatory Exchange in accordance with the Indenture (the &#8220;Mandatory Exchange Notice Date&#8221;); and (y) the trading day immediately before such Mandatory Exchange Notice Date, at the then prevailing Exchange Rate, subject to adjustment described above. The Issuer may settle Mandatory Exchanges in cash, ADSs, or a combination of cash and ADSs, at the Issuer&#8217;s election. Accrued and unpaid interest, if any, on April 2027 Notes subject to Mandatory Exchange to, but excluding, the exchange date in respect of the Mandatory Exchange shall be paid by the Issuer to holders of the April 2027 Notes in cash concurrently with the delivery of the other exchange consideration</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Issuer may redeem for cash all of the April 2027 Notes in connection with certain tax-related events at a redemption price equal to 100% of the principal amount of the April 2027 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date, but may not otherwise redeem the April 2027 Notes. No sinking fund is provided for the April 2027 Notes, which means that the Company is not required to redeem or retire the April 2027 Notes periodically.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considered the guidance in ASC 815-15, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Embedded Derivatives</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to the Company&#8217;s ability to settle the October 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#8217;s option. The Company has therefore applied the guidance provided by ASC 470-20, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as amended by ASU 2020-06. </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalty Financing Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 29, 2023, the Company and Avadel CNS entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $75,000 of royalty financing in two tranches. The first tranche of $30,000 is available subject to the Company&#8217;s first shipment of LUMRYZ. The second tranche is available to use, at the Company&#8217;s election, upon achieving quarterly net revenue of $25,000. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342488320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes The income tax benefit was $580 for the three months ended March&#160;31, 2023 resulting in an effective tax rate of 1.8%.  The income tax benefit was $4,323 for the three months ended March&#160;31, 2022 resulting in an effective tax rate of 14.1%.  The change in the effective tax rate for the three months ended March&#160;31, 2023, when compared to the same period in 2022, is primarily driven by the valuation allowances recorded against net deferred tax assets established in the second quarter of 2022. The Company's cumulative loss position was significant negative evidence in assessing the need for a valuation allowance on its deferred tax assets. Given the weight of objectively verifiable historical losses from operations, the Company recorded a full valuation allowance on its deferred tax assets. The Company will be able to reverse the valuation allowance when it has shown its ability to generate taxable income on a consistent basis in future periods. The valuation allowance does not have an impact on the Company's ability to utilize any net operating losses or other tax attributes to offset cash taxes payable as these items are still eligible to be used.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340491056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Assets and Liabilities</a></td>
<td class="text">Other Assets and Liabilities&#160;<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,931&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,322&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsourced contract manufacturing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,767&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342385152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss Per Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net loss per share is calculated by dividing net loss - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#8217;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#8217;s Employee Share Purchase Plan (&#8220;ESPP&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#8217;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#8217;s ESPP has been calculated using the treasury stock method. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Loss Per Share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,784)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,886&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Potential ordinary shares of&#160;12,463&#160;and&#160;17,696&#160;were excluded from the calculation of weighted average shares for the three months ended March&#160;31, 2023 and 2022, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from performance share unit awards (&#8220;PSUs&#8221;) for which the contingent vesting condition had not been achieved. For the three months ended March&#160;31, 2023 and 2022, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342312352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive Loss&#160;<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three months ended March&#160;31, 2023 and 2022, respectively, net of tax effects:&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,855)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,277)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,749)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,002)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,026)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,042)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect on the Company&#8217;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342312352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation &#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At March 31, 2023 and December 31, 2022, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations, cash flows or liquidity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">First Jazz Complaint</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#8220;Jazz&#8221;) filed a formal complaint (the &#8220;First Complaint&#8221;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#8220;Court&#8221;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#8220;Avadel Parties&#8221;). In the First Complaint, Jazz alleges the sodium oxybate product (&#8220;Proposed Product&#8221;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC (&#8220;Avadel CNS&#8221;) will infringe at least one claim of U.S. Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#8220;patents-in-suit&#8221;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Avadel Answer&#8221;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2021, Jazz filed its Answer (&#8220;Jazz Answer&#8221;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#8217;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#8217;s action on Avadel CNS&#8217;s NDA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation. A corresponding order was entered in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2022, Jazz filed an amended Answer to the Avadel Parties&#8217; Counterclaims (&#8220;the Jazz First Amended Answer&#8221;). The Jazz First Amended Answer is substantially similar to the Jazz Answer except insofar as it adds an affirmative defense for judicial estoppel and unclean hands. Corresponding amended answers were filed in the two below cases on the same day.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2022, Avadel CNS filed a Renewed Motion for Judgment on the Pleadings, with respect to its counterclaim against Jazz seeking to have U.S. Patent No. 8731963 (the &#8220;REMS Patent&#8221;) delisted from the Orange Book and seeking to have the motion resolved concurrent with the parties&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing on August 31, 2022. On July 7, 2022, Jazz filed a response it styled as Objections to Avadel CNS&#8217; Motion for Judgment on the Pleadings. On July 14, 2022, Avadel CNS replied to Jazz&#8217;s response, and on July 21, 2022, Avadel CNS requested oral argument on its delisting motion simultaneous with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing. On August 24, 2022, the Court ordered Jazz to respond substantively to Avadel CNS&#8217; motion, which Jazz did on August 26, 2022. Avadel CNS filed its reply on August 28, 2022.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2022, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was postponed. On September 7, 2022, the case was reassigned to a new judge, and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing was held on October 25, 2022. At the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing, Avadel CNS reiterated its request for an expedited hearing on the Renewed Motion for Judgment on the Pleadings for the delisting of the REMS Patent. On October 28, 2022, the Court granted Avadel CNS&#8217; request and scheduled the hearing for November 15, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Court held the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Markman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> hearing on November 15, 2022 and issued a claim construction ruling on November 18, 2022.  Also on November 18, 2022 the Court granted Avadel&#8217;s Renewed Motion for Judgment on the Pleadings and ordered Jazz to request delisting of the REMS Patent from the Orange Book. On November 22, 2022, Jazz appealed that decision and on December 14, 2022, the Federal Circuit issued a stay of the delisting order until further notice. Oral argument was held February 14, 2023. On February 24, 2023, the United States Court of Appeals for the Federal Court affirmed the previous ruling from the Court, ordering the delisting of the REMS Patent from the Orange Book, which has since occurred. On March 7, 2023, in response to a joint stipulation filed by the parties, the Court issued an order dismissing Jazz&#8217;s infringement claims against the Avadel Parties relating to the REMS Patent as well as Avadel Parties&#8217; noninfringement and invalidity counterclaims relating to the REMS Patent.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 15, 2023, the parties submitted a Stipulation and Proposed Order Modifying the Case Schedule to accommodate additional claim construction proceedings.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">That stipulation remains pending before the Court. On April 26, 2023 the parties filed their Supplemental Joint Claim Construction Brief.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Second Jazz Complaint </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2021, Jazz filed another formal complaint (the &#8220;Second Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#8220;Second Avadel Answer&#8221;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Third Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2021, Jazz filed another formal complaint (the &#8220;Third Complaint&#8221;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 7, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Third Avadel Answer&#8221;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fourth Jazz Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2022, Jazz filed another formal complaint (the &#8220;Fourth Complaint&#8221;) initiating a lawsuit in the Court against Avadel CNS. In the Fourth Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of the REMS Patent, which was asserted in the First Complaint. The FDA required Avadel CNS to file a Paragraph IV certification against the REMS Patent, which Avadel CNS did under protest, consistent with its Renewed Motion for Judgment on the Pleadings for the delisting of the REMS Patent from the Orange Book, which was later ordered to be delisted in the above First Jazz Complaint action. Avadel CNS provided the required notice of its Paragraph IV certification to Jazz, and Jazz reasserted the REMS Patent in a separate action following receipt of that notice. The Fourth Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 21, 2022, Jazz served the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 21, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#8220;Fourth Avadel Answer&#8221;) with the Court in response to the Fourth Complaint.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Fourth Avadel Answer generally denies the allegations set forth in the Fourth Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims for i) a declaratory judgment of non-infringement of the patent-in-suit,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit, iii) delisting of the patent-in-suit from the Orange Book; iv) monopolization under the Sherman Antitrust Act of 1890 (the &#8220;Sherman Act&#8221;); and v) attempted monopolization under the Sherman Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 9, 2022, Jazz filed a Motion to Dismiss Avadel&#8217;s Antitrust Counterclaims.  Avadel filed its opposition brief on December 27, 2022, and Jazz filed its reply brief on January 6, 2022.  On January 11, 2023, Avadel filed a request for oral argument on the motion, which is still pending.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 6, 2023, the parties filed a stipulation of dismissal, dismissing Jazz&#8217;s claims with respect to the REMS Patent and Avadel&#8217;s related non-infringement and invalidity counterclaims.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Court entered that stipulation on March 7, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avadel Complaint</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 14, 2022, Avadel CNS and Avadel Pharmaceuticals plc (collectively the &#8220;Avadel Plaintiffs&#8221;) filed a formal complaint (the &#8220;Avadel Complaint&#8221;) initiating a lawsuit in the Court against Jazz and Jazz Pharmaceuticals Ireland Ltd. (collectively, the &#8220;Jazz Parties&#8221;). In the Avadel Complaint, the Avadel Plaintiffs allege that the Jazz Parties breached certain confidential disclosure agreements and misappropriated certain of the Avadel Plaintiffs&#8217; trade secrets. The Avadel Complaint further </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">includes typical relief requests such as injunctive relief, monetary damages and attorneys&#8217; fees, costs and expenses, as well as seeking correction of inventorship of certain Jazz patents, for which the Jazz Parties claim ownership, to include former Avadel Plaintiffs&#8217; scientists.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2022, Jazz answered the Avadel Complaint. The Answer generally denies the allegations set forth in the Avadel Complaint and includes various affirmative defenses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 8, 2022, Jazz filed a Motion for Judgment on the Pleadings seeking to have all Counts dismissed for failure to state a claim upon which relief can be granted. The Avadel Plaintiffs&#8217; response to that Motion was filed with the Court on July 29, 2022. Jazz&#8217;s reply was filed with the Court on August 5, 2022. On February 2, 2023, the Court held a hearing on Jazz&#8217;s Motion for Judgment on the Pleadings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 7, 2022, the case was reassigned to a new judge.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 2, 2023, the Court held a hearing on Jazz&#8217;s Motion for Judgment on the Pleadings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Administrative Procedure Act</span><span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Complaint</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2022, Avadel CNS filed an Administrative Procedure Act suit against the FDA, the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs (the &#8220;Federal Defendants&#8221;) in the United States District Court for the District of Columbia (the &#8220;DC Court&#8221;) related to the NDA for LUMRYZ (sodium oxybate). This suit alleges that the FDA&#8217;s decision requiring Avadel CNS to file a patent certification concerning the REMS Patent was arbitrary, capricious and contrary to law and asks the DC Court to vacate the FDA&#8217;s decision and order the FDA to take final action on the LUMRYZ NDA. On July 28, 2022, the DC Court granted Jazz&#8217;s unopposed motion to intervene in the case to defend the FDA&#8217;s decision. The DC Court also entered an expedited briefing schedule governing Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and the Federal Defendant&#8217;s and Jazz&#8217;s oppositions to that motion and anticipated cross-motions for summary judgment. On August 19, 2022, the Federal Defendants and Jazz filed their combined oppositions to Avadel CNS&#8217;s motion for preliminary injunction or, in the alternative, summary judgment, and cross-motions for summary judgment. On September 2, 2022, Avadel CNS filed its combined reply in support of its motion for preliminary injunction or, in the alternative, summary judgment, and opposition to the cross-motions for summary judgment. On September 14, 2022, the Federal Defendants and Jazz filed their replies in support of their cross-motions for summary judgment. On October 7, 2022, the DC Court heard oral arguments of Avadel CNS&#8217;s motion and the Federal Defendants and Jazz&#8217;s cross-motions. On November 3, 2022, the DC Court issued its opinion determining that Avadel CNS is not entitled to seek relief under the APA because of the availability of adequate alternative relief in the Court, specifically, in the form of its counterclaim to have the REMS Patent delisted from the FDA&#8217;s Orange Book described above in the section regarding the First Jazz Complaint.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Commitments </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than commitments disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 11: Contingent Liabilities and Commitments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the Company's consolidated financial statements included in the 2022 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the Company&#8217;s guarantee to Deerfield Capital L.P. (&#8220;Deerfield&#8221;) and the guarantee received by the Company from Armistice Capital Master Fund, Ltd. largely offset and when combined are not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deerfield Guarantee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Company&#8217;s February 2018 divestiture of its pediatric assets, including four pediatric commercial stage assets &#8211; Karbinal&#8482; ER, Cefaclor, Flexichamber&#8482; and AcipHex&#174; Sprinkle&#8482; (&#8220;FSC products&#8221;), to Cerecor, Inc. (&#8220;Cerecor&#8221;), the Company guaranteed to Deerfield a quarterly royalty payment of 15% on net sales of the FSC products through February 6, 2026 (&#8220;FSC Product Royalties&#8221;), in an aggregate amount of up to approximately $10,300. Given the Company&#8217;s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $703 at March&#160;31, 2023.  This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Armistice Guarantee</span></div>In connection with the Company&#8217;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $702 at March&#160;31, 2023. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield noted above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342312352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Costs</a></td>
<td class="text">Restructuring Costs<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Corporate Restructuring Plan</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company announced a plan to optimize its cost structure to reduce total quarterly cash operating expenses, excluding inventory purchases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cost structure optimization efforts included a nearly 50% reduction in its workforce that was completed at the end of August 2022 (the &#8220;2022 Corporate Restructuring Plan&#8221;).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s 2022 Corporate Restructuring Plan obligations as of March 31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Corporate Restructuring Plan Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 Corporate Restructuring Plan liabilities of $207 are included in the unaudited condensed consolidated balance sheet in accrued expenses at March 31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342286720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Over the course of April 3 and April 4, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the Issuer completed an exchange of $96,188 of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">its $117,375 October 2023 Notes. The $96,188 of notes were exchanged for $106,268 of a new series of 6.0% exchangeable notes due April 2027 (the &#8220;April 2027 Notes&#8221;). The remaining $21,187 aggregate principal amount of the October 2023 Notes will mature October 2, 2023.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On April 3 2023, the Company completed the sale of ordinary shares, nominal value $0.01 per share (&#8220;Ordinary Shares&#8221;) in the form of ADSs and Series B Preferred Shares in an underwritten public offering. The Company issued 4,706 Series B Preferred Shares and 12,205 of its ADSs and received net proceeds from the equity financing of $135,125, of which $40,000 was received on March 31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$95,125</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> was received on April 3, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On May 1, 2023, LUMRYZ was approved by the FDA. At that time, the FDA granted Orphan Drug Exclusivity (&#8220;ODE&#8221;) to LUMRYZ for a period of seven years until May 1, 2030.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313338891024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_NatureOfBusinessPolicyPolicyTextBlock', window );">Nature of Operations</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#8220;Avadel,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221;) is a biopharmaceutical company.  The Company is registered as an Irish public limited company. The Company&#8217;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#8220;U.S.&#8221;).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lead product, LUMRYZ, formally known as FT218, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (&#8220;EDS&#8221;) in adults with narcolepsy. On May 1, 2023, LUMRYZ was approved by the U.S. Food and Drug Administration (&#8220;FDA&#8221;). In approving LUMRYZ, the FDA approved a risk evaluation and mitigation strategy (&#8220;REMS&#8221;) for LUMRYZ to help ensure that the benefits of the drug in the treatment of cataplexy and EDS in narcolepsy outweigh the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion of the drug. Under this REMS, healthcare providers must be specially certified, pharmacies, practitioners, or health care settings that dispense the drug must be specially certified and the drug must be dispensed to patients with documentation of safe use conditions. The FDA also granted Orphan Drug Exclusivity (&#8220;ODE&#8221;) to LUMRYZ for a period of seven years until May 1, 2030.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of LUMRYZ, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any other commercialized products in its portfolio.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_LiquidityAndGoingConcernPolicyTextBlock', window );">Liquidity and Going Concern</a></td>
<td class="text"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Going Concern. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#8220;U.S. GAAP&#8221;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The unaudited condensed consolidated balance sheet as of March&#160;31, 2023, which is derived from the prior year 2022 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#8217;s 2022 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#8220;SEC&#8221;) on </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 29, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_LiquidityAndGoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liquidity and Going Concern</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_LiquidityAndGoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_NatureOfBusinessPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for nature of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_NatureOfBusinessPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342245088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Instruments Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.714%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Measurements:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Note 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342286720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Schedule of Available-for-sale and Equity Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables show the Company&#8217;s available-for-sale securities&#8217; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;March&#160;31, 2023 and December&#160;31, 2022, respectively:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,749)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:46.623%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.234%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Marketable Securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mutual and money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,407&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,518&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342377856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt is summarized as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due October 2023</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of 4.50% exchangeable senior notes due February 2023</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: unamortized debt discount and issuance costs, net </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,593)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,654&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,282&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,139&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91,614&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313335430000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Assets and Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Liabilities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various other assets and liabilities are summarized as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Prepaid Expenses and Other Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,384&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,096&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Non-Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right of use assets at contract manufacturing organizations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,686&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee from Armistice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,931&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,322&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued Expenses </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,709&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued outsourced contract manufacturing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,683&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,334&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Schedule of Non-Current Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:61.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.908%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.910%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Non-Current Liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee to Deerfield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,767&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,743&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342272272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:&#160;</span></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.768%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Loss Per Share:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,784)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,886&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss per share - diluted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.48)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342253392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the components of accumulated other comprehensive loss for the three months ended March&#160;31, 2023 and 2022, respectively, net of tax effects:&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:73.055%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.381%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Foreign currency translation adjustment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,855)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,277)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(24,040)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on marketable debt securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(917)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,749)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,002)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss at March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,026)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25,042)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313342351328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Schedule of Restructuring and Related Costs</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth activities for the Company&#8217;s 2022 Corporate Restructuring Plan obligations as of March 31, 2023:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.913%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Corporate Restructuring Plan Obligation:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Charges for employee severance, benefits and other costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance of 2022 Corporate Restructuring Plan accrual at March 31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313334459168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Apr. 04, 2023</div></th>
<th class="th"><div>Apr. 03, 2023</div></th>
<th class="th"><div>Apr. 03, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 29, 2023</div></th>
<th class="th"><div>Feb. 05, 2020</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Feb. 14, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget', window );">Quarterly net revenue target for royalty financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares off the at-the-market offering program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,913<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock under at-the-market offering program, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,913<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">February 2020 private placement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock under at-the-market offering program, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Royalty financing</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OrphanDrugExclusivityTerm', window );">Term of orphan drug exclusivity</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingMember', window );">Public Stock Offering | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares off the at-the-market offering program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,125<span></span>
</td>
<td class="nump">$ 135,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheOneMember', window );">Public Stock Offering, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheTwoMember', window );">Public Stock Offering, Tranche Two | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds from stock offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_A2020ShelfRegistrationStatementMember', window );">2020 Shelf Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_SaleOfStockSalesAgentCommissionPercent', window );">Sales agent commission, as a percent of aggregate gross sales proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration', window );">Maximum aggregate offering price of ADSs under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_A2022ShelfRegistrationStatementMember', window );">2022 Shelf Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration', window );">Maximum aggregate offering price of ADSs under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_AtTheMarketOfferingProgramMember', window );">At-The-Market Offering Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration', window );">Remaining authorized aggregate offering price under shelf registration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Royalty financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember', window );">April 2027 Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember', window );">April 2027 Notes | Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OrphanDrugExclusivityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Orphan Drug Exclusivity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OrphanDrugExclusivityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Financing, Quarterly Net Revenue Target</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RoyaltyFinancingQuarterlyNetRevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Remaining Authorized Aggregate Offering Price Under Shelf Registration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_SaleOfStockSalesAgentCommissionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Sales Agent Commission, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_SaleOfStockSalesAgentCommissionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_A2020ShelfRegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_A2020ShelfRegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_A2022ShelfRegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_A2022ShelfRegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_AtTheMarketOfferingProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_AtTheMarketOfferingProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313337037504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Measured on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">$ 17,532<span></span>
</td>
<td class="nump">$ 22,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">22,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">22,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 1 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">22,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 2 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements, Recurring | Level 3 | Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Mutual and money market funds</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340592480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurement - Narrative (Details) - Senior Notes - 4.50% Exchangeable Senior Notes Due October 2023 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Estimated fair value of long-term debt</a></td>
<td class="nump">$ 124,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313334282576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities - Summary of Available-for-sale and Equity Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">$ 19,281<span></span>
</td>
<td class="nump">$ 24,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="num">(1,889)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">17,532<span></span>
</td>
<td class="nump">22,518<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember', window );">Mutual and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">19,281<span></span>
</td>
<td class="nump">24,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="num">(1,889)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 17,532<span></span>
</td>
<td class="nump">$ 22,518<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=avdl_MutualAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339240656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain', window );">Marketable securities, realized gain</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss', window );">Marketable securities, realized loss</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 790<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339182912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Feb. 01, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs, net</a></td>
<td class="num">$ (672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,019)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively</a></td>
<td class="nump">20,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,668<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 93,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: unamortized debt discount and issuance costs, net</a></td>
<td class="num">$ (3,721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,593)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying amount of debt</a></td>
<td class="nump">113,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Exchangeable Senior Notes Due October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount of 4.50% exchangeable senior notes</a></td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 4.50% Exchangeable Senior Notes Due February 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount of 4.50% exchangeable senior notes</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313336469888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 04, 2023 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>Rate</div>
</th>
<th class="th">
<div>Apr. 03, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 29, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 05, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 16, 2018 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>Rate</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 04, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,259<span></span>
</td>
<td class="nump">$ 2,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_CouponInterestExpense', window );">Coupon interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,873<span></span>
</td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature', window );">Change in fair value of notes conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease', window );">Increase in embedded conversion feature</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositorySharesConversionRatio', window );">ADSs, conversion ratio | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9269.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget', window );">Quarterly net revenue target for royalty financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Royalty financing</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRoyaltiesReceived', window );">Royalty financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositorySharesConversionRatio', window );">ADSs, conversion ratio | Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10230.18%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member', window );">4.50% Exchangeable Senior Notes Due February 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,375<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm', window );">Option to purchase aggregate principal amount, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount', window );">Option to increase aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from loans or conditional grants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 137,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtInstrumentExchangeAmount', window );">Debt instrument, exchange amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Face amount of debt repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member', window );">4.50% Exchangeable Senior Notes Due February 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="nump">$ 17,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositarySharesOptionPricePerShare', window );">ADS, option price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositarySharesPremiumPercentage', window );">ADS premium percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositarySharesPurchasedPricePerShare', window );">ADS purchased, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,188<span></span>
</td>
<td class="nump">$ 96,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes | Subsequent Event | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_DebtConversionPrincipalAmountNotExchanged', window );">Principal amount of debt not exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes | Third Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember', window );">April 2027 Notes | Convertible Debt | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AmericanDepositarySharesOptionPricePerShare', window );">ADS, option price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember', window );">April 2027 Notes | Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems', window );"><strong>Schedule of Capitalization, Long-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesOptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Option Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesOptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesPremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares, Premium Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesPremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositarySharesPurchasedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depositary Shares Purchased, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositarySharesPurchasedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AmericanDepositorySharesConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>American Depository Shares, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AmericanDepositorySharesConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_CouponInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Coupon Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_CouponInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtConversionPrincipalAmountNotExchanged">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Conversion, Principal Amount Not Exchanged</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtConversionPrincipalAmountNotExchanged</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentExchangeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Exchange Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentExchangeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option To Purchase Aggregate Principal Amount, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_DebtInstrumentOptiontoIncreaseFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Option to Increase Face Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_DebtInstrumentOptiontoIncreaseFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RoyaltyFinancingQuarterlyNetRevenueTarget">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Financing, Quarterly Net Revenue Target</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RoyaltyFinancingQuarterlyNetRevenueTarget</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRoyaltiesReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for royalties during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRoyaltiesReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=avdl_ThirdPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=avdl_ThirdPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313341815104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 580<span></span>
</td>
<td class="nump">$ 4,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340452480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expenses and Other Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid and other expenses</a></td>
<td class="nump">$ 5,384<span></span>
</td>
<td class="nump">$ 1,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">542<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_GuaranteeCurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">276<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">69<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 6,264<span></span>
</td>
<td class="nump">$ 2,096<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313338905248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrentAbstract', window );"><strong>Other Non-Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent', window );">Right of use assets at contract manufacturing organizations</a></td>
<td class="nump">$ 10,392<span></span>
</td>
<td class="nump">$ 10,686<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_GuaranteeNoncurrent', window );">Guarantee from Armistice</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OtherNoncurrentReceivables', window );">Other</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total &#160;</a></td>
<td class="nump">$ 10,931<span></span>
</td>
<td class="nump">$ 11,322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_GuaranteeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantee, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_GuaranteeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherNoncurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of other noncurrent receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherNoncurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339291824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 5,709<span></span>
</td>
<td class="nump">$ 4,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,581<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveCurrent', window );">Accrued restructuring</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AccruedOutsourceContractCosts', window );">Accrued outsourced contract manufacturing costs</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">1,208<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total &#160;</a></td>
<td class="nump">$ 7,683<span></span>
</td>
<td class="nump">$ 7,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedOutsourceContractCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Outsource Contract Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedOutsourceContractCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313336949888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OtherGuarantorObligationsCurrentCarryingValue', window );">Guarantee to Deerfield</a></td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OtherLiabilitiesMiscellaneousCurrent', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_AccruedInterestCurrent', window );">Accrued interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,649<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">$ 269<span></span>
</td>
<td class="nump">$ 1,941<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_AccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_AccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherGuarantorObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Guarantor Obligations, Current Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherGuarantorObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OtherLiabilitiesMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Miscellaneous, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OtherLiabilitiesMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339310512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Assets and Liabilities - Other Non-Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrentAbstract', window );"><strong>Other Non-Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities', window );">Tax liabilities</a></td>
<td class="nump">$ 5,333<span></span>
</td>
<td class="nump">$ 5,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total &#160;</a></td>
<td class="nump">$ 5,767<span></span>
</td>
<td class="nump">$ 5,743<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Liabilities And Other Noncurrent Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313333325392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,784)<span></span>
</td>
<td class="num">$ (26,424)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted Average Number of Shares Outstanding, Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic shares (in shares)</a></td>
<td class="nump">63,886<span></span>
</td>
<td class="nump">58,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive securities&#8212;employee and director equity awards outstanding, preferred shares and 2023 Notes (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted shares (in shares)</a></td>
<td class="nump">63,886<span></span>
</td>
<td class="nump">58,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share - basic (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share - diluted (in dollars per share)</a></td>
<td class="num">$ (0.48)<span></span>
</td>
<td class="num">$ (0.45)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339231792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Narrative (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">12,463<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313336395440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss - Components (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">$ (21,145)<span></span>
</td>
<td class="nump">$ 78,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="num">(30,469)<span></span>
</td>
<td class="num">(27,526)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(38,166)<span></span>
</td>
<td class="nump">55,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(26,341)<span></span>
</td>
<td class="num">(23,940)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(26,026)<span></span>
</td>
<td class="num">(25,042)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign currency translation adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(24,452)<span></span>
</td>
<td class="num">(23,855)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">175<span></span>
</td>
<td class="num">(185)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(24,277)<span></span>
</td>
<td class="num">(24,040)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized loss on marketable debt securities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1,889)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Net other comprehensive income (loss)</a></td>
<td class="nump">140<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (1,749)<span></span>
</td>
<td class="num">$ (1,002)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339113872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Comprehensive Loss - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Unrealized gain (loss) on marketable securities, benefit (tax)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313333707888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | 2016 MIPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuarantyLiabilities', window );">Guarantee to Deerfield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember', window );">Discontinued Operations, Disposed of by Sale | Cerecor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuarantyAssets', window );">Guaranty assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=avdl_FSCMember', window );">FSC | Discontinued Operations, Disposed of by Sale | 2016 MIPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_PercentageOfRoyaltyPayableOnNetSales', window );">Percentage of royalty payable on net sales</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RoyaltyPayableonNetSalesMaximum', window );">Royalty payable on net sales, maximum</a></td>
<td class="nump">$ 10,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_PercentageOfRoyaltyPayableOnNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of royalty that has to be paid by the company as per the royalty agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_PercentageOfRoyaltyPayableOnNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RoyaltyPayableonNetSalesMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Payable on Net Sales, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RoyaltyPayableonNetSalesMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the contractual right to receive fees, as compensation in exchange for providing a guarantee to a third party, over life of the guarantee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuarantyLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11019-110243<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123422226&amp;loc=d3e11049-110243<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuarantyLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_A2016MIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_A2016MIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_CerecorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=avdl_CerecorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=avdl_FSCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=avdl_FSCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313339057920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Restructuring Costs - Narrative (Details) - 2022 Corporate Restructuring Plan - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent', window );">Expected number of positions eliminated (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring reserve</a></td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">$ 435<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313340597120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs - Severance Obligation (Details) - 2022 Corporate Restructuring Plan<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance of 2022 Corporate Restructuring Plan accrual at January 1,</a></td>
<td class="nump">$ 435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment', window );">Charges for employee severance, benefits and other costs</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other adjustments</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Balance of 2022 Corporate Restructuring Plan accrual at March 31,</a></td>
<td class="nump">$ 207<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_RestructuringChargesBeforeGainLossDuetoCurtailment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Before Gain (Loss) Due to Curtailment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_RestructuringChargesBeforeGainLossDuetoCurtailment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=avdl_A2022CorporateRestructuringPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140313333522432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 01, 2023</div></th>
<th class="th"><div>Apr. 04, 2023</div></th>
<th class="th"><div>Apr. 03, 2023</div></th>
<th class="th"><div>Apr. 03, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, nominal value (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares off the at-the-market offering program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,913<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheOneMember', window );">Public Stock Offering, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from stock offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_avdl_OrphanDrugExclusivityTerm', window );">Term of orphan drug exclusivity</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Public Stock Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of shares off the at-the-market offering program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 135,125<span></span>
</td>
<td class="nump">$ 135,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Public Stock Offering, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from stock offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member', window );">4.50% Exchangeable Senior Notes Due October 2023 | Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Debt exchanged</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember', window );">April 2027 Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember', window );">April 2027 Notes | Senior Notes | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="nump">$ 106,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_avdl_OrphanDrugExclusivityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Orphan Drug Exclusivity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">avdl_OrphanDrugExclusivityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>avdl_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=avdl_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=avdl_PublicStockOfferingTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=avdl_April2027NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>avdl-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:avdl="http://www.avadel.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:exch="http://xbrl.sec.gov/exch/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avdl-20230331.xsd" xlink:type="simple"/>
    <context id="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNMS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i04f6a9d16de04b789dc6900996a220d4_I20230502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7323a019b2284fc9b9e443691e400926_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i89062f4901fb4064b1b764e65dc9de58_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaec6d203b20e439bb7974159ee3ab285_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibdf3bdc941f34464a7bf9fa40be806db_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i903766d6ab144cbabad37ccee612e697_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia55c8b3b05ca4e97a8b5e8eb0f54ab51_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6233a25a0f6643039089e9b1c97130c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2baa5a80eec849b5a0f4486fe12793a0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5c24b9e23aa046298a51a9d754352ec0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5a7ff8ffbee244ca80509872316b062e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i63e92efbb4524c27a795aa3163971409_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4cffb9bdee21463cb69a3591e5b768cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie36421a8d31c40bf86ddc323c5462b99_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6b7320cd55fe4ab18058db41d1e57eda_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i78f1152e9a48466b8a215efaaae5e183_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27631202d5c046d8aaf1d23d3fbe0814_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b3ed1730d5b44a7bf45fddfd3a024e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66549b0c08954370865a41008c6d2694_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie4b9e677c14d452196aa5ad64d25e194_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1bc61d0dbbd146d5a43f9b069e875f34_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98483cdf58e04129a5ec6313f54c3cdc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18e77b5caf7c40d2bbeb45dfdb667b30_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a509c386f934036a0284ec3e87da794_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i840bad64c34a40a3ad9185867cb3360a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id0ad5233c5c44233ba54f59fd93af68c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i53004be10dab4639ba1fae12c5448ea0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id929b7b0a00141a7808a5632cbfd6d5e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if8b9adec52d54e12a5433ac63da3e86b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia23425f025c4444db993802f31591093_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i23c52e144f274ff58d06a0258a38c8ec_D20230501-20230501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="if5fa690543384264a81ade629ded5283_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="i458c9dc9da4541feb9ebbfe26480f40d_D20230501-20230501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <context id="i4e5c2953230a4966ba6f9cfa4b87083d_D20230329-20230329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-03-29</endDate>
        </period>
    </context>
    <context id="ifd1c37ae66634e459ee51595272f19f9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie9937162cb764e1e9c3a6cde0e7174e9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3eb511cdd4014d98821a17670a113607_D20230404-20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-04</startDate>
            <endDate>2023-04-04</endDate>
        </period>
    </context>
    <context id="ife27a702c1604bfaab93fe6b27c28f80_I20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-04</instant>
        </period>
    </context>
    <context id="i26f74d8cc0d245b9946db9086ec31c5f_I20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-04</instant>
        </period>
    </context>
    <context id="i8fdfb2995db447c186216c675ed244de_I20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-04</instant>
        </period>
    </context>
    <context id="if8c8d5df3b6943cbb2ac5bbcccf925a6_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="i9961149acfda4623881e412da9b843c4_D20230331-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-31</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaaa294d327ad4af790c20a25c207e257_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="i62caf1e030104340aab6ddd08244c618_D20200205-20200205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:A2020ShelfRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-05</startDate>
            <endDate>2020-02-05</endDate>
        </period>
    </context>
    <context id="idf7fc9b9d98940b28248abcf3e548647_I20200214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:A2020ShelfRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-14</instant>
        </period>
    </context>
    <context id="i04744cf318cb4dcaa7cd020e5cec855f_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:A2022ShelfRegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i3e0581315acc4d4d86c90d917988c952_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:AtTheMarketOfferingProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i319121ad18c140788a5641e1758ab387_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie620788155bb4059a6e43c59c3299fdf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2657941fbea4497186c9ab34cdb5e0d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7643c428b463493c881600eddf2ee8f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if50b3d2f207a4e44a847e37ad9bb46e1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19812fad0ea54d67b5f37e1104be5f74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0b9a4e9f1f88462cab7139b14d632c0a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id1a64b1bae7e4770bf4e011bfe5a528d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6e58f2a47674b17839bf947e34800b8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8995e89e6594401fb4c210df4fd2a8de_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83723dc6749c4f99a73b5cf748193371_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i21753e8a8465424f9ed070cf17ff922a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64906691143a44d69f831d716ff11840_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied3528fbe48041a2a95e43b3cafa950d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">avdl:MutualAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic89b1f1ffe254a5fb320780bad1a88fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e3e3492dee14060b385540d4e0d7c18_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id408a9d6c330487193d4d6ecb5fd3650_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id57ed34c966748e1b0953df5e00479df_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i23b6a8070618442e9e19c0442c464ee3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6cc7030dee104960a48e1ef403016742_I20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-16</instant>
        </period>
    </context>
    <context id="id58b0ae1b79f447e8ae6e65bded423ca_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="iaf529448191847138180cb35876adf3b_I20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-05</instant>
        </period>
    </context>
    <context id="i4c67c57f5e464d2eb219e11bb8fa61ac_I20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-04</instant>
        </period>
    </context>
    <context id="ibe2ecd298ed14718958abd43e1bed64f_I20230201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-01</instant>
        </period>
    </context>
    <context id="ic84949ac67fc4d3487c6ff9086f64946_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="icb2258e7de744756bfdc93eb9badd9e4_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">avdl:ThirdPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="if20286047c044da782884c54495ecb0e_D20220405-20220405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2022-04-05</startDate>
            <endDate>2022-04-05</endDate>
        </period>
    </context>
    <context id="i1082dbc3efe8463fa3c8d5d339c6f683_D20180216-20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
        </entity>
        <period>
            <startDate>2018-02-16</startDate>
            <endDate>2018-02-16</endDate>
        </period>
    </context>
    <context id="i4bff811514e04cf0a407a2178a42e153_I20180216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-02-16</instant>
        </period>
    </context>
    <context id="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2c693d85f33f4ea6b145f6db4f849879_I20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-03</instant>
        </period>
    </context>
    <context id="i6165ba48ac2542de9fc80cf68aaf7a7c_D20230404-20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-04</startDate>
            <endDate>2023-04-04</endDate>
        </period>
    </context>
    <context id="i4e1dda052ae749c4b067a6c95a6a1377_D20230404-20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-04</startDate>
            <endDate>2023-04-04</endDate>
        </period>
    </context>
    <context id="ibb3721e3e0c345868370c7da3c4161dc_I20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-04</instant>
        </period>
    </context>
    <context id="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:April2027NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-04</startDate>
            <endDate>2023-04-04</endDate>
        </period>
    </context>
    <context id="i5886c0d106614c858fffef30aab67fd4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39f2e203d2b94d95b66e864ec15b4449_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfab2c03c2f64e0390fe6350accb23da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib999fc432bf54ee889b0167c94099114_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i74c73f0392b24707bcf0aa081fb42453_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i41dce19a3844455fae5e06d004fb2dae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibfed34d223564ae39def036cff17412b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie970e5169b154723b235fcca299a98c3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3b73e469fad46e381038498c748c0c5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iecb3550bc32e4b638a3f1849f6d8fac3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i884a39afb0a843b09e81a9e1e807a434_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4600b4ecedc44e2181775b186fbc6c78_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib86ab8d9c4634403b053a99efce9ad0f_D20180201-20180228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">avdl:FSCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-28</endDate>
        </period>
    </context>
    <context id="ieee9f18c297a4b43b9cc2748153d6ed6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:CerecorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifd63efb1c00f48f3823eae02ac5437c1_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">avdl:A2016MIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib4b8d582396945bdab449e41a5853249_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">avdl:A2022CorporateRestructuringPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i38b943b369fe40318b5dc1a1abcb5786_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">avdl:A450PercentExchangeableSeniorNotesDueOctober22023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="ide7281a9b4cc4e4a95874ed482a2c8f6_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="if79cc4b4f8a24f1db47139a8b309feab_D20230403-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">avdl:AmericanDepositarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-03</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <context id="i472c73ab7bb046679dab57540005d848_D20230329-20230403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012477</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">avdl:PublicStockOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-29</startDate>
            <endDate>2023-04-03</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="day">
        <measure>avdl:day</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV8zLTEtMS0xLTc5ODY5_90af719d-7c95-4eca-b688-069e93658986">0001012477</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV80LTEtMS0xLTc5ODY5_a61b71ba-2a70-4e0b-b476-1a0ef28af65e">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV81LTEtMS0xLTc5ODY5_6cd10ac9-8b96-400b-97ec-070aaec30ae6">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV82LTEtMS0xLTc5ODY5_9c83fea0-77d0-443a-997d-9937a212c94f">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV83LTEtMS0xLTc5ODY5_4e0b60bb-f620-4e39-9b41-655ba02b3324">false</dei:AmendmentFlag>
    <dei:NoTradingSymbolFlag
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180L2ZyYWc6YmU5NjhlOTI2NjIxNDVkN2IxNzUzZThmOGVjODgzYmYvdGFibGU6ZGZjMzhlNzFiNTA0NDRhODkwMGVhNjRhOTk0NmFmMDUvdGFibGVyYW5nZTpkZmMzOGU3MWI1MDQ0NGE4OTAwZWE2NGE5OTQ2YWYwNV84LTEtMS0xLTc5ODY5_2e2eb1fb-154e-4247-9dd2-dc9497e9af32">true</dei:NoTradingSymbolFlag>
    <dei:DocumentType
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjU3_b1af9a85-c68a-4d2c-8759-e36c3d3a7159">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYz_7ed4748d-f878-441c-9000-16088f990ce3">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yMzM_e3ed94b0-56de-4405-bbed-b08b22364a92">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY4_46d4adf5-2c26-4f99-8a70-fd86965c3bab">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6ODBiZDZhMTE5OTQ0NDA3MDk2NzJkYmM4MTVjZjUzNjYvdGFibGVyYW5nZTo4MGJkNmExMTk5NDQ0MDcwOTY3MmRiYzgxNWNmNTM2Nl8wLTAtMS0xLTg1NzA0L3RleHRyZWdpb246YjUxNmI4Mzc5ZTIwNGE5NzhlODJmOWI4ZTQ1ZWZhODhfMjc0ODc3OTA2OTU0Ng_f813c9fd-1048-4cf2-8118-deea62590bc6">001-37977</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY0_b8fd1b4a-7969-4469-b14a-c1f95e8e9e93">AVADEL PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NDFlMTAxMzMxZmQ4NGI4ZjlmMDhkNmQ2MzM3MGYyOWQvdGFibGVyYW5nZTo0MWUxMDEzMzFmZDg0YjhmOWYwOGQ2ZDYzMzcwZjI5ZF8wLTAtMS0xLTc5ODY5_f5bdb44f-cdf8-457e-842a-c4b5eeda70a2">L2</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NDFlMTAxMzMxZmQ4NGI4ZjlmMDhkNmQ2MzM3MGYyOWQvdGFibGVyYW5nZTo0MWUxMDEzMzFmZDg0YjhmOWYwOGQ2ZDYzMzcwZjI5ZF8wLTItMS0xLTc5ODY5_e7c43bed-9513-4898-b3f8-4abe5e293cc1">98-1341933</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjU5_a7c22711-ddad-48cd-bbff-33652d1feb76">10 Earlsfort Terrace</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY5_ce9bc2af-c00c-49c2-b722-6c3db576e6fa">Dublin 2</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYw_dc91da06-8e72-42f3-a174-ba58d09d6542">D02 T380</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYx_139376e9-b185-42d2-8258-9e58b470336e">IE</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjYy_5107cc9f-6caf-455b-9adc-cdb349703ff7">353</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY1_41d64aad-8ba0-4182-a375-84403fb04dd5">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjcw_f79a3a35-49fd-4350-a916-3c87a6feb022">901-5201</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8xLTAtMS0xLTc5ODY5_d0a5493c-5baa-4fd0-956d-28f7fb3e6104">American Depositary Shares*</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8xLTEtMS0xLTc5ODY5_6482e52e-4216-48d3-98fd-354f472a72c1">AVDL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie9a00b0fe2334823975b37132ebf2c6e_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8xLTItMS0xLTc5ODY5_beedc726-8f2d-44fa-8fdc-2122919c3dda">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6OGNhNWEyYjIzZGFiNGY1OGE2ODk1ZThiNjlkYTQ4NTQvdGFibGVyYW5nZTo4Y2E1YTJiMjNkYWI0ZjU4YTY4OTVlOGI2OWRhNDg1NF8yLTAtMS0xLTc5ODY5_52d68036-2d77-408b-9a87-bc30aca61328">Ordinary Shares, nominal value $0.01 per share**</dei:Security12bTitle>
    <dei:EntityCurrentReportingStatus
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjU4_85728188-c3b1-46d2-ad24-c785683d01b3">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjY2_a9a1db23-2c03-4649-b86d-0193c689c67a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NTYwOGE4NmQxZDlhNDFjYTkyNjhlYTM0YTc1Y2I4MTYvdGFibGVyYW5nZTo1NjA4YTg2ZDFkOWE0MWNhOTI2OGVhMzRhNzVjYjgxNl8xLTAtMS0xLTg1NDc2_712813ae-24a4-4927-a51e-e22ac2c39039">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NTYwOGE4NmQxZDlhNDFjYTkyNjhlYTM0YTc1Y2I4MTYvdGFibGVyYW5nZTo1NjA4YTg2ZDFkOWE0MWNhOTI2OGVhMzRhNzVjYjgxNl8xLTMtMS0xLTc5ODY5_e8fd4176-3c5e-424e-b28e-6adae96effbb">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGFibGU6NTYwOGE4NmQxZDlhNDFjYTkyNjhlYTM0YTc1Y2I4MTYvdGFibGVyYW5nZTo1NjA4YTg2ZDFkOWE0MWNhOTI2OGVhMzRhNzVjYjgxNl8yLTMtMS0xLTc5ODY5_ece86009-d031-4785-9158-5ad17872aead">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8yNjcx_0af8efb5-8593-4e65-bfc4-98360225be56">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i04f6a9d16de04b789dc6900996a220d4_I20230502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xL2ZyYWc6YjEzMmE4ZDY3ZDE1NGExN2I3ODQ5YzRiMmFkNjVhOTUvdGV4dHJlZ2lvbjpiMTMyYThkNjdkMTU0YTE3Yjc4NDljNGIyYWQ2NWE5NV8zODQ4MjkwNjk5OTU3_6c7925c7-fff7-4e55-8c94-c41e793d7c68"
      unitRef="shares">76768391</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNi02LTEtMS03OTg2OQ_1451160e-e492-49d4-95ef-1e22d09469f1"
      unitRef="usd">3830000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNi04LTEtMS03OTg2OQ_046c73a9-fa93-411c-88f8-deeac93951b3"
      unitRef="usd">6991000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNy02LTEtMS03OTg2OQ_22135089-ff43-4ab3-bbde-18748b0f4c8b"
      unitRef="usd">24468000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfNy04LTEtMS03OTg2OQ_e9999be5-3e46-4209-9632-4e3c1f197619"
      unitRef="usd">21635000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfOS02LTEtMS03OTg2OQ_ee779532-8dee-4295-9b29-504a289db5f8"
      unitRef="usd">28298000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfOS04LTEtMS03OTg2OQ_2b944bb4-2614-48fe-9851-c4edc2823377"
      unitRef="usd">28626000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTAtNi0xLTEtNzk4Njk_33b55b9a-a4b4-415f-8aec-c89b8f506e13"
      unitRef="usd">-28298000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTAtOC0xLTEtNzk4Njk_5c3055f6-669c-4d14-8e09-46e3d9a2eeaf"
      unitRef="usd">-28626000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeNet
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTEtNi0xLTEtNzk4Njk_6b05aa1f-4824-4ca3-aad4-4e12145addef"
      unitRef="usd">193000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTEtOC0xLTEtNzk4Njk_fa2df3b2-9c07-4330-acfe-21f8f35c70f8"
      unitRef="usd">-104000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InterestExpenseDebt
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTItNi0xLTEtNzk4Njk_969014ed-ac21-47b4-983b-73beeae9664f"
      unitRef="usd">3259000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTItOC0xLTEtNzk4Njk_adf0dddf-b213-4376-b987-83843b0fad9f"
      unitRef="usd">2017000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTQtNi0xLTEtNzk4Njk_c77f90e4-b729-4a52-bfa6-ee4427506621"
      unitRef="usd">-31364000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTQtOC0xLTEtNzk4Njk_94c2a972-573c-41f0-9f67-38979658347f"
      unitRef="usd">-30747000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTUtNi0xLTEtNzk4Njk_cc99fe6a-cc69-4d7d-a5c6-3e084075f58f"
      unitRef="usd">-580000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTUtOC0xLTEtNzk4Njk_5beb4ba3-b07f-4c38-8681-1941fd4140f5"
      unitRef="usd">-4323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTYtNi0xLTEtNzk4Njk_d6e105b4-d946-49ae-845b-e27c8f8c41d0"
      unitRef="usd">-30784000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTYtOC0xLTEtNzk4Njk_f0f748ea-6536-4f65-9474-e830789594f7"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTgtNi0xLTEtNzk4Njk_372781b3-3140-429d-8e60-4b20bec36c37"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTgtOC0xLTEtNzk4Njk_ae96e544-b46f-4c50-ab23-5a9b5fa3d386"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTktNi0xLTEtNzk4Njk_b3357ae1-6540-4f22-bde7-833b059e5c4a"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMTktOC0xLTEtNzk4Njk_67e9f468-1ba3-4231-901e-049eea53edc3"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjEtNi0xLTEtNzk4Njk_bdcb4196-88fc-4e75-a712-5c9990c50032"
      unitRef="shares">63886000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjEtOC0xLTEtNzk4Njk_7aee6cc7-252f-404e-82f7-e0902bd40642"
      unitRef="shares">58824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjItNi0xLTEtNzk4Njk_a0b54c10-0035-4c71-bb56-525d1f037547"
      unitRef="shares">63886000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xOS9mcmFnOjc1YjNiYjNmOWEwMTRhMTE4NjRmZjY5OWU1ZWI2MjliL3RhYmxlOmI4ZDI4N2UzMzg2NjQ5Zjg4MmVjZTdjN2Q5YTgzYTI3L3RhYmxlcmFuZ2U6YjhkMjg3ZTMzODY2NDlmODgyZWNlN2M3ZDlhODNhMjdfMjItOC0xLTEtNzk4Njk_3c26e5f7-0fcb-4241-9e99-b318f6942d23"
      unitRef="shares">58824000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfMy02LTEtMS03OTg2OQ_d6e105b4-d946-49ae-845b-e27c8f8c41d0"
      unitRef="usd">-30784000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfMy04LTEtMS03OTg2OQ_f0f748ea-6536-4f65-9474-e830789594f7"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNS02LTEtMS03OTg2OQ_bed7007a-f966-4cc0-808e-028d691a38ef"
      unitRef="usd">175000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNS04LTEtMS03OTg2OQ_24c9bffa-3f06-40a2-aa26-e461a96b99ea"
      unitRef="usd">-185000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmY5NzhjNTM2MGVkYTRlZDk4NDQ0ZGNhYTUyNmRmOGI3Xzcz_fed9c667-3f02-4402-886f-0af874491a7f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmY5NzhjNTM2MGVkYTRlZDk4NDQ0ZGNhYTUyNmRmOGI3Xzgw_9841e0ea-dd43-4132-90ef-b2ee3e08231c"
      unitRef="usd">-330000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi02LTEtMS03OTg2OQ_d73d788c-afb6-4682-bc09-0302567b55c8"
      unitRef="usd">140000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNi04LTEtMS03OTg2OQ_d240de32-4928-4983-a828-942ec2d6f153"
      unitRef="usd">-917000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNy02LTEtMS03OTg2OQ_461c0947-af95-4d4f-a7ed-dd8d06cddc3f"
      unitRef="usd">315000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfNy04LTEtMS03OTg2OQ_9373e779-120f-4054-9b51-aeccca0b14bf"
      unitRef="usd">-1102000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfOC02LTEtMS03OTg2OQ_7efd1fe0-00fa-4909-b019-9ca01caa76ae"
      unitRef="usd">-30469000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yMi9mcmFnOmZlODcyODdmYjYyZjRiN2I5ZTY0OTBlZTFlMTRjODBhL3RhYmxlOmY1YTY0NWYzMDRiYTQ2Y2RiZGFjODRlMDg0YjM3YmY5L3RhYmxlcmFuZ2U6ZjVhNjQ1ZjMwNGJhNDZjZGJkYWM4NGUwODRiMzdiZjlfOC04LTEtMS03OTg2OQ_be546daf-0893-41ca-8d7a-1eb80768b93e"
      unitRef="usd">-27526000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNC0yLTEtMS03OTg2OQ_7f8f8625-de1c-40cb-97ef-ac34926e8ca9"
      unitRef="usd">83391000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNC00LTEtMS03OTg2OQ_90d30df4-47f0-4f9d-81b5-86a86a117471"
      unitRef="usd">73981000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNS0yLTEtMS03OTg2OQ_89c77ef6-0d21-41f5-b167-df05d1dd264a"
      unitRef="usd">17532000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNS00LTEtMS03OTg2OQ_e101235d-bfbf-4690-ab8f-f919e6ac4a9b"
      unitRef="usd">22518000</us-gaap:MarketableSecuritiesCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOC0yLTEtMS03OTg2OQ_5c416e62-58e7-4600-a345-2a4183aae382"
      unitRef="usd">2283000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOC00LTEtMS03OTg2OQ_6b3179c7-36ac-4b17-9ba2-d7fd966177cd"
      unitRef="usd">2248000</avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOS0yLTEtMS03OTg2OQ_0f4e4c01-614f-47e9-a4c7-d1d10a904ff4"
      unitRef="usd">6264000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfOS00LTEtMS03OTg2OQ_a5578c6e-2778-4f54-9ad4-a1993c1118d5"
      unitRef="usd">2096000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTAtMi0xLTEtNzk4Njk_f397f4b6-cd8f-4107-af51-58fadbfc32a6"
      unitRef="usd">109470000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTAtNC0xLTEtNzk4Njk_ae5ebddf-3ed6-4a3d-b23d-fe0b1828b516"
      unitRef="usd">100843000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTEtMi0xLTEtNzk4Njk_27d15cb5-fa62-4e1d-87ef-c0889fa7aee6"
      unitRef="usd">782000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTEtNC0xLTEtNzk4Njk_f7b34e0d-3b46-4e25-b6a5-684d4609421e"
      unitRef="usd">839000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTItMi0xLTEtNzk4Njk_7b112689-6ec0-4774-9644-2ecbb12c52f2"
      unitRef="usd">1475000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTItNC0xLTEtNzk4Njk_76f76cc8-eee9-4bc6-8bde-feef9e5e9893"
      unitRef="usd">1713000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTMtMi0xLTEtNzk4Njk_37a49a98-f1e3-43b9-b70e-108cf2de0c87"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTMtNC0xLTEtNzk4Njk_5e888be8-f630-4cda-ad09-5fb0642b4579"
      unitRef="usd">16836000</us-gaap:Goodwill>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTUtMi0xLTEtNzk4Njk_cd6c6234-d366-45b0-a9cc-95ad452c392c"
      unitRef="usd">1245000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTUtNC0xLTEtNzk4Njk_781a0ab9-b119-4cbf-bda6-18e53bcfb5b8"
      unitRef="usd">1232000</avdl:ResearchAndDevelopmentTaxCreditReceivableNonCurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTYtMi0xLTEtNzk4Njk_fd0aa0f9-646e-42b2-9c16-c57f14c9fdf5"
      unitRef="usd">10931000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTYtNC0xLTEtNzk4Njk_f6ab6d23-4fe5-49b4-8967-4abc12977658"
      unitRef="usd">11322000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTctMi0xLTEtNzk4Njk_eaa053fe-c25d-480c-a0a7-eff80caa9340"
      unitRef="usd">140739000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMTctNC0xLTEtNzk4Njk_7d88a140-e42e-4d21-b8f0-62c2caccaaee"
      unitRef="usd">132785000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjEtMi0xLTEtNzk4Njk_243acd71-f220-421d-9eb5-c1f8bf109d7a"
      unitRef="usd">20515000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjEtNC0xLTEtNzk4Njk_dc9e7fe5-56a2-4188-8a41-b7a01e47150f"
      unitRef="usd">37668000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjItMi0xLTEtNzk4Njk_0b555068-613c-4fe6-b173-d06f09ea1e41"
      unitRef="usd">871000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjItNC0xLTEtNzk4Njk_32da00c9-f5b3-4765-a861-c2de23b07469"
      unitRef="usd">960000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjMtMi0xLTEtNzk4Njk_d03f2379-27ca-42b0-994d-af6db14f8714"
      unitRef="usd">10023000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjMtNC0xLTEtNzk4Njk_5d350c2c-c1e0-40b8-882e-c71cc2dbc4fd"
      unitRef="usd">7890000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjQtMi0xLTEtNzk4Njk_9ec3117c-0d34-4dd8-b47c-9fb3acb1abf7"
      unitRef="usd">7683000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjQtNC0xLTEtNzk4Njk_72b19c09-2928-4ff2-946e-87a41c0910e2"
      unitRef="usd">7334000</us-gaap:AccruedLiabilitiesCurrent>
    <avdl:ProceedsReceivedInAdvanceOfShareIssuanceCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtMi0xLTEtODgwNDk_56c3caad-fbfd-4012-9652-e3922acae7cb"
      unitRef="usd">40000000</avdl:ProceedsReceivedInAdvanceOfShareIssuanceCurrent>
    <avdl:ProceedsReceivedInAdvanceOfShareIssuanceCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtNC0xLTEtODgwNDk_6c0ff198-61a5-4165-90f5-904a868114a1"
      unitRef="usd">0</avdl:ProceedsReceivedInAdvanceOfShareIssuanceCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtMi0xLTEtNzk4Njk_f5efc04e-70c2-4199-bbdf-ee720807c927"
      unitRef="usd">269000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjYtNC0xLTEtNzk4Njk_af4bb454-8833-402d-bb9e-ce7fcf85a83d"
      unitRef="usd">1941000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjctMi0xLTEtNzk4Njk_52de76e2-8d92-465d-ac43-64493b722b62"
      unitRef="usd">79361000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjctNC0xLTEtNzk4Njk_a88c3d38-a4eb-4645-ba6d-632aa37c7007"
      unitRef="usd">55793000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjgtMi0xLTEtNzk4Njk_08264db7-2a46-4308-aa21-0708a6f25fd3"
      unitRef="usd">93139000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMjgtNC0xLTEtNzk4Njk_66f1a45a-becc-4746-8744-44aa3bfc3d8c"
      unitRef="usd">91614000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzAtMi0xLTEtNzk4Njk_5ce2692f-7a5a-45f6-ab1a-2a6c1d265736"
      unitRef="usd">638000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzAtNC0xLTEtNzk4Njk_72e4d703-e5c0-4fed-9ac5-0da03a7983d0"
      unitRef="usd">780000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzEtMi0xLTEtNzk4Njk_89806222-874e-4478-b8b1-a5d218ea0dd7"
      unitRef="usd">5767000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzEtNC0xLTEtNzk4Njk_3ac7b645-5530-416b-9b85-e3960a387415"
      unitRef="usd">5743000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzItMi0xLTEtNzk4Njk_6a919ab9-bc55-4ec2-aa3a-18e94c0778c8"
      unitRef="usd">178905000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzItNC0xLTEtNzk4Njk_84529a00-9498-4611-8feb-5fa43dbd1df7"
      unitRef="usd">153930000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18zOQ_7120fc8b-4829-40c9-9100-75699b61b15f"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18zOQ_be46c5f3-455b-4923-abde-b73cca241b4d"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM181Mw_71d940f6-302f-4ceb-b7e1-f32502c78810"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM181Mw_98629c53-0dd8-4f53-b2a7-2123c6f584ad"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM183NQ_43cff656-70c0-49e4-8b18-f2ce212641b4"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM183NQ_9807aa7b-e037-4b87-bf6a-ab42a43759d7"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18xMTE_4a1db895-256f-427f-8d0a-530fde0e0832"
      unitRef="shares">488000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjplMTkwMDMwYWNjNzM0YTE5YmQzMjczNDYyZTI4MTFlM18xMTE_8a3ade48-acf3-414e-bf50-e70f1bd24e29"
      unitRef="shares">488000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtMi0xLTEtNzk4Njk_f933e961-ecbf-475e-b567-9a12fb2edc6a"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzUtNC0xLTEtNzk4Njk_390f62cf-962f-47c6-b212-0d9b0132fab4"
      unitRef="usd">5000</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8zOA_6a10b503-42fb-4439-b972-9e4dde0f2483"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8zOA_a90a67cf-62fd-4c51-ad28-03ca9e88579c"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF81Mg_48daf4c1-7cb4-4f1a-b775-9bc269bdf5b6"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF81Mg_b2434a9f-dce0-4df2-adc3-8ef728759d5f"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF83NA_5f305913-f326-470b-9c30-9a9e4a9be51e"
      unitRef="shares">64478000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF83NA_8a715d15-7356-485c-b7fd-32d560055b7f"
      unitRef="shares">64478000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8xMTA_14cff396-08f4-43e2-8d57-c208956f7208"
      unitRef="shares">62878000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo2ZjJhYjQ4NzFlNmY0OTRiYjI2NjQ0MmZlNmY3MWYxNF8xMTA_d59a30fe-827b-4a4e-9e3e-2fa89b1edfb6"
      unitRef="shares">62878000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtMi0xLTEtNzk4Njk_2cc26d7b-b635-4f7f-ae58-f4bdaf536c09"
      unitRef="usd">644000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzYtNC0xLTEtNzk4Njk_5d82c8c8-7d40-4037-aae4-18dfc893b54f"
      unitRef="usd">628000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzctMi0xLTEtNzk4Njk_884dc3c6-650e-4daf-8101-f72bc3cac3e0"
      unitRef="usd">603215000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzctNC0xLTEtNzk4Njk_66158ccd-f075-4e98-a733-f0b8fc4b485e"
      unitRef="usd">589783000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzgtMi0xLTEtNzk4Njk_2f631486-84f9-4aeb-b16a-629e9879cf97"
      unitRef="usd">-616004000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzgtNC0xLTEtNzk4Njk_c042bdd4-863b-49e4-8323-2111ae6dd3eb"
      unitRef="usd">-585220000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzktMi0xLTEtNzk4Njk_4de91cbc-887d-4015-9150-dd896d8adf16"
      unitRef="usd">-26026000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfMzktNC0xLTEtNzk4Njk_5dcedeae-bd18-4258-b9aa-2834e96f2716"
      unitRef="usd">-26341000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDAtMi0xLTEtNzk4Njk_ce70bda4-387f-47ba-9bd1-bc27f9f6df7b"
      unitRef="usd">-38166000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDAtNC0xLTEtNzk4Njk_c04cc523-4e0f-4c66-8290-5e3298f64e38"
      unitRef="usd">-21145000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDEtMi0xLTEtNzk4Njk_ef46ed05-1067-4bc5-88b6-538c1bbfb8e1"
      unitRef="usd">140739000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yNS9mcmFnOjU3ZTM5YjlhODI3NTQwNTY4YjcwYTllMWI1YzllZDE3L3RhYmxlOjFmYmFjODNkZDkyZjQyNTc5ODNkMWZhOWMyZDAzZmViL3RhYmxlcmFuZ2U6MWZiYWM4M2RkOTJmNDI1Nzk4M2QxZmE5YzJkMDNmZWJfNDEtNC0xLTEtNzk4Njk_40a22205-145d-48e3-9dd3-89f1296e4e87"
      unitRef="usd">132785000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="iaec6d203b20e439bb7974159ee3ab285_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0yLTEtMS03OTg2OQ_a1103371-290b-486c-ba94-3119ea69830b"
      unitRef="shares">62878000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iaec6d203b20e439bb7974159ee3ab285_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi00LTEtMS03OTg2OQ_97b6d093-219b-4a66-8514-3e997a01ef4d"
      unitRef="usd">628000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ibdf3bdc941f34464a7bf9fa40be806db_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi02LTEtMS03OTg2OQ_022dd6d9-8d73-4225-b48c-8277ea1d0624"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ibdf3bdc941f34464a7bf9fa40be806db_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi04LTEtMS03OTg2OQ_31766244-c054-4b0b-b6b2-c8eb665689ed"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i903766d6ab144cbabad37ccee612e697_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xMC0xLTEtNzk4Njk_83c2cf34-0560-4ba4-afd4-650e301b5c73"
      unitRef="usd">589783000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia55c8b3b05ca4e97a8b5e8eb0f54ab51_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xMi0xLTEtNzk4Njk_0c4ba4ed-05d9-4201-af3d-4cb71bbc8406"
      unitRef="usd">-585220000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6233a25a0f6643039089e9b1c97130c3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xNC0xLTEtNzk4Njk_2863e9f2-ee63-4722-90d6-df5c1b12c106"
      unitRef="usd">-26341000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMi0xNi0xLTEtNzk4Njk_f68dbe96-d5fb-486b-ab35-f18a4e4bb96b"
      unitRef="usd">-21145000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i2baa5a80eec849b5a0f4486fe12793a0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMy0xMi0xLTEtNzk4Njk_d0069496-cff0-4dff-ae0f-43909b88cd8c"
      unitRef="usd">-30784000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfMy0xNi0xLTEtNzk4Njk_732d9dbc-b1a5-4f59-abfe-dad8a777b97a"
      unitRef="usd">-30784000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5c24b9e23aa046298a51a9d754352ec0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNC0xNC0xLTEtNzk4Njk_46d55516-035e-4073-bd11-a7784550076a"
      unitRef="usd">315000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNC0xNi0xLTEtNzk4Njk_b4fbd47f-e282-4f4c-85b4-709a1a449e24"
      unitRef="usd">315000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS0yLTEtMS04ODA1NQ_8170f2bf-b714-46c3-a837-33a5d73f695c"
      unitRef="shares">1564000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS00LTEtMS04ODA1NQ_4faff733-64e8-4431-b424-c58dca785992"
      unitRef="usd">16000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS0xMC0xLTEtODgwNTU_66ab6c45-b7d0-4032-90df-5d102d47cbe6"
      unitRef="usd">11897000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNS0xNi0xLTEtODgwNTU_f5446329-7067-4bba-9e91-29349989eeb2"
      unitRef="usd">11913000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0xMC0xLTEtODgwNTk_e8be07ff-536f-491c-ac7b-7b3ed03e7fd2"
      unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0xNi0xLTEtODgwNTk_caf6eb94-ef3e-456f-b163-56b163f20ed7"
      unitRef="usd">16000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0yLTEtMS03OTg2OQ_77bab506-6429-416f-be78-80df198c3e27"
      unitRef="shares">22000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNi0xNi0xLTEtNzk4Njk_edffa176-f94b-4a71-97b0-ff28cdbba555"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNy0yLTEtMS03OTg2OQ_8e4e6d00-50e8-4f2e-bede-221e4eec3c02"
      unitRef="shares">14000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNy0xMC0xLTEtNzk4Njk_5e80dadb-869e-4929-ad22-56fd9b1daf43"
      unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfNy0xNi0xLTEtNzk4Njk_ff5a9dbc-7445-4f55-a9f6-89e82ebea9ac"
      unitRef="usd">29000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iec3d76284dc348cd904df9e50bc49964_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOC0xMC0xLTEtNzk4Njk_5600c497-9092-403c-aea6-b438f9ee2b82"
      unitRef="usd">1522000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOC0xNi0xLTEtNzk4Njk_6a376af4-bfc9-4728-b33a-e1c4d6091ea4"
      unitRef="usd">1522000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i5a7ff8ffbee244ca80509872316b062e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0yLTEtMS03OTg2OQ_314e6792-5fc2-40a3-9a88-de28304a5111"
      unitRef="shares">64478000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5a7ff8ffbee244ca80509872316b062e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS00LTEtMS03OTg2OQ_c5559bb8-285d-4c01-960d-57aaf54ba280"
      unitRef="usd">644000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i63e92efbb4524c27a795aa3163971409_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS02LTEtMS03OTg2OQ_8c13d933-8b33-4978-bb2c-2231eac9fef9"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i63e92efbb4524c27a795aa3163971409_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS04LTEtMS03OTg2OQ_d6deaf0a-896c-4054-9062-ab30fe9ca81d"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4cffb9bdee21463cb69a3591e5b768cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xMC0xLTEtNzk4Njk_63a22b26-5f91-4482-8ceb-f1d6e605cda6"
      unitRef="usd">603215000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie36421a8d31c40bf86ddc323c5462b99_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xMi0xLTEtNzk4Njk_5a403277-313c-4c52-9bb4-bfe375fefe76"
      unitRef="usd">-616004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b7320cd55fe4ab18058db41d1e57eda_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xNC0xLTEtNzk4Njk_65f25e2b-5255-4e16-a7ac-4eb891d85909"
      unitRef="usd">-26026000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOmE5YTUwYzYzOWQwMDQ2MWRhNjM4MmY0Mjk1MWMxYzg2L3RhYmxlcmFuZ2U6YTlhNTBjNjM5ZDAwNDYxZGE2MzgyZjQyOTUxYzFjODZfOS0xNi0xLTEtNzk4Njk_8f324cd1-4869-4b7c-9ef3-c93b7124db40"
      unitRef="usd">-38166000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i78f1152e9a48466b8a215efaaae5e183_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0yLTEtMS03OTg2OQ_16bd7eda-23d1-4889-9f6a-28ffe9e8ee8f"
      unitRef="shares">58620000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i78f1152e9a48466b8a215efaaae5e183_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi00LTEtMS03OTg2OQ_e2040619-8c23-44e0-b4d7-31b094e41dee"
      unitRef="usd">586000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="i27631202d5c046d8aaf1d23d3fbe0814_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi02LTEtMS03OTg2OQ_199b3297-bd30-481a-b793-cf6244474c3e"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i27631202d5c046d8aaf1d23d3fbe0814_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi04LTEtMS03OTg2OQ_ccf87c0e-bd61-40dd-9c77-638304af4b48"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b3ed1730d5b44a7bf45fddfd3a024e3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xMC0xLTEtNzk4Njk_f9cc8679-24b1-46ac-ab15-994c4d946307"
      unitRef="usd">549349000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66549b0c08954370865a41008c6d2694_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xMi0xLTEtNzk4Njk_7a24db0a-5e28-4830-964a-03a7bd643806"
      unitRef="usd">-447756000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4b9e677c14d452196aa5ad64d25e194_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xNC0xLTEtNzk4Njk_ba75cb70-8902-46af-88b9-aa074712b74a"
      unitRef="usd">-23940000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1bc61d0dbbd146d5a43f9b069e875f34_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMi0xNi0xLTEtNzk4Njk_82049507-4c2f-4a12-93dc-427622c2f965"
      unitRef="usd">78244000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i98483cdf58e04129a5ec6313f54c3cdc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNC0xMi0xLTEtNzk4Njk_9f97cff4-a54c-4305-9e98-5741f7705955"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNC0xNi0xLTEtNzk4Njk_3104f7d2-6c02-4af4-b926-0ecf13e8a965"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i18e77b5caf7c40d2bbeb45dfdb667b30_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNS0xNC0xLTEtNzk4Njk_3ae34c77-869e-4ffa-bb74-25cdec67ac01"
      unitRef="usd">-1102000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNS0xNi0xLTEtNzk4Njk_7629cd32-a9fb-4df0-a3ea-f6a9a0749e59"
      unitRef="usd">-1102000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi0yLTEtMS03OTg2OQ_804dff06-1db4-43a5-b1e6-88151337e513"
      unitRef="shares">275000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi00LTEtMS04ODA1Mw_82382f3e-dc23-4d04-bbd8-8cb22ba2e454"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi0xMC0xLTEtNzk4Njk_28825ea6-6038-41c5-b81b-cf1ae9df94ca"
      unitRef="usd">1903000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNi0xNi0xLTEtNzk4Njk_b716b7a0-577a-4d19-853d-58744cd831cf"
      unitRef="usd">1906000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy0yLTEtMS03OTg2OQ_aeca7abc-27fa-4058-9f40-d38cf6b935c6"
      unitRef="shares">119000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy00LTEtMS03OTg2OQ_0ba165a3-c978-4ac9-b27f-c2c3e054b2bd"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy0xMC0xLTEtNzk4Njk_432e2594-289a-40ca-b950-f61ec1c55b67"
      unitRef="usd">-1000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfNy0xNi0xLTEtNzk4Njk_036524a8-b460-4693-a3f6-da3bb5ae37f0"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan
      contextRef="i4a509c386f934036a0284ec3e87da794_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOC0yLTEtMS03OTg2OQ_49d08e86-1e96-44aa-811f-1a35f5d5dc91"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOC0xMC0xLTEtNzk4Njk_7309ae2d-70f5-464d-833a-97c10528f9e7"
      unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOC0xNi0xLTEtNzk4Njk_933f4c4c-8a66-4d40-8f15-1b6cefeabbcd"
      unitRef="usd">103000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if87214231baf4cdb8db8a4f0c6118c59_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOS0xMC0xLTEtNzk4Njk_620ea592-52d3-4065-bbcb-0f59646de456"
      unitRef="usd">2505000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfOS0xNi0xLTEtNzk4Njk_03a4f0f6-79f4-49c0-a550-ececc2d0a545"
      unitRef="usd">2505000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:SharesOutstanding
      contextRef="i840bad64c34a40a3ad9185867cb3360a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMi0xLTEtNzk4Njk_8229d450-05f4-46fe-b25e-e9303d63df60"
      unitRef="shares">59032000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i840bad64c34a40a3ad9185867cb3360a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtNC0xLTEtNzk4Njk_b55a2e2a-e321-4d6b-8b6a-3ec2042b6145"
      unitRef="usd">590000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="id0ad5233c5c44233ba54f59fd93af68c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtNi0xLTEtNzk4Njk_323b2460-1d46-4a6b-a332-44c7a993edf2"
      unitRef="shares">488000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id0ad5233c5c44233ba54f59fd93af68c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtOC0xLTEtNzk4Njk_1f96bfc7-a851-468b-b673-fb587dfccf63"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i53004be10dab4639ba1fae12c5448ea0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTAtMS0xLTc5ODY5_2a2310fa-bd27-43c3-a7fc-c042fc0f2098"
      unitRef="usd">553859000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id929b7b0a00141a7808a5632cbfd6d5e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTItMS0xLTc5ODY5_7e8d5b34-a1f0-47e4-9270-4b3bc3f713c8"
      unitRef="usd">-474180000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8b9adec52d54e12a5433ac63da3e86b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTQtMS0xLTc5ODY5_0b6f372f-31d0-4cf3-8f26-32b3299459bf"
      unitRef="usd">-25042000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia23425f025c4444db993802f31591093_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18yOC9mcmFnOjAyNDAwYWQ1NzM3NzRiOTg5YWQ0ODk0ODQ1YWQwNTEyL3RhYmxlOjUwYTZmNTk5M2FmMjQ5MTA5ZmE1N2NiNWNmMzg4ODI2L3RhYmxlcmFuZ2U6NTBhNmY1OTkzYWYyNDkxMDlmYTU3Y2I1Y2YzODg4MjZfMTAtMTYtMS0xLTc5ODY5_7966dd8d-3eee-4a6b-8c6a-525247785bb1"
      unitRef="usd">55232000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNC0yLTEtMS03OTg2OQ_d6e105b4-d946-49ae-845b-e27c8f8c41d0"
      unitRef="usd">-30784000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNC00LTEtMS03OTg2OQ_f0f748ea-6536-4f65-9474-e830789594f7"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNi0yLTEtMS03OTg2OQ_d8dd9f4d-42ed-4ae3-9240-ced23d65e6ff"
      unitRef="usd">588000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNi00LTEtMS03OTg2OQ_1bcfb2b4-40f5-4a20-973d-3ae7e430abd0"
      unitRef="usd">259000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNy0yLTEtMS03OTg2OQ_20e0962c-f78f-4a12-969c-47439c29fb3a"
      unitRef="usd">1873000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNy00LTEtMS03OTg2OQ_e479e800-2f70-4684-9593-7bad4e0605ef"
      unitRef="usd">312000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOC0yLTEtMS03OTg2OQ_9e5b0cda-d941-45fd-a286-e8177f5646b4"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOC00LTEtMS03OTg2OQ_fadfb71b-bcb4-45ec-b7d1-4a97a4db021a"
      unitRef="usd">-4323000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOS0yLTEtMS03OTg2OQ_c4ea6b93-edde-425d-ab5e-40a1435774ad"
      unitRef="usd">1522000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfOS00LTEtMS03OTg2OQ_c0345b30-cbe2-4ce8-8234-825f4a3df6a6"
      unitRef="usd">2505000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTEtMi0xLTEtNzk4Njk_3e968185-1c4b-48cc-b28b-04fe583a880c"
      unitRef="usd">-1000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTEtNC0xLTEtNzk4Njk_f5eb0b8f-2618-4c74-a24e-167cd7943063"
      unitRef="usd">669000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTUtMi0xLTEtNzk4Njk_18678758-4942-4f1e-b18f-b9b1390ab841"
      unitRef="usd">4131000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTUtNC0xLTEtNzk4Njk_5db75a6f-363a-480f-9650-426bfc995506"
      unitRef="usd">2058000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTYtMi0xLTEtNzk4Njk_ac6ffad8-aa91-4bd8-9d77-54b5bb9ce46a"
      unitRef="usd">0</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTYtNC0xLTEtNzk4Njk_55465fb5-d8a4-4a3c-b07c-034596a52b40"
      unitRef="usd">19000</avdl:IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTctMi0xLTEtNzk4Njk_317cd402-282d-4899-ac0e-f3571a83e247"
      unitRef="usd">468000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTctNC0xLTEtNzk4Njk_f063951a-e8bd-4f18-bc90-6461ddf8c806"
      unitRef="usd">-5613000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTgtMi0xLTEtNzk4Njk_c5be649f-7c5d-4107-b77e-b5478bb9764c"
      unitRef="usd">348000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTgtNC0xLTEtNzk4Njk_88746c40-2c7c-4474-a4d4-82d6e0d5815f"
      unitRef="usd">2314000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTktMi0xLTEtNzk4Njk_38bfe2e7-1539-4ec1-b827-f74a384529bf"
      unitRef="usd">116000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMTktNC0xLTEtNzk4Njk_1da2d7dd-996e-42ad-b5c4-32bbb579ef6f"
      unitRef="usd">1667000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjAtMi0xLTEtNzk4Njk_a8432874-46b2-4959-bc04-81ca0f5c5420"
      unitRef="usd">-30233000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjAtNC0xLTEtNzk4Njk_c9a82fc9-711f-4f0d-8feb-b21df26a6cce"
      unitRef="usd">-34045000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjUtMi0xLTEtNzk4Njk_7c2b02d6-a232-4ddf-b349-cceda55ab3d5"
      unitRef="usd">15295000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjUtNC0xLTEtNzk4Njk_acb2a9f9-1a84-40ef-a7e2-0d44aa173d27"
      unitRef="usd">44341000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjYtMi0xLTEtNzk4Njk_e62e7ab5-cb7e-4c37-af87-03e574fa0552"
      unitRef="usd">10229000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjYtNC0xLTEtNzk4Njk_360c99a3-d8f2-42e4-9e82-5def2d4ced27"
      unitRef="usd">2090000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjctMi0xLTEtNzk4Njk_d6427206-a597-4e7b-b4a9-b22626219bc0"
      unitRef="usd">5066000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjctNC0xLTEtNzk4Njk_7a58e2ec-4de1-4201-afd4-145f1f14e60b"
      unitRef="usd">42251000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <avdl:ProceedsReceivedInAdvanceOfShareIssuance
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjktMi0xLTEtODg4NDY_b308e1ec-69db-418b-85a7-6d8bcc0549f6"
      unitRef="usd">40000000</avdl:ProceedsReceivedInAdvanceOfShareIssuance>
    <avdl:ProceedsReceivedInAdvanceOfShareIssuance
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMjktNC0xLTEtODkxNTk_cda81e07-d99d-4307-8029-2bf7031387a9"
      unitRef="usd">0</avdl:ProceedsReceivedInAdvanceOfShareIssuance>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtMi0xLTEtODgwNjc_d369528d-9031-4ecf-a93d-c42d6d5f2916"
      unitRef="usd">17500000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtNC0xLTEtODgwNjc_f4712513-8e11-445b-a508-301cdee300f6"
      unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtMi0xLTEtODgwNjc_7a862e1e-b05b-4fe2-bf60-69599c3e68f5"
      unitRef="usd">11913000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtNC0xLTEtODgwNjc_d8fb9a70-b52c-4845-a33f-9b6bab301f80"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtMi0xLTEtNzk4Njk_818a517e-2ab6-4f3a-8636-636e1995285e"
      unitRef="usd">29000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzAtNC0xLTEtNzk4Njk_caf0bf49-0083-44d1-b6b4-1963e74b2d1c"
      unitRef="usd">2009000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtMi0xLTEtNzk4Njk_c19e1a4d-59aa-400f-b4a1-8f2679d164ab"
      unitRef="usd">34442000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzEtNC0xLTEtNzk4Njk_1fb21fe5-e168-4050-ac07-a2679fe63ee2"
      unitRef="usd">2009000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzMtMi0xLTEtNzk4Njk_f89c77dd-93a7-4fca-9b1c-6f38c612cb3e"
      unitRef="usd">135000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzMtNC0xLTEtNzk4Njk_827d2c97-6b80-47f9-b97d-7aa3a03b2073"
      unitRef="usd">-50000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzUtMi0xLTEtNzk4Njk_6d6425c1-94a5-4394-9a00-a93f08a174c7"
      unitRef="usd">9410000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzUtNC0xLTEtNzk4Njk_a1fac248-67d4-4195-b6c0-9ebfa13cf75f"
      unitRef="usd">10165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzYtMi0xLTEtNzk4Njk_367a095e-1b29-4a82-8852-242580e45f40"
      unitRef="usd">73981000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1bc61d0dbbd146d5a43f9b069e875f34_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzYtNC0xLTEtNzk4Njk_e3220e2a-30a6-4104-a6a7-53099e71d94a"
      unitRef="usd">50708000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzctMi0xLTEtNzk4Njk_c1765b30-069e-4f9f-bb99-a871a8c3a40d"
      unitRef="usd">83391000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia23425f025c4444db993802f31591093_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfMzctNC0xLTEtNzk4Njk_e1476903-6b77-47d6-9cab-18c7e309c401"
      unitRef="usd">60873000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDAtMi0xLTEtNzk4Njk_c037f2a9-d29f-474c-828f-b4d5fc538661"
      unitRef="usd">3050000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDAtNC0xLTEtNzk4Njk_e11a9421-037b-4248-9b82-90f5e108a0ae"
      unitRef="usd">5531000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDEtMi0xLTEtNzk4Njk_0da4a98b-abc6-475f-bebe-f5bebbacd7e6"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zMS9mcmFnOmE5NzM4ZmNiNmJjMzQwZjBiOWViYTExNDc3M2U0MjA3L3RhYmxlOjU2ZDIzMWE2ODBjNjRmYWViNDI1YmJlMGExMzQ5OTVjL3RhYmxlcmFuZ2U6NTZkMjMxYTY4MGM2NGZhZWI0MjViYmUwYTEzNDk5NWNfNDEtNC0xLTEtNzk4Njk_4a8f282d-48a7-4e24-a351-8bb12a37b14e"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzA2Ng_b08c0e8f-30ea-4589-be2a-eab70ec0ecf1">Summary of Significant Accounting Policies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company.  The Company is registered as an Irish public limited company. The Company&#x2019;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#x201c;U.S.&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lead product, LUMRYZ, formally known as FT218, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (&#x201c;EDS&#x201d;) in adults with narcolepsy. On May 1, 2023, LUMRYZ was approved by the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;). In approving LUMRYZ, the FDA approved a risk evaluation and mitigation strategy (&#x201c;REMS&#x201d;) for LUMRYZ to help ensure that the benefits of the drug in the treatment of cataplexy and EDS in narcolepsy outweigh the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion of the drug. Under this REMS, healthcare providers must be specially certified, pharmacies, practitioners, or health care settings that dispense the drug must be specially certified and the drug must be dispensed to patients with documentation of safe use conditions. The FDA also granted Orphan Drug Exclusivity (&#x201c;ODE&#x201d;) to LUMRYZ for a period of seven years until May 1, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of LUMRYZ, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any other commercialized products in its portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#x201c;U.S. GAAP&#x201d;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a recent history of generating losses and negative cash flows from operations, an accumulated shareholders&#x2019; deficit as of the date of these unaudited condensed consolidated financial statements and approximately $83,391 of cash and cash equivalents and $17,532 of marketable securities available for use to fund its operations, debt service and capital requirements. The Company&#x2019;s ability to generate revenue is expected to start following the commercial launch of LUMRYZ in the U.S., which is dependent, in part, on the Company&#x2019;s ability to successfully complete its commercialization efforts and on market acceptance of LUMRYZ in the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 29, 2023, the Company and Avadel CNS Pharmaceuticals, LLC, an indirect wholly-owned subsidiary of the Company (&#x201c;Avadel CNS&#x201d;) entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $75,000 of royalty financing in two tranches. The first tranche of $30,000 is available subject to the Company&#x2019;s first shipment of LUMRYZ. The second tranche is available to use, at the Company&#x2019;s election, upon achieving quarterly net revenue of $25,000. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the Company had outstanding $117,375&#160;aggregate principal amount of its 4.50% exchangeable senior notes due October 2023 (the &#x201c;October 2023 Notes&#x201d;). Over the course of April 3 and April 4, 2023, Avadel Finance Cayman Limited, a Cayman Islands exempted company and an indirect wholly-owned subsidiary of the Company (the &#x201c;Issuer&#x201d;), completed an exchange of $96,188&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;its $117,375 October 2023 Notes for $106,268 of a new series 6.0% exchangeable notes due April 2027 (the &#x201c;April 2027 Notes&#x201d;) (the &#x201c;2023 Exchange Transaction&#x201d;). The remaining $21,187 aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 3, 2023, the Company completed the sale of ordinary shares, nominal value $0.01 per share (&#x201c;Ordinary Shares&#x201d;) in the form of American Depositary Shares (&#x201c;ADSs&#x201d;) and Series B Non-Voting Convertible Preferred Shares (&#x201c;Series B Preferred Shares&#x201d;) in an underwritten public offering. The Company received net proceeds from the equity financing of $135,125, of which $40,000 was received on March 31, 2023 and $95,125 was received on April 3, 2023. The $40,000 of net proceeds received prior to the completed public offering was included in the unaudited condensed consolidated balance sheet as proceeds received in advance of Series B Preferred Shares issuance at March 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the 2023 Exchange Transaction and the public offering, the Company has concluded that cash on hand provides sufficient capital to meet the Company&#x2019;s operating, debt service and capital requirements for the next twelve months following the date of this Quarterly Repor&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;t.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;At-the-Market Offering Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 5, 2020, the Company entered into an Open Market Sale Agreement&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;SM&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (the &#x201c;Sales Agreement&#x201d;) with Jefferies LLC (&#x201c;Jefferies&#x201d;) with respect to an at-the-market offering program (&#x201c;ATM Program&#x201d;) under which the Company may offer and sell its ADSs (such ADSs sold under the ATM Program, &#x201c;ATM ADSs&#x201d;) through Jefferies as its sales agent. The Company agreed to pay Jefferies a commission up to 3.0% of the aggregate gross sales proceeds of such ATM ADSs. The initial aggregate offering price of the ATM Program was up to $50,000 of ADSs pursuant to its prospectus, dated February 14, 2020, included with the Company&#x2019;s Registration Statement on Form S-3 (File No. 333-236258) (the &#x201c;2020 Prospectus&#x201d;). In August 2022, the Company filed an additional prospectus, dated September 12, 2022, included with the Company&#x2019;s new Registration Statement on Form S-3 (File No. 333-267198) (the &#x201c;2022 Prospectus&#x201d;), in order to allocate up to $100,000 in additional ADSs to the ATM Program. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 Shelf Registration expired on February 14, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the Sales Agreement, the Company had issued and sold 1,564 ADSs during the quarter ended March 31, 2023, resulting in net proceeds to the Company of approximately $11,913. The Company may offer and sell up to an additional $96,064 of ADSs under the ATM Program that remain available for sale pursuant to the 2022 Prospectus.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated balance sheet as of March&#160;31, 2023, which is derived from the prior year 2022 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#x2019;s 2022 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) on &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 29, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <avdl:NatureOfBusinessPolicyPolicyTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzA3NA_53e7e9ff-3424-459e-8dd4-4be073e1cd58">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;Avadel Pharmaceuticals plc (Nasdaq: AVDL) (&#x201c;Avadel,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;our,&#x201d; or &#x201c;us&#x201d;) is a biopharmaceutical company.  The Company is registered as an Irish public limited company. The Company&#x2019;s headquarters are in Dublin, Ireland with operations in Dublin, Ireland and St. Louis, Missouri, United States (&#x201c;U.S.&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lead product, LUMRYZ, formally known as FT218, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (&#x201c;EDS&#x201d;) in adults with narcolepsy. On May 1, 2023, LUMRYZ was approved by the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;). In approving LUMRYZ, the FDA approved a risk evaluation and mitigation strategy (&#x201c;REMS&#x201d;) for LUMRYZ to help ensure that the benefits of the drug in the treatment of cataplexy and EDS in narcolepsy outweigh the risks of serious adverse outcomes resulting from inappropriate prescribing, misuse, abuse, and diversion of the drug. Under this REMS, healthcare providers must be specially certified, pharmacies, practitioners, or health care settings that dispense the drug must be specially certified and the drug must be dispensed to patients with documentation of safe use conditions. The FDA also granted Orphan Drug Exclusivity (&#x201c;ODE&#x201d;) to LUMRYZ for a period of seven years until May 1, 2030.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of LUMRYZ, the Company continues to evaluate opportunities to expand its product portfolio. As of the date of this Quarterly Report, the Company does not have any other commercialized products in its portfolio.&lt;/span&gt;&lt;/div&gt;</avdl:NatureOfBusinessPolicyPolicyTextBlock>
    <avdl:OrphanDrugExclusivityTerm
      contextRef="i23c52e144f274ff58d06a0258a38c8ec_D20230501-20230501"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDc0MDExOQ_5dcdf192-9efd-489c-bdf1-fc32434c3d3a">P7Y</avdl:OrphanDrugExclusivityTerm>
    <avdl:LiquidityAndGoingConcernPolicyTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyMTg3Ng_daaba7d3-f794-4325-8102-e6190936f9f0">&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Going Concern. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the U.S. (&#x201c;U.S. GAAP&#x201d;) applicable to a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.&lt;/span&gt;</avdl:LiquidityAndGoingConcernPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODM5NDE2_7f8f8625-de1c-40cb-97ef-ac34926e8ca9"
      unitRef="usd">83391000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODM5NDIw_89c77ef6-0d21-41f5-b167-df05d1dd264a"
      unitRef="usd">17532000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="if5fa690543384264a81ade629ded5283_D20230329-20230329"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODQxMTQ5_8f637e33-87e1-4bbc-8f96-c8795fe1d21a"
      unitRef="usd">75000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i458c9dc9da4541feb9ebbfe26480f40d_D20230501-20230501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyNTg5MQ_5d30e8e1-04f6-4943-a25d-0a893b49f5f4"
      unitRef="usd">30000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <avdl:RoyaltyFinancingQuarterlyNetRevenueTarget
      contextRef="i4e5c2953230a4966ba6f9cfa4b87083d_D20230329-20230329"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMjc0ODc3OTExMjMwNw_db87f8db-234a-469f-98b2-1faf658ab97b"
      unitRef="usd">25000000</avdl:RoyaltyFinancingQuarterlyNetRevenueTarget>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NTM0_1f64595f-5eaa-4fca-970a-4d7ebe795b3d"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie9937162cb764e1e9c3a6cde0e7174e9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NTQw_24e2e4a6-86e0-42d9-886f-927acd9c4fcd"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjUw_f6cefa4e-234a-450c-a593-dd1f992ba21c"
      unitRef="usd">96188000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjU2_1f64595f-5eaa-4fca-970a-4d7ebe795b3d"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ife27a702c1604bfaab93fe6b27c28f80_I20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyNTkwMw_2ae4d092-919a-4815-8312-3d010f2f8c04"
      unitRef="usd">106268000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i26f74d8cc0d245b9946db9086ec31c5f_I20230404"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjYy_20976b5a-dd84-4862-bf18-f7043aac6b75"
      unitRef="number">0.060</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8fdfb2995db447c186216c675ed244de_I20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfNTQ5NzU1ODI0NjY4_0831a0a0-a5ff-478a-90f2-c25b7ee7d77b"
      unitRef="usd">21187000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTAyOQ_f1f70493-97f6-44f8-a58b-150fc24ceb6f"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="if8c8d5df3b6943cbb2ac5bbcccf925a6_D20230403-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyNTkxNg_9275e637-000d-4fd9-bfff-9740f7415c1b"
      unitRef="usd">135125000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i9961149acfda4623881e412da9b843c4_D20230331-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyMjg2OA_14b3696a-d02f-4a05-abe9-b40cd8a92949"
      unitRef="usd">40000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="iaaa294d327ad4af790c20a25c207e257_D20230403-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDcyMjg3Nw_c787afb6-4b58-46b7-b70b-b204831a02e5"
      unitRef="usd">95125000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i9961149acfda4623881e412da9b843c4_D20230331-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzI5ODUzNDkxMTgyNw_14b3696a-d02f-4a05-abe9-b40cd8a92949"
      unitRef="usd">40000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <avdl:SaleOfStockSalesAgentCommissionPercent
      contextRef="i62caf1e030104340aab6ddd08244c618_D20200205-20200205"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTAzNg_65257939-ceb0-48c5-a393-9e5ac2843e58"
      unitRef="number">0.030</avdl:SaleOfStockSalesAgentCommissionPercent>
    <avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
      contextRef="idf7fc9b9d98940b28248abcf3e548647_I20200214"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTA0Mg_8340abd5-0780-423e-8b21-83b414ecbba9"
      unitRef="usd">50000000</avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration>
    <avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration
      contextRef="i04744cf318cb4dcaa7cd020e5cec855f_I20220831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTA1NA_cf234040-fa3c-4d12-8780-2e6eeaba3250"
      unitRef="usd">100000000</avdl:MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic5095edce079460fa2cc6548cac36cd4_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMjc0ODc3OTEwNjY4Nw_8170f2bf-b714-46c3-a837-33a5d73f695c"
      unitRef="shares">1564000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMjc0ODc3OTEwNjc5Ng_f5446329-7067-4bba-9e91-29349989eeb2"
      unitRef="usd">11913000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <avdl:SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration
      contextRef="i3e0581315acc4d4d86c90d917988c952_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzg0ODI5MDczOTA2Nw_184556d9-5db3-4080-b393-06969fc3a5aa"
      unitRef="usd">96064000</avdl:SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18zNy9mcmFnOjA2NzJjMjIxY2M2NDQ3ZTNiODc0MWM3MzY5Yzg2OWRjL3RleHRyZWdpb246MDY3MmMyMjFjYzY0NDdlM2I4NzQxYzczNjljODY5ZGNfMzA2MQ_4be324f7-0072-46c4-a9da-0819fb6a1b22">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The unaudited condensed consolidated balance sheet as of March&#160;31, 2023, which is derived from the prior year 2022 audited consolidated financial statements, and the interim unaudited condensed consolidated financial statements presented herein, have been prepared in accordance with U.S. GAAP, the requirements of Form 10-Q and Article 10 of Regulation S-X and, consequently, do not include all information or footnotes required by U.S. GAAP for complete financial statements or all the disclosures normally made in an Annual Report on Form 10-K. Accordingly, the unaudited condensed consolidated financial statements included herein should be read in conjunction with the audited consolidated financial statements and footnotes included in the Company&#x2019;s 2022 Annual Report on Form 10-K filed with the United States Securities and Exchange Commission (&#x201c;SEC&#x201d;) on &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March 29, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company and subsidiaries and reflect all adjustments (consisting only of normal recurring adjustments) that are, in the opinion of management, necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the dates and periods presented. All intercompany accounts and transactions have been eliminated. Results for interim periods are not necessarily indicative of the results to be expected during the remainder of the current year or for any future period.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfMzU4OQ_3619040c-934e-4983-aa5f-0c7b58244d4a">Fair Value Measurement&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is required to measure certain assets and liabilities at fair value, either upon initial recognition or for subsequent accounting or reporting. For example, the Company uses fair value extensively when accounting for and reporting certain financial instruments, when measuring certain contingent consideration liabilities and in the initial recognition of net assets acquired in a business combination. Fair value is estimated by applying the hierarchy described below, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, defines fair value as a market-based measurement that should be determined based on the assumptions that marketplace participants would use in pricing an asset or liability. When estimating fair value, depending on the nature and complexity of the asset or liability, the Company may generally use one or each of the following techniques: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Income approach, which is based on the present value of a future stream of net cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Market approach, which is based on market prices and other information from market transactions involving identical or comparable assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a basis for considering the assumptions used in these techniques, the standard establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows: &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - Quoted prices for identical assets or liabilities in active markets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are derived principally from, or corroborated by, observable market data by correlation or other means. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - Unobservable inputs that reflect estimates and assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A review of fair value hierarchy classifications is conducted on a quarterly basis.&#160;Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. During the periods ended March&#160;31, 2023 and December&#160;31, 2022, respectively, there were no transfers in and out of&#160;Level&#160;1, 2, or 3. During the three months ended March&#160;31, 2023 and 2022, respectively, the Company did not recognize any allowances for credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s financial instruments, such as cash and cash equivalents and accounts payable, are reflected in the balance sheet at carrying value, which approximates fair value due to their short-term nature. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates the fair value of its $117,375 aggregate principal amount of&#160;its October 2023 Notes based on interest rates that would be currently available to the Company for issuance of similar types of debt instruments with similar terms and remaining maturities or recent trading prices obtained from brokers (a Level 2 input). The estimated fair value of the October 2023 Notes at March&#160;31, 2023 is $124,418. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 4: Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information regarding the Company&#x2019;s debt obligations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfMzU4Mw_e3f6de8e-20c6-46d5-9aca-ec34d11d72df">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial instruments measured at fair value on a recurring basis classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation in the accompanying unaudited condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.714%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Marketable securities (see &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Note 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i319121ad18c140788a5641e1758ab387_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC0yLTEtMS03OTg2OQ_9d926306-ffe9-4891-a967-262499b35806"
      unitRef="usd">17532000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie620788155bb4059a6e43c59c3299fdf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC00LTEtMS03OTg2OQ_7849a5f8-aca1-4446-8ae7-b2192c930db0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2657941fbea4497186c9ab34cdb5e0d2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC02LTEtMS03OTg2OQ_d437f518-2a7e-4957-81a7-8f39ae3a5694"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7643c428b463493c881600eddf2ee8f4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC04LTEtMS03OTg2OQ_b9d682f7-41a2-4f0d-acc0-5528cd671a88"
      unitRef="usd">22518000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if50b3d2f207a4e44a847e37ad9bb46e1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC0xMC0xLTEtNzk4Njk_33ef1cb3-8c6c-45b9-845a-a925ab55ff5f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i19812fad0ea54d67b5f37e1104be5f74_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfNC0xMi0xLTEtNzk4Njk_816b0730-e4ca-42ea-a554-a108328cdeab"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0b9a4e9f1f88462cab7139b14d632c0a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC0yLTEtMS03OTg2OQ_adf5ab62-652a-4acc-8edd-1bdba952af99"
      unitRef="usd">17532000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id1a64b1bae7e4770bf4e011bfe5a528d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC00LTEtMS03OTg2OQ_d0373610-5bda-4796-aaf6-ff238e8f0f2a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id6e58f2a47674b17839bf947e34800b8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC02LTEtMS03OTg2OQ_a68b512f-11a0-4fbe-9af7-59b5bcebb0df"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8995e89e6594401fb4c210df4fd2a8de_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC04LTEtMS03OTg2OQ_e6b94472-cbd1-4242-8824-10e1126008cb"
      unitRef="usd">22518000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i83723dc6749c4f99a73b5cf748193371_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC0xMC0xLTEtNzk4Njk_f09af004-d5db-42bd-a97b-884aa4716d9d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i21753e8a8465424f9ed070cf17ff922a_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RhYmxlOjc5NDBlYTM0NDMyMTQzZmZhY2FkZmNlZmQ1YTc1OWZmL3RhYmxlcmFuZ2U6Nzk0MGVhMzQ0MzIxNDNmZmFjYWRmY2VmZDVhNzU5ZmZfOC0xMi0xLTEtNzk4Njk_eb5e5895-412e-4353-a6a5-36ba5418dce1"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfNTQ5NzU1ODE4MjQ1_ebface8a-ad7e-4ac1-b70a-31881cc5e5fd"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtFairValue
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180MC9mcmFnOmU5ZjIxODQ4YTVhZjRiYTliN2JkYzFlZDM0NWFiYTM2L3RleHRyZWdpb246ZTlmMjE4NDhhNWFmNGJhOWI3YmRjMWVkMzQ1YWJhMzZfMzQ5Mg_bf4f99c1-e3cf-494b-bf9a-c197d28a1350"
      unitRef="usd">124418000</us-gaap:LongTermDebtFairValue>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMjIwOQ_cea88265-acd3-44bf-ae63-d8915874849e">Marketable Securities&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in available-for-sale debt securities which are recorded at fair market value. The change in the fair value of available-for-sale debt investments is recorded as accumulated other comprehensive loss in shareholders&#x2019; (deficit) equity, net of income tax effects. As of March&#160;31, 2023, the Company considered any decreases in fair value on its marketable securities to be driven by factors other than credit risk, including market risk.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;March&#160;31, 2023 and December&#160;31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines realized gains or losses on the sale of marketable securities on a specific identification method. The Company reflects these gains and losses as a component of investment and other income (expense), net in the accompanying unaudited condensed consolidated statements of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized gross realized gains of $1 and $304 for the three months ended March&#160;31, 2023 and 2022, respectively. These realized gains were offset by realized losses of $61 and $790 for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its investment in available-for-sale marketable securities as current assets in the consolidated balance sheets as the securities need to be available for use, if required, to fund current operations. There are no restrictions on the sale of any securities in the Company&#x2019;s investment portfolio.&lt;/span&gt;&lt;/div&gt;Total gross unrealized losses and fair value of the Company&#x2019;s marketable securities at March&#160;31, 2023 are driven by factors other than credit risk. The Company does not intend to sell the investments and it is not more likely than not that it will be required to sell the investments before recovery of their amortized cost bases.</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMjIwMQ_af0d468a-1af8-431f-a7c9-581bad354177">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables show the Company&#x2019;s available-for-sale securities&#x2019; adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category as of&#160;March&#160;31, 2023 and December&#160;31, 2022, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.234%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Marketable Securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Mutual and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i64906691143a44d69f831d716ff11840_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy0yLTEtMS03OTg2OQ_d92a929b-d9cf-4e0a-88f3-ec8ca2511291"
      unitRef="usd">19281000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i64906691143a44d69f831d716ff11840_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy00LTEtMS03OTg2OQ_5b52ce33-1440-4b6f-bb48-d928745a6337"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i64906691143a44d69f831d716ff11840_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy02LTEtMS03OTg2OQ_834badef-5138-4fea-a04f-f427fe32ba29"
      unitRef="usd">1749000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i64906691143a44d69f831d716ff11840_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfMy04LTEtMS03OTg2OQ_ec38b6d4-1934-4f93-ab4f-8a3fcb22921f"
      unitRef="usd">17532000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy0yLTEtMS03OTg2OQ_e085653b-be01-4da0-9e9c-4824eca2af9e"
      unitRef="usd">19281000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy00LTEtMS03OTg2OQ_bc3f0398-52f2-4eea-a468-4dcfa3303bae"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy02LTEtMS03OTg2OQ_3ddc394d-b10b-42f7-b17a-ad95f9694281"
      unitRef="usd">1749000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOmNhYjc2MzU0ZWQxZDQ3ZDBiNmIzNzBhZWU0YTcyZGMwL3RhYmxlcmFuZ2U6Y2FiNzYzNTRlZDFkNDdkMGI2YjM3MGFlZTRhNzJkYzBfNy04LTEtMS03OTg2OQ_a2692fef-c23e-4f46-bdd8-fb867740e305"
      unitRef="usd">17532000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy0yLTEtMS03OTg2OQ_17c754bc-924d-4e20-9b99-500f27fccee3"
      unitRef="usd">24407000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy00LTEtMS03OTg2OQ_f737f7ae-1b70-4ffe-9316-41059b1d83a2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy02LTEtMS03OTg2OQ_24448f89-a9dd-481c-8e84-519351e5baeb"
      unitRef="usd">1889000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ied3528fbe48041a2a95e43b3cafa950d_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfMy04LTEtMS03OTg2OQ_b4301285-be43-479f-ad2e-4d9418ea4622"
      unitRef="usd">22518000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy0yLTEtMS03OTg2OQ_6cd09364-ad9d-41f1-a477-f8333b522f8d"
      unitRef="usd">24407000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy00LTEtMS03OTg2OQ_840ce862-0e23-4636-bbdb-4b1f2f84f839"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy02LTEtMS03OTg2OQ_234ece6d-e2c3-495d-b784-8cd6b93fd280"
      unitRef="usd">1889000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RhYmxlOjFmMGQxYjg3OTg0OTRhYTJhOGFhZjhlMDE5ZmVlZDllL3RhYmxlcmFuZ2U6MWYwZDFiODc5ODQ5NGFhMmE4YWFmOGUwMTlmZWVkOWVfNy04LTEtMS03OTg2OQ_509f4262-1312-4a1d-9afc-959de5ab5035"
      unitRef="usd">22518000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTA1MA_7e053a18-9dfa-4d7a-8c73-6299be53b803"
      unitRef="usd">1000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGain
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTA1Nw_e6694cdb-ee60-44fa-8bec-94ca88cdefa1"
      unitRef="usd">304000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGain>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTE2NA_acf47241-4bd5-42d2-8875-001d1e9dd8ba"
      unitRef="usd">61000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180My9mcmFnOjU5YmRjZjNmNTNkNzQyYzJhMzQ4Njg3Njk0OGFhZjUxL3RleHRyZWdpb246NTliZGNmM2Y1M2Q3NDJjMmEzNDg2ODc2OTQ4YWFmNTFfMTE3MQ_54ff50b8-2f01-4169-8a37-0f94e34689f3"
      unitRef="usd">790000</us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTA4MzA_bd012106-2179-4902-b8ca-aa6f08602368">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due October 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ended March&#160;31, 2023 and 2022, the total interest expense was $3,259 and $2,017, respectively, with coupon interest expense of $1,386 and $1,617 for each period, respectively, and the amortization of debt issuance costs and debt discount of $1,873 and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $312 for each period, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;February 2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 16, 2018, the Issuer issued $125,000 aggregate principal amount of its February 2023 Notes in a private placement (the &#x201c;Offering&#x201d;) to qualified institutional buyers pursuant to Rule 144A under the Securities Act. In connection with the Offering, the Issuer granted the initial purchasers of the February 2023 Notes a 30-day option to purchase up to an additional $18,750 aggregate principal amount of the February 2023 Notes, which was fully exercised on February 16, 2018. Net proceeds received by the Company, after issuance costs and discounts, were approximately $137,560. The February 2023 Notes were the Company&#x2019;s senior unsecured obligations and ranked equally in right of payment with all of the Company&#x2019;s existing and future senior unsecured indebtedness and effectively junior to any of the Company&#x2019;s existing and future secured indebtedness, to the extent of the value of the assets securing such indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;October 2023 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 5, 2022, the Issuer completed the exchange of $117,375 of its February 2023 Notes for a new series of its October 2023 Notes (the &#x201c;2022 Exchange Transaction&#x201d;). The remaining $26,375 aggregate principal amount of the February 2023 Notes were not exchanged and maintained a maturity date of February 1, 2023. On November 4, 2022, the Company repurchased $8,875 of its February 2023 Notes and on the maturity date of February 1, 2023, the Company repaid, with cash on hand, the remaining $17,500 aggregate principal amount of its February 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the October 2023 Notes as a modification to the February 2023 Notes. The Company paid $4,804 in fees to note holders of the October 2023 Notes that are amortized over the remaining term of the October 2023 Notes. The Company paid approximately $5,450 in fees to third parties that were expensed as part of the completed 2022 Exchange Transaction. Additionally, the fair value of the unseparated, embedded conversion feature increased by $5,508, which reduced the carrying amount of the convertible debt instrument as an unamortized debt discount, with a corresponding increase in additional paid-in capital. The $5,508 is amortized over the remaining term of the October 2023 Notes as a component of interest expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The October 2023 Notes are exchangeable at the option of the holders at an initial exchange rate of 92.6956 ADSs per $1 principal amount of 2023 Notes, which is equivalent to an initial exchange price of approximately $10.79 per ADS. Such initial exchange price represents a premium of approximately 20% to the $8.99 per ADS closing price on The Nasdaq Global Market on February 13, 2018. Upon the exchange of any October 2023 Notes, the Issuer will pay or cause to be delivered, as the case may be, cash, ADSs or a combination of cash and ADSs, at the Issuer&#x2019;s election. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company, at its option, may redeem for cash all of the October 2023 Notes if the last reported sale price (as defined by the indenture) of the ADSs has been at least 130% of the Exchange Price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period ending on, and including, the trading day immediately preceding the date on which the Company provides notice to redeem the October 2023 Notes. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;April 2027 Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Over the course of April 3 and April 4, 2023, the Issuer completed an exchange of $96,188 of its $117,375 October 2023 Notes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;for $106,268 of new&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; April 2027 Notes. The remaining $21,187 aggregate principal amount of the October 2023 Notes will maintain a maturity date of October 2, 2023. Due to the 2023 Exchange Transaction, the $96,188 principal amount of the October 2023 Notes is classified as long-term debt, net of unamortized debt discount and issuance costs, as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the April 2027 Notes may convert their April 2027 Notes, at their option, only under the following circumstances prior to the close of business on the business day immediately preceding January 15, 2027, under the circumstances and during the periods set forth below and regardless of the conditions described below, on or after January 15, 2027 and prior to the close of business on the business day immediately preceding the maturity date:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;Prior to the close of business on the business day immediately preceding January 15, 2027, a holder of the April 2027 Notes may surrender all or any portion of its April 2027 Notes at an initial exchange rate (the &#x201c;Exchange Rate&#x201d;) of 102.3018 ADSs of the Company (each of which represents as of the date hereof one ordinary share of the Company, nominal value $0.01 per share (the &#x201c;Ordinary Shares&#x201d;)) per $1,000 principal amount of the April 2027 Notes (so long as the principal amount of such holder&#x2019;s April 2027 Notes not exchanged is at least $200,000), which is equal to an initial exchange price of approximately $9.78 per ADS. Upon exchange, the April 2027 Notes may be settled in cash, ADSs, or a combination of cash and ADSs, at the Issuer&#x2019;s election. The Exchange Rate is subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. Following a &#x201c;Make-Whole Fundamental Change&#x201d; (as defined in the Indenture) or upon the Issuer&#x2019;s issuance of a notice of redemption, the Issuer will increase the Exchange Rate for a holder who elects to exchange its April 2027 Notes in connection with such &#x201c;make-whole fundamental change&#x201d; or during the related redemption period in certain circumstances. In addition, the Issuer will increase the Exchange Rate for a holder who elects to exchange its April 2027 Notes prior to January 15, 2027 or whose April 2027 Notes are subject to a Mandatory Exchange (as defined below) in certain circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt"&gt;The Issuer may cause the then outstanding principal amount of the April 2027 Notes to be exchanged, in whole but not in part, at its option (the &#x201c;Mandatory Exchange&#x201d;), prior to the close of business on January 15, 2027, if the last reported sale price of the ADSs has been at least 130% of the exchange price then in effect on (x) each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately before the date that the Issuer provides notice of the Mandatory Exchange in accordance with the Indenture (the &#x201c;Mandatory Exchange Notice Date&#x201d;); and (y) the trading day immediately before such Mandatory Exchange Notice Date, at the then prevailing Exchange Rate, subject to adjustment described above. The Issuer may settle Mandatory Exchanges in cash, ADSs, or a combination of cash and ADSs, at the Issuer&#x2019;s election. Accrued and unpaid interest, if any, on April 2027 Notes subject to Mandatory Exchange to, but excluding, the exchange date in respect of the Mandatory Exchange shall be paid by the Issuer to holders of the April 2027 Notes in cash concurrently with the delivery of the other exchange consideration&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Issuer may redeem for cash all of the April 2027 Notes in connection with certain tax-related events at a redemption price equal to 100% of the principal amount of the April 2027 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date, but may not otherwise redeem the April 2027 Notes. No sinking fund is provided for the April 2027 Notes, which means that the Company is not required to redeem or retire the April 2027 Notes periodically.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considered the guidance in ASC 815-15, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Embedded Derivatives&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine if this instrument contains an embedded feature that should be separately accounted for as a derivative. ASC 815 provides for an exception to this rule when convertible notes, as host instruments, are deemed to be conventional, as defined by ASC 815-40. The Company determined that this exception applies due, in part, to the Company&#x2019;s ability to settle the October 2023 Notes in cash, ADSs or a combination of cash and ADSs, at the Company&#x2019;s option. The Company has therefore applied the guidance provided by ASC 470-20, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as amended by ASU 2020-06. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalty Financing Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On March 29, 2023, the Company and Avadel CNS entered into a royalty purchase agreement with RTW Investments, L.P. that could provide the Company up to $75,000 of royalty financing in two tranches. The first tranche of $30,000 is available subject to the Company&#x2019;s first shipment of LUMRYZ. The second tranche is available to use, at the Company&#x2019;s election, upon achieving quarterly net revenue of $25,000. The second tranche will expire on August 31, 2024, if the quarterly net revenue target is not reached and if it is not used by the Company by that time.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTA4NDA_6d6e4901-7aa5-44de-8fb9-3e632b8dab81">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.371%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due October 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;117,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of 4.50% exchangeable senior notes due February 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt discount and issuance costs, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,593)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMS0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmFjMGZjMjFlMTdjODQzNGY5MmJmYzcyYWMzZGExNTkwXzI3NDg3NzkwNjk1MjQ_98e2269a-3cbd-492c-b37a-7b9f43dd2406"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMS0yLTEtMS03OTg2OQ_ebface8a-ad7e-4ac1-b70a-31881cc5e5fd"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ic89b1f1ffe254a5fb320780bad1a88fc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMS00LTEtMS03OTg2OQ_d7441ce6-9dbe-48bc-9934-aad0bcb414d9"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e3e3492dee14060b385540d4e0d7c18_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi0wLTEtMS04NDM5My90ZXh0cmVnaW9uOjYzNGE1ZDdiMTNkNTRjOTc4ZmZhZWRkYzlhZDVjYzQ5XzI0_039d430e-89ac-4088-af79-02ca4cf73f82"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i7e3e3492dee14060b385540d4e0d7c18_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi0yLTEtMS04NDM4Mg_c2a86ba2-c0d8-4354-8534-63ac1f8c4e03"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id408a9d6c330487193d4d6ecb5fd3650_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi00LTEtMS04NDM4Mg_6d5f0aba-9904-4a1e-86c4-09eb29a8f69b"
      unitRef="usd">17500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="id57ed34c966748e1b0953df5e00479df_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi0yLTEtMS03OTg2OQ_28a6320c-6a5e-4633-a7f8-4da5b11e6304"
      unitRef="usd">3721000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i23b6a8070618442e9e19c0442c464ee3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMi00LTEtMS03OTg2OQ_a5a002f0-20f9-42e3-9ccb-a2f3120bb68a"
      unitRef="usd">5593000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="id57ed34c966748e1b0953df5e00479df_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMy0yLTEtMS03OTg2OQ_ee6aaddd-cc7c-4b5f-b9ef-1070b7c6accc"
      unitRef="usd">113654000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i23b6a8070618442e9e19c0442c464ee3_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfMy00LTEtMS03OTg2OQ_98db23e6-f1f1-4333-9f91-36b58fe9c787"
      unitRef="usd">129282000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmM3OTg0YzU1YThlNjRkZGY4M2FlYjI4OTM0YmIyZDJjXzM3_d28884ac-9e74-479c-8e6b-3c1058d4380a"
      unitRef="usd">672000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi0wLTEtMS03OTg2OS90ZXh0cmVnaW9uOmM3OTg0YzU1YThlNjRkZGY4M2FlYjI4OTM0YmIyZDJjXzIxOTkwMjMyNTU2NDA_eb44aa00-420a-48b7-a24b-37a4cd4e158e"
      unitRef="usd">1019000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi0yLTEtMS03OTg2OQ_bbb19a86-cf24-485f-870d-aa3f0aefe036"
      unitRef="usd">20515000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNi00LTEtMS03OTg2OQ_d9377317-4d42-4728-95fc-a013cb2c6e9f"
      unitRef="usd">37668000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNy0yLTEtMS03OTg2OQ_6e23d8fa-e499-4680-b757-41abb0a56b51"
      unitRef="usd">93139000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RhYmxlOjIwNDEwNWFlZTBhOTQ1NWE4MDQyNmVhZTkwNWM0Y2I1L3RhYmxlcmFuZ2U6MjA0MTA1YWVlMGE5NDU1YTgwNDI2ZWFlOTA1YzRjYjVfNy00LTEtMS03OTg2OQ_2e26d69c-2370-438f-ac55-2befe757e6e3"
      unitRef="usd">91614000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTQz_902818f2-a640-4637-9e3f-2f749f4fe0ba"
      unitRef="usd">3259000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTUw_72a99ccc-45f2-4c6e-b809-e5e6fef1f8dd"
      unitRef="usd">2017000</us-gaap:InterestExpenseDebt>
    <avdl:CouponInterestExpense
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjAw_01d75995-f317-474c-9280-807918458c7a"
      unitRef="usd">1386000</avdl:CouponInterestExpense>
    <avdl:CouponInterestExpense
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjE5OTAyMzI5MTEwMQ_6819738e-0cf8-4f2b-9408-5c2eb9940469"
      unitRef="usd">1617000</avdl:CouponInterestExpense>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjg0_6f50d4ba-60c2-43f5-9a0b-6b7071b9c4e4"
      unitRef="usd">1873000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjE5OTAyMzI5MTIwOQ_e8a7aeee-0b29-4591-91bb-278d3997d4fe"
      unitRef="usd">312000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6cc7030dee104960a48e1ef403016742_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNjcz_80e9f2df-519c-4967-9d31-40dbbd71809f"
      unitRef="usd">125000000</us-gaap:DebtInstrumentFaceAmount>
    <avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm
      contextRef="id58b0ae1b79f447e8ae6e65bded423ca_D20180216-20180216"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTA4Mzc_ea774c4b-9cc1-4d09-aa6b-143012f8779d">P30D</avdl:DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm>
    <avdl:DebtInstrumentOptiontoIncreaseFaceAmount
      contextRef="i6cc7030dee104960a48e1ef403016742_I20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTAwMg_9b0dbecb-43e5-49ad-a38b-9ba6d18e793f"
      unitRef="usd">18750000</avdl:DebtInstrumentOptiontoIncreaseFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="id58b0ae1b79f447e8ae6e65bded423ca_D20180216-20180216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMTIwMQ_25c346b4-d85a-4b73-9603-4892f20ab956"
      unitRef="usd">137560000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <avdl:DebtInstrumentExchangeAmount
      contextRef="iaf529448191847138180cb35876adf3b_I20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI3Njg2_417ced84-48b9-4727-8360-31d852d3d62c"
      unitRef="usd">117375000</avdl:DebtInstrumentExchangeAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaf529448191847138180cb35876adf3b_I20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI3ODA0_25b06552-5b8f-44a5-bef5-01b2e3c232fe"
      unitRef="usd">26375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i4c67c57f5e464d2eb219e11bb8fa61ac_I20221104"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI3OTc4_6484ccb0-0fd3-4d02-8249-273f7e93f13c"
      unitRef="usd">8875000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ibe2ecd298ed14718958abd43e1bed64f_I20230201"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4MTA4_9a3f7211-6a8a-40bb-915a-7e69645fb579"
      unitRef="usd">17500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ic84949ac67fc4d3487c6ff9086f64946_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4Mjgw_f3f1a4e5-35a8-482c-949c-2f86dd895df7"
      unitRef="usd">4804000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="icb2258e7de744756bfdc93eb9badd9e4_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4NDM1_fd64944c-ceda-4366-9d40-aff9fe9f4976"
      unitRef="usd">5450000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease
      contextRef="if20286047c044da782884c54495ecb0e_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4NjIw_2c44690e-8161-4156-93b1-2ca44d8e7e18"
      unitRef="usd">5508000</avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease>
    <avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature
      contextRef="if20286047c044da782884c54495ecb0e_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4NjIw_a4222b0e-4217-43e8-b591-4934e0dd8ae4"
      unitRef="usd">5508000</avdl:AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature>
    <avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease
      contextRef="if20286047c044da782884c54495ecb0e_D20220405-20220405"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI4Nzky_1c10421d-2004-49d1-b5c6-12bb90bf4625"
      unitRef="usd">5508000</avdl:DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease>
    <avdl:AmericanDepositorySharesConversionRatio
      contextRef="i1082dbc3efe8463fa3c8d5d339c6f683_D20180216-20180216"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5MjA1_f38386a0-196f-4731-88bc-eeedeb64b604"
      unitRef="rate">92.6956</avdl:AmericanDepositorySharesConversionRatio>
    <avdl:AmericanDepositarySharesOptionPricePerShare
      contextRef="i4bff811514e04cf0a407a2178a42e153_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5MzE5_ecfbc6aa-cb0d-4538-a20e-6e1d414127e9"
      unitRef="usdPerShare">10.79</avdl:AmericanDepositarySharesOptionPricePerShare>
    <avdl:AmericanDepositarySharesPremiumPercentage
      contextRef="i4bff811514e04cf0a407a2178a42e153_I20180216"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5Mzk4_ae2534ac-653b-4ea9-9743-b0adba5cf77c"
      unitRef="number">0.20</avdl:AmericanDepositarySharesPremiumPercentage>
    <avdl:AmericanDepositarySharesPurchasedPricePerShare
      contextRef="i4bff811514e04cf0a407a2178a42e153_I20180216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODI5NDA5_5804a0bf-dcbf-4ebf-a540-dd4015fb892a"
      unitRef="usdPerShare">8.99</avdl:AmericanDepositarySharesPurchasedPricePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMDA_9ac564b0-0b00-43e5-8b47-60a62784cb63"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMDQ_e3741eaa-448d-447d-bcf6-12dde8c38704"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="icf4326da16cc4075b53afb1ffd9b74a6_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMDg_2287c91e-31ba-492d-ab34-651a7cde45c9"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NDUx_f6cefa4e-234a-450c-a593-dd1f992ba21c"
      unitRef="usd">96188000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NDU3_1f64595f-5eaa-4fca-970a-4d7ebe795b3d"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2c693d85f33f4ea6b145f6db4f849879_I20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTExMTI_6b91f266-d201-4de8-bf5b-b68ebf5cda9e"
      unitRef="usd">106268000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8fdfb2995db447c186216c675ed244de_I20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NTI3_0831a0a0-a5ff-478a-90f2-c25b7ee7d77b"
      unitRef="usd">21187000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfNTQ5NzU1ODU3NTc2_f6cefa4e-234a-450c-a593-dd1f992ba21c"
      unitRef="usd">96188000</us-gaap:DebtConversionOriginalDebtAmount1>
    <avdl:AmericanDepositorySharesConversionRatio
      contextRef="i6165ba48ac2542de9fc80cf68aaf7a7c_D20230404-20230404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODMzMQ_04371ce2-d046-4321-b7e0-2182b33b5d54"
      unitRef="rate">102.3018</avdl:AmericanDepositorySharesConversionRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM2Mg_0a72a7cc-7140-4acb-bd3d-6000f17e9ad0"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <avdl:DebtConversionPrincipalAmountNotExchanged
      contextRef="i4e1dda052ae749c4b067a6c95a6a1377_D20230404-20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM2OQ_f5b4f6ca-314b-4aa6-8519-581609db6f17"
      unitRef="usd">200000000</avdl:DebtConversionPrincipalAmountNotExchanged>
    <avdl:AmericanDepositarySharesOptionPricePerShare
      contextRef="ibb3721e3e0c345868370c7da3c4161dc_I20230404"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM1NQ_80bf604a-47a1-4e60-9260-2666024df718"
      unitRef="usdPerShare">9.78</avdl:AmericanDepositarySharesOptionPricePerShare>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM0MQ_39e52caa-2292-4139-b360-8295cec2e1cb"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM0Nw_edc35104-68fa-4b19-8e76-dccede0fac67"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODM1MQ_614be247-78ac-4258-973e-c4747ef67c00"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i1d3d9250360649cc9a0e8c794040a387_D20230404-20230404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMzg0ODI5MDc0ODQwNQ_b3c7a8bf-0ce4-432d-b975-7d4a048ad2cd"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="if5fa690543384264a81ade629ded5283_D20230329-20230329"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjc0ODc3OTEwODUwNg_8f637e33-87e1-4bbc-8f96-c8795fe1d21a"
      unitRef="usd">75000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <us-gaap:ProceedsFromRoyaltiesReceived
      contextRef="i458c9dc9da4541feb9ebbfe26480f40d_D20230501-20230501"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjc0ODc3OTEwODUxMg_5d30e8e1-04f6-4943-a25d-0a893b49f5f4"
      unitRef="usd">30000000</us-gaap:ProceedsFromRoyaltiesReceived>
    <avdl:RoyaltyFinancingQuarterlyNetRevenueTarget
      contextRef="i4e5c2953230a4966ba6f9cfa4b87083d_D20230329-20230329"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180Ni9mcmFnOmZlNTQ2MGNiOWQ4YjQ3MTE4MTIyMTI0YzQ3YTY0MTYxL3RleHRyZWdpb246ZmU1NDYwY2I5ZDhiNDcxMTgxMjIxMjRjNDdhNjQxNjFfMjc0ODc3OTExMDg1Ng_db87f8db-234a-469f-98b2-1faf658ab97b"
      unitRef="usd">25000000</avdl:RoyaltyFinancingQuarterlyNetRevenueTarget>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNDQw_b4fc1315-dcf0-4357-a347-784d7324f08a">Income Taxes The income tax benefit was $580 for the three months ended March&#160;31, 2023 resulting in an effective tax rate of 1.8%.  The income tax benefit was $4,323 for the three months ended March&#160;31, 2022 resulting in an effective tax rate of 14.1%.  The change in the effective tax rate for the three months ended March&#160;31, 2023, when compared to the same period in 2022, is primarily driven by the valuation allowances recorded against net deferred tax assets established in the second quarter of 2022. The Company's cumulative loss position was significant negative evidence in assessing the need for a valuation allowance on its deferred tax assets. Given the weight of objectively verifiable historical losses from operations, the Company recorded a full valuation allowance on its deferred tax assets. The Company will be able to reverse the valuation allowance when it has shown its ability to generate taxable income on a consistent basis in future periods. The valuation allowance does not have an impact on the Company's ability to utilize any net operating losses or other tax attributes to offset cash taxes payable as these items are still eligible to be used.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNTY_cc99fe6a-cc69-4d7d-a5c6-3e084075f58f"
      unitRef="usd">-580000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNTQ5NzU1ODE2OTE2_140e1bee-043b-4e4f-bf3f-a2612da636da"
      unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfMTU5_5beb4ba3-b07f-4c38-8681-1941fd4140f5"
      unitRef="usd">-4323000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY180OS9mcmFnOjQ5OTJlNDljM2M2YTQwZDFhYmEyYWY4ODcyYjJmZjAyL3RleHRyZWdpb246NDk5MmU0OWMzYzZhNDBkMWFiYTJhZjg4NzJiMmZmMDJfNTQ5NzU1ODE2OTIw_c5f6d561-f0a0-4983-a965-1b01746f48be"
      unitRef="number">0.141</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTIz_67ccc553-29bd-415f-ba71-a97a6a4d0ecd">Other Assets and Liabilities&#160;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsourced contract manufacturing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTQx_8c8f600f-225f-48da-8afb-c9b377c09603">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Various other assets and liabilities are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Prepaid Expenses and Other Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prepaid and other expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Income tax receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMi0yLTEtMS03OTg2OQ_b3ab0bb2-03af-4650-a7f3-609a58ebf7f1"
      unitRef="usd">5384000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMi00LTEtMS03OTg2OQ_15d5c608-f1e1-4a82-825b-a123dd685333"
      unitRef="usd">1523000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMy0yLTEtMS03OTg2OQ_90f1bccc-2fa5-4e6f-ba11-7d3e55ee2af7"
      unitRef="usd">542000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfMy00LTEtMS03OTg2OQ_cecd918a-feb9-4dc5-a0d9-f7dd281da90e"
      unitRef="usd">228000</us-gaap:OtherAssetsCurrent>
    <avdl:GuaranteeCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNC0yLTEtMS03OTg2OQ_afc36e85-aa26-47d7-a60d-a124408aadcd"
      unitRef="usd">269000</avdl:GuaranteeCurrent>
    <avdl:GuaranteeCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNC00LTEtMS03OTg2OQ_d00c10d9-93a3-4cab-a955-56ddb1fd7e9b"
      unitRef="usd">276000</avdl:GuaranteeCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNS0yLTEtMS03OTg2OQ_db9cc86b-ca61-429c-8b8a-bdd0f86872b4"
      unitRef="usd">69000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNS00LTEtMS03OTg2OQ_57b3f6ec-8115-4067-a843-98d4f2dba1e0"
      unitRef="usd">69000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNi0yLTEtMS03OTg2OQ_424b3287-27e6-484a-8fb4-34a9d2445235"
      unitRef="usd">6264000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjc0M2JlZmI2OGQ3ZjQ1NjhiN2Y2OWJmZmJlODVkM2QyL3RhYmxlcmFuZ2U6NzQzYmVmYjY4ZDdmNDU2OGI3ZjY5YmZmYmU4NWQzZDJfNi00LTEtMS03OTg2OQ_ae73b9a7-9b75-4918-8d14-7b6d4b5025ea"
      unitRef="usd">2096000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTI2_6ebe3f89-a021-4326-8e22-83d9acf5b51e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Right of use assets at contract manufacturing organizations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee from Armistice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMi0yLTEtMS03OTg2OQ_e8cba4bd-6b9c-471e-9ebc-08a117f2b840"
      unitRef="usd">10392000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMi00LTEtMS03OTg2OQ_3e03877e-fbb3-4653-b0cb-d0679c4b67f1"
      unitRef="usd">10686000</avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMy0yLTEtMS03OTg2OQ_acdad8bc-9cfc-479f-ba41-776ba3d8c1d1"
      unitRef="usd">433000</avdl:GuaranteeNoncurrent>
    <avdl:GuaranteeNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfMy00LTEtMS03OTg2OQ_1cb0664f-fd41-4079-9b75-345170262239"
      unitRef="usd">495000</avdl:GuaranteeNoncurrent>
    <avdl:OtherNoncurrentReceivables
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNC0yLTEtMS03OTg2OQ_2d453d56-65d4-4396-98fd-c784b08ff1a5"
      unitRef="usd">106000</avdl:OtherNoncurrentReceivables>
    <avdl:OtherNoncurrentReceivables
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNC00LTEtMS03OTg2OQ_395c6811-75d1-4927-901b-5cdee9cf5cd7"
      unitRef="usd">141000</avdl:OtherNoncurrentReceivables>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNi0yLTEtMS03OTg2OQ_15cdb4e9-2ba9-4267-ac02-ee02de99d23c"
      unitRef="usd">10931000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOmY2ZmQ3MzY3NzFkZTQ1NjM4YzJlMjdjYjdmYzIxZDhjL3RhYmxlcmFuZ2U6ZjZmZDczNjc3MWRlNDU2MzhjMmUyN2NiN2ZjMjFkOGNfNi00LTEtMS03OTg2OQ_0afd185f-58b9-410b-9186-fc171733fe2a"
      unitRef="usd">11322000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTM3_8aae1feb-162f-4c9b-bf9e-a0bc10209599">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued Expenses &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued outsourced contract manufacturing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMi0yLTEtMS03OTg2OQ_0e9026a5-454b-435e-8318-64230142a76f"
      unitRef="usd">5709000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMi00LTEtMS03OTg2OQ_45263a2e-a992-4f32-83ab-79bd51394a26"
      unitRef="usd">4040000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMy0yLTEtMS03OTg2OQ_73f83752-426c-4712-a540-821a17648120"
      unitRef="usd">1581000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfMy00LTEtMS03OTg2OQ_12f92049-4307-429d-8726-c27575165383"
      unitRef="usd">1613000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNC0yLTEtMS03OTg2OQ_5001358a-09c0-40df-9c4d-141a931f8fcc"
      unitRef="usd">246000</us-gaap:RestructuringReserveCurrent>
    <us-gaap:RestructuringReserveCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNC00LTEtMS03OTg2OQ_961dd8e0-6294-4c03-8a8b-a5d72a74d648"
      unitRef="usd">473000</us-gaap:RestructuringReserveCurrent>
    <avdl:AccruedOutsourceContractCosts
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNS0yLTEtMS03OTg2OQ_c4b9a77a-8157-4c4a-b01d-43cd9122815e"
      unitRef="usd">147000</avdl:AccruedOutsourceContractCosts>
    <avdl:AccruedOutsourceContractCosts
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNS00LTEtMS03OTg2OQ_bab7fb9d-08dd-40c3-a8fb-742e4cb851f6"
      unitRef="usd">1208000</avdl:AccruedOutsourceContractCosts>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNy0yLTEtMS03OTg2OQ_5c3499d8-2048-4a58-91a9-1a7959312bbf"
      unitRef="usd">7683000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjM3M2E3ZmIzMGQwYjQ1NThiODU5MDRkMDFmODQ1ODE3L3RhYmxlcmFuZ2U6MzczYTdmYjMwZDBiNDU1OGI4NTkwNGQwMWY4NDU4MTdfNy00LTEtMS03OTg2OQ_9ccdb057-ca5d-4d68-a09c-c2346db9d011"
      unitRef="usd">7334000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTIx_36fc0a41-4551-4ff9-be37-c714c396cc4b">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMi0yLTEtMS03OTg2OQ_86f37ec5-8545-45c1-bcfb-9d22a92657e2"
      unitRef="usd">269000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherGuarantorObligationsCurrentCarryingValue
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMi00LTEtMS03OTg2OQ_69c9dc3b-9811-4058-8c3e-77d857ef6bbe"
      unitRef="usd">277000</avdl:OtherGuarantorObligationsCurrentCarryingValue>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMy0yLTEtMS03OTg2OQ_71ecfd89-2e28-474c-9863-1f20e74ea918"
      unitRef="usd">0</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <avdl:OtherLiabilitiesMiscellaneousCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfMy00LTEtMS03OTg2OQ_47dd10e1-d949-4f37-9555-843257fa7bf1"
      unitRef="usd">15000</avdl:OtherLiabilitiesMiscellaneousCurrent>
    <avdl:AccruedInterestCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNC0yLTEtMS03OTg2OQ_84ed7265-65fc-4eff-acc2-f6487179410d"
      unitRef="usd">0</avdl:AccruedInterestCurrent>
    <avdl:AccruedInterestCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNC00LTEtMS03OTg2OQ_ca0735ae-1315-423b-8a62-5a2f96046dbb"
      unitRef="usd">1649000</avdl:AccruedInterestCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNS0yLTEtMS03OTg2OQ_454ff65e-31ee-4165-93b3-d94c8ea2c869"
      unitRef="usd">269000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjZiYjc1MDBkZDE5YzQ0YzE5MDQxNWU4MzQ4NmMxZjc1L3RhYmxlcmFuZ2U6NmJiNzUwMGRkMTljNDRjMTkwNDE1ZTgzNDg2YzFmNzVfNS00LTEtMS03OTg2OQ_5b4350b4-4ba2-4379-a499-3e31a3ac549d"
      unitRef="usd">1941000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RleHRyZWdpb246ZWQ5NWFjMzkwMTZlNDA1ZGE5YzVhNjM1NDFkY2YzNDRfMTMw_89b785a2-6286-4058-bdce-2ae8fcd3ffdf">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.418%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.908%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.910%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other Non-Current Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee to Deerfield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMi0yLTEtMS03OTg2OQ_3432535c-b872-4408-9c68-555cae9c7539"
      unitRef="usd">5333000</avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities>
    <avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMi00LTEtMS03OTg2OQ_925e9e7f-b74c-4f5f-a314-840e86f881cc"
      unitRef="usd">5246000</avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMy0yLTEtMS03OTg2OQ_3b153dbf-a2ae-4ae2-be61-8733fe18a6ff"
      unitRef="usd">434000</us-gaap:GuarantyLiabilities>
    <us-gaap:GuarantyLiabilities
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfMy00LTEtMS03OTg2OQ_b348ea9a-fff8-441f-a581-1d2325be44fe"
      unitRef="usd">497000</us-gaap:GuarantyLiabilities>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfNC0yLTEtMS03OTg2OQ_dcd2d4d2-71d5-4142-9ba5-1041bee7100c"
      unitRef="usd">5767000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i89062f4901fb4064b1b764e65dc9de58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181Mi9mcmFnOmVkOTVhYzM5MDE2ZTQwNWRhOWM1YTYzNTQxZGNmMzQ0L3RhYmxlOjVjNGM1NTlhY2MxMTQ2NDY5NDIxNWNmZjkwNGJiNWI5L3RhYmxlcmFuZ2U6NWM0YzU1OWFjYzExNDY0Njk0MjE1Y2ZmOTA0YmI1YjlfNC00LTEtMS03OTg2OQ_2f41d644-a8ee-44df-ba59-0f647b483134"
      unitRef="usd">5743000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMjE1Mw_a5708041-bc9e-4b6c-b219-27d2761da04e">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is calculated by dividing net loss by the weighted average number of shares outstanding during each period. Diluted net loss per share is calculated by dividing net loss - diluted by the diluted number of shares outstanding during each period. Except where the result would be anti-dilutive to net loss, diluted net loss per share would be calculated assuming the impact of the conversion of the 2023 Notes, the conversion of the Company&#x2019;s preferred shares, the exercise of outstanding equity compensation awards, and ordinary shares expected to be issued under the Company&#x2019;s Employee Share Purchase Plan (&#x201c;ESPP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a choice to settle the conversion obligation under the 2023 Notes in cash, shares or any combination of the two. The Company utilizes the if-converted method to reflect the impact of the conversion of the 2023 Notes, unless the result is anti-dilutive. This method assumes the conversion of the 2023 Notes into shares of the Company&#x2019;s ordinary shares and reflects the elimination of the interest expense related to the 2023 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The dilutive effect of the stock options, restricted stock units, preferred shares and ordinary shares expected to be issued under the Company&#x2019;s ESPP has been calculated using the treasury stock method. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Loss Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding, preferred shares and 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Potential ordinary shares of&#160;12,463&#160;and&#160;17,696&#160;were excluded from the calculation of weighted average shares for the three months ended March&#160;31, 2023 and 2022, respectively, because either their effect was considered to be anti-dilutive or they were related to shares from performance share unit awards (&#x201c;PSUs&#x201d;) for which the contingent vesting condition had not been achieved. For the three months ended March&#160;31, 2023 and 2022, the effects of dilutive securities were entirely excluded from the calculation of net loss per share as a net loss was reported in these periods.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMjE0Nw_7f57db81-6a22-4ee7-ba51-6970e6819bc0">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted net loss per share, together with the related shares outstanding in thousands is as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.768%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Loss Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities&#x2014;employee and director equity awards outstanding, preferred shares and 2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net loss per share - diluted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMy02LTEtMS03OTg2OQ_d6e105b4-d946-49ae-845b-e27c8f8c41d0"
      unitRef="usd">-30784000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMy04LTEtMS03OTg2OQ_f0f748ea-6536-4f65-9474-e830789594f7"
      unitRef="usd">-26424000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOC02LTEtMS03OTg2OQ_190242a7-d6d3-45cc-a9ab-c478eff1fbca"
      unitRef="shares">63886000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOC04LTEtMS03OTg2OQ_5b8f1823-a919-4983-9165-8b6934fe0512"
      unitRef="shares">58824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOS02LTEtMS03OTg2OQ_994fa049-f4f5-4812-999a-e5deebf8a197"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfOS04LTEtMS03OTg2OQ_c989492b-39e7-4505-a013-51c65fe8bb34"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTEtNi0xLTEtNzk4Njk_ad0fba21-9693-4dc2-9cec-de1c23f702d2"
      unitRef="shares">63886000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTEtOC0xLTEtNzk4Njk_16ecc962-acad-42e0-9d31-e59ba50dfe1d"
      unitRef="shares">58824000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTMtNi0xLTEtNzk4Njk_5c86b28a-74a8-4338-8b47-6774b36dc064"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTMtOC0xLTEtNzk4Njk_9e56b18f-7a76-42dd-801b-00df02322536"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTQtNi0xLTEtNzk4Njk_d5884f18-f526-4487-8f8a-55e7fc068ef3"
      unitRef="usdPerShare">-0.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RhYmxlOmVjODMxNGIxMTJmNzRhMmJiMTk1NTc2MzBhOTBhYmJmL3RhYmxlcmFuZ2U6ZWM4MzE0YjExMmY3NGEyYmIxOTU1NzYzMGE5MGFiYmZfMTQtOC0xLTEtNzk4Njk_f7bf368f-c8d0-490d-9913-f7624351a86a"
      unitRef="usdPerShare">-0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMTY2OA_6478e21d-7730-44c0-b506-d1555a329e7d"
      unitRef="shares">12463000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181NS9mcmFnOjE3ZDM3OTM5NDFlNDRjZGRiNzZiOGM0MjM5ZDI0ZTAzL3RleHRyZWdpb246MTdkMzc5Mzk0MWU0NGNkZGI3NmI4YzQyMzlkMjRlMDNfMTY3NQ_1c584787-00de-4dfe-a995-71143a92803d"
      unitRef="shares">17696000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RleHRyZWdpb246ZWFhNDU1ODRiNjk5NDZjZDlkMDI2ZmNmZjcxNjAyYmFfMzg2_338f37f0-fabb-4af8-8611-8bf2d69d8c55">Comprehensive Loss&#160;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the three months ended March&#160;31, 2023 and 2022, respectively, net of tax effects:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized loss on marketable debt securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect on the Company&#x2019;s unaudited condensed consolidated financial statements of amounts reclassified out of accumulated other comprehensive loss was immaterial for all periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RleHRyZWdpb246ZWFhNDU1ODRiNjk5NDZjZDlkMDI2ZmNmZjcxNjAyYmFfMzgz_976ec1be-f9a2-4583-b743-2c93140d3116">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the components of accumulated other comprehensive loss for the three months ended March&#160;31, 2023 and 2022, respectively, net of tax effects:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.055%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,855)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(24,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized loss on marketable debt securities, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(917)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,002)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(26,026)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(25,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i5886c0d106614c858fffef30aab67fd4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNC02LTEtMS03OTg2OQ_ac10313b-84a4-4c68-94ab-e054ef8c5917"
      unitRef="usd">-24452000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i39f2e203d2b94d95b66e864ec15b4449_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNC04LTEtMS03OTg2OQ_5556d9a1-4a6c-4e7d-89d2-2c0870e0bc43"
      unitRef="usd">-23855000</us-gaap:StockholdersEquity>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icfab2c03c2f64e0390fe6350accb23da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNS02LTEtMS03OTg2OQ_45d6937c-a960-431a-804c-a2d07dd8fbb2"
      unitRef="usd">175000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib999fc432bf54ee889b0167c94099114_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNS04LTEtMS03OTg2OQ_458b1db4-bd04-4327-922f-e9e01399ec86"
      unitRef="usd">-185000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i74c73f0392b24707bcf0aa081fb42453_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNi02LTEtMS03OTg2OQ_43291122-b02c-42a4-993f-c5c19e0306fe"
      unitRef="usd">-24277000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i41dce19a3844455fae5e06d004fb2dae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfNi04LTEtMS03OTg2OQ_e19cf1f8-240d-4659-a3db-3b2fe35452a0"
      unitRef="usd">-24040000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibfed34d223564ae39def036cff17412b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfOS02LTEtMS03OTg2OQ_bbcc6853-ca1d-432e-b830-41a644c40e1f"
      unitRef="usd">-1889000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie970e5169b154723b235fcca299a98c3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfOS04LTEtMS03OTg2OQ_fe45dd76-1922-4dec-a4d7-22410fac932f"
      unitRef="usd">-85000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo5MmFjZDk1NTI3NzU0MjExOTNmZmU0M2M4ZjJhMGYxN183NA_fed9c667-3f02-4402-886f-0af874491a7f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i6b1e1e6189d8459aa6464a8feee7ef68_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtMC0xLTEtNzk4NjkvdGV4dHJlZ2lvbjo5MmFjZDk1NTI3NzU0MjExOTNmZmU0M2M4ZjJhMGYxN184MQ_9841e0ea-dd43-4132-90ef-b2ee3e08231c"
      unitRef="usd">-330000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id3b73e469fad46e381038498c748c0c5_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtNi0xLTEtNzk4Njk_efbf4487-a1b6-4a10-886a-dc77f7a3305f"
      unitRef="usd">140000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iecb3550bc32e4b638a3f1849f6d8fac3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTAtOC0xLTEtNzk4Njk_a77a8683-383f-4e15-afe3-fbfbd26b6011"
      unitRef="usd">-917000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i884a39afb0a843b09e81a9e1e807a434_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTEtNi0xLTEtNzk4Njk_8a7c72fa-002b-46fe-87b0-62f0efc4d05d"
      unitRef="usd">-1749000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4600b4ecedc44e2181775b186fbc6c78_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTEtOC0xLTEtNzk4Njk_ada07f06-7e8a-4c9d-bfc8-f0200a7c8ac4"
      unitRef="usd">-1002000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b7320cd55fe4ab18058db41d1e57eda_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTItNi0xLTEtNzk4Njk_2e3c2d62-fdfb-4ef1-9d5e-ba78b9a7e0ec"
      unitRef="usd">-26026000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8b9adec52d54e12a5433ac63da3e86b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY181OC9mcmFnOmVhYTQ1NTg0YjY5OTQ2Y2Q5ZDAyNmZjZmY3MTYwMmJhL3RhYmxlOjAxYjdmZTZiMDc0MjQwOTY5ZjQ5NzJhY2EzNmMyYmRlL3RhYmxlcmFuZ2U6MDFiN2ZlNmIwNzQyNDA5NjlmNDk3MmFjYTM2YzJiZGVfMTItOC0xLTEtNzk4Njk_35f8315b-c2eb-410e-b369-7f1405dac65c"
      unitRef="usd">-25042000</us-gaap:StockholdersEquity>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfODcwMw_09abbab1-53ef-48c5-9b99-4bf5ee51cc2d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation &#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to potential liabilities generally incidental to its business arising out of present and future lawsuits and claims related to product liability, personal injury, contract, commercial, intellectual property, tax, employment, compliance and other matters that arise in the ordinary course of business. The Company accrues for potential liabilities when it is probable that future costs (including legal fees and expenses) will be incurred and such costs can be reasonably estimated. At March 31, 2023 and December 31, 2022, there were no contingent liabilities with respect to any litigation, arbitration or administrative or other proceeding that are reasonably likely to have a material adverse effect on the Company&#x2019;s consolidated financial position, results of operations, cash flows or liquidity. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;First Jazz Complaint&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 12, 2021, Jazz Pharmaceuticals, Inc. (&#x201c;Jazz&#x201d;) filed a formal complaint (the &#x201c;First Complaint&#x201d;) initiating a lawsuit in the United States District Court for the District of Delaware (the &#x201c;Court&#x201d;) against Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel CNS Pharmaceuticals, LLC (collectively, the &#x201c;Avadel Parties&#x201d;). In the First Complaint, Jazz alleges the sodium oxybate product (&#x201c;Proposed Product&#x201d;) described in the NDA owned by Avadel CNS Pharmaceuticals, LLC (&#x201c;Avadel CNS&#x201d;) will infringe at least one claim of U.S. Patent No. 8731963, 10758488, 10813885, 10959956 and/or 10966931 (collectively, the &#x201c;patents-in-suit&#x201d;). The First Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Avadel Answer&#x201d;) with the Court in response to the First Complaint. The Avadel Answer generally denies the allegations set forth in the First Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patents-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of each patent-in-suit, and ii) a declaratory judgment of invalidity of each patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 18, 2021, Jazz filed its Answer (&#x201c;Jazz Answer&#x201d;) with the Court in response to the Avadel Answer. The Jazz Answer generally denies the allegations set forth in the Avadel Answer and sets forth a single affirmative defense asserting that Avadel has failed to state a claim for which relief can be granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 21, 2021, the Court issued an oral order requiring the parties to i) confer regarding proposed dates to be included in the Court&#x2019;s scheduling order for the case, and ii) submit a proposed order, including a proposal for the length and timing of trial, to the Court by no later than July 21, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 30, 2021, the Court issued a scheduling order establishing timing for litigation events including i) a claim construction hearing date of August 2, 2022, and ii) a trial date of October 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 18, 2021, consistent with the scheduling order, Jazz filed a status update with the Court indicating that Jazz did not intend to file a preliminary injunction with the Court at this time. Jazz further indicated that it would provide the Court with an update regarding whether preliminary injunction proceedings may be necessary after receiving further information regarding the FDA&#x2019;s action on Avadel CNS&#x2019;s NDA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2022, the Court entered an agreed order dismissing this case with respect to Avadel Pharmaceuticals plc, Avadel US Holdings, Inc., Avadel Specialty Pharmaceuticals, LLC, Avadel Legacy Pharmaceuticals, LLC, and Avadel Management Corporation. A corresponding order was entered in the two below cases on the same day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 25, 2022, Jazz filed an amended Answer to the Avadel Parties&#x2019; Counterclaims (&#x201c;the Jazz First Amended Answer&#x201d;). The Jazz First Amended Answer is substantially similar to the Jazz Answer except insofar as it adds an affirmative defense for judicial estoppel and unclean hands. Corresponding amended answers were filed in the two below cases on the same day.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 23, 2022, Avadel CNS filed a Renewed Motion for Judgment on the Pleadings, with respect to its counterclaim against Jazz seeking to have U.S. Patent No. 8731963 (the &#x201c;REMS Patent&#x201d;) delisted from the Orange Book and seeking to have the motion resolved concurrent with the parties&#x2019; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing on August 31, 2022. On July 7, 2022, Jazz filed a response it styled as Objections to Avadel CNS&#x2019; Motion for Judgment on the Pleadings. On July 14, 2022, Avadel CNS replied to Jazz&#x2019;s response, and on July 21, 2022, Avadel CNS requested oral argument on its delisting motion simultaneous with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing. On August 24, 2022, the Court ordered Jazz to respond substantively to Avadel CNS&#x2019; motion, which Jazz did on August 26, 2022. Avadel CNS filed its reply on August 28, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2022, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing was postponed. On September 7, 2022, the case was reassigned to a new judge, and the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing was held on October 25, 2022. At the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing, Avadel CNS reiterated its request for an expedited hearing on the Renewed Motion for Judgment on the Pleadings for the delisting of the REMS Patent. On October 28, 2022, the Court granted Avadel CNS&#x2019; request and scheduled the hearing for November 15, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Court held the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Markman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; hearing on November 15, 2022 and issued a claim construction ruling on November 18, 2022.  Also on November 18, 2022 the Court granted Avadel&#x2019;s Renewed Motion for Judgment on the Pleadings and ordered Jazz to request delisting of the REMS Patent from the Orange Book. On November 22, 2022, Jazz appealed that decision and on December 14, 2022, the Federal Circuit issued a stay of the delisting order until further notice. Oral argument was held February 14, 2023. On February 24, 2023, the United States Court of Appeals for the Federal Court affirmed the previous ruling from the Court, ordering the delisting of the REMS Patent from the Orange Book, which has since occurred. On March 7, 2023, in response to a joint stipulation filed by the parties, the Court issued an order dismissing Jazz&#x2019;s infringement claims against the Avadel Parties relating to the REMS Patent as well as Avadel Parties&#x2019; noninfringement and invalidity counterclaims relating to the REMS Patent.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 15, 2023, the parties submitted a Stipulation and Proposed Order Modifying the Case Schedule to accommodate additional claim construction proceedings.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;That stipulation remains pending before the Court. On April 26, 2023 the parties filed their Supplemental Joint Claim Construction Brief.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Second Jazz Complaint &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 4, 2021, Jazz filed another formal complaint (the &#x201c;Second Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Second Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11077079. The Second Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 9, 2021, the Avadel Parties timely filed their Answer and Counterclaims (the &#x201c;Second Avadel Answer&#x201d;) with the Court in response to the Second Complaint. The Second Avadel Answer generally denies the allegations set forth in the Second Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity of the patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 22, 2021, the Court issued an oral order stating that this case should proceed on the same schedule as the case filed on May 12, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Third Jazz Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 10, 2021, Jazz filed another formal complaint (the &#x201c;Third Complaint&#x201d;) initiating a lawsuit in the Court against the Avadel Parties. In the Third Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of U.S. Patent No. 11147782. The Third Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses. This case will proceed on the same schedule as the cases associated with the First and Second Complaints above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 21, 2021, the Court entered a revised schedule for the First, Second and Third Complaints, setting a new claim construction date of August 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 7, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#x201c;Third Avadel Answer&#x201d;) with the Court in response to the Third Complaint. The Third Avadel Answer generally denies the allegations set forth in the Third Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims seeking i) a declaratory judgment of non-infringement of the patent-in-suit, and ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fourth Jazz Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 15, 2022, Jazz filed another formal complaint (the &#x201c;Fourth Complaint&#x201d;) initiating a lawsuit in the Court against Avadel CNS. In the Fourth Complaint, Jazz alleges the Proposed Product described in the NDA owned by Avadel CNS will infringe at least one claim of the REMS Patent, which was asserted in the First Complaint. The FDA required Avadel CNS to file a Paragraph IV certification against the REMS Patent, which Avadel CNS did under protest, consistent with its Renewed Motion for Judgment on the Pleadings for the delisting of the REMS Patent from the Orange Book, which was later ordered to be delisted in the above First Jazz Complaint action. Avadel CNS provided the required notice of its Paragraph IV certification to Jazz, and Jazz reasserted the REMS Patent in a separate action following receipt of that notice. The Fourth Complaint further includes typical relief requests such as preliminary and permanent injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On September 21, 2022, Jazz served the Fourth Complaint.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On October 21, 2022, Avadel CNS timely filed its Answer and Counterclaims (the &#x201c;Fourth Avadel Answer&#x201d;) with the Court in response to the Fourth Complaint.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Fourth Avadel Answer generally denies the allegations set forth in the Fourth Complaint, includes numerous affirmative defenses (including, but not limited to, non-infringement and invalidity of the patent-in-suit), and asserts a number of counterclaims for i) a declaratory judgment of non-infringement of the patent-in-suit,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ii) a declaratory judgment of invalidity/unenforceability of the patent-in-suit, iii) delisting of the patent-in-suit from the Orange Book; iv) monopolization under the Sherman Antitrust Act of 1890 (the &#x201c;Sherman Act&#x201d;); and v) attempted monopolization under the Sherman Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On December 9, 2022, Jazz filed a Motion to Dismiss Avadel&#x2019;s Antitrust Counterclaims.  Avadel filed its opposition brief on December 27, 2022, and Jazz filed its reply brief on January 6, 2022.  On January 11, 2023, Avadel filed a request for oral argument on the motion, which is still pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On March 6, 2023, the parties filed a stipulation of dismissal, dismissing Jazz&#x2019;s claims with respect to the REMS Patent and Avadel&#x2019;s related non-infringement and invalidity counterclaims.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Court entered that stipulation on March 7, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Avadel Complaint&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 14, 2022, Avadel CNS and Avadel Pharmaceuticals plc (collectively the &#x201c;Avadel Plaintiffs&#x201d;) filed a formal complaint (the &#x201c;Avadel Complaint&#x201d;) initiating a lawsuit in the Court against Jazz and Jazz Pharmaceuticals Ireland Ltd. (collectively, the &#x201c;Jazz Parties&#x201d;). In the Avadel Complaint, the Avadel Plaintiffs allege that the Jazz Parties breached certain confidential disclosure agreements and misappropriated certain of the Avadel Plaintiffs&#x2019; trade secrets. The Avadel Complaint further &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;includes typical relief requests such as injunctive relief, monetary damages and attorneys&#x2019; fees, costs and expenses, as well as seeking correction of inventorship of certain Jazz patents, for which the Jazz Parties claim ownership, to include former Avadel Plaintiffs&#x2019; scientists.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 2, 2022, Jazz answered the Avadel Complaint. The Answer generally denies the allegations set forth in the Avadel Complaint and includes various affirmative defenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 8, 2022, Jazz filed a Motion for Judgment on the Pleadings seeking to have all Counts dismissed for failure to state a claim upon which relief can be granted. The Avadel Plaintiffs&#x2019; response to that Motion was filed with the Court on July 29, 2022. Jazz&#x2019;s reply was filed with the Court on August 5, 2022. On February 2, 2023, the Court held a hearing on Jazz&#x2019;s Motion for Judgment on the Pleadings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 7, 2022, the case was reassigned to a new judge.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On February 2, 2023, the Court held a hearing on Jazz&#x2019;s Motion for Judgment on the Pleadings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Administrative Procedure Act&lt;/span&gt;&lt;span style="color:#0d0d0d;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 21, 2022, Avadel CNS filed an Administrative Procedure Act suit against the FDA, the U.S. Department of Health and Human Services, the Secretary of Health and Human Services and the Commissioner of Food and Drugs (the &#x201c;Federal Defendants&#x201d;) in the United States District Court for the District of Columbia (the &#x201c;DC Court&#x201d;) related to the NDA for LUMRYZ (sodium oxybate). This suit alleges that the FDA&#x2019;s decision requiring Avadel CNS to file a patent certification concerning the REMS Patent was arbitrary, capricious and contrary to law and asks the DC Court to vacate the FDA&#x2019;s decision and order the FDA to take final action on the LUMRYZ NDA. On July 28, 2022, the DC Court granted Jazz&#x2019;s unopposed motion to intervene in the case to defend the FDA&#x2019;s decision. The DC Court also entered an expedited briefing schedule governing Avadel CNS&#x2019;s motion for preliminary injunction or, in the alternative, summary judgment, and the Federal Defendant&#x2019;s and Jazz&#x2019;s oppositions to that motion and anticipated cross-motions for summary judgment. On August 19, 2022, the Federal Defendants and Jazz filed their combined oppositions to Avadel CNS&#x2019;s motion for preliminary injunction or, in the alternative, summary judgment, and cross-motions for summary judgment. On September 2, 2022, Avadel CNS filed its combined reply in support of its motion for preliminary injunction or, in the alternative, summary judgment, and opposition to the cross-motions for summary judgment. On September 14, 2022, the Federal Defendants and Jazz filed their replies in support of their cross-motions for summary judgment. On October 7, 2022, the DC Court heard oral arguments of Avadel CNS&#x2019;s motion and the Federal Defendants and Jazz&#x2019;s cross-motions. On November 3, 2022, the DC Court issued its opinion determining that Avadel CNS is not entitled to seek relief under the APA because of the availability of adequate alternative relief in the Court, specifically, in the form of its counterclaim to have the REMS Patent delisted from the FDA&#x2019;s Orange Book described above in the section regarding the First Jazz Complaint.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Material Commitments &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than commitments disclosed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 11: Contingent Liabilities and Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to the Company's consolidated financial statements included in the 2022 Annual Report on Form 10-K, there were no other material commitments outside of the normal course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the Company&#x2019;s guarantee to Deerfield Capital L.P. (&#x201c;Deerfield&#x201d;) and the guarantee received by the Company from Armistice Capital Master Fund, Ltd. largely offset and when combined are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deerfield Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Company&#x2019;s February 2018 divestiture of its pediatric assets, including four pediatric commercial stage assets &#x2013; Karbinal&#x2122; ER, Cefaclor, Flexichamber&#x2122; and AcipHex&#xae; Sprinkle&#x2122; (&#x201c;FSC products&#x201d;), to Cerecor, Inc. (&#x201c;Cerecor&#x201d;), the Company guaranteed to Deerfield a quarterly royalty payment of 15% on net sales of the FSC products through February 6, 2026 (&#x201c;FSC Product Royalties&#x201d;), in an aggregate amount of up to approximately $10,300. Given the Company&#x2019;s explicit guarantee to Deerfield, the Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee liability was $703 at March&#160;31, 2023.  This liability is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Armistice Guarantee&lt;/span&gt;&lt;/div&gt;In connection with the Company&#x2019;s February 2018 divestiture of the pediatric assets, Armistice Capital Master Fund, Ltd., the majority shareholder of Cerecor, guaranteed to the Company the FSC Product Royalties. The Company recorded the guarantee in accordance with ASC 460. The balance of this guarantee asset was $702 at March&#160;31, 2023. This asset is being amortized proportionately based on undiscounted cash outflows through the remainder of the contract with Deerfield noted above.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <avdl:PercentageOfRoyaltyPayableOnNetSales
      contextRef="ib86ab8d9c4634403b053a99efce9ad0f_D20180201-20180228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfNTQ5NzU1ODQ5MjI2_f7cc511e-92a6-4722-8248-ecfbe5333360"
      unitRef="number">0.15</avdl:PercentageOfRoyaltyPayableOnNetSales>
    <avdl:RoyaltyPayableonNetSalesMaximum
      contextRef="ib86ab8d9c4634403b053a99efce9ad0f_D20180201-20180228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfNTQ5NzU1ODQ5MzYx_a3ae7d1d-003f-4df5-8b3b-a47462085c28"
      unitRef="usd">10300000</avdl:RoyaltyPayableonNetSalesMaximum>
    <us-gaap:GuarantyAssets
      contextRef="ieee9f18c297a4b43b9cc2748153d6ed6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfMjE5OTAyMzI5NTA2Ng_94f545e2-8e98-4e43-bd80-97c04338e0a4"
      unitRef="usd">703000</us-gaap:GuarantyAssets>
    <us-gaap:GuarantyLiabilities
      contextRef="ifd63efb1c00f48f3823eae02ac5437c1_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182MS9mcmFnOjNiN2ZkYzBhMzEzZTRlYjViY2YwNmU4YjcyN2UxMDRjL3RleHRyZWdpb246M2I3ZmRjMGEzMTNlNGViNWJjZjA2ZThiNzI3ZTEwNGNfMjE5OTAyMzI5NTA2Mg_c3a7c5de-d58f-4b89-8cc2-7b293cd6c59a"
      unitRef="usd">702000</us-gaap:GuarantyLiabilities>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV80Mzk4MDQ2NTEyMTY5_ea418790-2ad6-4bac-a467-5892c5bd4e85">Restructuring Costs&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Corporate Restructuring Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company announced a plan to optimize its cost structure to reduce total quarterly cash operating expenses, excluding inventory purchases. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cost structure optimization efforts included a nearly 50% reduction in its workforce that was completed at the end of August 2022 (the &#x201c;2022 Corporate Restructuring Plan&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s 2022 Corporate Restructuring Plan obligations as of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022 Corporate Restructuring Plan Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2022 Corporate Restructuring Plan liabilities of $207 are included in the unaudited condensed consolidated balance sheet in accrued expenses at March 31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent
      contextRef="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV81NDk3NTU4MTQyMzM_e0907bf9-c1f2-497b-bd1f-1646ba8a414b"
      unitRef="number">0.50</avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV80Mzk4MDQ2NTEyMTcw_785237b8-3423-45f1-845d-b75f7dadf5b7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth activities for the Company&#x2019;s 2022 Corporate Restructuring Plan obligations as of March 31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.913%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022 Corporate Restructuring Plan Obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at January 1,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Charges for employee severance, benefits and other costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance of 2022 Corporate Restructuring Plan accrual at March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ib4b8d582396945bdab449e41a5853249_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl8yLTItMS0xLTgzNTM0_bc2a7693-9e92-4ca8-a1e9-30b6e1614fe2"
      unitRef="usd">435000</us-gaap:RestructuringReserve>
    <avdl:RestructuringChargesBeforeGainLossDuetoCurtailment
      contextRef="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl8zLTItMS0xLTgzNTM0_2646bd3d-e697-4af3-947e-e3ab9e6b51c3"
      unitRef="usd">0</avdl:RestructuringChargesBeforeGainLossDuetoCurtailment>
    <us-gaap:PaymentsForRestructuring
      contextRef="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl80LTItMS0xLTgzNTM0_fba9906e-ccc9-42ba-965f-c664ba00141a"
      unitRef="usd">228000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl81LTItMS0xLTgzNTM0_7c3725c3-b962-4133-8207-361d197a41dd"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGFibGU6YmRkMTRkN2M0ZTM0NDgxYTg4MmJjZmFiMzVlMzRiMjYvdGFibGVyYW5nZTpiZGQxNGQ3YzRlMzQ0ODFhODgyYmNmYWIzNWUzNGIyNl82LTItMS0xLTg0MDI0_29a80633-9385-4331-aea7-e1641010d02f"
      unitRef="usd">207000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ibb6e95646d3a4db3bae727414fbd7a2c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY18xMTIyL2ZyYWc6MTkxMDNjMTg3ZjZhNDZkNDhhZGE3ODY1ODdhMTk4YWUvdGV4dHJlZ2lvbjoxOTEwM2MxODdmNmE0NmQ0OGFkYTc4NjU4N2ExOThhZV8zODQ4MjkwNjk4NzI2_031b0827-5c09-4379-905d-89eb908f942c"
      unitRef="usd">207000</us-gaap:RestructuringReserve>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMTM1Mw_c87070b2-6689-4a3e-b4fc-cdf5fb2c63d0">Subsequent Events&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Over the course of April 3 and April 4, 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;the Issuer completed an exchange of $96,188 of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;its $117,375 October 2023 Notes. The $96,188 of notes were exchanged for $106,268 of a new series of 6.0% exchangeable notes due April 2027 (the &#x201c;April 2027 Notes&#x201d;). The remaining $21,187 aggregate principal amount of the October 2023 Notes will mature October 2, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On April 3 2023, the Company completed the sale of ordinary shares, nominal value $0.01 per share (&#x201c;Ordinary Shares&#x201d;) in the form of ADSs and Series B Preferred Shares in an underwritten public offering. The Company issued 4,706 Series B Preferred Shares and 12,205 of its ADSs and received net proceeds from the equity financing of $135,125, of which $40,000 was received on March 31, 2023 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$95,125&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; was received on April 3, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On May 1, 2023, LUMRYZ was approved by the FDA. At that time, the FDA granted Orphan Drug Exclusivity (&#x201c;ODE&#x201d;) to LUMRYZ for a period of seven years until May 1, 2030.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i3eb511cdd4014d98821a17670a113607_D20230404-20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfNTQ5NzU1ODE2NTU1_f6cefa4e-234a-450c-a593-dd1f992ba21c"
      unitRef="usd">96188000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifd1c37ae66634e459ee51595272f19f9_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfNTQ5NzU1ODE2NTYx_1f64595f-5eaa-4fca-970a-4d7ebe795b3d"
      unitRef="usd">117375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i38b943b369fe40318b5dc1a1abcb5786_D20230403-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzY4Mw_35b23e9f-3256-40f2-a7ef-c5bb05ee598c"
      unitRef="usd">96188000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ife27a702c1604bfaab93fe6b27c28f80_I20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzY5Mg_bbb8aacd-7965-4995-9663-298e97c35ede"
      unitRef="usd">106268000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i26f74d8cc0d245b9946db9086ec31c5f_I20230404"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcwMg_9f9b4492-b9aa-4426-b459-dad911a238e8"
      unitRef="number">0.060</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i8fdfb2995db447c186216c675ed244de_I20230404"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcwOA_46cc133a-7027-43b7-86b4-bcfa65a90651"
      unitRef="usd">21187000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7323a019b2284fc9b9e443691e400926_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwNDM1MA_f643b972-760e-4858-b053-36b5e2007b25"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ide7281a9b4cc4e4a95874ed482a2c8f6_D20230403-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcxNw_e8b3518f-22f3-435c-815f-d2be418720c4"
      unitRef="shares">4706000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="if79cc4b4f8a24f1db47139a8b309feab_D20230403-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzczNw_001b56a6-460a-41da-9212-1c92ad3c3508"
      unitRef="shares">12205000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i472c73ab7bb046679dab57540005d848_D20230329-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwMzcyNA_2a137925-6580-48f7-be7f-6358402afc7e"
      unitRef="usd">135125000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i9961149acfda4623881e412da9b843c4_D20230331-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzI5ODUzNDg4OTcxMA_14b3696a-d02f-4a05-abe9-b40cd8a92949"
      unitRef="usd">40000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="iaaa294d327ad4af790c20a25c207e257_D20230403-20230403"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzI5ODUzNDg4OTc0OQ_c787afb6-4b58-46b7-b70b-b204831a02e5"
      unitRef="usd">95125000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <avdl:OrphanDrugExclusivityTerm
      contextRef="i23c52e144f274ff58d06a0258a38c8ec_D20230501-20230501"
      id="id3VybDovL2RvY3MudjEvZG9jOjI1MDg5N2RkZDk0OTQyOTU4ZDg2ZmE2ZGZlNzgxOGFjL3NlYzoyNTA4OTdkZGQ5NDk0Mjk1OGQ4NmZhNmRmZTc4MThhY182NC9mcmFnOjg2ZGM1MTYxMWEzYzQ4NTdiOWM0NGVmMmU5OGM2ZDEzL3RleHRyZWdpb246ODZkYzUxNjExYTNjNDg1N2I5YzQ0ZWYyZTk4YzZkMTNfMzg0ODI5MDcwNDM3Nw_0187ecc3-7e32-471b-8a2b-bfe9ea267780">P7Y</avdl:OrphanDrugExclusivityTerm>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>60
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M^U.L3AF7UBU2>#:-IRY!NWXM]%KM>M?='=*WF 7->O#;[(A8HR+6N)BAF4I
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M_:3:@$$<$#)0[FC;05!W!]%ENCVR$@64E&7]7F$-TB>4_333[!+&)/1(_Y3
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M%^\GVP4M"HAW%^R'5.S MSTDAJ;6!ZB?R"/K*?!3QU*Z3;=;]A+M%,90D@J
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MW7;#S,#3M-,-MZB5:>C"OB'SW^HXA1)/Z$P -/<<9<$P%P?%EN1E%&UM^"&
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M &]XTW"7TS1 ;3,V-^Q"?VRC-4/B0,2CSIS&EG/.YM8EN9^.C'6=6V+2HY.
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M7 BJV^#L1PY;YZ46)J%?@&&:<8I2Z3F:[_(TI,&CNKV,CBN#I05(.T WM-A
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MV( .-PX+_*1@)P>PGUL;MA,QL/N1,O\'4$L#!!0    ( -N!I%;#6Q&D(0X
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M!$($$/@B\P,^4J>A"$F[(3I0+'7+6F;S#<-WX;3S0> I$\YT:+;RY;;'QY(
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M _V2!H#>,5G<HLCR+8ZK[6';:"@J(SF'T<VBFM]L%-8;X:96@@KJ2J@Q.L,
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M;"]W;W)K<VAE971S+W-H965T,30N>&ULE59MC]LV#/XKA#OTDW>V9<5.TB1
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M=G@/AF&!!S@9+X#]E4:XZHDWT#SIY_\ 4$L#!!0    ( -N!I%:T-C23F ,
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MX4]ES#RVA.MNXZ+#6 >,[!&,'-XK:6L#[V2)Y<_R,?'I264/I-;9DX#OF;Z
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M1:(:#GLIOE,T)V]!3FY)/HJ6JE><3%%QY3/_0 *H_-MH.)@,A[ +"+;_]P0
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;)56:8_;-A#]*P/%#5)
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MB #?KM3Q^-FO8N84A%P =\=C7KNG93>ES)[]C3<,Q5"(P'&[&8).A$R >=N
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M-MW8\\5O2I?)#.8HF,4,QNYZ<,O1P/?Q@E!T7W[LJT 3H+<_@.NA@:E8BJ.
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M+W-H965T,CDN>&ULS5EM;]LV$/XKA%8,+9!%(OV:S!;0)"A:(!F"I.T^#/O
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M]_-;35'8LDQXA=)P)4'CM!^<QB>#S.7[A >.2[.V!E?)6*E'%UQ.^D'D!*'
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MTJ3QRY*^!:A= KV?*NKC)G#CIOVZY+\ 4$L#!!0    ( -N!I%9/-ZW9+P,
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MQSV5'2]:QV(BV3+OOJ9,JEXN'RY4NPU<!ZCW,\;DXT0W=%4#'_X%4$L#!!0
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M4AKL/VZ8XQ\"E W _9649C>Q"=I_3O(;4$L#!!0    ( -N!I%94L:W8H 0
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M>:7-T+<YF10+#8FUR(YJLB.C+7YDDJ))L="06(OBN*8XUEZ?MYE<AL %8D1
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MK^^2D@7'88P6Z(O$8V<XLR27XXU4#[H",.2QYD)/@LJ8U2@,=5%!3?697('
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M!-($Z/FU$'C?,<6O>^N2OU!+ P04    " #;@:16/P17E&@"  !R!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6RM56MOVC 4_2M65DVMM#8A"; Q
MB%1 >TA[5*7=/IOD0JPZ=F;? /OWLYV001?0)NU+XFO?<WS.M7P]WDKUI',
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ME,F4,R3H9F[<X.F*6(5#:?%G2H^R\XR*J:PY?RP:O\1SPRH8T8Q&JH (X>]
M5S3+"B3@\4\-:C1C%H[=YR?TG\K)PV36H:0KGOV5QBJ9&X&!8KH)]YGZS(\_
MTWI";H$7\4R6O^A8V7J^@:*]5#ROG8%!GK+J/_Q2"]%Q !R] ZD=R-#!.>%@
MUPYV.=&*63FMVU"%BYG@1R0*:T K'DIM2F^83<J*SWBO!+Q-P4\M5CR'SY\4
MW^5 T:]<2G2%BD[.*%,27=Q2%::9O(3NA_M;=/'A$GU *4-_)'PO0Q;+F:F
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M?%$[!SI?*'HH[<8%Z.0\^P-02P,$%     @ VX&D5JR9MQK! P  .A,  !D
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M>Z^=M"R9P:D27WEARTEP'D"!*]8(NU";*^STG#J^7 GC?V'3Y48!Y(VQJNK
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M-+S?5GJPEG]4.NJ5C@XJW7WC'?\^(2W->$M(')W](>3OG%'R6VQ;7[C5Q&Z
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M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-V3MNPD 4A>&M("^
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M'9>DWCK2N2^(0EVENZ+]\\DA[C#MKOSJ_*[,N< X<^:,]?'$'%T>=SB2=O7
MQD+D0GG^$X^)L?35WT?M:>>4_S([;N^'<<ON/#SK;M?O\=<S/M:_L \!TH<$
MZ4.!]'$#TL<(I(];D#[N0/JX!^F##U$:01&5HY#*44SE**AR%%4Y"JL<Q56.
M BM'D56@R"I09!4HL@H4606*K )%5H$BJT"15:#(*E!DE2BR2A19)8JL$D56
MB2*K1)%5HL@J4625*+)*%%D5BJP*15:%(JM"D56AR*I09%4HLBH46=5_ROIN
MS/*O_\"U][3697/(9]UOSNDG4$L! A0#%     @ VX&D5@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" #;@:16N;T/X>\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " #;@:16F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( -N!I%::
M,,!W808  ),C   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " #;@:16L9*+,Q\$   ^#@  &
M    @(&E#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @
MVX&D5JYTH'I5 P  UPD  !@              ("!^A(  'AL+W=O<FMS:&5E
M=',O<VAE970S+GAM;%!+ 0(4 Q0    ( -N!I%8G8+&/JP(   L&   8
M          " @846  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4
M    " #;@:16^;ZL'7P&  !@&P  &               @(%F&0  >&PO=V]R
M:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ VX&D5NAN8_$# P  @0H
M !@              ("!&"   'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+
M 0(4 Q0    ( -N!I%:L[-.2_@<  &<\   8              " @5$C  !X
M;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " #;@:162<TX)N\&
M  #S'   &               @(&%*P  >&PO=V]R:W-H965T<R]S:&5E=#@N
M>&UL4$L! A0#%     @ VX&D5D99(/$&#@  SR0  !@              ("!
MJC(  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( -N!I%;L
M&.IQT@<  .X3   9              " @>9   !X;"]W;W)K<VAE971S+W-H
M965T,3 N>&UL4$L! A0#%     @ VX&D5N\9WL'^!   L P  !D
M     ("![T@  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -N!I%:T-C23F ,  #T(   9              "
M@39I  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ VX&D
M5IOK?FJ<%   9$D  !D              ("!!6T  'AL+W=O<FMS:&5E=',O
M<VAE970Q-RYX;6Q02P$"% ,4    " #;@:16CJ'6?YX#  "9"   &0
M        @('8@0  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0
M   ( -N!I%9M$W'DZ@,  (8(   9              " @:V%  !X;"]W;W)K
M<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ VX&D5M^WK#@:"   VA,
M !D              ("!SHD  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q0
M2P$"% ,4    " #;@:16]XT9AAT#   R!P  &0              @($?D@
M>&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( -N!I%:$W8P[
M' ,  (P'   9              " @7.5  !X;"]W;W)K<VAE971S+W-H965T
M,C(N>&UL4$L! A0#%     @ VX&D5BOB-K0* P  JP8  !D
M ("!QI@  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " #;
M@:16]17DQ00$  "?"P  &0              @($'G   >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( -N!I%;GH6#R @,  ,H&   9
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M970R.2YX;6Q02P$"% ,4    " #;@:16J)8&'IP"  !I!@  &0
M    @(%FO0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    (
M -N!I%9/-ZW9+P,  ,P+   9              " @3G   !X;"]W;W)K<VAE
M971S+W-H965T,S$N>&UL4$L! A0#%     @ VX&D5@Z?H.&* @  ?P8  !D
M             ("!G\,  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"
M% ,4    " #;@:165+&MV* $  !.&@  &0              @(%@Q@  >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( -N!I%;('&SJQ@\
M $_H   9              " @3?+  !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&UL4$L! A0#%     @ VX&D5A2U'GU] @  3P8  !D              ("!
M--L  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #;@:16
M20JIK[ "  #%!P  &0              @('HW0  >&PO=V]R:W-H965T<R]S
M:&5E=#,V+GAM;%!+ 0(4 Q0    ( -N!I%8@ZD>_H@(  "H'   9
M      " @<_@  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%
M  @ VX&D5IFSX%ZT @  O <  !D              ("!J.,  'AL+W=O<FMS
M:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " #;@:16,$K(GXD"  #W!@
M&0              @(&3Y@  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+
M 0(4 Q0    ( -N!I%8_!%>4: (  '(&   9              " @5/I  !X
M;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ VX&D5DOGHNZ)
M P  ^ H  !D              ("!\NL  'AL+W=O<FMS:&5E=',O<VAE970T
M,2YX;6Q02P$"% ,4    " #;@:16"W.*E(0"  #Z!0  &0
M@(&R[P  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( -N!
MI%:O$F0#'00  'D2   9              " @6WR  !X;"]W;W)K<VAE971S
M+W-H965T-#,N>&UL4$L! A0#%     @ VX&D5G1^_Y.( @  V@4  !D
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M=#0X+GAM;%!+ 0(4 Q0    ( -N!I%8<Q0^@'@,  $@1   -
M  "  5D, 0!X;"]S='EL97,N>&UL4$L! A0#%     @ VX&D5I>*NQS
M$P(   L              ( !H@\! %]R96QS+RYR96QS4$L! A0#%     @
MVX&D5BAB*BP+!   ."    \              ( !BQ ! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( -N!I%:2+*"6N $  .<<   :              "
M <,4 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( -N!
MI%:,3^J/N@$  .X<   3              "  ;,6 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     X #@ /P\  )X8 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>110</ContextCount>
  <ElementCount>214</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>36</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/Coverpage</Role>
      <ShortName>Cover page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical</Role>
      <ShortName>UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS??? (DEFICIT) EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Fair Value Measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurement</Role>
      <ShortName>Fair Value Measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Other Assets and Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilities</Role>
      <ShortName>Other Assets and Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLoss</Role>
      <ShortName>Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Restructuring Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCosts</Role>
      <ShortName>Restructuring Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Fair Value Measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementTables</Role>
      <ShortName>Fair Value Measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/FairValueMeasurement</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/MarketableSecurities</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/LongTermDebt</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Other Assets and Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesTables</Role>
      <ShortName>Other Assets and Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/OtherAssetsandLiabilities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/NetLossPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLossTables</Role>
      <ShortName>Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/ComprehensiveLoss</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Restructuring Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsTables</Role>
      <ShortName>Restructuring Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.avadel.com/role/RestructuringCosts</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurement - Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Fair Value Measurement - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/FairValueMeasurementNarrativeDetails</Role>
      <ShortName>Fair Value Measurement - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Marketable Securities - Summary of Available-for-sale and Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails</Role>
      <ShortName>Marketable Securities - Summary of Available-for-sale and Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Long-Term Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails</Role>
      <ShortName>Other Assets and Liabilities - Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>Other Assets and Liabilities - Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Net Loss Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/NetLossPerShareNarrativeDetails</Role>
      <ShortName>Net Loss Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Comprehensive Loss - Components (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLossComponentsDetails</Role>
      <ShortName>Comprehensive Loss - Components (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Comprehensive Loss - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/ComprehensiveLossNarrativeDetails</Role>
      <ShortName>Comprehensive Loss - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/CommitmentsandContingencies</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Restructuring Costs - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsNarrativeDetails</Role>
      <ShortName>Restructuring Costs - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Restructuring Costs - Severance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails</Role>
      <ShortName>Restructuring Costs - Severance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="avdl-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avadel.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.avadel.com/role/SubsequentEvents</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="avdl-20230331.htm">avdl-20230331.htm</File>
    <File>avdl-20230331.xsd</File>
    <File>avdl-20230331_cal.xml</File>
    <File>avdl-20230331_def.xml</File>
    <File>avdl-20230331_lab.xml</File>
    <File>avdl-20230331_pre.xml</File>
    <File>exhibit311q12023.htm</File>
    <File>exhibit312q12023.htm</File>
    <File>exhibit321q12023.htm</File>
    <File>exhibit322q12023.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="413">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>65
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "avdl-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 17,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 413,
    "http://xbrl.sec.gov/dei/2022": 32
   },
   "contextCount": 110,
   "dts": {
    "calculationLink": {
     "local": [
      "avdl-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "avdl-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "avdl-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "avdl-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avdl-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "avdl-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd"
     ]
    }
   },
   "elementCount": 346,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 6,
    "total": 6
   },
   "keyCustom": 37,
   "keyStandard": 177,
   "memberCustom": 16,
   "memberStandard": 20,
   "nsprefix": "avdl",
   "nsuri": "http://www.avadel.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.avadel.com/role/Coverpage",
     "shortName": "Cover page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Fair Value Measurement",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.avadel.com/role/FairValueMeasurement",
     "shortName": "Fair Value Measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Marketable Securities",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.avadel.com/role/MarketableSecurities",
     "shortName": "Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.avadel.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.avadel.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Other Assets and Liabilities",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilities",
     "shortName": "Other Assets and Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.avadel.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Comprehensive Loss",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.avadel.com/role/ComprehensiveLoss",
     "shortName": "Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.avadel.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Restructuring Costs",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.avadel.com/role/RestructuringCosts",
     "shortName": "Restructuring Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.avadel.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF LOSS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:NatureOfBusinessPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Fair Value Measurement (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.avadel.com/role/FairValueMeasurementTables",
     "shortName": "Fair Value Measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Marketable Securities (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.avadel.com/role/MarketableSecuritiesTables",
     "shortName": "Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Long-Term Debt (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.avadel.com/role/LongTermDebtTables",
     "shortName": "Long-Term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Other Assets and Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables",
     "shortName": "Other Assets and Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.avadel.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Comprehensive Loss (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.avadel.com/role/ComprehensiveLossTables",
     "shortName": "Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Restructuring Costs (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.avadel.com/role/RestructuringCostsTables",
     "shortName": "Restructuring Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i62caf1e030104340aab6ddd08244c618_D20200205-20200205",
      "decimals": "3",
      "lang": "en-US",
      "name": "avdl:SaleOfStockSalesAgentCommissionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Fair Value Measurement - Measured on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
     "shortName": "Fair Value Measurement - Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i0b9a4e9f1f88462cab7139b14d632c0a_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ifd1c37ae66634e459ee51595272f19f9_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Fair Value Measurement - Narrative (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
     "shortName": "Fair Value Measurement - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ifd1c37ae66634e459ee51595272f19f9_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Marketable Securities - Summary of Available-for-sale and Equity Securities (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails",
     "shortName": "Marketable Securities - Summary of Available-for-sale and Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Marketable Securities - Narrative (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails",
     "shortName": "Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Long-Term Debt - Schedule of Debt (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
     "shortName": "Long-Term Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Long-Term Debt - Narrative (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:CouponInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Income Taxes - Narrative (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.avadel.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "avdl:ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Other Assets and Liabilities - Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails",
     "shortName": "Other Assets and Liabilities - Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:OtherGuarantorObligationsCurrentCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Other Assets and Liabilities - Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:OtherGuarantorObligationsCurrentCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical",
     "shortName": "UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails",
     "shortName": "Other Assets and Liabilities - Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "avdl:TaxLiabilitiesAndOtherNoncurrentLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Reconciliation of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Net Loss Per Share - Narrative (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.avadel.com/role/NetLossPerShareNarrativeDetails",
     "shortName": "Net Loss Per Share - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i89062f4901fb4064b1b764e65dc9de58_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Comprehensive Loss - Components (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.avadel.com/role/ComprehensiveLossComponentsDetails",
     "shortName": "Comprehensive Loss - Components (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i5886c0d106614c858fffef30aab67fd4_I20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Comprehensive Loss - Narrative (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.avadel.com/role/ComprehensiveLossNarrativeDetails",
     "shortName": "Comprehensive Loss - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuarantyLiabilities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.avadel.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ifd63efb1c00f48f3823eae02ac5437c1_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GuarantyLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ibb6e95646d3a4db3bae727414fbd7a2c_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Restructuring Costs - Narrative (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
     "shortName": "Restructuring Costs - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ibb6e95646d3a4db3bae727414fbd7a2c_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "avdl:RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ib4b8d582396945bdab449e41a5853249_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Restructuring Costs - Severance Obligation (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails",
     "shortName": "Restructuring Costs - Severance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i6b2aa1c6d1c74e0b80b3efe83cbb8420_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:RestructuringChargesBeforeGainLossDuetoCurtailment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.avadel.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "ide7281a9b4cc4e4a95874ed482a2c8f6_D20230403-20230403",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "avdl:ResearchAndDevelopmentTaxCreditReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i7323a019b2284fc9b9e443691e400926_I20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i78f1152e9a48466b8a215efaaae5e183_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 (DEFICIT) EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS\u2019 (DEFICIT) EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "i78f1152e9a48466b8a215efaaae5e183_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "avdl-20230331.htm",
      "contextRef": "if9441dd4d7a047b590091d8b2e03c259_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 36,
   "tag": {
    "avdl_A2016MIPAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2016 MIPA [Member]",
        "label": "2016 MIPA [Member]",
        "terseLabel": "2016 MIPA"
       }
      }
     },
     "localname": "A2016MIPAMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A2020ShelfRegistrationStatementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Shelf Registration Statement",
        "label": "2020 Shelf Registration Statement [Member]",
        "terseLabel": "2020 Shelf Registration Statement"
       }
      }
     },
     "localname": "A2020ShelfRegistrationStatementMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A2022CorporateRestructuringPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Corporate Restructuring Plan",
        "label": "2022 Corporate Restructuring Plan [Member]",
        "terseLabel": "2022 Corporate Restructuring Plan"
       }
      }
     },
     "localname": "A2022CorporateRestructuringPlanMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A2022ShelfRegistrationStatementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Shelf Registration Statement",
        "label": "2022 Shelf Registration Statement [Member]",
        "terseLabel": "2022 Shelf Registration Statement"
       }
      }
     },
     "localname": "A2022ShelfRegistrationStatementMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDueFebruary2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Point Fifty Percent Exchangeable Senior Notes Due 2023 [Member]",
        "label": "4.50 Percent Exchangeable Senior Notes Due February 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due February 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDueFebruary2023Member",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_A450PercentExchangeableSeniorNotesDueOctober22023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.50 Percent Exchangeable Senior Notes Due October 2 2023",
        "label": "4.50 Percent Exchangeable Senior Notes Due October 2 2023 [Member]",
        "terseLabel": "4.50% Exchangeable Senior Notes Due October 2023"
       }
      }
     },
     "localname": "A450PercentExchangeableSeniorNotesDueOctober22023Member",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest, Current",
        "label": "Accrued Interest, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterestCurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AccruedOutsourceContractCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Outsource Contract Costs",
        "label": "Accrued Outsource Contract Costs",
        "terseLabel": "Accrued outsourced contract manufacturing costs"
       }
      }
     },
     "localname": "AccruedOutsourceContractCosts",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature",
        "label": "Adjustments to Additional Paid in Capital, Adjustments In Fair Value Of Convertible Debt Conversion Feature",
        "terseLabel": "Change in fair value of notes conversion feature"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalAdjustmentsInFairValueOfConvertibleDebtConversionFeature",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares [Member]",
        "label": "American Depositary Shares [Member]",
        "terseLabel": "American Depositary Shares"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AmericanDepositarySharesOptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Option Price Per Share",
        "label": "American Depositary Shares, Option Price Per Share",
        "terseLabel": "ADS, option price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesOptionPricePerShare",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositarySharesPremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares, Premium Percentage",
        "label": "American Depositary Shares, Premium Percentage",
        "terseLabel": "ADS premium percentage"
       }
      }
     },
     "localname": "AmericanDepositarySharesPremiumPercentage",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_AmericanDepositarySharesPurchasedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares Purchased, Price Per Share",
        "label": "American Depositary Shares Purchased, Price Per Share",
        "terseLabel": "ADS purchased, price per share (in dollars per share)"
       }
      }
     },
     "localname": "AmericanDepositarySharesPurchasedPricePerShare",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "avdl_AmericanDepositorySharesConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depository Shares, Conversion Ratio",
        "label": "American Depository Shares, Conversion Ratio",
        "terseLabel": "ADSs, conversion ratio"
       }
      }
     },
     "localname": "AmericanDepositorySharesConversionRatio",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "avdl_April2027NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "April 2027 Notes",
        "label": "April 2027 Notes [Member]",
        "terseLabel": "April 2027 Notes"
       }
      }
     },
     "localname": "April2027NotesMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_AtTheMarketOfferingProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At-The-Market Offering Program",
        "label": "At-The-Market Offering Program [Member]",
        "terseLabel": "At-The-Market Offering Program"
       }
      }
     },
     "localname": "AtTheMarketOfferingProgramMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CerecorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cerecor [Member]",
        "label": "Cerecor [Member]",
        "terseLabel": "Cerecor"
       }
      }
     },
     "localname": "CerecorMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_CouponInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coupon Interest Expense",
        "label": "Coupon Interest Expense",
        "terseLabel": "Coupon interest expense"
       }
      }
     },
     "localname": "CouponInterestExpense",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtConversionPrincipalAmountNotExchanged": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Conversion, Principal Amount Not Exchanged",
        "label": "Debt Conversion, Principal Amount Not Exchanged",
        "terseLabel": "Principal amount of debt not exchanged"
       }
      }
     },
     "localname": "DebtConversionPrincipalAmountNotExchanged",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)",
        "label": "Debt Instrument, Convertible, Embedded Conversion Feature, Increase (Decrease)",
        "terseLabel": "Increase in embedded conversion feature"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleEmbeddedConversionFeatureIncreaseDecrease",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentExchangeAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Exchange Amount",
        "label": "Debt Instrument, Exchange Amount",
        "terseLabel": "Debt instrument, exchange amount"
       }
      }
     },
     "localname": "DebtInstrumentExchangeAmount",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option To Purchase Aggregate Principal Amount, Term",
        "label": "Debt Instrument, Option To Purchase Aggregate Principal Amount, Term",
        "terseLabel": "Option to purchase aggregate principal amount, term"
       }
      }
     },
     "localname": "DebtInstrumentOptionToPurchaseAggregatePrincipalAmountTerm",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_DebtInstrumentOptiontoIncreaseFaceAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Option to Increase Face Amount",
        "label": "Debt Instrument, Option to Increase Face Amount",
        "terseLabel": "Option to increase aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentOptiontoIncreaseFaceAmount",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_FSCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "FSC [Member]",
        "label": "FSC [Member]",
        "terseLabel": "FSC"
       }
      }
     },
     "localname": "FSCMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_GuaranteeCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Current",
        "label": "Guarantee, Current",
        "terseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeCurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_GuaranteeNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Guarantee, Noncurrent",
        "label": "Guarantee, Noncurrent",
        "verboseLabel": "Guarantee from Armistice"
       }
      }
     },
     "localname": "GuaranteeNoncurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in research and development tax credit receivable.",
        "label": "Increase (Decrease) In Research and Development Tax Credit Receivable",
        "negatedTerseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_LiquidityAndGoingConcernPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liquidity and Going Concern",
        "label": "Liquidity and Going Concern [Policy Text Block]",
        "terseLabel": "Liquidity and Going Concern"
       }
      }
     },
     "localname": "LiquidityAndGoingConcernPolicyTextBlock",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration",
        "label": "Maximum Aggregate Offering Price of American Depositary Shares Under Shelf Registration",
        "terseLabel": "Maximum aggregate offering price of ADSs under shelf registration"
       }
      }
     },
     "localname": "MaximumAggregateOfferingPriceofAmericanDepositarySharesUnderShelfRegistration",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_MutualAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual And Money Market Funds",
        "label": "Mutual And Money Market Funds [Member]",
        "terseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "MutualAndMoneyMarketFundsMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_NatureOfBusinessPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for nature of business.",
        "label": "Nature Of Business Policy [Policy Text Block]",
        "verboseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfBusinessPolicyPolicyTextBlock",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "label": "Operating Lease, Right-Of-Use Asset, Contract Manufacturing, Noncurrent",
        "terseLabel": "Right of use assets at contract manufacturing organizations"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetContractManufacturingNoncurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OrphanDrugExclusivityTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orphan Drug Exclusivity, Term",
        "label": "Orphan Drug Exclusivity, Term",
        "terseLabel": "Term of orphan drug exclusivity"
       }
      }
     },
     "localname": "OrphanDrugExclusivityTerm",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "avdl_OtherGuarantorObligationsCurrentCarryingValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Guarantor Obligations, Current Carrying Value",
        "label": "Other Guarantor Obligations, Current Carrying Value",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "OtherGuarantorObligationsCurrentCarryingValue",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherLiabilitiesMiscellaneousCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Liabilities, Miscellaneous, Current",
        "label": "Other Liabilities, Miscellaneous, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLiabilitiesMiscellaneousCurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_OtherNoncurrentReceivables": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of other noncurrent receivables.",
        "label": "Other Noncurrent Receivables",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncurrentReceivables",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_PercentageOfRoyaltyPayableOnNetSales": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of royalty that has to be paid by the company as per the royalty agreement.",
        "label": "Percentage Of Royalty Payable On Net Sales",
        "terseLabel": "Percentage of royalty payable on net sales"
       }
      }
     },
     "localname": "PercentageOfRoyaltyPayableOnNetSales",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_ProceedsReceivedInAdvanceOfShareIssuance": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds Received In Advance Of Share Issuance",
        "label": "Proceeds Received In Advance Of Share Issuance",
        "terseLabel": "Proceeds received in advance of Series B Preferred Shares Issuance"
       }
      }
     },
     "localname": "ProceedsReceivedInAdvanceOfShareIssuance",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ProceedsReceivedInAdvanceOfShareIssuanceCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds Received In Advance Of Share Issuance, Current",
        "label": "Proceeds Received In Advance Of Share Issuance, Current",
        "terseLabel": "Proceeds received in advance of Series B Preferred Shares issuance"
       }
      }
     },
     "localname": "ProceedsReceivedInAdvanceOfShareIssuanceCurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_PublicStockOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering [Member]",
        "label": "Public Stock Offering [Member]",
        "terseLabel": "Public Stock Offering"
       }
      }
     },
     "localname": "PublicStockOfferingMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_PublicStockOfferingTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering, Tranche One",
        "label": "Public Stock Offering, Tranche One [Member]",
        "terseLabel": "Public Stock Offering, Tranche One"
       }
      }
     },
     "localname": "PublicStockOfferingTrancheOneMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_PublicStockOfferingTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Stock Offering, Tranche Two",
        "label": "Public Stock Offering, Tranche Two [Member]",
        "terseLabel": "Public Stock Offering, Tranche Two"
       }
      }
     },
     "localname": "PublicStockOfferingTrancheTwoMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Tax Credit Receivable, Current",
        "label": "Research And Development Tax Credit Receivable, Current",
        "terseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableCurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ResearchAndDevelopmentTaxCreditReceivableNonCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The non current portion of tax credit receivable on research and development as on the balance sheet date.",
        "label": "Research and Development Tax Credit Receivable Non Current",
        "verboseLabel": "Research and development tax credit receivable"
       }
      }
     },
     "localname": "ResearchAndDevelopmentTaxCreditReceivableNonCurrent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent",
        "label": "Restructuring And Related Costs, Expected Number Of Positions Eliminated, Percent",
        "terseLabel": "Expected number of positions eliminated (as a percent)"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostsExpectedNumberOfPositionsEliminatedPercent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_RestructuringChargesBeforeGainLossDuetoCurtailment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Before Gain (Loss) Due to Curtailment",
        "label": "Restructuring Charges Before Gain (Loss) Due to Curtailment",
        "terseLabel": "Charges for employee severance, benefits and other costs"
       }
      }
     },
     "localname": "RestructuringChargesBeforeGainLossDuetoCurtailment",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RoyaltyFinancingQuarterlyNetRevenueTarget": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Financing, Quarterly Net Revenue Target",
        "label": "Royalty Financing, Quarterly Net Revenue Target",
        "terseLabel": "Quarterly net revenue target for royalty financing"
       }
      }
     },
     "localname": "RoyaltyFinancingQuarterlyNetRevenueTarget",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_RoyaltyPayableonNetSalesMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Payable on Net Sales, Maximum",
        "label": "Royalty Payable on Net Sales, Maximum",
        "terseLabel": "Royalty payable on net sales, maximum"
       }
      }
     },
     "localname": "RoyaltyPayableonNetSalesMaximum",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Remaining Authorized Aggregate Offering Price Under Shelf Registration",
        "label": "Sale Of Stock, Remaining Authorized Aggregate Offering Price Under Shelf Registration",
        "terseLabel": "Remaining authorized aggregate offering price under shelf registration"
       }
      }
     },
     "localname": "SaleOfStockRemainingAuthorizedAggregateOfferingPriceUnderShelfRegistration",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_SaleOfStockSalesAgentCommissionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Sales Agent Commission, Percent",
        "label": "Sale Of Stock, Sales Agent Commission, Percent",
        "terseLabel": "Sales agent commission, as a percent of aggregate gross sales proceeds"
       }
      }
     },
     "localname": "SaleOfStockSalesAgentCommissionPercent",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "avdl_ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of prepaid expenses and other current assets.",
        "label": "Schedule Of Prepaid Expenses and Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "avdl_TaxLiabilitiesAndOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Liabilities And Other Noncurrent Liabilities",
        "label": "Tax Liabilities And Other Noncurrent Liabilities",
        "verboseLabel": "Tax liabilities"
       }
      }
     },
     "localname": "TaxLiabilitiesAndOtherNoncurrentLiabilities",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "avdl_ThirdPartyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Party",
        "label": "Third Party [Member]",
        "terseLabel": "Third Party"
       }
      }
     },
     "localname": "ThirdPartyMember",
     "nsuri": "http://www.avadel.com/20230331",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityListingsExchangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Listings, Exchange [Axis]",
        "terseLabel": "Entity Listings, Exchange [Axis]"
       }
      }
     },
     "localname": "EntityListingsExchangeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Smaller Reporting Company"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_ExchangeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383.",
        "label": "Exchange [Domain]",
        "terseLabel": "Exchange [Domain]"
       }
      }
     },
     "localname": "ExchangeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag",
        "terseLabel": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "exch_XNMS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NASDAQ/NMS (GLOBAL MARKET) [Member]",
        "terseLabel": "NASDAQ/NMS (GLOBAL MARKET)"
       }
      }
     },
     "localname": "XNMS",
     "nsuri": "http://xbrl.sec.gov/exch/2022",
     "presentation": [
      "http://www.avadel.com/role/Coverpage"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r165",
      "r166",
      "r257",
      "r287",
      "r418",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r300",
      "r390",
      "r404",
      "r412",
      "r413",
      "r431",
      "r438",
      "r441",
      "r489",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r300",
      "r390",
      "r404",
      "r412",
      "r413",
      "r431",
      "r438",
      "r441",
      "r489",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r205",
      "r391",
      "r432",
      "r440",
      "r484",
      "r485",
      "r491",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r205",
      "r391",
      "r432",
      "r440",
      "r484",
      "r485",
      "r491",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r293",
      "r300",
      "r304",
      "r305",
      "r306",
      "r366",
      "r390",
      "r404",
      "r412",
      "r413",
      "r431",
      "r438",
      "r441",
      "r479",
      "r489",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r244",
      "r293",
      "r300",
      "r304",
      "r305",
      "r306",
      "r366",
      "r390",
      "r404",
      "r412",
      "r413",
      "r431",
      "r438",
      "r441",
      "r479",
      "r489",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r165",
      "r166",
      "r257",
      "r287",
      "r419",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r301",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r181",
      "r301",
      "r449",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r181",
      "r301",
      "r449",
      "r450",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Loss:"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Total",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r14",
      "r417"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "verboseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r139",
      "r140",
      "r141",
      "r143",
      "r150",
      "r151",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member]",
        "terseLabel": "Unrealized loss on marketable debt securities, net"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r25",
      "r26",
      "r135",
      "r399",
      "r409",
      "r410"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r149",
      "r150",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r22",
      "r26",
      "r93",
      "r356",
      "r405",
      "r406",
      "r457",
      "r458",
      "r459",
      "r467",
      "r468",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "verboseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r21",
      "r26",
      "r93",
      "r150",
      "r151",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r6"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r307",
      "r308",
      "r309",
      "r467",
      "r468",
      "r469",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r85",
      "r86",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r76",
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "negatedLabel": "Amortization of deferred issuance costs"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r276",
      "r352",
      "r429",
      "r430",
      "r461"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r101",
      "r112",
      "r130",
      "r162",
      "r199",
      "r201",
      "r203",
      "r212",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r327",
      "r329",
      "r342",
      "r439",
      "r487",
      "r488",
      "r496"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r125",
      "r138",
      "r162",
      "r212",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r327",
      "r329",
      "r342",
      "r439",
      "r487",
      "r488",
      "r496"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r207",
      "r219"
     ],
     "calculation": {
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Adjusted Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r55",
      "r206",
      "r219",
      "r393"
     ],
     "calculation": {
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "verboseLabel": "Mutual and money market funds"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale, Fair Value to Amortized Cost [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r47",
      "r127",
      "r415"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "verboseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r41",
      "r47",
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at March 31,",
        "periodStartLabel": "Cash and cash equivalents at January 1,"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r41",
      "r95"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r162",
      "r184",
      "r185",
      "r187",
      "r189",
      "r196",
      "r197",
      "r212",
      "r245",
      "r247",
      "r248",
      "r249",
      "r252",
      "r253",
      "r285",
      "r286",
      "r288",
      "r289",
      "r291",
      "r342",
      "r414",
      "r448",
      "r462",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r65",
      "r238",
      "r239",
      "r411",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r467",
      "r468",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Ordinary shares, nominal value (in usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Ordinary shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Ordinary shares, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "verboseLabel": "Ordinary shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 64,478 issued and outstanding at March\u00a031, 2023 and 62,878 issued and outstanding at December\u00a031, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r27",
      "r146",
      "r148",
      "r153",
      "r395",
      "r401"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "terseLabel": "Net other comprehensive income (loss)",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails",
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r35",
      "r152",
      "r394",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r71",
      "r254",
      "r255",
      "r266",
      "r267",
      "r268",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expense"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r49",
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Amount",
        "terseLabel": "Debt exchanged"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r72",
      "r161",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r270",
      "r277",
      "r278",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r102",
      "r103",
      "r111",
      "r167",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r353",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r103",
      "r111",
      "r281"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Principal amount of 4.50% exchangeable senior notes"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r97",
      "r99",
      "r254",
      "r353",
      "r427",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt instrument, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r17",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r18",
      "r167",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r353",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Face amount of debt repurchased"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r18",
      "r77",
      "r80",
      "r81",
      "r82",
      "r96",
      "r97",
      "r99",
      "r110",
      "r167",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r260",
      "r266",
      "r267",
      "r268",
      "r269",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r279",
      "r353",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r98",
      "r266",
      "r282",
      "r427",
      "r428"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Less: unamortized debt discount and issuance costs, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGain": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Gain",
        "terseLabel": "Marketable securities, realized gain"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedLoss": {
     "auth_ref": [
      "r210"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Realized Loss",
        "terseLabel": "Marketable securities, realized loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r45",
      "r89",
      "r315",
      "r320",
      "r321",
      "r465"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Changes in deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r45",
      "r59"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsDisposedOfBySaleMember": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results.",
        "label": "Discontinued Operations, Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r154",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r182",
      "r184",
      "r187",
      "r188",
      "r189",
      "r193",
      "r333",
      "r334",
      "r396",
      "r402",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share - basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r154",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r184",
      "r187",
      "r188",
      "r189",
      "r193",
      "r333",
      "r334",
      "r396",
      "r402",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share - diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of foreign currency exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r76",
      "r122",
      "r149",
      "r150",
      "r151",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178",
      "r180",
      "r195",
      "r213",
      "r292",
      "r307",
      "r308",
      "r309",
      "r316",
      "r317",
      "r332",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r356",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r335",
      "r336",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r268",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r336",
      "r363",
      "r364",
      "r365",
      "r427",
      "r428",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r335",
      "r336",
      "r337",
      "r338",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r268",
      "r294",
      "r299",
      "r336",
      "r363",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r268",
      "r294",
      "r299",
      "r336",
      "r364",
      "r427",
      "r428",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r268",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r336",
      "r365",
      "r427",
      "r428",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r268",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r363",
      "r364",
      "r365",
      "r427",
      "r428",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r339",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r208",
      "r209",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r279",
      "r290",
      "r331",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r424",
      "r473",
      "r474",
      "r475",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r128",
      "r225",
      "r392",
      "r425",
      "r439",
      "r477",
      "r478"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuarantyAssets": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the contractual right to receive fees, as compensation in exchange for providing a guarantee to a third party, over life of the guarantee.",
        "label": "Guaranty Assets",
        "terseLabel": "Guaranty assets"
       }
      }
     },
     "localname": "GuarantyAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuarantyLiabilities": {
     "auth_ref": [
      "r66",
      "r67",
      "r106",
      "r117"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur.",
        "label": "Guaranty Liabilities",
        "terseLabel": "Guarantee to Deerfield"
       }
      }
     },
     "localname": "GuarantyLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r29",
      "r100",
      "r107",
      "r120",
      "r199",
      "r200",
      "r202",
      "r204",
      "r397",
      "r423"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r312",
      "r313",
      "r314",
      "r318",
      "r322",
      "r324",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r164",
      "r179",
      "r180",
      "r198",
      "r310",
      "r319",
      "r323",
      "r403"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit",
        "terseLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r105",
      "r118",
      "r455"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "verboseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable &amp; other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Net changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating assets after deduction of noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "verboseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r34",
      "r274",
      "r284",
      "r429",
      "r430"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r156",
      "r158",
      "r159"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r33",
      "r34"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Net",
        "terseLabel": "Investment and other income (expense), net"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r13",
      "r162",
      "r212",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r328",
      "r329",
      "r330",
      "r342",
      "r422",
      "r487",
      "r496",
      "r497"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r10",
      "r104",
      "r115",
      "r439",
      "r464",
      "r476",
      "r493"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 (deficit) equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 (DEFICIT) EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r16",
      "r126",
      "r162",
      "r212",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r328",
      "r329",
      "r330",
      "r342",
      "r439",
      "r487",
      "r496",
      "r497"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r3",
      "r103",
      "r113",
      "r267",
      "r283",
      "r427",
      "r428"
     ],
     "calculation": {
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Net carrying amount of debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Less: current maturities, net of $672 and $1,019 unamortized debt discount and issuance costs, respectively"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Estimated fair value of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r18",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r68",
      "r69",
      "r240",
      "r241",
      "r242",
      "r482",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r41",
      "r43",
      "r46"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r30",
      "r46",
      "r108",
      "r119",
      "r124",
      "r144",
      "r147",
      "r151",
      "r162",
      "r171",
      "r173",
      "r174",
      "r175",
      "r176",
      "r179",
      "r180",
      "r186",
      "r199",
      "r200",
      "r202",
      "r204",
      "r212",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r334",
      "r342",
      "r423",
      "r487"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails",
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r199",
      "r200",
      "r202",
      "r204",
      "r423"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r137",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "totalLabel": "Total",
        "verboseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent [Abstract]",
        "terseLabel": "Other Non-Current Assets:"
       }
      }
     },
     "localname": "OtherAssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r90",
      "r91",
      "r92"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r76",
      "r145",
      "r148",
      "r152",
      "r344",
      "r349",
      "r350",
      "r394",
      "r400",
      "r457",
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r90",
      "r91",
      "r92",
      "r145",
      "r148"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "verboseLabel": "Other comprehensive loss, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r139",
      "r142"
     ],
     "calculation": {
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Net other comprehensive income (loss), net of income tax benefit of $0 and $330, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r24",
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "negatedTerseLabel": "Unrealized gain (loss) on marketable securities, benefit (tax)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossNarrativeDetails",
      "http://www.avadel.com/role/UNAUDITEDCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r14",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities Disclosure [Abstract]",
        "terseLabel": "Other Liabilities Disclosure [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "verboseLabel": "Other Assets and Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Other Non-Current Liabilities:"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Non-Current Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r228",
      "r460"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "terseLabel": "Payments of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]",
        "terseLabel": "Preferred shares"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r4",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred shares, nominal value (in usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred shares, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r4",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred shares, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred shares, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r4",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; 488 issued and outstanding at March\u00a031, 2023 and 488 issued and outstanding at December\u00a031, 2022"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]",
        "verboseLabel": "Prepaid Expenses and Other Current Assets:"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r136",
      "r223",
      "r224",
      "r416"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "verboseLabel": "Prepaid and other expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesPrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of shares off the at-the-market offering program"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "verboseLabel": "Proceeds from loans or conditional grants"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r37",
      "r84"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "verboseLabel": "Proceeds from stock option exercises and employee share purchase plan"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRoyaltiesReceived": {
     "auth_ref": [
      "r42"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for royalties during the current period.",
        "label": "Proceeds from Royalties Received",
        "terseLabel": "Royalty financing"
       }
      }
     },
     "localname": "ProceedsFromRoyaltiesReceived",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r36",
      "r54",
      "r155"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "verboseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r60",
      "r116",
      "r398",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedTerseLabel": "Payments for February 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r88",
      "r121",
      "r504"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r226",
      "r228",
      "r231",
      "r236",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring Costs"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r228",
      "r232"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Balance of 2022 Corporate Restructuring Plan accrual at March 31,",
        "periodStartLabel": "Balance of 2022 Corporate Restructuring Plan accrual at January 1,",
        "terseLabel": "Restructuring reserve"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveCurrent": {
     "auth_ref": [
      "r452",
      "r480",
      "r481"
     ],
     "calculation": {
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset.",
        "label": "Restructuring Reserve, Current",
        "terseLabel": "Accrued restructuring"
       }
      }
     },
     "localname": "RestructuringReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r63",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r7",
      "r83",
      "r114",
      "r408",
      "r410",
      "r439"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r122",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178",
      "r180",
      "r213",
      "r307",
      "r308",
      "r309",
      "r316",
      "r317",
      "r332",
      "r405",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Aggregate net proceeds from stock offering",
        "verboseLabel": "Proceeds from stock offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares sold in offering"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r26",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/ComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Capitalization, Long-Term Debt [Line Items]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCapitalizationLongtermDebtTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning the long-term debt component of the capitalization of the entity. The table may be detailed by subsidiary (legal entity) and include information by type of debt detailed by instrument.",
        "label": "Schedule of Capitalization, Long-Term Debt [Table]",
        "terseLabel": "Schedule of Capitalization, Long-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfCapitalizationLongtermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r18",
      "r77",
      "r80",
      "r81",
      "r82",
      "r96",
      "r97",
      "r99",
      "r110",
      "r427",
      "r429",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Instruments Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Non-Current Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/OtherAssetsandLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r227",
      "r228",
      "r229",
      "r230",
      "r233",
      "r234",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsNarrativeDetails",
      "http://www.avadel.com/role/RestructuringCostsSeveranceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r61",
      "r62",
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/RestructuringCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r83",
      "r132",
      "r133",
      "r134",
      "r196",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r431",
      "r448",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/LongTermDebtScheduleofDebtDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [
      "r453",
      "r454",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r52",
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r162",
      "r184",
      "r185",
      "r187",
      "r189",
      "r196",
      "r197",
      "r212",
      "r245",
      "r247",
      "r248",
      "r249",
      "r252",
      "r253",
      "r285",
      "r286",
      "r288",
      "r289",
      "r291",
      "r342",
      "r414",
      "r448",
      "r462",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r20",
      "r76",
      "r122",
      "r149",
      "r150",
      "r151",
      "r168",
      "r169",
      "r170",
      "r172",
      "r178",
      "r180",
      "r195",
      "r213",
      "r292",
      "r307",
      "r308",
      "r309",
      "r316",
      "r317",
      "r332",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r350",
      "r356",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r168",
      "r169",
      "r170",
      "r195",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": {
     "auth_ref": [
      "r4",
      "r5",
      "r76",
      "r83",
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan",
        "terseLabel": "Employee share purchase plan share issuance (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r76",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "February 2020 private placement (in shares)",
        "verboseLabel": "Issuance of common stock under at-the-market offering program, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Shares, Other",
        "terseLabel": "Vesting of restricted shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r76",
      "r83",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r4",
      "r5",
      "r76",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee share purchase plan share issuance"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r4",
      "r5",
      "r76",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock under at-the-market offering program, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of shares of stock issued attributable to transactions classified as other.",
        "label": "Stock Issued During Period, Value, Other",
        "terseLabel": "Vesting of restricted shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r20",
      "r76",
      "r83"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r5",
      "r8",
      "r9",
      "r53",
      "r439",
      "r464",
      "r476",
      "r493"
     ],
     "calculation": {
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 (deficit) equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSDEFICITEQUITY",
      "http://www.avadel.com/role/ComprehensiveLossComponentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Shareholders\u2019 (deficit) equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/LongTermDebtNarrativeDetails",
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r357",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/SubsequentEventsDetails",
      "http://www.avadel.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "verboseLabel": "Schedule of Available-for-sale and Equity Securities"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/MarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r208",
      "r209",
      "r279",
      "r290",
      "r331",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r473",
      "r474",
      "r475",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/FairValueMeasurementMeasuredonRecurringBasisDetails",
      "http://www.avadel.com/role/MarketableSecuritiesSummaryofAvailableforsaleandEquitySecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r472"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Effect of dilutive securities\u2014employee and director equity awards outstanding, preferred shares and 2023 Notes (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r183",
      "r189"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r182",
      "r189"
     ],
     "calculation": {
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic shares (in shares)",
        "verboseLabel": "Weighted average number of shares outstanding - basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.avadel.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFLOSS",
      "http://www.avadel.com/role/NetLossPerShareReconciliationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r442": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r443": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r444": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r445": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r446": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r447": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=123422226&loc=d3e11019-110243",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=123422226&loc=d3e11049-110243",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "40",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>66
<FILENAME>0001012477-23-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001012477-23-000012-xbrl.zip
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MFB,-&$9*E\A$SU&A\.E3:/I5LIG%QD@4$6F+Y&F%XD3&6D0REI@F5=WW1SS
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MNPG$SH.ZO0CV>AW9_=_+N>SF80[3XLH;\_2[7<4,.EA\O2@[G4 [[;1K1X/
MQ'?[H+[3W-H,]IOKS:W]NWV>P=[N;VT<[.TT=[;V@_7Z9K#UKXV_U^O;6\%&
MHU;;V=_?:=2G. 3RI"%\E7D+Q+S?ZRX'FRL;*P%!$1,_[G;:];IHE<9G_8GW
M&MWK-7NPU__K/W&,_ICBY#ZUFYQ@\L?3_WET1!V9'8/ ]WMGJQ1>/2L"\+&Q
M5PO^!-76[77K@P*,!$,-N&>=QV*",6P,,XE$+%&10$A@PQ6Q/IT[$@^%(8*N
M]*;1V'1ULZ<+3\V;BZ51LLV7*[79.]\E>^>'M#8P)UOG1]OBI'&R@VN;QU&=
M[)T>;9ZB1O/S5:-YP(XVC\E19XL<;1^UZ]^/+QO;'T]V:;U]^+UW56^NLT;3
MG!YM?X[J\$SMY!0WMC^S>N>H5>_L=8Z:FM6:K=8AYI>[Y.CJ\*N.#T^VOM<Z
M6]#N(3W:W,(@[Y=ULD,;FY^CP^][::WS\;1^\J4%[SXWVU^8^?N?[2/2/E<G
M9VFM6;LZ;+;@NCFM-0_087.+'IYH5M]LG]2W=Z#]SZ3^=2NJ?^%7]9,#^DUA
MZ0"Y1J&.N0R9(3KD221"2V--#94)CL32&D;AY\+ W%!A+7B?P@$JZ8\S:7QH
M/&Q;UU\ER4A<AEHK]+\\?<CK62K;P4$WU3UC@]K^4[7MPV-^ U'Y/  H8[/V
MU1[X!%E_*7"]K"/[\ *8 \"8JZK7:RO9;O?ZJG?Y[H3J\/NWQ!J6,&Y"QQ,>
MPJ3K$.8:A6!2.'="(&VI9T^1L/B/^W(U8L+I6;WQOZ_3IZ=Q].>#];WFUM[N
M8;"W]:FQUPP^'>SM'ZS7FT&S$0 ^:@((*GN):=#8"W#TF_F]_*'Q,6C^O17<
M E'7 &I]HQG 92PH>[H>^^/-P<G#1G%.P,G'7A;T6S;X]TAA!*4K$X"'8\WJ
M6YCU3\4+MTJ/ZHZF6C7P2]B!=[;\8Z&15^&5E5EHN^],9=6^U[Y9:L$Y5"B,
M8F-!8Z$H5,J:4"&8<D)C)@596JOY\\9*YJ-X.? 3_W)4\)#W^+CIG17>;NQ5
M8.%)N-KO="G2#2JT\"!:8-]8;)@T+@J))G'H#]T,N4Q0Z R/11QIJJ0:H@56
MH86?]*FYMU[?W_&8X,WAPHQJJI$5[E]+XL@,NZS7":;'0.4,&9^P5B05K0Y
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MRMSCLWZ0]]JI"4:,.[SJ$[+&+\[1(D,S[;>+-!LK=2O0OEC0$Q9<WLG<9++
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M6JV3]ON@#&T;M%O6ZWIO <"%5X)@=/V5WG C_.@LJ^"K50&88UOD)LCNU3(
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M%-U&KVO*M!9_SY[-!^U^<4OCS)9=FI _7FG 668?0MZQSUVH0%JAMSGF88S
MC'_V"71IOU@K+-09_- >???:L-W+![Y$TKKJ#?K#FDC!7IJ?5B#O'; '$>\=
MYK$*YLTU$XNE-<!K_0R(5NBW3UE/6^-56H71W@'M*7K'(*U:&*D61JJ%D7E8
M&,%DM#+BET8:S;^W]JIED6I9I'*LYQ)XX&AI;=<>RW:)-HO*?-6BR'N@.L7O
MW5_&ZY7#/-=<S)?6?'@O^"AUOY=57O)[(/CDU-:\(JY?7,VM$-=L,#'!2VL'
MW5M'#^_+MBW69+?^/4C[5[?+Z_LHX$%>')DYA&<5-GL/_%%ALU]<KZV@V8PP
M,5M:V[1.%NDF!V>^#+SMIKWLEG*KT-H[X($*K?WBHFR%UF:$B9.EM1H\ RC-
M60!GM_),*B3V#FA?(;&H0F+SS,04+:TUBMIB.]VR; PT56&O=T#U"GO%%?::
M:R:F2VM;EZU4I=4^K7=!;/K#;0H_KE@[3]7WIG4@-X[\@=R-YE:PM[6]OK>Y
M4]\.FGOKFUNU];W_&:_=]-QB8-,M*OC5!KV+;G NL[0WR(MCEVU16W543[4\
MP\J'U.796=M78?4_E,?&#FX'Y*\?S7V58=T>%!5-UK_ 1.V^2CVX>"5ZPA ?
MJ)CFRY^$=.6!$EA*YK94!\W:-&O8+0>[![6]PZ-JWIX[;[6=C;W&IX/:IVKJ
MGLUR.Y\/=IH[M:UJZIX[=5X9UK8V#_8?K-%:S=WC<[<2K+?;0:\LX^TM2%'3
M%4S(C3DI9A>:/T^U#<I?>F[X2%G?NUCT/3NSLC@O-^T&_5::^XUN_DC<]E50
MGA(>R,P.#]/MG<%L7 U+@*:^,'U^9LN3?%N]-N"P?"78[[4M/%M6M.^>6WA+
M5]OEHH5[G;O5\<??WI%7_D!@@'8V&Y[ Z^OC^TUWODG 00F[/KB1<?)'D%]U
M%,#TY4 -^J-3V^%AWXW<'_@[:)>E^:%5Z&'NCXT!*YT7%?>'=?Z+$]K+HX#O
M#A.,/HP2>@"S[]N0.<QP?]GWRO?&#=IMF_?+4O_]H,"F(P#@*U"VY<7RJ%%/
MS=Q_R6R_MQ( HC"]HLVTZ\\)&)T< %T9UJ6\3[OAYNP?S2JTD?I3!0(9E,P-
MXVVE9\4,%H=RPHMZ65[L]?9?\S.X 7[P]P"5 =FHJ^5B8NZ]^TEE7N]"M'F!
M=A^S7B?H0XL%4>'?Y>#"%FQ8D&.0P5=5'FR]FW9/K=GI^JGS%YH7_LSJ;'0\
M0_#;_UT_!V*T/[5DUI&_^P:-1X<I<*9O$N[U^^;3FUC92M" =FX=]  $+:?^
MH;M]R7[P//LP!J#Q\)1L>$D!.S6P>YYZKNMU"^;< 6G,?>H::(6RP+37![?'
M(\]EVBX8%7C_XN)B11;=7P&RK]QZW"L$D"9X5!Z7+_0G5,#L/^4M('9:^ID<
M3FIQAO:#@RNZ#1TIGBH^P7"]@!03<I%"&S";P+PP6W[@RE-HY7;D\?HI7SA;
MIL-3#/SL:. K98>3Y,?0@GD\;MV=#O_EFL2^G_E]0I<_^ODH!??Z]'/_HGZO
MM'"F9\M^^WZ!))Z!AH-)67Y8X4U>LMZB%/(,^9V%$(<!"<))U&3V-02KHLP/
M;O(I)OI64<Z;U<KQTISA0Z4YGQJ[>/L3#QX>Z[R<>-!\$$B!.OSH%1!&X>=A
MI %>.3SMV@W)U!Z2*;\FT^C :P\9TM*0="Q@ +@)%/OH>"&2K(\JP]_**/3'
M"\&O6%"Z7""L3GD TF\E<BO>?/?VX=M^+S7GL/7A,0EXZX%7W#G*J'P7N_VN
MY3LONWWWZ%4 I0'?W PXD$5%!Z_F[:7'?:/0C0+D;QU\ ##FO_?428D*?5@G
MSP>=L^'!Y6# !WTO!O:\:!!^ .!<6"7 H-?F J@$=M([%X&3NE^BMR'<O4>/
ME:#9LKF]TTM?=Q^43[?$N:-&2TVT#.T8>VW5_ P,RLS.BYX_*LKWJ)6!+Y.7
M %E>,P*\__ZQZ1[LWO]->Q0]=KYZZZ%?RTG,[_]<HMRQG\NYO7^R>Q=\L/0,
MQCYVJ2#*^?CO@$'2SD,/G($3D3[0'_!N3A[JYUG/0WG )N-3X _@&M@[A\?G
M*<BS+#@GLT6]I+S V9X"75"*I1-1<+$_%<QFG?+Z \\!7P*,++1H^VIY^,0M
M!DB[Y[TVM'8STMM<N P.1C[T" ; =9G'/X7$7+12[4\V\VY0B<2 ^0; A-FP
M8%.!4IV[A3F]/U>@XE8OMZ,^EF *NM7YP5'W<^\-/$&7#L%E?E]H;Q.K *)>
M1GT P?CGO7[IC!?:*I5,B>!OZ93"#^C>@<>@ L&G[7OG[AJV ^GNMON XBA@
M7W'KF);RSPY_O'%!;JFN4BN/&.^TZT/@)8.5GPN66[[';S<NC"MWSI23X15=
MR7[^K7=9<#EH0Z?:1<#"'X]RGO9! F[KT)Y_I.4E?SB_/:\U;_%KR<'>K2TX
MU[NPPY']\CMN^!ZN>+<Z+9V.4C(?)_[*-0AZ@#&&AOBN$F^#-BA=N>4QP[0Z
M<5D;KE.&?E&R@%=_C+=T!X*%F$]QW0N4;?S']&)O?]R9+LQ6BA-&0,J /&D[
M+<-CY3+$D"O!PGHOT\>&KGP$I6,S+UCP1E,(QS%(2A&@L_W"(3WK>_9['&?.
M"[TPF3J]H L/T\M'64;T BK=(5%;@@)KE6&"V]0:4?6WO&?202?H75XID,W?
MAV;0'U_HA;;P</+@MR%,.%C97QE!S2(J6@9"K>R703<'6K OS]KV\JH(R%T6
M81M0KT9>%5&HO&WM6>H/O;YN<VMS_[I)'] PA=TNC@T%3PSFU9[E5W\\;I4?
MX:"*77[$+@4R+2=Y&! >F=L;+O$&&F!U/QOHPM:4B-Y+-C2Y?%O(\_P>@XV,
M$)C,Z8E^<0[G0BKH>P+?\>A$#H.!F=6V*/-GRO*E!1 Y'K3].L"5#]]GO7/9
M+O#=2 <43XZBXB?@C.;>J2C=OT$_3TVY9.*%OP1-_NX2>?GW^1BP'N+TPMC?
M2@_X &\!M. ]['RD6@#=V?:-89E_VS#KK'+;\_?,,(QF%2?F>O1<Q'7M<68+
M;V[,>-]BE8I6;RC61;BP"+T'11*./4YU$6_WJW:M]"R_ML"W+7M!9J^=NP/O
MH@R*Y=""PJ/%FN$RQHWPCX2[HNYK4Q>49EJZ8UU_/+6/AH ^M-+X]6@#=G:Y
M$K0W(H6Q9SZF>DV,D9O:'704B!T(2#[P:]U^A7PD9W>%ZD:&"O!31@E HUY<
MN^ZY#U06D:5;-Q;>NTS;@R+F688L;U[EXU7 ).?0A7S@7*I3#ZS_71;P3<O=
M[J6/?N=%RW<B82WI <#-0J0TT)X/=CGGD=XP8*,&>8'$;Z?JC6F22E-,W0Z4
MT:LRM-2[+CY?<&UIHXM@61E]M6F917,K5I[)-!^RJY9G@,[:9?X*$+T(NNF"
M#8OTEJQ?+K%G0RSH2:1 *(9<DN<#.;S=%@47EH.L=R7;_:NPC 0.XVR ]89Q
MXK(7-];K^H:@ESW :[>-6\5B4X2%9X#H1[@ALVE'#:[S:ESI OB[AHE!/HFI
M4#YGT);_08+/GY?0$<S:<28[Y0H/0(\R4 3ZM#)T4R%SN1Q8D'BT%#0"_/Y=
MMWS\0AC+A2HOFI4/,'7!!'N0'I?4&#G?('I#HCP[/E9197+JL@_8\5I;7A\4
M4T;3\GYP$T+KG?E;A]8.T%@OZ]^!7X56'2Z! J1LR>S8CF)K>;EJ WTH":^N
M37@9>1^N^5HS?*D\'P5=P+9WAZD-1<2O@)Q/Z%DEZ5/BJ8)S9-X*LD'W0OH@
M?MXOV>,&UMVD$=P)O [C_15JGS9J'V54%"LRP\1U3]=1UDZ!VH>E??P)T'E@
MX.9U0%[M@""2W$GUN?5S<>_U@DFQ'OW35ANZW_-.+31 [[1[Y\+MEGT2^+$M
MG(!"9?AG[G=B.;C5TIUNW59I'7DZTFR][G&O3,[WN\5R#S&NRL7@85+OL-G<
M]OMM?Z,=CFKD]0Z'Y%6:EX[2ASAK%PL2PZ T^"59$94^&V3P<'[OV4H$7GOA
M^ 97IIVS(A,,YG^C\65G,\3",X8K4_=+:UFZIM<,D16KC??B$\6=PWR'H?\+
MSPP-;470-]1IK72X#)C9(M9U:J^"CO7QLFO XX.9I0<?]*WLW$J8 <KE'HBT
MB^2RBFRO2+8-T(JV7YY>:"_3(7CH&7D5C#8#^8PEF?EM!T. 4 K8 F^%:?XD
MLZE,6!H&T !,=]*\V.J0!<<#F0'<LJ4M&6JBV\E5IC3SLMA";<NLF<<R%L<S
MR#J]K-QLY1.]BI,IK[,11];U=JWF48;F:$<*W/G);\+860Z&M;E'%F^]V_5Y
M:.-I?O\3N+0-+[DV[1X=WJ^>>IU>#-P$<U$<ESG*V=C?VKB&(/!S38*M#0BH
M]P)(C.)#?@JN1UEN5+G.K[\U[\;F.DM5.6BO0_*!RL&0%_EN:;OP8JY["F]>
M";;3<]L=AL'OS.XR:*9"_]S>&G?6EMK?YZET>P&F2!#\0:+;3QDF/[/R%%KR
M68O7,,/X%57O:14A,?_+K2<NP,R5V<S%2L P0^YG_+7B:6'/?&#M!N&HJW(#
MWH4M<RM]4T%/M4<A K_C[JSHS,]2^H*S 3RF?5ZNUP[E!BB?2=N]^F$6J+_1
MM?V"PDW2I?%IB+VS(:K3WCTML)G?6')K>MS#VX66BY:"U($<7MS)#U46D)YG
MS.OLT">JK?>Y7XA.:+\0K?8+_6@/37F83Z&D,6CDCSOU]?K&SOKN[5-]'MMG
M\T0*Q$L_G8XI#7ZGN54+\$I0#O"QOS=SLM]<AR>VZLW]%TZ)^/F4S R'E*5/
M@D]_KP,[;&P=-'<VUG?W@T^[&S-4[>:1S7"-^N96?7]K$[RW^GYC=V<3Z+=Y
MBXQ!XV.PV]@?KWXSA9$4+:[ZQ<U4/T%#_K;CK4=O *T:OVI:FM<SO^C>\E89
MK)3\?1['=="5 ^/S&)[?^Z?C^.O'RJ7G:X.9 ?+R9</:\BRWJZ,/?PQW_*^F
MW:+#Q4-_#.5U:&4?*$Y1O*^\?&,Y5E!I/88E^(9O'EY>*2Z-BIO=N1:+%1HG
MCUY&*_@7KT7T\9?>>_*!:FNCF>GVBNICLW'GDR<5DQ5!H^E.ZO,ZRY_4[$^*
M/(XJX2%?!^_',_R,6R='8#'V^BD?!2A^9FY0Z9[[_-,:W-?*@ZUB9VWI5E*\
M_)SS 6>BU.;](;_P+-.I\-'KWCFT%AZOP9@"\*Q2$XQF?*X8UX<\GE(L]2D#
M?@*!%VKBR$.2?<]UI\6,S*<NG@$9FNS4//^5/U'7\S+7\WSGA KN!_[?I(SE
MS+!5;5PO$?KLBFYN\]6GJ.>?3<(BZ8U?*$M?5'B;)3*_X"#XYU-V46>L4LY3
MOW-"1PH4RAF<7#+CVGG/YK9PZ\I-A]>K1=?*>A+G#LRKKGX.S5$P!Q[N?]VG
MYK-&.-/:],_TTI/O8R;+9?A!-^WO^9+]@]PL%=E_T/GBA]0)QK QS"02L41%
M B&!#5?$(JI))+YM>A\2883#X@.E> ED0Z<=V<[_L10"W_@*J+[I\%C*L]61
M$*UWS>:-"&V5$K04E,NF\.++_FIWT E-KSADP#<'' C39PM>+)9;#/URI39[
MY[MD[_R0U@;F9.O\:%N<-$YV<&WS.*J3O=.CS5/4:'Z^:C0/V-'F,3GJ;)&C
M[:-V_?OQ96/[X\DNK;</O_>NZLUUUFB:TZ/MSU$=GJF=G.+&]F=6[QRUZIV]
MSE%3LUJSU3K$_+*Q+SJZ\[';.-'X\*2>PO\[C:];%[7F7JO6W&+U$[C_Y#!J
M?#W 1U]W2.VDG>[2O=9AY[+=Z.Q /W98G1Q\KWT_)O63S]'1R3&K=;Z<'#7-
M29U\C@Z;Q]\/FSMT] R\:W!$#N+#D]9I[>28'C5KWQN;AZ2^V>XT-H^OCK[6
MVW52HT>;[59CL]ZJG1A73Q'9;6[U:_N(-IK'I/'Y&V81!BMJ0\L$"9DP+!21
M=2&VA!@D6"R</X1TF5/TYX>['/((8OD5/?\,R9BD&JW4TT*JIUAABVV,N3"<
M14+*F,5,<F>M3:R+>:&>R$@]D4H]S8YZ8O?4$V*Q3J@4P%*"A@QC'7+N.$RO
ME5I0$6%%E];B92'P#*FG2<8GY@ "[]MVNZB@<VR[-AO6Q9:FDW:'AZV<VY>A
MX46+7)#GL<*#IF>>%?3$\>.0 [=+_@,UO7Z'^RI-/6E-?34&) G!U&<ZA<XQ
MT-12T5 I8T/,$\85<DQSM;1&V#*+^4M5]0_4Y6LAR:>JH/<NVA/'7I5HO[EH
MWP=A5L#_E(U":ED<,H)$*&(*WJ*E&CLLDMBG,!*\'--HAD1[DH'(V5\E:O;Z
M@+QZ]]>*@O<<?GR25AZ.]<EI" NGLB>.QC;\UG[0U$/=G%?*>5+*N;$_AKO
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M$8'3RBI3+2E+R>XF$<?>3+6$J1]W5E+*EH!U7=U:_78JNW/(*ZAV"U2;KX.
MG1 "2XTD83YGH$CDB&(H8)FPB1;$1596M2JY8\_75!^F"D(QU7N:ZBP!8318
MC+U!23B&N)("62T)\C1$RAQ67)J552/O78>VH4EB2\ ^UKR'EQD.JA-[5C;@
M+0G#F KMW5AFQ9E:.);-5S\(F"7*E$%4>9NSUC$RA@=DDPR.\ 2$@]=9ZR#!
M!CE3Q82;R3R*"3^\"<_50@A,8$\]\B1BQ+'32&L:D5?$ R5QGJ>PLJI:(.,&
M6? +"X> 8?1'\:*#60EY+ <AR4)[>Y%O4 !MX8#VYQPG,=$S0I1'.#".> @:
M.0[_-,DQZQVQ+JD,:/+^K59+,*2Q1KQ 2E*,^.&->"YCF3IB/ ;'PM#<EBQ1
M9/+&6*TL)_ ]P9%F(V:L24T&2X&FYQ(!>M?OP?.'P:0*$U"O=K>RX8OM^I@7
MH_;@JG"SWZMW_9@B $*H]HYL'[YJ#P:C?%2)&368HM6%7:8R?C\1\59W;2S@
MW53+<FLBR0+X"P?\B_H'NQN'I_!.!T)ZYJT-*+D4P TE /A24!29H=1Z&Y5W
M*ZL<MT %&^2'%L-N%FV[OV&G]M<8T+?8[Q6;OJ5-3TG<U*:EQRD1DQ>EK4"<
M2($,3OD/;K74A'!+<I:T!H'^UB"C?F'!I7&I)C^_/:)$F1I,8:Y4>KG./2W@
M=2="<E[.1<3D,8](89_S!(U!SH6$8E04:ZR\H6IEE<I%-5<J0:3FV>A"JS&5
M$-+CL(_S]J^).\<%1UHS!AX%#6# )B(?5?))"ZM9R&4B#6]24MP+*X1]M;/]
M?;G'8W2Z?MZ(M[!-5@7L'A#LYDL7"1JBDI$B'0RP%9BAD/6<(<FY84Y1ZF2.
MEYL6D_=&NUM9R!(%5EZHR2]L)U,Q^0<U^3E^H[5G@6ED>71@\EP@9V5 DE%K
MF?(*8W!0A&@I\^#=[1L7=ED"ZO/V_AOA%^C'O=Q6UP^QK[S4W'T(##R<W_:D
MJ>3!*41M[H#-,*"AI01AA;65B8H4V,JJ82VR/$VPB_$O(_DIQO_@QC]+@*1,
MQ')AD8O>(ZX  ;3B''$._,<E($?:@_&3EB2+2A)ZK**&3YWMT_0,HJ6B=XO=
MN%XR"1JQ<?TRR!<<OSF.?UN;CUWY2*6A"2D+8,Y%DL@Z8H'324\"E4(QN;(J
M69/*<11K;28/*]:Z:&N=S\R./"C,4!0>YTH3 1GK!<+!8F:5T2S@E56EFY2E
M]\(B2_.]UTI2SY*1CIF$@>)2/@2XS9<JU$;#/$1I=B0C.))*(Z<=058$2G2T
M.(0<4V\IJ1J4,U"LN*%DI%CQHUCQ7(4=ZY7+ZV%",)SSCATR3HN\ET!BR\"V
MB:BMF#=I!^@+BX^,,W^6(>/GV0?!'R#IIP#<X@!NOMJ?M(:8N@.V%P+QZ"FR
MEMG< =MPCY72/K>:5+IE\-+T\RDFOX04IYC\ YG\+*?17%!C,4:&&XVX) 3I
M%!T2R7(67" A5[4@@K4,6U3HI;3PNE]SK.\/VO(]Y MCI_4^T:->!T9I<-ZQ
M*\34]NWAKU7\WZ@]/+M;]Z#2?ZJ,V!-W[/J9X1VW0^CD=?O0_C*]]N02*!__
MFNA: D]2EV-:;F-0E]MH5=W><;L+GN07VQG5I3G^]2,:]"[V:]->"!VBLVSH
M_.GVACW_^9WM[_;WAG88PU_YX2[N/>%"N'"A&W"A#\/MJUSH2_C/7SS\\=_.
M/[3SQ7TZZ6SO?S[=WM@^_?CWSJ>=;]OXXSY<X_C/;]N?_+>=C8]G_^QOP3N_
MZ6P3_6WWSP-%*$Y>.\0U-8CG4LP&M LI(8UQDC@BTH_)]'>TZ&Y^=-&BI=0B
M%[GT(C'$A0!5,I0AZT)$3C'O+>7$\;"RBE_A^?TV<U]4)[$_!K3?JN_JW1CP
M%J)R6SMO?JQTXUI&:Z/A4:\/X!R*;]=0323;IX!GP7"<)&*8)L0]>(5.18(2
MHP)3K[0F^ =X=JU>W6U"+'KUG/3*:$F-%PSA7$.3)_CDJ%4HB]W+)#2W@'#B
M^I),\Q@WUK/*G@O_<;!N/F9UG4KNCH:#H>UFBEO4[NG4CNW\><"93TD*F0MO
M8)A8(T?:$8T2]1%43^:9];9P]I"JDZM)920K6O.46F,T5M8JAR)F"G&G%7))
M6N!DG%K.E# Y<X/K^232>:1JUQ*M  ZJW@4N5'98;=N^/QH[YHRTJJPT]6&/
M,;D6(%LBE?RZO;]YP"T)3AN!J)! S*A*2 =LD6 XA8@CUHP^#C$K2+9$:J,M
MLR%RC:S/[B7AX%0F@5%4.!$7*(_4W!_*-J*/QR[VKZ 9/0\WAO:7DEW6Z&R+
MJQ9<QX:*Z=[6=&>+OAG&HI$$1>\ L94 TQ-2(6,)38[&X*4%EZ=!66/%.IN9
M&%&L\_[6.9?7:7"2U"=D9 YT*2^1 U$@'(S#A-%DLV?8).M<T*KYC5?*F[=@
MM]N'I[#]L\6NURUHI66]=WS<ZY9EEL49[<>?L.$>_>?3?X\^?H)W_/:FLW/\
M$<;I??OCIRVZ\^E/O'W\3_Z.;?_]\>O.&_UM=^U 6H*=P,"#80)&(&2#G%$4
M@< #^%")<LWNM%BWH"7?HD*-5R%KL)4*I@V0=T#<"X)LH!IAYJV)6@ME_!*M
MU%W2N+*<LB1J2+8/#[@.-G%/D/*.(YZ(14XI@8SS5!H7DG#RR9;IBE(MIU(Y
MRAFW)J'@<_?.D"A@FV=(QZ2HSE'OG,LB\-(MTLTIY#0X692QD<K(=M8.1&)8
M&,)RYH$$_PP[9#S#R, T"TKJHB#QJ5;NYO3IRD))4:K&*I6VBHA !%),@%)I
MX6':!![':! 28R'@7RNKDK>X>DYK>T5?EU!?OV[OKQT0[E-B1B*L$_ \5A?E
M%@IYBK41,N7V(4^UZE=FU254J"",93A%I*ERB%L>D8DL(IJL-H[$D++C(&E+
MWQ,!%[XD6*I?/>Z2X"7S+BL.=S+=F?5 ZL$W#V!U3C(!/KM*R +<HL0=./."
M28]-)A_WKB]:2M,UUC@?8.XMQGD7XYQ=#A1!4Z^]1BIPC'C.^[,V<D1T2%X;
MY@3/G@%M4MW(A5:B,\W>0[L&CYR'VW:J$]L.J-VMO#UI#VVGU*!; C)Q(;YW
M(+VM[OI8=I=@K+@-BX.W^99.6O/@F9=("AP1![Z!-,$$@0/I<J]LSR(&>,.L
M14F3<AZ*/3>3?Q1[?EQ[GF]70(3V/J"$52[:9#2RBC'XI]/)<\>UB"NK0IN6
MTL^V+EW3*8OWH^-1)Z=P5)-J'T]=EF[YL.V71R$K WA-^#2+<N_CT,(3A4W;
M[\*P#2Y)=&,LT()RBT.Y^8Y,-$E&N)8(Q&D0MWDS,I$626H \93QR2A@+42V
M,)Z/FOQ: B;/P*COSEB*43?"J&>IB\><NA XTI*YR99< &Y$"2$VRA!8=)FZ
MB!:E\UDF3V+4+RK0<HFU].K:_[YW?-*/1[$[:'^)5:<W*&7_EXO&7!)I745\
M_;) M[H@W_@6I+H3A[MIWWXM\+<X^/L\QVEXB(9XYY'6*B".B4"&"(Q"T$8&
M;4,B<F65 J6A\A[H5V(PS37PA5.:8N!/:.#S*TD^AF@C<H%HQ*G0R!EK$=6,
M1R,351,#9WQ^C\"3&/@+*\<Z;A8PN$%1UJ<.USRSDN)/2H+JH/1$WINU= L,
M+@H&=S;F&S'ZJ+ +EB.F5=Y?ZRPR@(C(>:J223(D!6X>TRTB[\-S2D.!YVC]
M"V=(Q?H?UOJO"?)X+RA#/.)<1E)*I*G!2$1&C4X@2Z:!!)$6X?/+S<VS_D4&
M@-0KM10$Z5(WI3J_]\$(TT_\QANV'Q@/V&L&HQQZ(]>)YPIP/QQMFG#^=<<V
M\XL8GT;/+T_;HVJM&\H<\Y!SS'Q_S9BXC $+1+#,51J]0%H[B033GCB7G(YD
M995PW%+,+"@'8G'&],31N(*J!54;FEM64/4Q4766N7-L*:495;D(B.O(D F!
M(6T2H49&'G7N#<9H2^E%98H^/:K6!/_?0PLWG6Y.NU3^ZMCV#]O=^O;J*H[Y
M" ;0'W_3[@;XUVLF%U\>B^"IL=97?)US+=O^Q^9++_K^[,5869_7<6WW+._/
MZ_:&<-=A#\S9CD([K_6"*</C#\:?Z@&NEX!3NVN[OIT#IKD8T3&\X>#5U5U\
MEP9J<F].QS[.26]09XF^[L>.';:_Q-].VV%X-(662R=.1(\O3K$.'F(T_/XI
M<U)XN$'_X1"C2E9H9E_CI3_S$]= 1 761H40##><&J&#ELG*D*+21%M_0/-.
MWO%)1^=M[$[L842N'^UG9!.\Y&O;.;5G@Y5_7U50T,Z9L9\=MO'@K/Z?Z\.I
MUSSMDXZLNG9DU_Y:V]A\6[W[8^W]]MKZYH?]K?6UMWO5N[?KWU7 ICSZ^BY@
MZ\[>YD8%G_9VWVYMK.W#/_;VX:_MS9W]O6KW3;4'+[;YQ^[;C<WW>^<>]<;F
MFZWUK?U?J\T_/VSM?VS"F]X2<W[9ZE;#H]X(KAH&OR[C"WR8HN+\TW_?C!JH
MA?M'?4#^;3CN:%!M KZ':PM3W.H]ZCGR K;K>1G>IV-/!O'U],-OH3TXZ=BS
MU^UN_53U2;]-IM$)UF>0FIF3Z_N-?[[ KU=XC&&3\-ODSI.?7]4_S?",\6\4
MOR*$?O=G^/6.OU%VMZO^Z&'U*T9$>=;RK.59R[,NS[-2=:.K_F3YY*X%BIO1
M1_7'[_3=!6!SD]>?N)=/,@!SE.*Z$LPO>"1FN\<N8BAN9!/-&XJ+W: O>1 N
MDC#+*-2CD'VD>@M!_>G*-H(7/$+UZGH](M>LJ-^F0_>+G#8O+7G=(B;<;(W8
MN^G\<:-7?E%#MW;<&W5OLJWZ18Y.4:Q&*=92#<#MJRP]UY&X>>V&YSH"-]SS
M^5Q??\Q>?ICK^ 2]F9YD*'ZW'=OUL75>WK5J5F779Y8S?[O"SC9Z&2AFCN+(
MF7%.&<6),#$RZZ@6-TW 6=(:X;OKTXR;M;.=C;73CW__27:^;;.=;^_;N_N'
M OZ-=_-]-_XD\/ET9W_S[#SC)F?&['\X_?CMX[==^&U[XT^Z_??[HYU/VWS[
M^&-]W^V_M[]^_'9(9S-N/NYWCG;V?_\$QXI_X+X[&Q^__O.?3;K][;#.W(%W
MA/-R-L\_:;N-SW*VS?8>9O!,=/?/ TL(9DP11 UVB&OID;.&(T:(B58:S;#[
M;D7FNQ6?;$R2XD\L_V&MO6E.\LUS$&_]^LL)<O,IA@M#N&N2"@N*W0;%\ R*
M&>5DP":7<3&YKGS>\",(H%@T1EE,8N)AD?5SEP7""GFY(7EQ(3$7O.$D,<XE
MM\HEDRS'+FHL@[L'>2F6?1O+IC.6#:,>@@P&Z:!RYTPJD./:YP82*EH2L*3\
M^@[RS\.R[Q0;*\RE,)>'@;?"7.Z);WP&WQA1$B",(X\%1]SAW*##4>1U=%(*
MJ4T,"V@$WE!T*P!6 .Q& &8P SL)TCK"N7?6V<!4'@U):)1&W0? 2G1I8>CV
M=:9AV(%FGGJ8<Q 6$@.\68YL"KQN!, P<<(KMK!*X07D"L@U#N1N4WC&"N&U
M8PX+;WDTRFHG(A !G 2W3I 74WAF:>!NIB@ ]AGB8@"X Y>54TP [EA ,&4I
MXIS7',L%5A<N2%>0KCGO?1NDDY0Q2X7%24K.,#,8'!WCB#>*,.Q90;J&(=WL
M1GVJ)8LF4004G"&N*$4&!XE"$IXX0CW!BZ@S6H"N -U2 UVI);AL0#=#Z9+4
MP44#R"92G2#AD'5,H$0T,#WNG)&NU!)L*$+MQ&%I&7''/1,:4.FWTGNQ2*E(
MJ4BI2*E(J4BI2.D!/"3JK!56XQB]YL;EF! 'FITBH<HPBP\VZG*XN5_T+9LN
M /N[:#]3O*2%>4EG\X'O@+$T'+PDGQ)&/*2$;%U[G1ELG-8^:+^RRG!+Z?NT
MRBQV7-"V2.D^:)L,YR0$'I3%7#EA,#8D:$<C9IX*4]"V@6@[&Y-2C 83G$>.
M6(%X$@99ER(*-FBKE')&V6:A[2*;?#4_[+1[3>?2=FT;3]W3:_G [6Y34.FI
M7:14I%2D5*14I%2D5*14I-1D*=W"?Q6><F<B91;\5TF-MH)8$Y3@3-#H;Q(M
MO.JVWJQE=7%8;^RPYDRQN;8N,@@AB$28B8@X5BSWIR8(G%7-A<!8R>RPDD7M
M<RJ6VSS+74#DJ5CNPUON3*C)\>0"5PE%JBGBB7NDA>-(86.)Y1R@F#?-<E]6
MCM/68##*5;&J7LHAI^->?H">_PRV&&*_LD,$=H*.;?]S',(Q"6[2/:Q.^KW#
MOCUN5=WZVZH]O8KO#88E7^J!RTUX@8V(P4>L#)<X6>J]%%Q[ZYGT@=\:"^NL
MT*P),6R,LH#?P5OTPK@<!;QA_5.)RB\.*O?.*VGQW8TULO/G@28*)^H2<HIP
MQ*5GR&JF$&-6!,62-,*OK)*6D/,Q^;+ MIS&/<]R'LNR_[*=4;QDV,5V;V.[
M>,9V>;(I*<:0Y%$CSAE!CE..O-#!6Z6%,11L5Q;#72[#+?D+14I%2H\^"4;/
M@I)4\^ 93'W!8!Z2B0([SXV1#S8)%G:[L!GRO)+'[L8A/,.' RFMDYX+H+<!
M(XY9O>$S(1$(IH$K[Z*$*9*TM%%EFEPNTRX 7*14I+3\$?$R33[Z-#F-ET^G
MR20XEXP:I+!4B#MGD8DFEU=G0'VTB='1>IHTY-[UKDI^YAUM=.VX!\_RS=8&
MVDM@4Y->B@N(@K_HY<"2;E&D5*14I%2D5*34)"G=9H?4PH-7:^'3:# \CMWA
M8+^W%J;-BM_9=MCJKH\;W%UB[M/U_/5,00H?OPT?;\^&K3X?1.TB5BDAP61"
MW!"/K%<.*<=BP"RJ%*Y?V;EUZ9YBS 5RBY2*E)9*2H^\=;A,C$\V,5X-5'T^
M\#;)Z Q',;&(N(#9T1')D)#YKT1Q#*HY$^-/XE.A/3CIV+/\G/'']E^.+$<V
MX\B7E:7\5QP,<]YQ+U5]^-AO^V$$Z+AQB_BRR+0LV<;UMHPR/=]N>IYMRZN4
MLTY@B22G!G&29^>H--(X)&*T9Y'"[)S[7C=F":D8;EG#+U(J4BI2*E(J4BI2
M*E(J4GJ14FIJ!N#$,;N<_9?:7V- WV*_5QRV.\93IQOE8TC)$B41R-0A;A5!
M1CF,4J+:!^>L$.+<@AODMKVLS+_-XY-.[RS&<>2I.AGU_9$=P(=.?I3ZNVD.
M8,G^>TY1J:G@ZX-V3[NQ/SAJG[P#L1?DNPWRG<V%JG3D40:,D<!Y[VRB$;D8
M(J*4P"_1,X]SAL6]-[V7I>%E()M%2D5*14I%2LLHI:;N<+["7=Y-*&NA+K>G
M+N?9H5.G342-@PT.:6DBXH8:9 .E2,@4C"/!)LY65JDIW&6Y++G@;9%2D=+S
M#F>667%1L^)<R^,D;-U>1G%>MY<1R)HDD391T^BB-=8W;%9\6<ET=4@+.=#W
M4'>9B=W!>"]S_)H_WRUT^:+7;,K*6I%2D5*14I%2D5*3I-3X?<N9B=1$9/T2
M#WD?_S=J#]K#N!?[7]H^CEG[^^A[A]WZ*C6!+X6(%D7B=]>O"6U)C$'P"AEL
M:*[7YY&-5B+'F0:UB-1I6I>C+DGDRP8*!;J+E(J4EC^Z52;899I@9Z-DTC(E
M;>+()6\05U0CQYA%D7@>)*A&M+QY$^R"TOUN'!T+[2\/;-?J6KO^W79R$E^K
MVK9]?U0QTJJR49X/>?U<3[4(X'K]$/MH/$BO&8@R]$:N$ZL\+--?A[V3UUG*
M@UZG'<:_/"-XO38E4%B5DD[) 3WEW%N-!39:44:DPY+&@ZT;+AN,-Z*.AH.A
M[>81*TBX,"3<FTL 9(1'J<#)$,EG3\,R9*S6,+Q4,\RM((2LK$K>XDHO:,E@
M$0;TQ(N&3X8135O,^-=3"/\60F\2:E[3#W51D)E748]Z'1B[P2:0R^%9@<7;
MP2*>@44OA##.:42U"(A[< N,Q $)96T2W%FJ<8;%125&/P-,+!SJ_AQ*LFAH
M3,YQ0;FGRBHCK 4X8$81CLT].%3!@]O@ 9W=)^$)"X8QI,%-1-PH\!<=]8@"
M5D?K38K)K*QR73A2X4B%(RV2(RT,$@M'NB<F\AE,##)$F[!%VD@/KJ/@R !K
M1=8QG*(!.DO"RNJB>DL71"R(6! Q(R+WX#$:%\!I)%PR[Z2Q3!@2A5-2^W0?
M1"R1MH7!Y=RBOF264D<E$LD0Q+FF2/OH4")!1HF%#U:"3XE9BY*"F@4U"VHN
MM )V9))38G5@Q'/LDI8A>$:9%UQ29WY ) ?PFO"IX.<CX^?,FJVPN7&I4H@1
M!GS3"XH,N 7(I<B4  \\JHR?1+8PGH_+W;KR=8'. IT%.L<^N%.,8A\$6!FW
MCF@L='"<!."<*@9;H+-AT+DS2SU%HB)2AP05 O%()++* HA&IW,:E##8K*Q2
M0$ZZ@)X!!3D+<A;DK)$3<)-93(RC5//DC3.1<R;!68=K&RH+<C8-.6=(ITZ,
M<A_ 7]?2(.Z41R8FAKQA3A'*81K$*ZM,MXA<<N0L75K*D<_LR*+2Y<AG=F11
MZ7+D,SNRJ'0Y\ID=652Z'/G,CBPJ78Y\9D<6E2Y'/K,CBTJ7(Y_9D46ERY'/
M[,BBTN7(9W9D4>ERY#,[LJAT.?*9'5E4NASYS(XL*EV.?&9'%I4N1SZS(XM*
MER.?V9%%I<N1S^S(6J7_/;2N$U<G57;AC^D9E[83^-@=QO[*>/O-ZO^Y_K]7
MKQ;G+:>5T\IIY;0%GS;9A\?IN,O?26]0%\Q_W8\=.VQ_B;^=ML/P:%I2Y]*)
MDQU5^.(4ZP:]SFCX_5.^]XC3W_U]=QL2_+/MAC0_$ZI4A69*GU_Z\Z@_?: 3
M>QB1ZT?[&=D$S_O:=D[MV6#EWU=>Z[C=13/#.#L"WQ?%C>7X<(,T5S&^'J2U
MO]8V-M]6[_Y8>[^]MK[Y87]K?>WM7O7N[?JM5?"Q'WU]=V=C<V=O<Z."3WN[
M;[<VUO;A'WO[\-?VYL[^7K7[IMJ#%]O\8_?MQN;[O;HWB?JM^F5C\\W6^M;^
MK]7FGQ^V]C\VX4WK*[[.O2_:_@:Z_<M6MQH>]49PU3#X=1E?X$/7CD)[&,/M
MG_Z.$/G8^KE_U(^QVH;CC@;59C?$,&[+,"Y(->G-0*M;O4=-,2^PN=[6"N_3
ML2>#^'KZX;<I16UWZZ>J3_KMV/8/ <(F@)[A:V97:WV_\<\7R/8*C]%MXJ]-
M[CSY^57]TY0K7_F-XE>$T._^#+_>\3?*[G;5'SVL?L6(*,]:GK4\:WG6Y7E6
MJFYTU9_$V^[:XVBA4^I-F\M=5\KQ!^_TW5+[YB:O/YYUGV8 KN_OM-N'9[7]
MLVI<!/\%C\2[?DRQWP=.M;BAN)%--&\H+GKH52>V'5"[^Y('P_O1\:ACP;$H
MHU"/0O:5>L.CV*\_^=[Q23\>Q>Z@_26^X!':[X&G6H](C1^3PE#3",&5@2GS
MYX\._6YMI6O**S5;)?9N.I'<Z)5?U-"M'?=&W6%1K*)82Z!82S4 ?MP0^06/
M0(BI[=LO60<ZO<%+]F]^F6C KU6LZW;>BIT]O];.&]''8Q?[T^[.I%'=G7\^
MYSS']H-*)T($C<9RS:5TVE(B8K+61A&)9G6U6D)H:>$\7Z/VTX?3C_O_'._L
M?Q;;],WQ]J<_Q?;^FH#G(CMTI[WS]\[Q]K=#OKNQ-5>C=F?_=WB6CV1W__.W
MCW]_A'M__KJ]T3G^N/^!?:1;Y"/]^&UWXY!O?_HG;;?G6C@3Z4*NPHXHJ^O4
M:H-,DO!/G5(T4<>HT\JJT"U)\6+;RMR(F2U!&>\[6GO3_.*[UNJ^P>LO)\A=
M4X][40CW3+L)/AZ*S79<CA1S+(E!VE.&.(\8.1YRLQ>'#8^<A!@SBLU7V7[>
M$%;(RPW)"U62$;#>(#SF,FAK$PDP);+D(M:$WX.\%,N^C67/]DXFQCA&C4(N
M, S\A%CDE&'()TDYYXI[%A^@=W)C+/M.X;#"7 IS>1AX*\SEGO@VVP?9^Z25
MQQ'P38+_A4- QBN%)-,,<YNXXWKA?9 ;@VX%P J W:QML6,Q$,5P$(YSJUSB
M(H60 K.8\G@OUZM$EQ:&;G-MBY/Q7DME$.4.X$U:CZPC AG#/0^&2X85P!LW
M+<9- ;D"<L\.Y&[5*E.")3CLL3:",X6U%);#9;27@4KS YI6&KX]#=S--'Q3
M-C=UPQ:)2#5XJ^"R&LDMP@RFK" YTUB"M\I52XG%=7PK2-<HBR](=X-^ZMR9
M*)7RA <N*#'26F'!0@(5D12D:QS2S38%=E8)[Q1&VF":B5U"6CN#K,6**T*=
MXG9EE;*6X?/KA@7H"M M,=#= N>(\Y($')P+A,L =(XE8'C21*U$8O<*O!5X
M6R"\S7;NI9@;@17BGB;$+:'(L. 1ITI2"M\9*596E6Y1SI?%;;UUEEBJ_W?M
MO=6X^$.#P6DG#JL;)@W^],WOM*QZS>@MQ\IIO0&$_G9++?Z!LCS49%RD5*14
MI%2D5*14I%2DU! IW28*9#37S(<D=,2<4&-%])(1E@3W\+T_V,C5@3#!!-4?
MV(W#0<#^MKJ^=QS? @4LKM*B7*4<!9J->9MDE$^)(PM20YQA@4PT&@G%25(*
M"R/ 5:*RQ>F\JW3S2%"QXX*V14KW6EUT))(HB39!<V&LE5QRJU.,4<4D=4';
M!J+M;&"*$<R3"A1)G^/N%G#7&2H1CCX1%K6M U--0ML%;4Y<DK#3;JXR4EVI
M,'+W,-0"L_N7#]KN-@']0'F68 ]&D5*14I%2D5*14I%2D5*1TG.7TFW<5Z*C
M4DYXFY3G.%#GHN,BI."D5([AN[NO-6=?OTS9+[Q9<&UWT[[]6KS:A7FU>_/9
M9,Q&QO.V)RU-1#PEBYQ3'%'A88BELAZ3E572(IC>/YFL6'<#K?OA@E/%NA_=
MNF>SXB4U/C"*K$D.\9 PLBQ:E*0U.5W41&$:9=TO*U-J\VOL^_8@5KT$=^[Y
MSU7O)(]]29UZX*(3W IL/-,R&<8QDQ93S:-G4:M@E>$WP+QKLD2W!H-1#!NC
M/@S=.WB+7A@7I:A_W!U+=BKR4+#M-M@V7SY+8X"SA"4BP7'$F14()C*)M":"
M,*8B_+FR2M6]-W"7A;6&6/(U>Y,?R8S_LIU1+%:\ "N>EH^":ZV1[=,#39FF
MB444ZO)1 7-P/X)&VCM*G:61"[ZRRHH-+Y<-EQ2&(J4BI4>?#Y-6E'#*B+.)
M^^ T_+_E"7M)B/;"/,9\6-SYA4V6<S4]J-941"N1Q$PC3CQP7DT<\HG8:$(R
MW-OLSAM<9LPEL_*"Q45*14J//F,N(/A=9LP&S9BS 7"GB'3*8B24LN!?YD+%
M@@4DM.+ D#0C/HUGS'L7*"Z)FW<TU[_B8 A/G8/@??C8;_OA;1HKEJ6_I0F$
MUPN"!=-N@VEG<X%O&[U5UGE$50)(PT(CDSA&@6F?I#-,> F01A95U*\LVC^U
MY3YQX+M8[1VL=K9/ G:62&$9\D:!ZVZ]00X,&'D*4L.".^H"6&VQV>6RV9+L
M6*14I/3X26L+B'3_J)QAF0D7-Q/.1;$YHY$*PQ'5)A-8;Y$S J,D2?3$"^&D
MNFXJ+.FF3;7<@J]%2D5*SSMX/9G[+@>K4_MK#.A;[/?*G'C+.7$V3@T^O* @
M.^2XQ(A+PY!E2:)@F7/"1J82/K?@!CF)+RQ?^_BDTSN+<1R<KDY&?7]D!_"A
MDQ^E_JX-UI,[)9<,[N<4N)X*?KR"=]J-_<%1^^0=B+T@WRV0;W=]+IK-3< Z
M:HE(-!)Q;BW2A"1$+!-)!!&\R?O/[MUDL*S!+P/9+%(J4BI2*E):1BDU-4_W
M"G=Y-Z&LA;K<GKK,!3(5P\9&&I#"28#3Q@/2C%EDE"=84)U,S(',DHR[;*9<
M +=(J4CI><<SR[2XJ&EQ-I9I& -6PSW25H)+'SA&.A&!B),^IFB=\Z%IT^++
MRKBM@UK(@<*'NF!J[ YL;9SQ:_Y\M^#EBUZU*6MK14I%2D5*14I%2DV2TE,&
MI=;"I]%@>!R[P\%^;PU&+C^![;RS[;#57;<G[:'MU$RD)B+KEWC(^_B_47O0
M'L:]V/_2]G%,V]]'WSOLUE>I&7S9.;<P%K\W']R2%$<K#$6"!H8XE@(!<7<(
M)V' +PN1"[FR2EL"W[O"4@&% MU%2D5*RRBEIPQOE0EVF2;8^92_S*Z21,HD
MCKCQ&%DA,(H^>D\#MH*+YDVP"TKX:T9T3%UKTK_;3L[@:U7;MN^/*D9:5;;'
MI\[HFW0I'X_,:P;R"[V1Z\2Z4_GW>Y@_)TR]-A-0<^QLD-PS;CFVS 9#M-!2
M><>8Q/9@ZX:+!>,MZJ/A8&B[><0*_"T*_N":P]GFE9I2$SC@'189_F2*R%$1
M430,LR!92!*OK K3PFR^-O7=%@H684%/O%;X9"#1M"6,?SV%\&\A]";!YCP5
M71AFYL73HUX'QFZP"91R>%9P\9:X.-N0PPEA::06148)XD$ZI)VTB$5/,:=.
MDDP+A<$%% N+6AR+ G\C",J8%YYS^-N!^Y&$2<$P"[ZIOP>+*H!P.T"8[3M+
MF:-Y5Q@)7")N 1 L8Q1Q[I4UAL60Z,HJUXO:(O$, *&PI,*2%L"2%H:)A27=
M%Q1W9U@224:ZY!6R6@!+DMHA)Q5#R0FM0O(^208LJ4!B@<0"B0N$1,$PYBX2
M'*SCDAEG2;*14"\XU]'B^T!BB;8M,-J6_]O+F.G%[L9'<4 M903G[HZ!*L29
M9\BJY)$'GS)YG"@V&@!3L)86]ZX<66"SP.;SA\W;U"L+AAJG'+88$TZLTEA;
M(1GU+@491/P^;OZH3%D!T <$T*VK *JB#L(QCF#&PXBKR)&A"CXYYCQ+BC /
M ,H5;Q$]'YN[>>VR@IT%.PMV7DU,=<8"C@D:! >N"5XX8]9+%BR+6KJ"G8W#
MSC^O8B=V,C%%$V(D &+ZQ)!.5")&':/&<&%<6EFEH@5DM$!G@<X"G8OQUL'G
MXU0D3', D_/@C&$:T\2(, 0;5KSUI@#FQQFR::0,00?$8HSC-1_MI46""LJ5
MTL(YDKWU%GT6R3%U4N&_AQ9N!W^']I?5_X,_IH]\Z5H^@G;W)W:W^G^N_^_5
M\_></6UB-)R.M^.>] 9U9NOK?NS88?M+_.VT'89'4Z.Z=.)D"/#%*=;!"X^&
MWS_E>X^X,&@@^&?80/,SH4I7Z.J(7/XS/W%MD%1@;50(P7##J1$Z:)FL#"DJ
M3;3U!X (TY..^M.W.+&'$;E^M)^13?"2KVWGU)X-5OY]92R.VUTT,_:SP_9]
M^<U)\=CV#^&"6?',U:GJD09Z+D>T'NBUO]8V-M]6[_Y8>[^]MK[Y87]K?>WM
M7O7N[?IW];$IC[Z^N[.QN;.WN5'!I[W=MUL;:_OPC[U]^&M[<V=_K]I]4ZVO
M[?U1O7F[^_?>T[V/GKY.?<'7.9N][6]@!+]L=:OA46\$%PV#<_;X,(_VPP>9
M >+E&< /73L*[6$,O][JX6L OT#1>L: E^C8DT%\/?WP6V@/3CKV['6[6]^Y
M/NFWB9E/H#=CQLR$4=]O_/,$3HQYI;#*B#))1Y_<> (VKVJPF9G]QK])_8I@
M_=V?\2MRQ]\$8W<Z\T</2]@K(>DR/2R_T65_LI'@I[E>MSC4S!UZC><SUN(F
M[4/8/^K'6&W#<4>#:K,;8KC8D7"%W=UP*)>K1LGU+/9^FO)=%GL-D6VV;H#?
MQFZR(>4F+_S2!HY>9SPS7@.K1^3AH6GQHGK06RXYTERO$NMV<%2E3N]T4*5^
M[[CJG<2^K3N29H?Z"[B <?!ZL4#T Y-I7+SI(8!XR=]_D=7""'U%&V,@UX_
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M%B?A!:?CIDV4W2<*?5M36J+XS@N&AP=MD%3@X0G@898_>6,U3=X@14A"/.&
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MO@.A#^"PSBB/>PVDN[72E$KG=PWTG)=$)MH*HB*BUDE@0LPB+9E$\%\D)L>
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M9WNBI' ,HSS1(YY,0LX9@ZQ6Q&K/+,=A956S%C/W)G\/E\?T()&T H<%#J_
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M_UXVI__-7YSY3M__7G2M;Q93UM863XO=M8<=/73-HC-VQ\6+TT^)EJ+V!ML
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MO0V6<S-LN>L!"W>BD ^ "=U>OS3+!R>P<!9HISFH]9K]'[.VO^M&\NM&JA\
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M'WD6:Z: %;0(!ZGHO]?VI'8&:D;7S<-#I(O43JTX[R_J-)<1_','_>G:V6B
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M<H.S7&=6"9UIPO+;FSKCS(8)\LV5*81ICQ#<5?;.;:AY=^\H",/!ZM&($6Z
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M38ZGM.G^ZPMS;4HM*NS")5/H/X"IN'6]/9?TF.3,[786%:^I=UNR6(/N1E+
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MER)['B;Z9Y1B,.<AKT[?5R2F%F.!..6&49DCFOL,<<DUDJ!-(,:U<I1S09D
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M1EG$<^*1\L8B+#4A>:!&<AQ;&VXP]<L1Z^L79E9!UHN$K)4$S560M2:0->]
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MFV0"+#:\Q6%^3";)J=CM TW\W"A)*V6KDA1*,0W.4.I.,F5<S>5.$Q8DJ9C
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M,WJ*%XEGS^8I^?CC_OXG*7!K?/QS"@_2M9*G([ )/%4;]IL82BUUFN0PKQ0
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M=;,#Z[KYHL?9OL#@^CIZ*HZR:<79&R1=QMD1@YXTSMZK0MKWBE.W!&<=T1_
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M E3G3\[G<C$Q2W+EG*7P6/F8,!L!UA;XX)BSR32OOCD*)UG <['7?C;A!6Y
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M9W.54Z-6X<U9XL,9G$PU8Y<9FWR%^JZMP/@U&4+B*2P80L(04HEYZ9*=):9
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M&6R )6R.\KMV\ T@ZEJW5-FZMT2/O1BLD?P[LH9SQ"9/UQC[NM1;C.0,$##
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M7+J%%0'F@?R) MR:;R'H]?0W.,%QA.0"GSG&>5GI.^4H&O*:U&0X>)6TZ<T
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M^<(6-(CI:,=SW,O"S=.([!_*'$SN]N7#/): ;*,C^1V,(SCN@:,T**X&04T
M,\64CL6ID]/(M8E:8EC'Z4*4!4Z;X5O)0X_4R^R_*2;S&>K\5$4K3LIB8 5H
M$7DVNI_B^K<%I@'J*Z72<(Q>9ZVFK( D.1-12_U;!S4LVU=A$<4H4EBBRHOP
M/F76BF "&'=$28RN1899%G]12/GR8:H]3<)I%$DX/Z!@@+8--[J)@SA3QWB7
MB@0)'78)C=4NR>F!'#G./]!*!=%[Y Y5VG1\8Z9EP]%_SSTBOH4)\R#94;4
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M5$'H PKEVAS>'Z?6QZ*/H\#L-$']X5![4$CGTLM-T($*DET^/L!#\OF$N+G
M6+P+9.H,Y:'&CX?E:W'-B:&PD)^]5V%P6D1(Z0"$0[Y,N<=L3#*D[ %7.NG:
M[QAFA $!&BXQ<7"LG^+II%\^45*<A4J\D(P36E>G7#70U7B'@:Y:;J"K=7W5
M[UY?]BC(==.];K7/,:Y51+$V(@+;Z$2-:?'<#H8.JQ,8A/<]AT7!#28= *=,
MM>M]QS#*QH&DRX>V2U11F)%T=R#9ASYR#3 ,J[0FMAR+]G<YC,@K<HU!(\D"
ME:]=Q%Q$73.$9+BK"@!FW=A=3O5KRBKQ'"6',TP?SBP^G'QKFAFS1!;)+U<N
MGR%&.K3'X\FHO]+ T40C5[JJ"WAZ889NLX%MLR0P5;:-NA%VI3*KUI%Y<@!B
M!Q\R3T;J+\)2;JJ1^/9C9VAS2.=D-JHU@YQ*4Y;8NE@A?:.N3P"E1%K<J")9
M92I7B8%(+L2A*@B,$Y=&$EM'Q&EL5/T;)S.1[S#RR5S4*D J@X<"A2/5WT)!
MZV'MH7;#$. #3"K#WB(4:P*#@R)X"4@6X)#RKQF\$[ ;X)]!!.: 'QL=VBPU
M=+<34GJ AA0V!'&,,4[0[[5;,?[Y=%H40X.]@5 ]7P$A4?ES F]-\%':6QJ&
M6'V:<A.J:"M%K+05ET4RTYBFT^'!9Q,M:B,8T22@<?L0.R#=+,G2BD\[H0I-
M-Y^M@*LLV+DH8]9KI!HQ_""-&IEP>,9N,U/-G\F6#EZ=[ _9_(WY:#XG?(:A
M^UZTD8WF5)LG/^ET]E;2UI629% /U^K$^S6R=1^L=/ILLE&.):O-*CK@?HN)
M"9$$7"C!.F:T0[1@V#45:QH)<T@X"K64\ZU;WYI-Q '@O#=>) PD+$57*#68
MIIARR?U+;&E=>S?EUM=&;&PMH2Q!UT%>8N^#!XQ,0 6YD'K+3B4_:*:9E2PS
M[=%\R#>*SV>;:3?-;E]T.J3$F:":7?=_;7=%Y^KBNONEV>]<7VVQ0;:?^135
M\F/Y%.N@ZDF,JIO-PMAR)X:9Z\2X;/_2O&3O1?N\<_7+5KLO5H?R.Q+#"^8!
MRA%+JY?;522P?I'#ILL*LI3\S909H-F'@4*5>TD:$%4QD],;53';??N*4K.>
M)>BWQ->G.5<SEW5AR8"X:+;ZU]VMY%IK3#=Y6ZV?5."!E"ZJ_G$\9\D&H-BR
M[EFJ.EIX0=KKHVY\K*6L"I?,,83#>OF#2KZ,OK-;60V7T0SWS0FV8FZZ!%Q1
M9267*+]>==N_='K]=K=]+GK-RW9/7%^(]N]?._V_\&R_=CO]3IMC)E][;;RH
ME(^MI.&="0I<>>Y+]H%;%6%K6X*PU9+(P]CS]D7SZV6_)[[>7%\!BEYUKKLI
M3"V]'^Z>?<8O<Y!G6W*0^>'8+YVK-G"<BS8PFE29X39RE:W$G1!S#<$4P##&
M*V%1M;PE6'22BT4/G$<%_KP:[]EO'YCY0CZP:G5+?&  B^$1P!>3G#YRQ';^
M:=%M;-8VZP<[S:7[]K]^[7SN]+=27&2[X!F4JK)4$X0_DCX:2(XU"^1'_0],
M;)@YUORC[=)'Z:&EH\'#7QH?2L3"EQ.\*)49-]2L;_5E=;E$EY:&FJIKE5*E
M7,N]7"Z9S[QV>G;VK"<?6VR]5CHS&RN]]HG!YTN#6S<SU/QI$J$S;7^?V ,[
M%%>IPM'\\;Y/3O%]GT XE\'0MV?I)BTK#;AGT@N]V4><STO^1*%7^PQ0K7#K
M2I_<+I!GCPK.&(G\LE0%(-K0UJHE<SM(Z3'%<#Q^M6S^QS(V_VEE:@Z2N="G
MC2]03'PY!O4T#&?!Q^/C^_O[$JRS=.O='3?]X02;>QS+T:WE'X^LT#HVRV:E
M=G9V#.LUS7+M]*11J9:KC<II]3B<5JIF^>RD,JK^6WZO'IFE20B'TL*SHBX>
M5$%V3IEE<4;FVMV-L37RG362CKB!'Z;64$:$"H&8.4-#<'AC>9[707Y8(O2$
ME@B QGF9:2VJ"PJ7_;_UH]_$P84-ZP1I(@ D1]6SQMG9X:-CQJIE7M;A/X^M
M96USE[A"K> *>\T5:F;]K,%<P:Q73D8F<(6:Y@H=BF;3%$ F6<X 7.J]/N!&
M00,9WF,@1Q$^)S\"D5IS@("XQ'8YF-J4SL[%QS#L_-ERO^&+$6!_>?XW\44Z
MCDKA[/M1$$JY(G>HO39WX+V?[ MSJ.PO<R@_7N2Q>>;P^ )?G3E<J!D(IV"&
M_Q3G3)(/H,<C5RA- \O>>.Y&.G,A1:^I46X%B;\YB9OE?58 "AHO5^M YRFS
M &G<+"\3>9(2'0_U^S&QK_NLJ=XSNCR#J&WOH4XIX@4H$!0\%&DUY0]YV5O8
MAMIDW0/94.A_^RT;3NIITJPP:5:8-&_B!IDX  OG;<7"(=O%8RP+B]95;]E!
M9(C+R]:"N##$A6--X>X.1F'A4Y?AJ,2M"7"D;%<-A.UTQ'FSM3JGJ+RE%VG'
M&475+)D_%YSB?7,*M1XP]?XVR2&[Y!A6OF#$\9NX!_3#\M=9Y.,(+.K G-3.
MU0XLKDGEG["(CGZ:^=XT<FZ)6+,+L7>?="H%Z>P*Z536()V'U>$%Z:Q'.A60
M.@7M[ CM5%Y.[)AUZAS8*F&W WJ!63TI<VN#D3?C09K)[?JF1OE4?ZEG^0/+
ME<'1]7='SG6#A$JY7-E]FJH4-+4S-/5R\JB@J1]PHYBE7NO7+:&J34"@0[F>
MXE^?NY>B;WWW7&\Z!QX>8C-R0)+><"*GECCWAC2S8R>SKQ )6LW+ @GRD*!E
M.<-(M="\M-UO _0L[3Q*G+<O"I3(0XES;&]E[QE&7#8_%QB1AQ&7UD Z>X0,
M-]UV@0QYR'##HY+W2V34]A@?6M31[ :G[U //(O;$IY;H24H,G/ W6M4IJ*=
M0A\>*! 7E>(<-T8G&:-3;N\;%30*!%+DSX?B(68=4Q73Q@L?_YWYO[4JN1IO
M4!27O?B?\\KA+BB^AMU"\!#S:N"W;CNY^UGEOQ>1[]K!Y 7V_43!ZS,?>\LZ
MV<Q:SBTJGJUL[T"^MR>&[(+77N>7JV8?6R"\FY)6+ _.'[/]UDN_2;G6N)]U
M,B<W]J\]U=F7'[RU QQVP^/.1I$S%T.+YY--J.4U)3UP5VW571IE(WQF(">6
M,]8-MLGGJ-M/(Y.*<$P4O<^*PHE'';+79EJZ$!@+"4]R^GJ^;9EQHU&JG#:>
M4V5<*Y?J9]47KP>NE:JUU<J!UWGKB5FJG=5WM\IXY6K/]*9.MWQ3V57#S3^:
MY^U+<?-KL_NEV6I_[7=:S<N>N+EL/<<DRC4AMATXV2=^T(T9X.$K6HC;C-7%
MIK9Y4SN$AV"7RX_BBS47-9T%N5.G]WG^<<=V=!P<BU] 1?3\N?A?G$5R9P>[
MBIW[PE!VO&%'@:[%IMY\4_3&E=J5L]\Z>U)0@:K%IE;+=GMC?#TX1S=.,W;C
M+"/L)N!/&=!;,X6 EO1(.NKADF,V/U*4XWTT-]!1K]$HU4^JSW1U-2KYEW_
MU66^?$,]='6=KN:7VQ^F_-";L^#X48!8"O^8)XRE+^5 ROKD'L"^V-0V;VJ'
M\+!PR+RW':%#IC^!]P2B5Q)?AK]&MY-=Q<Y]82@[[I IT+78U+8[9%1_LC_
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MFM(OZ.)85(MNS!.Z+TSV24@:)EJZ@) MG_;(Z.YX&*2/4M9@^\%G/O=.GOW
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MF77X 8/T?Q]_HN LI482'@(CDEI! A>>",-Y5HZ91,7\HJ/A^,^?RH_@6SA
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M\=B)!0^FL%2LLO),QF696D;K!FY4EH+$7%JRY.1*M"Z0)(-F-@JG5'TCZ!%
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MKER_>%$"R14GC&9<7V4(0J3*<]X XYCYXK4UX[Z]TU7JM;>N5Y/YY61\#]7
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MN:+)L+"0%G4@BU8'W-5L1N-':>:(M 5$R;9E@E**"@]!MTK9><KN7P]XFF;
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M#AIXF)F=D$GU#%6AAT/5G0#?JF_9!O8A[+7VD(]CQ3U'+7IL<^]9!?HV$7>
M[Y57+!E-HA6E-T,J$8"0"'#.G) 6?]FKX7ALS7W"G#QAQ=V%^=IG62\Y9?KW
M=Q]?KDO]&Q=!*4UP9(WV#E7$RI )VNI."8FB@9:]L>X^^,A&9%]L3"J)LG:4
MR2MH($Z:%1+KF4R&9R*B#L7LP"E9CS.,)GGM+&7.MR+USF-_ DKW%^/6][1B
MC.(G*$W?XFS>H!!>3:8SG'-39O\-.L0HMGAJYQC%79'?BU$4 C+-:"U3(65
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M&6Y]R;>47EE]7+X$/X5_^Y?_'U!+ P04    " #;@:16HK@!R0N@  !:<08
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M\G@?] QZSV^&/;1W]"_+?586)%L37,!+4AO1,_(![XN>9V"H**.O.IE;>)N
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M*;:+(;L-#V_W<Y%.(4_:<'V!G)+EF:)T?]%;=2]I_G/AW!$J%4<8R)QS@*'
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MI*A%UCC/BO:]P.%M =K S;*"*4ZU<WH)@'-"@,@I!@7.[0<$Y]@$57*+!>Y
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M-CX27QP1,"@CG#;PY3/?<F77WO/::+N$4CLNYNH8:T(TSJ0TQ#[80MHU#D&
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M_NWFX]MWG[_\TQ]I!LF?DQ_>OGO_X<V'NQ^3=__W;Q_N_I\P-Y+WE/@YD?H
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M18#,:"$PUTB(/"0</S;ZHRZ-Z@.P'Y-'AJUG2F^^K[6ZY=>UJN)7:=S#&C
MH$AT[B-Q4%X/@. EP8?<VO4PUI6Q<^4:WUO%[19U/9T_3>?W-X_U1G7UBS:+
M95WN[HY_UZMWW^TKQLJ8SOGR^<-:/ZQ<HQ)[IP7%2KIOSCXFTBAI<)H!E;NN
MCQ#F@!'FBI'P%!.D$-1%"$?UJ.O8N,T9F8C2FJ9<ZMK9$WJ6V=_D^IZ)CF+*
M>C];W:EZ6GE&MZ8F6UN;&:VO+\V]2O;-2QK[8A[-]CX)T8YX^]-TX*/BWB$_
M/'+N7V2W=XP[_?XP=W4!70%4JYG=^:^GKN"I_=JLW/[E5MLG<;[F]XVO]'8Y
ME?IN.;V_U\N)_99PR',!#,KLVP/+#' .,R!Q 7-I!,U44/?@"_49VRYDH[7K
M\%VK[0X3JL.91Z=YLJY4#WM]7#IO?J^( 6>CY]= 60UP:TIYCM,8<Y5LI^EV
M;YI*BY+2I.3NS#0%4W\D<"/1^Z7:#$KAD:![2=.QANUX1%05 BK?!S=FDX5;
MEF=U_>+KPD"K22ZU*##3@#!76RDO*.!4"Y!I!%FF-.7<JV5JJ."QD>NNWNYI
M/:R?5'ZR7T0I\)S)=TX\3YYZ0+KOLZ@7(%=$VD!:58)V4&]TCWA&%8A6K%,K
M7['#GF,%@G%PLA5Z?S<2>\>7<SOLRA)E>;JSK0VD<D@R2@@0D"* =88 DX4!
M(B/&&&*$ZV<:=-1U4M;X3KI<Z8S2;V!UK3+&PWCH-*Q^Q!,%JIZ9IM%QBU%/
ME9/.@A&)2$[+&90YSIK[DBK.WW!!SZC#3E2; UK"=)$6QE*")G8O2?/"KFN*
M'"@I!=.DT(8%[27/R!O;<J;R]A]KE]8Y;>T<XG[D$1''GBGD,@B[=24Z#TS,
M/D(MTH;O_'/>]*.]>CQNB]N4[K?Y4O.9J['Z;W8/9ZGM+WPZ=Z_CF_E.O?CE
M=&5_];;LCF&I;[I0=_S[A!%5Y)H)P$C* 3:* N9^8$85D0()HGB'[+<>5/5Z
M#H?/GMM:E-Q;6^K6<BY@]F%;+7&UTZ=!Z+DVTW7RPYI_C]2"[I(O0 !'OL)\
M#L2K;SY4.6EG&VKLS'9M</*7<M;KKG/U*<MN/SEK:O^-XB+,0\_MX"[1<!1-
MWR) [-O:+8:H\%2_=_/U=/W\?CJS.EGVO%\LGR<<:6;2#(,L=[O:5"+ );2K
M5Y<7E#,B!,U\4_V.C#^V-6JE8E+JF#1*^F?Z'4.PG5\CX-+WMC4(DJ!$OQ;#
M.R7Z'1MOL$2_%F-V$_W:+NL:,%FE1;FCU\9Q>6,LJSPLYJ4/?R+RC.J",5!
M;!]B@ET\=D% @23!D$!H4A$6+GE&XM@>Z_UDOHW#W!U45M4-%\8DEHL3O@;V
M#U"MW#;)92[S['[)'T(C_<[-B]_2*RK:/9/%/M ?=H"N]*U.'&.&^'EB$RW
M[YR\@</[/,T_#.[SO;'?BKBN\XV<&&Y0BJ0&7!D#,"XR0 MD0&$,E8(1J8O
M9BI!\L?G3M^48^5U.=;YIAQK0UA;&Q*0"&=&\H/=AU2_#MQ6ALT6A9#E1*5
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M.S.2VHZ[I+8$?-# V-)LW.M:V<W4G-AS'#HWUL1X^+IC3=!(_N_0$^7G%\<
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MPT@(>'6?I%>^-$*^JO6O2J\J]1N;+VU;RE=;M5F]W%8;-E_8-3037 E>J@S
M,B_MA7X!*"<98)AA(1G-(75RY0/E3^TEW"I==_-4WQ\6JT>EDK7ZH2K;Y/,N
MX6JI]+P-I%EMOIDE+E;KC4_MXX!)<GC!#@O]P&_1T_SNW1PTZB=6_^2%M>"7
MY%73B_7(BF&!]W@=#CL!([WSAI@(O_=:.(R=+Z^ 8<=[0X7;?/(:ZC%,[P9W
M'RP5VFR=2GU3R_7\AVVWL?JNK-1W\Z5ZNU'?US-.L$*YQB"O+U/2.NM.ID A
M+ 1+L8(PM-6=DP)3>]L<=VBK#4A.+$@:$W9K[@]K1U(;XML>W'>BW(ZCAH1_
MX#?. ,CW:8?G!5_\QGANXI^K19X7.!W-\OS&":Z>I,Q#W^Z7\I4M[[9ZL#S[
M^N>#$:AF!&,BB<@ +C$!L& $4 5+(*GYPNI"Y1G,_9(,.^7YK+=QT@MWZM;N
MLSPHG*A&8T<_V@UM-Q*+AN#P/O(!NB--DU;5J$6/;B,2K]!1AZRQBQO=-OM"
M02.'AP*+.L[7#ZLU6_Q6K;8/:\-5BZV]:[?1=76H_]90VH-J3@W6[\U7Y]7*
MMCN>(4%(43 !.,D5@"3- >=E 0A%3!42"TJ]O*Q /:;F;.W,2&H[$JMH\D>C
MJF_]Z,")<2.D$> >F*J"D/8O%-D/IUA%) .U&+? 9#^HSHI/]APN<+?YX>7;
MXU;57U9-H^KW:O-!?V$_/ZT6BS>KZD]6R5G)<"F*C -$L30;34H!8P4&F4(*
M(:D1Y$Y5WP)D3XWV;NUTK/?[/SVWDQXSX;B3' ;?H3>11NLKW=/O$J.ZO2$R
MRB=_6/635O^8&TA_U&+M'3TDC[MM](?D;,<8,$0$!^_E@JW7<ST734U?&Q0D
M2PFAS"1 TO90UVEAMHN% $2)@MC2NYHXQ4XXRIL:<SUQ(TX5#@J]N@5X@(/6
M#\9Q'3$_!/LY9-=Q&<+QNB#M^1RLZZ9W.E(=C\5K&Y*W&;NBR,L":0@X30F
M*)6 (6);V982L5)GI/2JW=TA:VJTTG3!R/NW#<F=LKXC(S0P8UQO&Y*/U#8D
M=R]/$Y);>4'2L[<-R2\G8/L\$IIQ\7:I5]7WFG$.MS^,924JA0809[;CGV*
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M <&^&"X_I+S@+E%&_EJ]4LU_WR[WE?O:PGZ'S)U<H@SE#'"=*?/B(87Y&].
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MA&@=DR\*&;E'<I>AYUV1.S\=N,7;\K7ZY]:\,%[_,'_4#K<MN:Z$+#&@JBP
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MS!F,<*=LD&NPT\&?Q_WJOOJZ_*D 1^NW+:O8<J/V32QRE3+!\@((CFW\8$8
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M54LC<_U15;O I[DP\E[-%UN;Y&K#Z0\1O$7**-6%-BR70EO]%P*"<@5HR:B
M12FX5IZ5]<(T\5FDX^1X?%+V2S-?S)MUN=));4"]0%L3:C>B+O-D;$QJ(ST#
MFP*GS8TI1YB*@?ER9X%%?V?# >N["S/25-ARJHWC'R#5#\]885.!6HP;3-4/
MJK,0JY[#!=\-BKJ(V%;)]E1BM5PWUP/F)_K7NAIJFXVEA;(EOQ H4XH!Y)@
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MJ2B()+1 N]I5;I06IHC3"CRM4S4PP;5:[\O(U]NKMLA!&VH?4DHE<)[<&&]
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M&7PP"):KF)4D!7F@77+'PMT0\ES"K"VX.RJ ; OXMIOPBF4G2B9+6]7*BVS
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ML_X$-(I(^!W;.SM-M]-SDU;%"T=^ 7<U$=,$<IJ]!6:28(4,/NY:!R@>2>)
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MC<."W[VO3=;RY;9*")P%;J 8E^A8606>D;\=DS8A9>G:5REW(FS8G-\1X.\
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M)3 "?78SU2?CR;5(YWE,*B(K+AH.)6&L]4L:O% &3$S(,M.,J;X3LNX@K1L
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M8D/]8T RK^U2T7M9P*92:V 3.9]%%!"EEL(2-UKIPXS,WC7ZS1AT94+:B'0
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MA1D0/C'+/%?BZ7SYE[#TRFH#N-GM#$(M!=TW<C;^XOWDZ7L67%:QL&# 2Q]
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MRK+[#OR;7]0_8ICC?_['_P%02P,$%     @ VX&D5O\6QXT6"   4RH  !0
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M+"-FNIVKR$_DL W._Z1"%LB0E=ZOLN^V9.^]YO99W;+:^][3?P!02P,$%
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MK5"0*,*#M>\5-^!B+.XQ,*7Q5FRJL/SW'#3GZ0G6O]DOX(9J#>UJ(W5;,YM
M/',?]_?:W8$T3P@2M"=A;L';\*Q<)I^Y^@/E]0'Y=R=R0W2]#*!/('G*(JCQ
M/2>/OT9F'>UEXX<I_#G-&6[T?L%#"UQBZV*ZXYL^MN-DLQTSVRSP6[WLD<NW
M>ZWEP?U=P:L+3%_0%#OF-=VZT;LK1M- G#L5LL"*+-5NE5V7#CNO!S?/ZK+2
M7)N>_ 502P$"% ,4    " #;@:16:IM@V )P 0 /9 \ $0
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M+3(P,C,P,S,Q7VQA8BYX;6Q02P$"% ,4    " #;@:16LZI4W*%H  !Y>00
M%0              @ '^> ( 879D;"TR,#(S,#,S,5]P<F4N>&UL4$L! A0#
M%     @ VX&D5O\6QXT6"   4RH  !0              ( !TN$" &5X:&EB
M:70S,3%Q,3(P,C,N:'1M4$L! A0#%     @ VX&D5H=\L?4<"   GRD  !0
M             ( !&NH" &5X:&EB:70S,3)Q,3(P,C,N:'1M4$L! A0#%
M  @ VX&D5MHU_C/L!   2A8  !0              ( !:/(" &5X:&EB:70S
M,C%Q,3(P,C,N:'1M4$L! A0#%     @ VX&D5@R<G<OS!   D14  !0
M         ( !AO<" &5X:&EB:70S,C)Q,3(P,C,N:'1M4$L%!@     *  H
*D@(  *O\ @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
